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Abstract 
Skin comprises an epidermis, dermis, skin appendages including hair follicles, and a fat 
layer. There is a growing interest in the biology of specific fat depots, and skin fat is 
relatively poorly studied. Importantly, most knowledge about the molecular control of 
adipocyte differentiation comes from in vitro studies on cell lines. This thesis aimed to 
provide new insights into adipogenesis in vivo by directly studying development of the 
skin fat layer and its relationship to the surrounding skin and hair follicles. 
Work, presented in Chapter 2, investigated the timing and localisation of 
developing fat cells in back skin of rodent embryos. Analysis of the adipogenic 
transcription factor C/EBPalpha and lipid accumulation revealed preadipocytes in the 
lower dermis of embryonic mouse skin at e17 and the start of lipid accumulation by e19. 
The dermal fat cells then created an adipose layer between and beneath hair follicles 
apparently independently of subcutaneous fat tissue. In Chapter 3, a combined laser 
capture microdissection and microarray approach generated gene expression profiles 
of cells from upper and lower dermis over three time points. Verification of the 
microarray data by qPCR and immunohistochemistry, and bioinformatics analysis 
confirmed a subdivision of the lower dermis with enriched fat-related pathways. 
Comparison of this microarray data with published information on adipogenesis of 3T3-
cells in vitro showed important early differences with regard to transcription factor, cell 
cycle, cytoskeletal and extracellular matrix gene expression. Later time points revealed 
greater similarities between in vivo and in vitro data involving genes characteristic of 
mature adipocytes. In Chapter 4, the involvement of the Egfr gene (selected from 
generated microarray lists) in dermal fat development was investigated functionally 
using a skin organ culture model. In Chapter 5, a marker gene selected from the arrays 
(Cd36) was successfully used to develop a method of isolating dermal preadipocytes 
by fluorescence activated cell sorting. Specialised organ culture techniques, presented 
in Chapters 4 and 5, allowed the adipogenic capabilities of cells from different mouse 
embryonic skin compartments to be investigated. This revealed a high plasticity of 
dermal cells at earlier embryonic time points (e15 - 15.5) and their specialisation into 
either non-fatty cells (upper dermis) or adipocytes (lower dermis) later (e18.5 - 19). 
As summarised in Chapter 6, this thesis confirmed that the fat layer that 
develops from cells of the lower dermis should have a distinct nomenclature (dermal 
adipose tissue) from the subcutaneous fat depot and could be under different 
regulatory mechanisms. The work has established a new in situ model of in vivo 
adipogenesis and the microarray data obtained has provided novel information on 
molecular control of adipogenesis in general, as well as pointers as to why the lower, 
but not the upper compartment of the late embryonic dermis turns into fat.  
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1.1. Skin. 
Skin creates the most outer organ in the body crucial for protection and 
thermoregulation. It allows contact with the outside environment and takes part in 
sensation or immune response. It consists of epidermis and dermis layers (see 
sections 1.1.1 and 1.1.2). The proper function of skin is also associated with fat 
tissue adjacent to dermis (for more details see section 1.2). The very basic, general 
view of skin compartments and fat cells related with skin dermis is shown in Figure 
1.1A. Among structures seen in skin are hairs (see section 1.1.3).  
Skin is a complicated organ, created by different cell types where niches for 
stem cells have been observed (see section 1.1.4). 
 
1.1.1. Epidermis.  
 Epidermis, stratified epithelium, is the most outer part of skin. Epidermis is 
crucial for the protection against water loss and creates a barrier against infections 
(Elias and Feingold, 1992; Schröder, 2010). During epidermal differentiation 
changes in lipid content take place which are related with a barrier function of this 
skin compartment. For example, both cholesterol and fatty acids are shown to be 
synthesized straight after the disruption of skin barrier.  
Epidermis can be divided into several cell layers, such as stratum basale 
(stratum germinativum) and stratum spinosum, stratum granulosum and stratum 
corneum (reviewed by McGrath et al, 2008; see also Figure 1.1B). The outermost 
layer is the stratum corneum, created by flattened cells without both nuclei and 
cytoplasmic organelles. These cells are called corneocytes. The stratum basale, the 
innermost layer of epidermis, is created by two to three layers of small cells which 
are dividing constantly. The basement membrane, beneath the stratum basale layer, 
separates epidermis from dermis. 
The main cells of this skin part are keratinocytes. Keratinocytes are formed 
from dividing cells in the basal layer of epidermis and they are constantly moving 
from the innermost to the outermost part of epidermis, creating finally the stratum 
corneum. Keratin is a protein produced by keratinocytes and it creates a 
cytoskeleton of keratinocytes. Keratinocytes are connected with each other by 
desmosomes (protein bridges). Among other epidermal cells are Merkel cells, 
Langerhans cells and melanocytes. Merkel cells, localised in the basal layer of the 
epidermis, are suggested to have a mechanoreceptive role related with a detection 
of deformations along the tissue (reviewed by Lucarz and Brand, 2007). Langerhans 
cells are specialized dendritic cells (reviewed by Merad et al, 2008). Melanocytes, 
originated from neural crest, are in close contact with kerationcytes. These cells 
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produce melanin which is transported to keratinocytes and they are involved in skin 
pigmentation (reviewed by Tsatmali et al, 2002).  
 
1.1.2. Dermis. 
Dermis has mesenchymal origin and is localised beneath the epidermis layer 
(reviewed by Sorrell and Caplan, 2004 and McGrath et al, 2008). The heterogeneity 
along dermis seems to be crucial for proper functions of skin. It is consisted of a 
papillary layer and a reticular layer (Figure 1.1B). The thinner papillary layer lies 
below epidermis and has loose fibers of collagen. This dermis layer is responsible 
for a supply of nutrients to the avascular epidermis. Then, there is a bigger reticular 
layer which consists of dense, organized collagen fibers.  
Fibroblasts are the main components of dermis and they produce elastin 
(crucial for skin elasticity), proteoglycans (related with hydration) and collagen 
(dermis strength). The papillary dermis has more type III collagen, when compared 
with the reticular dermis. Next, types XII or XVI collagen are specific for the papillary 
dermis and type IV collagen is seen in the reticular dermis (reviewed by Sorrell and 
Caplan, 2004). Among other cells seen in dermis are mast cells or histiocytes. 
Dermal mast cells are suggested to have immunological functions in skin as well as 
their relation in skin cancer development have been investigated (Grimbaldeston et 
al, 2004; Byrne et al, 2008). 
In this skin compartment, the blood supply is very well developed 
(Braverman and Keh-Yen, 1981). The rete subpapillare (vascular plexus) is 
localised between two dermis layers and is connected with rete cutaneum (Figure 
1.1B). The rete cutaneum is also a vascular plexus, presented at the base of the 
reticular layer (reviewed by reviewed by Sorrell and Caplan, 2004). Also interactions 
between elements of the nervous system and skin are crucial for the proper function 
of skin (Ansel et al, 1997).   
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Figure 1.1. A schematic description of skin compartments. (A) Epidermis, dermis 
and hair follicle with fat cells. (B) Layers creating epidermis and dermis with 
basement membrane. Direction of keratinocyte movement along the dermis is 
shown by green arrow. Adapted from Sorrell and Caplan, 2004 and McGrath et al, 
2008. 
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1.1.3. Hairs. 
1.1.3.1. The hair follicle development.  
The hair follicle is a complex structure formed from the ectoderm (that gives 
the epidermis) and the mesoderm (that forms the dermis) (reviewed by Hardy, 1992; 
Millar, 2002; Schmidt-Ullrich and Paus, 2005). In general, the hair follicle 
development is divided into three steps (induction, organogenesis and 
cytodifferentiation) and consists in total of eight stages (Figure 1.2). The formation of 
the hair follicle is observed during embryogenesis and is connected with the 
epithelial-mesenchymal interactions. The dermal mesenchyme activates (first 
dermal signal) agglomeration of cells from epidermis which leads to the 
development of a placode. The thickening from the epidermis (placode) and its 
growth into the deeper parts of the skin is observed. When the epithelial signal 
occurs, at the germ stage, the dermal papilla (DP) is formed. Then, second dermal 
signal is directed to the epithelium to grow down to the dermis. Next, at the bulbous 
peg stage the hair follicle bulb occurs and development of both inner root sheath 
(IRS) and hair shaft takes place.  
In mice, the primary hair follicle development starts in about 14.5 day old 
embryos. The placode can be seen in 14.5 day old embryos, peg at day 15.5 and 
bulbous peg at day 18.5. The secondary intermediate hairs (awl and auchene) start 
to develop in about 16.5 - 17 day old embryos, whereas downy (zigzag) hairs occur 
after the animal’s birth. 
Different factors and signalling pathways are involved in the regulation of hair 
follicle development. For example, WNT-signalling and beta-catenin are involved in 
the induction step. Other key regulatory molecules that control the hair follicle 
development are members of the TGF/BMP, FGF or TNF families (reviewed by 
Hardy, 1992; Millar, 2002; Schmidt-Ullrich and Paus, 2005; Schneider et al, 2009). 
 
 
 
 
 
 
 
 
 
 
                                                                                                           Chapter 1 
 6 
 
Figure 1.2. A schematic presentation of primary hair follicle development in mouse 
skin. Arrows show epithelial-mesenchymal interactions during hair follicle 
development. E - epidermis; D - dermis. Based on Millar, 2002 and Schneider et al, 
2009. 
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1.1.3.2. The structure of hairs and the hair follicle cycle. 
A fully developed (in anagen phase, see below) hair follicle can be divided 
into two parts: the upper, less dynamic part and the lower part which undergoes 
changes during hair follicle cycle (reviewed by Schneider et al, 2009). The upper 
part consists of the outermost infundibulum and the isthmus, whereas the lower part 
is divided into suprabulbar region and the bulb part (Figure 1.3A).  
Sebaceous glands are seen in the upper part of hair follicles and they 
produce sebum, which consists of lipids (Picardo et al, 2009). Small smooth 
muscles, called arrector pili muscles, are also in the upper part of hair follicle and 
they connect hairs to the dermis (reviewed by Schneider et al, 2009). A bulge region 
is in the isthmus part and is treated as a stem cell niche (see section 1.1.4 for 
details).  
The progenitor cells from the bulge can move to the upper part of skin and 
populate sebaceous glands as well as epidermis between hair follicles (inter-
follicular epidermis). Other progenitor cells move down along the skin and take part 
in forming hair follicles. Progenitor cells in hair matrix divide, move from dermal 
papilla (DP) and then stop their division and differentiate into layers of growing hair 
follicle. The growth of hair continues during the anagen phase of the so-called hair 
follicle cycle (see above). The anagen bulb has matrix stem cells where 
keratinocytes move to the adjacent area undergoing proliferation or create layers of 
hair shaft and inner root sheath (IRS). Matrix surrounds DP which is a key signalling 
center for maintaining the hair growth and which control the hair follicle life cycle. 
Hair shaft consists of medulla, cortex and hair cuticle, whereas IRS is created by 
four parts (companion, Henle’s and Huxley’s layers and IRS cuticle; see Figure 
1.3B). The outermost layer of hair follicle is called outer root sheath (ORS). Finally 
the hair follicle is surrounded by a dermal sheath (DS) which is believed to have an 
important function in the process of reparation of the injured skin (Jahoda and 
Reynolds, 2001).  
The upper part of hair follicle, the bulge and matrix of the hair bulb have 
ectodermal origin. Both dermal papilla and dermal sheath have mesodermal origin 
(reviewed by Schneider et al, 2009). 
 
Hair follicles undergo the cyclic growth that consists of four phases: anagen 
(an active phase), catagen (a regression and shortening phase), telogen (a resting 
phase) and exogen phase (a shedding stage) (reviewed by Schneider et al, 2009). 
In the anagen, as it was mentioned above, keratinocytes of the hair matrix cells give 
rise to hair follicle layers and development of the hair takes place. In mouse, the first 
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anagen phase starts at embryonic level and continues to about 12 days after the 
animal’s birth. In the next phase (the catagen phase), the follicle stops producing 
hair and cell death (apoptosis) occurs. It is also observed that the dermal papilla 
shrinks and is released from the bulb. In a resting telogen phase, the papilla is 
localised very close to the bugle which is believed to be related with interaction 
between cells from these two areas. The telogen hair (club hair) is a dead hair. Next, 
the activation of anagen takes part and new hair is created. 
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Figure 1.3. A schematic representation of the hair follicle structure. (A) Elements of 
the hair follicle. (B) Parts that create hair shaft and inner root sheath - IRS, 
surrounded by outer root sheath - ORS and dermal sheath - DS. Adapted from 
Schneider et al, 2009. Drawing of hair (A) by Paweł Wojciechowicz. 
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1.1.4. Skin and hair follicles as a source of adult stem cells. 
Recently, the attention has been focused on so-called adult stem cells, that 
are undifferentiated cells found in different tissues, and which are able to renew 
themselves and differentiate into some specialized cell types of tissues/organs 
(reviewed by Wagers and Wiessman, 2004). These kinds of cells are responsible for 
maintaining and repairing tissues in which they are localised. It is suggested that 
these cells are quiescent for most of the time and are activated after the injury of 
tissue/organ or the onset of disease.  
 
 Adult stem cells have been investigated in the skin. The stratum basale layer 
of epidermis is treated as a source of epidermal stem cells, which are crucial for the 
proper regenerative processes of skin (reviewed by Kamstrup et al, 2008). Stem 
cells isolated from the rodent and human skin dermis and called “skin-derived 
precursors” (SKPs) were shown to produce adipocytes, smooth muscle cells or 
neurons and glia (Toma et al, 2001; Fernandes et al, 2004). Stem cell niches have 
been found along hair follicles. The bulge region of hair follicles has been 
characterised by the presence of epithelial stem cells. These cells are a source of 
hair follicle cells and are crucial for replacement of stem cells in epidermis (Taylor et 
al, 2000). In addition, it is said that the whisker follicle dermal papilla can be a niche 
for SKP cells (Fernandes et al, 2004). In the context of stem cell capability, it was 
observed that when dermal papilla (DP) and dermal sheath (DS) cells were cultured, 
they expressed different types of blood cell markers and had interesting 
haematopoietic potential (Lako et al, 2002). It was also published that follicle dermal 
cells can express some osteogenic markers (for example osteopontin or alkaline 
phosphatase) or can accumulate lipids (Jahoda et al, 2003). It is suggested that DP 
and DS cells are able to differentiate into different lineages (such as adipogenic or 
osteogenic) in vitro and this process can occur spontaneously or can be induced (by 
adipogenic medium, for details see section 1.3.2.2). 
 
Adult stem cells are thought to be a good source of cells used in cell 
therapies, for transplantations in different diseases (Wagers and Wiessman, 2004). 
Thus, it is important to enlarge the knowledge about adult stem cells, analyse their 
features and check their potential implications in different fields of medicine. 
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1.2. Adipose organ. 
1.2.1. General division of adipose depots. 
 Adipose organ is created by two tissues: brown adipose tissue (BAT) and 
white adipose tissue (WAT) (Cinti, 2001). These two depots have different fat cells 
(adipocytes) morphology and function in relation to energy expenditure and 
accumulation. In addition, they differ because of the colour appearance (brown cells 
in BAT and yellowish in WAT depot) (Avram et al, 2005). Because of the localisation 
in the body, fat depots can be subcutaneous - SAT (subcutaneous adipose tissue) 
and visceral - VAT (visceral adipose tissue) (Cinti, 2001). White adipose tissue in 
subcutaneous and visceral localisation can contain brown adipocytes, whereas BAT 
tissue can be characterised by a presence of white fat cells (section 1.2.2.3). 
The human subcutaneous depots are these observed beneath the skin 
(abdomen, thighs or buttocks areas as well as under the head/face skin), whereas 
adipose depots that surrounds internal organs can have omental, retroperitoneal or 
visceral localisation; see Figure 1.4a) (reviewed by Gesta et al, 2007). In human 
skin, fat cells localised between hairs (dermal adipose tissue) are not separated 
from subcutaneous adipose tissue (Cinti, 2007) (Figure 1.4b). In addition, human 
BAT has especially interscapular localisation and was found in cervical, 
supraclavicular or paravertebral areas. It is abundant in humans at birth and its level 
decreases in adults. In rodents, the brown adipose tissue has mainly the 
interscapular localisation and is seen throughout the whole animal’s life (Figure 1.5. 
Part A). The visceral tissue, in mice and rats, can be mesenteric and mediastinic, 
retroperitoneal, perirenal or perigonadal and epididymal (Figure 1.5. Part A) (Cinti, 
2001; Cinti, 2007; Gesta et al, 2007; Tran and Kahn 2010). In relation to fat cells 
associated with mouse back skin, two fat compartments are seen: subcutaneous 
adipose tissue (SAT) and dermal adipose tissue (DAT) (Figure 1.5. Part A and Part 
B). The subcutaneous adipose tissue is localised below the skin, whereas the 
dermal adipose tissue develops in lower dermal compartment and is localised 
between hair follicles. These two adipose depots are divided from each other by a 
muscle layer (panniculus carnosus). DAT is observed along the whole length of 
mouse back skin lower dermis, whereas SAT is can be divided into anterior and 
posterior depots (Figure 1.5. Part B). The study presented in this thesis was focused 
on the dermal adipose tissue - DAT. 
Except main fat depots, adipocytes were observed in many organs and 
tissues (bone marrow, pancreas, synovial, skin) and have for example intramuscular 
or pericardial localisation (Cinti, 2001, Gesta et al, 2007). In addition, the word 
“infiltrate” has been used for the description of fat cells in these organs (Cinti, 2001). 
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a) 
 
b) 
 
Figure 1.4. A schematic presentation of selected fat depots in human body. (a) The 
main known fat depots are subcutaneous (shown in green) and visceral (shown in 
yellow). Small amounts of brown fat depots can be seen in adults (shown in red). In 
addition, fat cells are present in other tissues and organs (shown in blue). 
*Information based on Gesta et al, 2007. (b) Dermal adipose tissue is connected 
with subcutaneous adipose tissue in human body (based on Cinti, 2007). HF – hair 
follicle. Drawings by Paweł Wojciechowicz.  
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Figure 1.5. Part A. For description see Figure 1.5. Part B.  
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Figure 1.5. Part B. A schematic presentation of main fat depots in rodents.  
(Part A) The brown adipose tissue (shown in brown) is seen in the anterior part of 
the rodent body. Subcutaneous adipose tissue, just beneath the skin, develops in 
anterior and posterior areas (shown in darker yellow colour). Selected visceral 
depots are shown in a lighter yellow colour. *Information based on Cinti, 2001; Cinti, 
2007; Gesta et al, 2007 and Tran and Kahn, 2010. Drawing by Paweł 
Wojciechowicz. 
(Part B) The localisation of adipose depots associated with rodent back skin. 
Adipocytes create dermal adipose tissue along the whole back skin. Subcutaneous 
fat depot is seen below the skin in anterior (near head and upper limbs) and 
posterior (near lower limbs) localisation (see Chapter 2, for more details). HF – hair 
follicle. Based on Cinti, 2007. Drawing by Paweł Wojciechowicz. 
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1.2.2. Morphology and function of adipose tissue. 
Development of fat depots starts in foetuses, continues after the birth and 
subcutaneous depots can occur before visceral ones (Cinti, 2001).  
 
Adipose organs consist of fibroblasts and fibroblast-like cells, histiocytes and 
mast cells, blood vessels and nerves, preadipocytes and mature fat cells, called 
adipocytes (Cinti, 2001; Cinti, 2007). Elongated fibroblasts, elements of the 
connective tissue, produce a connective matrix and are characterised by the 
presence of the rough endoplasmic reticulum (that comprises most of the 
cytoplasmic space). Histiocytes, with many lysosomes and well developed Golgi 
complexes, are suggested to take part in adipose tissue modifications, depending 
on the amounts of stored lipids. Some adipose organs (anterior and posterior 
subcutaneous depots in rodents) can have their own, specific vascular and nerve 
elements. Whereas white visceral fat depots can be connected to the vascular and 
nervous systems of other organs, such as the kidneys or intestines. 
 
Preadipocytes undergo a specific differentiation process that leads to a 
development of mature fat cells. Adipocytes are capable of accumulating lipids and 
are crucial for the specific functions of this organ (Avram et al, 2005). Detailed 
description of adipocyte differentiation (adipogenesis), analysed mainly by in vitro 
studies, is presented in section 1.3. 
 
1.2.2.1. Brown adipose tissue (BAT).  
1.2.2.1.1. Brown adipocytes. 
Brown fat cells in brown tissue can have an ellipsoid shape with sizes, 
depending on the literature source, between 10 - 15 and 25 - 50 µm (Cinti, 2001; 
Cinti, 2007). Lipids are accumulated in small vacuoles (multilocular cells) of these 
brown adipocytes that have round-shaped nuclei (usually in central areas of cells) 
and high number of large mitochondria. On the surface of these small lipid droplets, 
perilipin protein has been characterised. Both, Golgi apparatus and rough 
endoplasmic reticulum are not well-developed, whereas smooth endoplasmic 
reticulum is easy to detect in these cells. Also, external lamina can be easily 
detectable outside of the plasma membrane. 
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1.2.2.1.2. Main function of BAT. 
 The unique feature for brown cells is related with the presence of so-called 
uncoupling protein-1 (UCP-1) in the inner mitochondrial membrane. This protein is 
responsible for main function of BAT, as an organ important for energy expenditure. 
Uncoupling proteins are related with dissipation of the proton electrochemical 
gradient and releasing of energy as heat (thermogenesis) (reviewed by 
Wajchenberg, 2000). For example, in adult rodents kept for several hours in low 
temperatures (4 - 8oC), most lipids disappear from BAT (Cinti, 2001).  
 
1.2.2.1.3. BAT in humans.  
In human the amount of BAT significantly decreases after birth (Gesta el at, 
2007). For quite a long time BAT was thought not to have an important function in 
adult humans. However, this view underwent changes when BAT was investigated 
in adults. In one study, the PET-CT (Positron Emission Tomography - Computed 
Tomography) technique was used that allowed the identification of potential brown 
adipose depots that had a high rate of uptake of 18F-fluorodeoxyglucose (18F-FDG) 
(Cypess et al, 2009). Brown tissue (with large depots seen in area from anterior 
neck to the thorax) was analysed in patients that differ in age or sex. The mass of 
BAT was higher in women (than in men) and the inverse correlation was noticed 
between BAT amount and BMI index (people with lower BMI tend to have higher 
activity of BAT) and this was mainly related with older people. 
Interestingly, the presence of brown depots (mainly around the neck) was 
also observed in a group of people that were working outside (in Finland) (Huttunen 
et al, 1981).  
To sum up, brown adipose tissue has become an interesting depot for 
researchers because of its suggested role in metabolism in adults and as a potential 
tool that could be used in controlling the energy expenditure in humans and maybe 
developing treatments for obesity (Celi, 2009; Seale and Lazar, 2009).  
 
1.2.2.1.4. Development of BAT in rodents. 
The electron microscope allowed the investigation of BAT development 
during the perinatal period in rats (Cinti, 2001). BAT in rat could be detected in the 
dorsal area (in the trunk), near the spinal cord. In young, 15 day old embryos, this 
part of rat body was filled only with mesenchymal tissue, whereas in 19 day old 
embryo, brown adipocytes were observed together with UCP-1 expression. During 
rat development, progressive accumulation of mitochondria was spotted in these 
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cells. At the early step of development (so-called adipoblast stage 1) cells had high 
number of mitochondria. Then, during differentiation process the number of 
mitochondria increased which became more similar to these seen in mature brown 
fat cells and lipid accumulation was observed. At so-called adipoblast stage 2, 
unilocular lipids were seen. Then, at next differentiation stage (adipocyte precursors) 
multilocular lipids were spotted. In general, at 19 - 21 day old rat embryos, cells at 
all mentioned above stages were observed. 
 
1.2.2.2. White adipose tissue (WAT). 
1.2.2.2.1. White fat cells and their development. 
Cells of white adipose depot are characterised by small, elongated 
mitochondria, an easy to observe smooth endoplasmic reticulum and lamina on the 
outside area of plasma membrane (reviewed by Cinti, 2001). In addition, these fat 
cells can differ from each other because of the size, which can be between 20 and 
150 µm and such big difference depends on the amount of accumulated lipids (Cinti, 
2007). Developed white adipocytes, have spherical shape with one big vacuole 
(unilocular) that takes central place in the cell and leads to a creation of a thin 
cytoplasm and elongated nuclei localised at the edge of the cell. 
 
First signs of rat white fat cells were observed in perinatal period and were 
related with the inguinal region (Cinti, 2001). Preadipocytes differ from other 
surrounding cells because of the presence of external lamina. Differentiating cells 
are characterised by small lipid droplets and granules of glycogen. Then, an 
increase in accumulating lipids leads to the development of unilocular (mature) white 
fat cells.  
During the development of white adipocytes, the increase in cell size 
(hypertrophy) is followed by the increase in cell number (hyperplasia). It is 
suggested that a fat cell has a maximum volume for the lipids accumulation and this 
differs depending on type of fat depot (Cinti, 2007). For example, in adult male rats 
(Wistar) hypertrophy was mainly observed in mesenteric and epididymal fat depots, 
whereas hyperplasia dominated during development of the retroperitoneal depot 
(DiGirolamo et al, 1998). 
Among characteristic proteins produced by white fat cells, are S-100 protein 
and leptin (reviewed by Cinti, 2001). S-100 protein is suggested to be an example of 
carrier protein for fatty acids in adipocytes (Haimoto et al, 1985). Leptin is described 
in section 1.2.2.2.2.3. 
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1.2.2.2.2. WAT functions. 
White adipose tissue is the largest energy storage organ that controls 
synthesis and accumulation of triacylglycerols and functions as an endocrine organ 
(reviewed by Gregoire et al, 1998). In addition, subcutaneous fat depots function as 
a thermo-insulator (reviewed by Cinti, 2007). 
 
1.2.2.2.2.1. Lipid metabolism. 
 Lipid metabolism in fat cells is related with the uptake of fatty acid, 
lipogenesis and lipolysis (Large et al, 2004; Avram et al, 2005). After food 
consumption, accumulation of lipids increases in WAT and free fatty acids (FFAs) 
are stored in a form of triacylglycerol (TG/TAG) in adipocytes. The term lipogenesis 
is used for the description of fatty acid and TG synthesis.  
When a fasting period occurs, lipolysis takes place. In this process, TG is 
hydrolyzed into fatty acids (FAs) and glycerol. Then, fatty acids leave adipocytes, in 
the form of free fatty acids (FFAs), which can be processed in muscles and liver and 
used as a source of energy for different organs.  
In addition, lipid storage and lipid release are controlled by hormonal signals 
(for example insulin), exercise and the food intake. Dysregulation of processes that 
control lipid metabolism in adipocytes is thought to lead to obesity and fat-related 
disorders (diabetes, insulin resistance) and is discussed in section 1.2.7. 
 
1.2.2.2.2.1.1. Fatty acid (FA) transport. 
Two main processes are suggested to be responsible for fatty acid (FA) 
transport: a passive diffusion through a flip-flop process and transport by protein 
transporters (for example integral membrane protein called FAT/CD36, which is 
discussed in Chapter 3 and Chapter 5) (reviewed by Kampf and Kleinfeld, 2007). 
Inside the fat cell, transport of FA has a membrane to membrane feature or 
can be carried by cytoplasmic LBPs (lipid-binding proteins also known as fatty acid 
binding proteins - FABPs). Among well-known LBPs is adipocyte lipid binding 
protein (FABP4/ALBP/A-FABP/aP2), seen in fat cells. In addition, KLBP 
(keratinocyte lipid binding protein) is seen in adipocytes and other cell types 
(Simpson et al, 1999). 
Also present in adipocytes are caveolae which take part in the transport of 
fatty acids and their conversion into TG (Öst et al, 2005). A subclass of caveolae 
responsible for this process is characterised by the presence of perilipin protein. 
Perilipins are encoded by a Plin gene and create a family of phosphoproteins and 
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their expression goes up during adipogenesis. They were found on the lipid droplet 
surfaces in fat cells (white and brown adipocytes).  
 
1.2.2.2.2.1.2. Synthesis of triacylglycerol. 
After the transportation of fatty acids into the fat cell, they are quickly 
changed into triacylglycerol (TG/TAG), which is accumulated in central fat droplets 
in adipocytes. Adipocytes synthesize triacylglycerol mainly from fatty acids bound to 
plasma albumin or from TAG-rich lipoproteins (such as very low density lipoprotein 
VLDL-TG). Adipocytes have VLDL-receptors that seem to control uptake of TG-fatty 
acids and these cells express lipoprotein lipase (LPL) responsible for the release 
process of TG-fatty acids from lipoproteins (Large et al, 2004). Non lipid substrates 
can also be involved in the fatty acid synthesis (for example carbohydrates) and this 
process is called “de novo lipogenesis” (DNL). DNL process takes place in liver and 
can be present in adipocytes. However, DNL process in human adipose organ has 
not been fully characterised (Large et al, 2004). 
 
1.2.2.2.2.1.3. Lipolysis. 
In white adipocytes, during the lipolysis process TAGs are changed into 
diacylglycerols (DAG) and monoacylglycerols (MAG). Finally, free fatty acids (FFA) 
and glycerol are released (Large et al, 2004). In the lypolysis process, the hormone-
sensitive lipase (HSL) is one of the crucial enzymes, sensitive to insulin and which 
controls modification of TAG into DAG and MAG. In addition, perilipins (see also 
section 1.2.2.2.2.1.1) are thought to be involved in regulation of lipolysis in 
adipocytes (Holm, 2003). The protein kinase A–mediated phosporylation of HSL and 
perilipins can result in enhanced lipolysis. 
  
1.2.2.2.2.2. Glucose metabolism. 
Fat cells are involved in glucose metabolism (Avram et al, 2005). Glucose is 
a sugar used by the body to store energy. Adipocytes are characterised by the 
presence of insulin-dependent glucose transporter 4 (Glut4) which allows the 
transport of glucose into these cells. In addition, adipose tissue can influence 
glucose metabolism in other organs, such as liver (Wajchenberg, 2000). By 
releasing FFAs (from fat cells) into the circulation, skeletal muscles can be 
influenced in relation to promotion of insulin resistance (Avram et al, 2005). Insulin 
resistance is discussed in section 1.2.7. 
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1.2.2.2.2.3. Adipose tissue as an endocrine organ. 
The endocrine function of WAT was suggested with a discovery that this 
adipose organ is capable of producing a hormone related with food intake or 
activation of energy dispersion, called leptin (Cinti, 2007).  
 
Leptin, encoded by the obesity (ob) gene, is expressed mainly in adipocytes 
(Margetic et al, 2002). It functions through the leptin receptor. Leptin expression 
starts at embryonic level and leptin is thought to be a signalling factor that influences 
the nervous system and controls proper food intake and weight in rodents and 
humans (reviewed by Wajchenberg, 2000). Abnormalities in leptin levels and their 
function are known to lead to obesity and metabolic abnormalities (commented by 
Ahima, 2008). Increased levels of leptin were observed in obese individuals in whom 
an energy expenditure and appetite seemed to be disturbed (Münzberg and Myers, 
2005). In rodents and humans, plasma leptin was correlated with body mass index. 
Food restrictions that leaded to weight loss were associated with lower levels of 
leptin (Maffei et al, 1995).  
 
Secreted by adipocytes factors control function of many organs as well as 
they control adipose tissue. In general, their action can have autocrine, paracrine 
and endocrine roles (Kim and Moustaid-Moussa, 2000). Several factors, secreted by 
adipose tissue have been summarised in Table 1.1. In addition, several proteins 
related with mature adipocytes are presented and discussed in Chapter 3 (sections 
3.3 and 3.4).  
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Table 1.1. Examples of factors that are produced and secreted by adipose tissue. 
Information based on Kim and Moustaid-Moussa, 2000.  
 
Examples of factors secreted by adipose tissue*: 
 
1) Obesity genes: Leptin 
Agouti 
2) Sex steroids 
3) Cytokines: Tumor necrosis factor (TNFalpha) 
Interleukin-6 (IL-6) 
4) Free fatty acids (FFAs) 
5) Complement components: Acylation stimulating protein (ASP) 
Adipsin 
6) Proteins of lipoprotein metabolism: Lipoprotein lipase (LPL) 
Apoprotein E (ApoE) 
7) Proteins related to cardiovascular 
function: 
Plasminogen activator inhibitor-1 (PAI-
1) 
Angiotensinogen (AGT) 
8) Eicosanoids: Prostaglandin E2 (PGE2) 
Prostaglandin I2 (PGI2) 
9) Growth factors: Transforming growth factor beta 
(TGFbeta) 
Insulin-like growth factor-1 (IGF-1) 
*Reference for each presented factor is included in Kim and Moustaid-Moussa, 2000. 
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1.2.2.3. The presence of white and brown cells in the same fat depot. 
 Brown and white adipose cells can occur along the same adipose tissue 
depot (Cinti, 2007). In obese animals, presence of white adipocytes was observed 
along brown fat depots. In addition, so-called Sv129 mice had enhanced resistance 
to obesity and diabetes and higher number of brown adipocytes was observed in 
their adipose depots (Almind and Kahn, 2004; Cinti, 2007). Moreover, as an effect of 
cold-exposure, brown adipocytes were present in white adipose organs in rodents 
(Cinti, 2001). 
A general suggestion has been made, that so-called reversible 
transdifferentiation process occurs along some fat cells and allows the transfer of 
white adipocytes into brown cells (Cinti, 2007). Moreover, all fat depots can consist 
of two types of adipocytes and their differentiation might be dependent on such 
factors as age or changes in outside temperatures. 
 
1.2.3. Developmental origin of fat cells. 
 Still little is known about the exact steps of fat cell origin (Cinti, 2007; Gesta 
et al, 2007; Billon et al, 2007; Billon et al, 2008). It is accepted that adipocytes might 
develop from mesenchymal stem cells (MSCs). Embryonic stem cells give a rise to 
MSCs which were observed for example in human bone marrow and are capable to 
differentiate into several cell types, such as myoblasts, osteoblast or adipocytes.  
MSCs were suggested to develop from mesoderm. In addition, it was 
suggested that there might be another source of mesenchymal cells, related with the 
neural crest (NC). Neural crest, derived from neuroectoderm, leads to the 
development of facial bones. In addition, the neural crest cells (NCCs) are capable 
of an epithelial-to-mesenchyme transition and develop into different cells, depending 
on their localisation along the body (for example neurons or endocrine cells) 
(reviewed by Billon et al, 2008). 
 
Adipocytes could develop from so-called adipoblast (early precursor of fat 
cells) which differentiate from mesenchymal stem cells, however the exact 
mechanism of such process has not been yet confirmed (Gesta et al, 2007). 
Questions arise in relation to pathways that control embryonic stem cells, 
differentiation of MSC into adipocytes or number and types of precursors for fat cells 
(one or several precursors for white and brown fat cells, for visceral and 
subcutaneous fat preadipocytes, see Figure 1.6). 
 
                                                                                                           Chapter 1 
 23 
 
Figure 1.6. A schematic presentation of suggested differentiation processes that 
lead to development of mature fat cells and different fat depots. The origin of fat 
cells remains elucid, however it is believed that these cells develop from 
mesenchymal stem cells (MSCs). Some differentiation stages have yet to be 
clarified. Adapted from Gesta et al, 2007 and Billon et al, 2007. 
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The suggested origin of fat cells was related with several studies where a 
capability to undergo adipogenesis was analysed in different embryonic cell lines 
(reviewed by Billon et al, 2008). Mouse embryonic stem cells (mESCs), isolated 
from mouse blastocyst, after the integration into the embryo take part in 
development of all cell lineages. It was shown that mESCs can differentiate into 
adipocytes, when treated with retinoid acid (RA) or insulin (Dani et al, 1997). Also, 
human embryonic stem (hES) cells were capable of undergoing adipogenesis after 
the exposure on adipogenic factors (Xiong et al, 2005; for adipogenic factors see 
section 1.3.2.2).  
In addition, in mESCs treated with RA, reduction of mesodermal markers 
was observed and high concentrations of RA were able to activate neural 
differentiation (Bain et al, 1995). Billon et al (2007) designed experiment where 
mouse embryonic stem cells, expressing Sox2 (that is specific for neuroepithelial 
cells), were treated with retinoid acid in order to activate neural differentiation. Then, 
neuroepithelial cells (purified by fluorescence activated cell sorting - FACS method) 
were treated with adipogenic factors (for example insulin) and differentiated into 
adipocytes. The neural crest stem cells were shown to differentiate into adipocytes. 
Finally, it was shown that during mouse development in vivo, adipocytes can 
develop from neural crest (NS) cells (Billon et al, 2007). In this work, transgenic 
animals with Sox10-Cre/Rosa26R-YFP were used where Cre recombinase was 
under control of the Sox10 promotor. The Sox10 is believed to be efficient marker of 
NC cells and is not expressed in mesoderm. The immunofluorescence staining was 
performed where antibody against perilipin (adipocyte marker seen on the surface of 
lipid droplets) was used. This study showed the co-expression of perilipin with YFP 
(yellow fluorescent protein) in the area of salivary gland. It suggested that YFP-
positive and perilipin-positive (YFP+/perilipin+) adipocytes developed from NC and 
not from mesoderm. Then, subcutaneous fat depots, positive for perilipin, were not 
expressing YFP (Billon et al, 2007). Thus, different fat depots along animal body 
seemed to differ because of the origin.  
 
To sum up, it is suggested that white adipocytes in the cephalic region 
develop from the neural crest (NC) and adipocytes from the trunk area might arise 
from the mesoderm (Billon et al, 2008). This hypothesis remains to be elucidated by 
more detailed studies. 
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1.2.4. Human adipose tissue. 
 In humans, first signs of adipose tissue were observed in the second 
trimester of gestation (Poissonnet et al, 1984). The term “mesenchymal lobules” was 
used to describe structures without lipids, which developed into a “primitive fat 
lobules” (first signs of lipids) and then to “definitive fat lobules” (Poissonnet et al, 
1984). In this study, adipose organ was observed to develop first in the head and 
neck (for example chin fat developed between 14.5 and 17 week of foetal life), then 
trunk area (for abdominal wall between 14.5 and 20.5 week), whereas the fat organ 
in limbs developed as the latest depot (from 15 untill 23.5 week for shoulder fat). 
   
General morphological features of human (white and brown) fat cells and 
localisation of SAT and WAT fat depots is in agreement with rodent-related work 
(Cinti, 2007). Because of the sex, amount of intra-abdominal WAT in men is higher 
when compared with women. In women there are more subcutaneous fat depots 
(hips and thighs) (Gesta et al; 2007). 
 
1.2.5. Adipose tissues in animals: subcutaneous depots and fat cells 
around hairs. 
Because of the importance of fat production from meat animals, detailed 
studies on adipose depots were performed, mainly on pigs and developed in XIX 
century (Flemming, 1871). In addition, the association between fat cells and hair 
follicles in pigs and rats was elucidated (sections 1.2.5.1 and 1.2.5.2).  
 
 Studies on such animals as pigs, lambs or calves allowed to systematize 
developmental steps of subcutaneous adipose fat depots (Hausman, 1978; 
Hausman and Kauffman, 1986). The area lacking lipids and filled with short, not 
organized collagen fibers and cells with different sizes and shapes was named as 
“presumptive adipose tissue”. Next, during development of adipose organ, fibers 
became more organized and were capable of creating so-called “connective tissue” 
(CT) between clusters of fat cells. First lipids were observed before the CT was fully 
formed. During the gradual occurrence of adipocytes, the connective tissue became 
thicker. Next, after reaching maximum thickness, the size of CT decreased during 
progressive hypertrophy of fat cells. 
 The fat cell clusters were suggested to derive from so-called “presumptive 
adipose lobules”, which can be a source of both adipocytes and capillaries. Lipids 
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were first accumulated in a form of many small droplets. Then, multilocular fat cells 
became unilocular (when small droplets were modified into one big lipid droplet).  
   
Because of the morphological similarities between very early preadipocytes 
and endothelial cells, a suggestion was made that fat cells, creating subcutaneous 
depots in pigs have endothelial origin (Hausman, 1978). In addition, the occurrence 
of both adipocytes and capillaries at the same time during fat depot development 
was treated as a confirmation of suggested hypothesis about fat cells origin. For 
more recent and detailed studies on fat cell origin see section 1.2.3.  
 
The association between blood vessels and adipocytes was noticed during 
foetal development of pigs and blood vessels seemed to be crucial for the proper 
features of fat cells in subcutaneous swine depots (Hausman et al, 1981b).  
 
1.2.5.1. Pigs. 
1.2.5.1.1. General features of pig subcutaneous tissue. 
The major fat depot in pigs is a subcutaneous tissue. During animal growth, 
increase in size of adipocytes and amount of accumulated lipids were observed in 
some basic studies on pig fat tissue (Mersmann et al, 1975). In Mersmann et al 
(1975) study, the subcutaneous depot in dorsal area was observed in lower skin 
dermis and reached muscle layer. The connective tissue, that divided fat depot into 
upper and lower layers, was observed in newborn animals. Just after birth, 
multilocular cells with many lipid droplets were observed. Next, adipocytes were 
becoming (very fast) bigger and at day 3 fat cells were characterised by large 
(central) lipid droplets and some additional smaller fat droplets on the periphery of 
the cells. In addition, presence of collagen was spotted in all analysed time-points 
(day 0, 3, 9, 23, 40, 60, 110 and 160). 
 
1.2.5.1.2. Association between fat depots and skin compartments 
during foetal pig development. 
 Detailed analysis of fat cells features was performed on decapitated (in utero) 
pig foetuses (at 45 day of pregnancy) (Hausman et al, 1981b). The analysis was 
related with dorsal depot of subcutaneous tissue (with skin layer) at 110 days of 
gestation (when laparotomy was performed). Decapitation resulted in not fully 
developed epidermis and dermis, decreased number of hair follicles or blood 
vessels. Moreover, the outer layer of adipose tissue was thin and there was reduced 
                                                                                                           Chapter 1 
 27 
amount of fat cells around hair follicles in decapitated animals. Interestingly, 
adipocytes seen in decapitated animals (in outer fat layer) were characterised by 
bigger diameter of fat cells when compared with adipocytes from control animals.  
 
Hausman et al (1981b) suggested that normal development of subcutaneous 
depots in pigs might be related with developmental processes of skin compartments. 
Next, abnormal development of subcutaneous fat depot might lead to an enhanced 
hypertrophy of fat cells that are still seen in decapitated animals. 
 
1.2.5.1.3. Development of subcutaneous fat depot in foetal and newborn 
pigs. 
Detailed analysis of subcutaneous fat development was carried out on pig 
foetuses (Hausman and Kauffman, 1986). Pig foetuses (at age: 45, 60, 75 and 105) 
were obtained for the analysis of dorsal subcutaneous depot. In addition, newborn 
pigs were included in this analysis. 
Hausman and Kauffman (1986) suggested an age-dependent development 
of subcutaneous fat depot that started in pig foetuses between day 45 and 60. This 
depot developed into two distinguishable layers: the outer and the inner and this 
division was strongly marked in the caudal (posterior) body part and much less 
obvious in the cranial (anterior part). From 60 day old foetus a clear connective 
tissue border was seen between the outer and inner layers. At day 60, the outer 
subcutaneous layer was thinner when compared with inner layer. However, after 
day 75, the thickness of both layer become similar and did not change significantly 
after the onset of fat deposition and during next steps of foetal development. 
Short strands of collagen fibers were observed between cells in 
subcutaneous area. Blood vessels with different size were mainly related with 
subcutaneous layer localised near the skin. Whereas, the inner layer was “almost 
avascular” and only bottom part of this layer contained of large vessels (Hausman 
and Kauffman, 1986). 
 
 First fat cell clusters were observed in the bottom part of the inner 
subcutaneous layer in pig foetuses at day 60. Then at day 75, fat cell clusters were 
seen in the outer layer and near the hair follicles. Progressive development of 
clusters was observed with lipid deposition at similar level in caudal and cranial 
samples. Vascular and stromal occurrence, together with differentiation of fat cell 
clusters was suggested to have a gradient from the muscle to the skin.  
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1.2.5.1.4. Adipocytes related with hair follicles in pigs. 
 Fat cells between hair follicles were suggested to be different from other 
adipocytes of subcutaneous fat depot in pigs (Hausman and Kauffman, 1986).  
 The hair follicle-related fat cells were analysed in 45, 65, 85 and 112 day old 
foetal pigs (Hausman and Martin, 1982). First, the general features of skin dermis 
were investigated, such as presence of so-called papillary dermis (with horizontally 
organized elastic fibers and collagen) just below epidermis layer and dense reticular 
dermis in the lower skin area. The term “hypodermis” was used by Hausman and 
Martin (1982) to describe layer filled with adipose tissue and into which developing 
hair follicles extends. Areas localised in close proximity to hair follicles and 
contained lipids were called “hair follicle adipose lobules”. The developing hair 
follicle was growing through two layers of dermis (mentioned above) and both 
collagen and fibroblast from the reticular dermis seemed to be localised very close 
to the outer parts of hair follicles. While hair follicles were growing inside the 
hypodermis, cells closely attached to these follicles were thought to “unravel” to the 
hypodermis. The connective tissue, localised around follicles in the hypodermis, was 
characterised by different (frizzled, unorganized) morphology when compared with 
connective tissue (flattened) from the reticular dermis. Small hair follicle lobules 
were related with bottom part of hair follicles, whereas bigger lobules (with more 
spaces lacking fat cells around areas with adipocytes) were seen in middle part of 
follicles (Hausman and Martin, 1982).  
 
 Hausman and Martin (1982) suggested that in pigs interactions between 
growing hair follicles and connective tissue close to hairs could lead to a creation of 
“undifferentiated cells” from which fat cells (and other types of cells seen in fat 
lobules) developed and surrounded hair follicles. Moreover the translocation of hairs 
along skin into the hypodermis could be crucial for development of these fat cells. 
 
Interestingly, adipose clusters around hairs developed earlier in obese 
foetuses (for example at day 90 and 110) and were characterised by the bigger size, 
when compared with lean animals (Hausman, 1985). A suggestion was made that 
some metabolic factors might have a capability to influence fat cells near hair 
follicles, whereas other subcutaneous adipocytes are more resistant to these factors 
(Hausman and Kauffman, 1986).  
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1.2.5.2. Rats. 
 The light microscopy technique was applied for the analysis of newborn rat 
skin with developing fat cells (Hausman et al, 1981a). The correlation between hair 
follicles and adipocytes in rat hypodermis (filled with fat cells) was studied. In whole 
body section, from one day old rat, more hair follicles were seen along the dorsal 
(back) part of the body. The hypodermis was separated from subcutaneous tissues 
by a muscle layer. Thinner hypodermis was seen in ventral (abdominal) area, 
whereas thicker layer of hypodermis existed in dorsal (back) part of rat body. The 
hypodermis consisted of different cells: macrophages, mast cells, cells of blood 
vessel walls, immature adipocytes and adipocytes. Immature adipocytes were 
though to have the largest nuclei.  
The hair follicles were observed to grow along the skin, inside the 
hypodermis layer. So-called “precursor cells” (with big nuclei and low amount of 
cytoplasm) could be localised very close to the external root sheath and were 
developing into adipocytes. In small rats, first lipid droplets were observed in cell 
aggregates in close proximity to lower part of hair follicles. Unilocular fat cells were 
seen in bigger animals. Increase in body weight was related with higher diameter of 
fat droplets, however changes in number of litters influenced this correlation. 
When developed hair follicles were presented along the hypodermis, 
adipocytes around lower areas of hairs were seen. Then, areas where hairs were 
characterised by a non-finished development were lacking fat cells. It was 
suggested that fat cells from hypodermis and from other subcutaneous fat depots 
were characterised by similar size. 
 
A suggestion was made that the growing hairs (in rat skin) influenced dermis 
cells and this lead to adipocyte development (Hausman et al, 1981a). Hair follicles 
were thought to grow into “reaction areas” and this resulted in the translocation of 
dermis cells into the hypodermis layer (“star-shaped” cells, observed after the 
activation of hair development, were next presented in the hypodermis, close to 
growing hairs). After the movement of hairs down to the skin compartment, 
concentrated cells close to hairs were able to develop into adipocytes. It was 
suggested that pathways which controlled hairs growth might be also involved in the 
regulation of rat hypodermis development.   
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1.2.6. Comparison of hair follicle-related adipocytes in different species: 
man, pig and rat.  
As was shown in section 1.2.5.1, subcutaneous tissue is the major fat organ 
in pigs and is suggested to develop in a form of several distinguishable layers 
(Mersmann et al, 1975). Fat cells, localised between developing hairs, are thought 
to create the outer subcutaneous layer in pigs (Mersmann et al, 1975). In rodents, 
fat cells that create dermal adipose tissue are thought to be divided from 
subcutaneous depots (beneath the skin) by a muscle layer (Cinti, 2007). Next, in 
humans subcutaneous depots and fat cells in skin dermis (skin adipose tissue) are 
not separated (as it is suggested in rodents) and create together a distinguishable 
structure (Cinti, 2007).  
 
It was suggested that rat hypodermis share anatomical similarities with fat 
cells around hairs in humans and pigs (Hausman et al, 1981a). In addition, a 
similarity in development of such hair follicle-related fat cells was suggested 
between rats, pigs and man.  
 
Because of the number of fat cells around hairs, more adipocytes were seen 
in man and pig specimens when compared with rat samples (reviewed by Hausman 
et al, 1981a). Then, more hairs (hair coat) were spotted in rats. Thus, Hausman et al 
(1981a) commented that increase of fat cells might compensate decreased 
insulating function of hairs. 
 
Hair follicle adipose lobules were seen in human scalp, where the hair cycle 
is characterised by long growing time (reviewed by Hausman and Martin, 1982). 
Then hair follicles from other parts of the body seemed to have longer resting 
periods. Thus, a suggestion was made that adipocyte lobules in the scalp help to 
enhance activity of growing hairs. In humans, each hair follicle was though to have 
own growth cycles, whereas in mouse skin hair follicles undergo the same growth 
phase. Moreover, in adult mice hair follicles were observed in close proximity to 
adipocytes, but these fat cells were not considered as a part of distinct lobules (as it 
is observed for human scalp follicles). The presence of lobules around hairs was 
suggested to be related with cycles of hair growth (Hausman and Martin, 1982). 
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To summarise, morphological-based studies on several animals suggested 
the correlation between growing hair follicles and development of fat cells adjacent 
to follicles (see above). Moreover, developing hair follicles might be responsible for 
the features of adipose lobules (Hausman and Martin, 1982). However, to best of 
my knowledge, no more specific in vivo studies have been performed that would 
verify this hypothesis and analyse, on molecular level, events which take part along 
the skin dermis cells and lead to gradual differentiation of fat cells between hair 
follicles.  
 
Thus, in this thesis, after the basic analysis of the onset and development of 
fat cells in mouse embryonic skin dermis (Chapter 2), a microarray approach was 
applied in order to obtain information about gene expression profiles in dermis cells 
(in both adipocytes and non-fatty dermis cells) from mouse embryos (Chapter 3).   
 
1.2.7. Brief description of obesity and fat-related disorders. 
 The imbalance between food intake and energy expenditure develops 
abnormal accumulation of fat in organs that are crucial for metabolism (such as 
pancreatic muscle, liver or adipose tissue) and leads to obesity (reviewed by 
Wajchenberg, 2000; reviewed by Ahima, 2008; reviewed by Puhl and Heuer, 2009).  
 
Obesity occurs in adults as well as in children and is an issue during 
pregnancy. In relation to the size of developing subcutaneous fat organ in humans, 
the correlation between obese mothers and fatter newborn babies was suggested 
by Whitelaw (1976). Maternal excess in fat depots has been related with high risk of 
diabetes development in mothers (Tsoi et al, 2010). North America, Great Britain 
and countries in south-western Europe were characterised by the highest number of 
overweight and obese kids (Janssen et al, 2005) and because of the growing 
number of obese people, the better understanding of development and features of 
fat cells is crucial for creating treatments for abnormal lipid accumulation. 
 
Among known obesity-related disorders are insulin resistance, type 2 
diabetes mellitus, atherosclerosis or cardiovascular disease (Reaven et al, 2004; 
Sydow et al, 2005; de Paula et al, 2010). Obesity was related with changes in 
secretory capability of fat cells (dramatic increase in production of factors secreted 
from adipocytes) which can lead to the development of insulin resistance and 
diabetes type 2 (Hajer et al, 2008).   
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Insulin is a hormone produced by the pancreas and responsible for the 
control of glucose levels (De Meyts, 2004).  After meals, high levels of glucose in 
blood lead to increase in insulin levels (in blood) and glucose can be used 
immediately by cells or stored in the form of glycogen (in muscles and liver) or as 
triglycerides (in adipose tissue, see section 1.2.2.2.2.1). Insulin is also capable of 
preventing the excessive release of glucose from organs.  
In general, the term “diabetes mellitus” is used to describe a group of 
metabolic abnormalities related with high levels of blood glucose (hyperglycemia) as 
an effect of absence or abnormal function of insulin (reviewed by Raslova, 2010). 
Type 1 diabetes is related with destruction of pancreatic beta-cells producing insulin, 
whereas type 2 diabetes is associated with lower levels of produced insulin and 
reduced sensitivity of different cells in the body (insulin resistance). The insulin 
resistance syndrome (IRS), observed in individuals with insulin resistance can be 
associated with metabolic abnormalities: high plasma triglyceride or low 
concentration of high-density lipoprotein cholesterol: HDL-C. Insulin resistance 
syndrome is also called as the metabolic syndrome (Sydow et al, 2005). 
 
Treatments of diabetic patients are related with monitoring of glucose levels 
in blood, with healthy diet and lifestyle that will help to keep proper weight and finally 
with injections of insulin and/or implication of oral anti-diabetic agents (Keating, 
2010). The untreated diabetes can result in cardiovascular problems, development 
of chronic dental diseases, blindness or so-called diabetic foot alternation (Neely et 
al, 1998; Ship, 2003; Wajchenberg et al, 2008; Vuorisalo et al, 2009). 
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1.3. Adipogenesis. 
 The differentiation process during which preadipocytes develop into mature 
fat cells (adipocytes) and accumulate lipid droplets is called adipogenesis (reviewed 
by: Gregoire et al, 1998; Rosen, 2005; Poulos et al, 2010). 
 
 Detailed analysis of adipocyte differentiation steps and investigation of genes 
involved in this process were obtained from in vitro work, where different cells lines 
were used (see section 1.3.1.1). These cells, influenced by so-called adipogenic 
medium, were capable of progressive differentiation which leaded to accumulation 
of lipids and development of mature fat cells (see section 1.3.2). In addition, the use 
of transgenic animals allowed the verification of fat-related functions of genes, 
whose role in adipogenesis in different cell lines was studied (section 1.3.1.2). 
 
Development of a microarray approach has lead to detailed studies of cell 
features on a molecular level and made it possible to analyse gene expression 
pathways and investigate mechanisms involved in the control of cell fate and 
development of different tissues and organs (Heller, 2002; Shergill et al, 2004; Chen 
and Tzeng, 2006). Microarray-based studies, in relation to adipocyte differentiation 
in different cell lines, are presented in Chapter 3, section 3.1. In addition, in Chapter 
3, microarray work has been presented for the investigation of adipocyte 
differentiation of skin dermis cells located around hair follicle end bulbs. 
  
1.3.1. Investigation of adipocyte differentiation process: in vitro and in 
vivo studies.  
1.3.1.1. Cell lines. 
The most popular cell lines, used for the analysis of adipogenesis, were 
clonally isolated from Swiss 3T3 cells. First, whole embryos from Swiss mice (at age 
between 17 and 19 days) were used for the establishment of cell line (Todaro and 
Green, 1963). Embryos were minced and trypsinised and grown in monolayers. It 
was observed that this 3T3 fibroblast cell line, when reaching their confluency, 
seemed not to grow anymore and be alive for a while (Todaro and Green, 1963). In 
addition, some cells from resting cultures were showed to accumulate lipid droplets 
and be organized in clusters (Green and Kehinde, 1974). In very first experiments, 
after the trypsiniation of confluent 3T3 cells, lipid-accumulated cells disappeared. 
When this cell line reached once again its confluency and resting phase, the fatty 
cells developed. Next, two clones, called 3T3-L1 and 3T3-L2 were isolated that were 
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able to accumulate high amounts of lipids. The established 3T3-L1 line has become 
a widely used pre-adipose cell line that has the capability of undergoing 
adipogenesis and differentiates into mature fat cells (Green and Meuth, 1974; Green 
and Kehinde, 1975; Green and Kehinde, 1976).  
 
 In addition, the 3T3-F442A cells have also been derived from the same 
source as 3T3-L1 cells and are widely used for adipocyte-related studies (Kuri-
Harcuch et al, 1984; Moustaïd et al, 1988). These two cell lines can be influenced by 
so-called inducing agents (see section 1.3.2.2) in order to activate/enhance 
adipogenesis process.  
 
Because of the increase in obesity and diabetes epidemic, a need for better 
understanding of the mechanisms that control fat cell differentiation led to the 
establishment of many other cell lines and primary cultures capable of undergoing 
adipogenesis and some of them are summarised in Table 1.2.  
 
 
Despite, all knowledge that was gained from preadipocyte/adipocyte cell 
lines, several disadvantages and problems can be pointed in relation to in vitro 
studies which are discussed in Chapters 3, 4 and 5 of this thesis. Experimental work 
presented in these three Chapters aimed to develop an in vivo-like technique for the 
investigation of very early steps of adipogenesis in mouse embryonic skin dermis. 
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Table 1.2. Selected cell lines and primary cultures used for the analysis of 
adipogenesis process.  Based on table from Gregoire et al, 1998.  
 
Organism: 
 
Cell lines; 
Primary cultures: 
 
 
Reference: 
 
Human LS14 cell line from human 
metastatic liposarcoma. 
Hugo et al, 2004 
Pig Pig culture from stromal-
vascular (SV) subcutaneous 
adipose tissue cells.  
Hausman and Richardson, 1998 
3T3-L1 cells and  
3T3-F442A cells from mouse 
embryos (from 17 to 19 days) 
Green and Meuth, 1974 
Moustaïd et al, 1988 
mES cells from mouse 
blastocyst. 
Dani et al, 1997 
Ob17 cells from epididymal 
fat pads of Ob/Ob (obese) 
mouse*. 
Négrel et al, 1978; 
Grimaldi et al, 1982 
Preadipocyte cell line, AP-
18 from subepidermal layer of 
ear skin from an adult mouse. 
Doi et al, 2005 
Mouse 
Mouse culture from inguinal 
fat pads. 
Litthauer and Serrero, 1992 
Rat Rat culture from stromal-
vascular cells from the 
epididymal fat pad.  
Deslex et al, 1987 
*For more details about ob/ob mouse see section 1.3.1.2. 
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1.3.1.2. Mouse models. 
Mouse models have been widely used for analysis of fat depot development 
in vivo (reviewed by Valet et al, 2002). Mice have been used for such studies 
because of their small size, easier breeding and maintaining requirements (in 
comparison to other animals), beneficial effects of mating process and relatively 
high number of pups. Finally, because of the availability of sufficient and well 
established techniques for gene manipulation in these animals. 
Functions of a particular gene can be analysed by the specific expression of 
this gene in adipose fat depot and examples of such animals for adipogenesis 
related studies are presented in Table 1.3. The preparation of such animals is 
related with the expression of different genes under promoter regions specific for 
adipose fat depots, such as UCP-1 (uncoupling protein-1) that is specific for brown 
adipose tissue (for more details see section 1.2.2.1.2) or ALBP (adipocyte lipid 
binding protein, also known as aP2 or FABP4, for more details see sections 3.3 and 
3.4 of Chapter 3) which targets white and brown adipose tissue. In addition, some 
promoters can target adipose depots and other organs (for example GLUT4 - 
insulin-dependent glucose transporter 4). 
 
Table 1.3. Examples of promoters used for the specific (over-) expression of 
selected genes in mouse models. Such study allowed to investigate fat-related 
features in these animals. Based on Valet et al, 2002. 
 
Promoter: 
 
 
Targeted 
tissue: 
 
Gene: 
 
Analysis of 
transgenic 
animals: 
 
 
Reference: 
UCP-1 brown 
adipose 
tissue 
Beta3-adrengeric 
receptor (β3-AR) 
β3-AR needed to 
rescue effect of β3-AR 
agonists on insulin 
secretion or food 
intake 
Grujic et al, 
1997 
GLUT4 increased adipose 
tissue 
Shepherd et 
al, 1993 
UCP-1 
 
reduced 
subcutaneous 
adipose tissue 
Kopecky et al, 
1995 
ALBP 
(FABP4) 
brown 
and white 
adipose 
tissues 
Leptin changes in adipose 
tissue weight, 
dependent on age 
Qiu et al, 
2001 
GLUT4 adipose 
tissue and 
muscles 
Glutamine: 
fructose-6-
phosphate 
amidotransferase 
development of 
insulin resistance 
Hebert et al, 
1996 
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In addition, mice with silenced (invalidated) gene or with specific mutations 
incorporated into the gene have been used for the fat-related studies (reviewed by 
Valet et al, 2002; Table 1.4). Such mouse models allowed the investigation of 
features of many adipogenic transcriptional factors, such as C/EBPalpha or 
PPARgamma (described in section 1.3.3), genes involved in lipid and glucose 
metabolism or factors secreted by adipose tissue (Table 1.4).  
Interestingly, some of these transgenic animals die just before or after birth, 
thus the analysis of fat depots development is difficult in them. For example, the 
knockout animal for C/EBPalpha gene (C/EBPα-/- mice) died within 8 hours after 
birth as a result of hypoglycemia (low levels of blood glucose) (Wang et al, 1995). 
This work showed that C/EBPalpha factor has a crucial role in controlling the proper 
energy homeostasis. Next, in order to keep C/EBPα-/- mice alive for longer, these 
animals were crossed with transgenic mice which expressed C/EBPalpha in liver 
(because of the albumin enhancer/promoter) (Linhart et al, 2001). Normally, the 
C/EBPalpha is expressed by both adipose tissue and liver. Expression of 
C/EBPalpha in liver enhanced survival of these transgenic animals which at day 7 
were lacking white adipose tissue (perirenal, epididymal or subcutaneous fat depots). 
Brown adipose tissue (BAT) was still detected, however it was characterised by 
higher accumulation of lipids, when compared with wild type BAT. This work showed 
that C/EBPalpha is needed for the development of white adipose fat depots in vivo 
(Linhart et al, 2001). 
 
Similar complications were related with PPARgamma gene in transgenic 
mice (Barak et al, 1999). Barak et al (1999) performed a mutation on the 
PPARgamma gene related with the elimination of DNA-binding and ligand-binding 
functions of this factor. PPARgamma null mice were characterised by severe 
lethality at embryonic level (in utero). These embryos were characterised by 
disrupted function of placenta and abnormal cardiac development (which occurred 
at about 10 day of embryonic development). Next, the chimeric embryos were 
created which allowed the supplementation of PPARgama null embryos with wild 
type tertraploid cells (they contributed to placenta but not embryo development). 
Such animal survived several days after birth, and PPARgamma null tetraploid-
rescued mice were characterised by the lack of fat depots, thus it was suggested 
that PPARgamma is crucial for adipogenesis in vivo. Barak et al (1999) mentioned 
that “…white fat pads and subcutaneous fat started to emerge in the heterozygote 
pup, while completely absent in the mutant (data not shown)...” (citation from Barak 
et al, 1999). Next, in analysed pups, brown adipose fat (BAT) depot was seen in 
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heterozygote, whereas it was not present in null animal. In addition, the observation 
was made that similar pattern of an establishment of PPARgamma-positive-brown 
adipose lineage seemed to take place at E15.5 in both heterozygote and 
homozygote. Thus, PPARgamma was suggested not be crucial for the onset of BAT 
but for further modifications of BAT (Barak et al, 1999).  
Moreover, the brown adipose tissue is suggested to be the first fat depot with 
high PPARgamma (together with PPARalpha and PPARbeta) expression in rats 
(Braissant and Wahli, 1998).  
 
 
Table 1.4. Examples of knockout animals used for the analysis of genes function in 
relation to adipogenesis in vivo. Based on Valet et al, 2002. C/EBPalpha, 
PPARgama are discussed in Chapters 2 and 3, angiotensinogen in Chapter 3, 
whereas CD36 in Chapters 3 and 5.  
 
Target: 
 
Analysis of 
transgenic animals: 
 
 
Reference: 
C/EBPalpha 
knockout 
 
hypoglycaemia; 
newborns died within 8 
hours after the birth 
Wang et al, 1995 
C/EBPalpha 
expressed only in 
the liver but not 
in other tissues 
absence of white 
adipose fat depots 
(visceral and 
subcutaneous); 
enhanced accumulation 
of lipids in brown 
adipose tissue 
Linhart et al, 2001 
PPARgama 
mutation 
utero lethality 
 
Barak et al, 1999 
Transcription 
factors 
PPARgamma 
mutation with 
rescued placental 
defect 
lack of adipose tissue Barak et al, 1999 
CD36/FAT defective fatty acid 
uptake 
Febbraio et al, 1999 Lipid and 
glucose 
metabolism Perilipin reduced adipose tissue;  
aberrant adipocyte 
lipolysis 
Martinez-Botas et 
al, 2000 
Tansey et al, 2001 
Interleukin-6 mature-onset obesity Wallenius et al, 
2002 
Secreted (by 
adipose tissue) 
factors  Angiotensinogen  alteration in development 
of adipose tissue 
Massiera et al, 2001 
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It is worth mentioning the animal models used for the investigation of obesity 
and diabetes. A mouse with spontaneously developing obesity was observed in the 
Jackson laboratory (Ingalls et al, 1950). These animals started to gain weight 
between four to six weeks of their life and could become four times bigger than 
normal mice. In 1994, the nonsense mutation of ob gene (which codes leptin, for 
more details about leptin see section 1.2.2.2.2.3) has been related with the 
development of these obese animals (for example in C57BL/6J ob/ob mouse strain) 
and mouse ob gene and its human homologue was successfully cloned and 
sequenced (Zhang et al, 1994). Briefly, the occurring point mutation changes C to T 
and arginine codon is changed for a stop codon (at position 105) (Zhang et al, 1994). 
As an effect of such change, no 16kDa leptin is present in homozygous mice. 
 
In addition, obese animals can develop diabetes (Coleman, 1982), thus the 
ob/ob mouse model became very popular in the analysis of fat-related disorders 
(Drel et al, 2006). Moreover, mutations in the ob gene were combined with other 
mutations in order to further investigate adipose tissue features, metabolic 
processes and obesity. For example, mice were created that were lacking leptin and 
neuropeptide Y (NPY) gene and this work confirmed a role of NPY in energy 
homeostasis (reviewed by Butler and Cone, 2001). 
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1.3.2. Adipocyte differentiation in vitro. 
 Adipogenesis process, analysed in different cell lines and primary cultures 
(section 1.3.1.1), is related with such terms as the growth arrest, clonal expansion or 
adipogenic medium and inducing agents (Figure 1.7A and Figure 1.7B).  
 
1.3.2.1. Growth arrest and clonal expansion.  
 The growth arrest, together with the occurrence of confluence, is observed 
as a first step of the activation of adipogenesis in vitro and the contact inhibition 
leads to the growth arrest (Rosen and Spiegelman, 2000). In relation to confluence, 
this feature is dependent on the type of cell line and primary culture and for example 
it was shown that primary preadipocytes established from rat and kept at low density, 
are capable of differentiation without the cell-cell contact (reviewed by Gregoire et al, 
1998).  
It is suggested that the growth arrest (the G1/S boundary) can be activated 
by a hormonal “regimen” and seems to be related with adipogenic transcriptional 
factors (such as C/EBPs and PPARgamma, which are also discussed in section 
1.3.2.2). The growth arrest is followed by the clonal expansion process (Ailhaud et 
al, 1989; Rosen and Spiegelman, 2000). C/EBPalpha, antimitotic agent, inhibits cell 
proliferation and is involved in activation of a cell cycle component p21/SDI-1 
(Timchenko et al, 1996). Also, p18 (cyclin-dependent kinase inhibitor) can be 
influenced by adipogenic factors and its level was induced by expression of 
PPARgamma in NIH-3T3 fibroblasts (Morrison and Farmer, 1999).  After the growth 
arrest, cells require factors (see section 1.3.2.2 for more details) which activate the 
next steps of differentiation and then, during the clonal expansion one or two rounds 
of cell division take place (Ailhaud et al, 1989). Depending on the type of cells, DNA 
synthesis seems to be important for adipocyte conversion (for example in 3T3-
F442A cells: shown by Kuri-Harcuch and Marsch-Moreno, 1983) or the cell division 
is not needed for further steps of in vitro differentiation (precursor cells from human 
adipose tissue, shown by Entenmann and Hauner, 1996).  
 
Retinoblastoma proteins have been related with adipogenesis in vitro 
(Richon et at, 1997; Ross et al, 2008). Such proteins as pRb, p107 (retinoblastoma 
like-1) and p130 (retinoblastoma like-2) bind and regulate the activity of E2F 
transcription factors and control the cell cycle progression. At the G1 phase of the 
cell cycle, complex pRB-E2F (with underphosphorylated pRb) inhibits the E2F-
dependent transcription. The p130 is related with GO/G1 phase, whereas the 
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complex p107-E2F occurs during S-phase. Both, p107 and p130 were analysed in 
relation to adipogenesis and the re-entry step into the cell cycle (clonal expansion) 
from the growth arrested step (Richon et al, 1997; Ross et al, 2008).  
 
Richon et al (1997) showed that confluent 3T3-L1 preadipocytes at day 0 
(non-treated cells, before the addition of adipogenic medium) were in the growth 
arrested phase (low number of BrdUrd positive cells), whereas at day 1 
(approximately one day after the addition of adipogenic medium with insulin, 
dexamethasone and isobutylmethylxanthine which are discussed later in this 
Chapter) cells were proliferating, while at day 3 they become “quiescent” (Richon et 
al, 1997). On the protein level, it was shown that in 3T3-L1 cells at day 0, both p130 
and the p130-E2F complex were observed, whereas no free E2F or p107 were 
seen. At day 1, complex p107-E2F together with p107 and free E2F were detected, 
whereas the level of p130 dramatically decreased. During next days of adipogenic 
induction, p130 protein level was gradually increasing, whereas the p107 protein 
was decreasing. In addition, on mRNA levels, only p107 was changed (but not 
p130) during the adipocyte differentiation and it was related first with a dramatic up-
regulation at day 1 and then its dramatic down-regulation during days 2 - 4. This 
suggested the specific regulation of p107 at a transcriptional level during 
adipogenesis in vitro. Because p130 mRNA levels did not change during analysed 
time-points, it was suggested that its regulation occurs at post-transcriptional level 
(Richon et al, 1997). 
A study performed on human adipose derived stem cells (hASC) aimed to 
analyse changes in p107 and p130 levels (Ross et al, 2008). These multipotential 
stem cells (not already committed cells to adipogenesis as 3T3-L1 preadipocytes) 
required longer treatment with adipogenic medium (10 days) for terminal 
differentiation and occurrence of fat cells with lipids. During these ten days, hASC 
cells did not undero the clonal expansion and levels of p130 gradually decreased 
during the adipogenesis process (Ross et al, 2008). In addition, p107 protein was 
up-regulated in hASC cells at day 4 and then gradually its level decreased, 
suggesting a similar expression pattern of p107 in both 3T3-L1 and hASC during 
adipocyte differentiation (Ross et al, 2008). 
 
In general, it is not clear if the clonal expansion is always needed during 
adipogenesis. A suggestion was made that clonal expansion can be a form of an 
“artifact” of cell culture environment or that some isolated cells are already after this 
step (Rosen and Spiegelman, 2000). 
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A) 
 
B) 
 
C) 
 
Figure 1.7. A schematic presentation of adipogenic differentiation in vitro. (A) Stages 
of preadipocyte differentiation. (B) Components of adipogenic medium and 
suggested pathways of adipogenesis activation. (C) Chronology of adipogenic 
transcription factor activation progress to terminal differentiation of the fat cell.  
Information derived in part from: Richon et al, 1997; Gregoire et al, 1998; Morrison 
and Farmer, 1999; Rosen and Spiegelman, 2000; Rosen et al, 2002. 
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1.3.2.2. Adipogenic medium and steps of adipogenesis in vitro. 
Adipogenic medium, with specific agents, is used for the activation and 
enhancement of adipogenesis in vitro (reviewed by Gregoire et al, 1998). Such 
agents as insulin, dexamethasone (DEX) and isobutylmethylxanthine (IBMX, MIX: 
methylisobutylxanthine) are widely used for the induction of adipogenesis in 3T3 
cells and were applied in experiments shown in Chapter 4 and 5 of this thesis (see 
also Figure 1.7B). In addition, insulin is the main ingredient of adipogenic medium 
used on both cell lines and primary cultures (reviewed by Gregoire et al, 1998).  
It is worth mentioning that, depending on the exact type of cells, other factors 
(for example together with insulin) were observed which activated adipogenesis. 
The influence of both insulin and lipolytic hormones (epinephrine and corticotrophin 
which induce lipolysis) or 3,3’,5-triiodothyronine was analysed on Ob17 cells (Négrel 
et al, 1978; Grimaldi et al, 1982). Insulin-like growth factor 1 (IGF-1), similarly as 
insulin, was shown to be important for the activation of adipogenesis in 3T3-L1 
preadipocytes (Smith et al, 1988). 
 
Insulin was suggested to react with insulin-like growth factor 1 receptor 
(similarly as IGF-1) and stimulate ras and protein kinase B (Akt). Both ras and Akt 
were shown to influence adipogenic differentiation (Benito et al, 1991; Magun et al, 
1996). Dexamethasone (DEX) might interact with the glucocorticoid receptor 
(nuclear hormone receptor) and was shown to induce C/EBPδ (C/EBPdelta) mRNA 
and reduce mRNA and protein levels of Pref-1 (Cao et al, 1991; Smas and Sul, 
1993). Isobutylmethylxanthine (IBMX, MIX: methylisobutylxanthine), a 
phosphodiesterase inhibitor, was shown to activate C/EBPβ (C/EBPbeta) probably 
by the increase of cAMP (cyclic AMP) levels and this was shown to influence 
adipogenesis in 3T3 cells (Cao et al, 1991; Yarwood et al, 1995; Rosen and 
Spiegelman, 2000). It is important to mention here that the exact role of suggested 
adipogenic factors and detailed description of pathways involved in adipogenesis 
activation, especially in relation to in vivo process, are not fully understood or 
defined and still have to be examined (Rosen and Spiegelman, 2000). 
After the activation of both C/EBPdelta and C/EBPbeta, expression of 
PPARγ (PPARgamma) occurs, which is suggested to influence the activation of 
C/EBPα (C/EBPalpha) (Figure 1.7C). In mice fibroblasts, null for PPARgamma 
(PPARγ-/- cells), C/EBPalpha was not capable of promoting adipogenesis on its own 
(Rosen et al, 2002). In addition, it is believed that activated C/EBPalpha influences 
PPARgamma in order to remain adipocyte differentiation (positive feedback loop). 
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C/EBPalpha null fibroblasts were capable of adipogenesis, however these cells had 
lower amount of lipids and were characterised by low levels of PPARgamma (Wu et 
al, 1999). Then, the application of C/EBPalpha to these cells (by the retroviral vector) 
allowed the activation of PPARgamma expression. 
 Among other factors involved in regulation of adipogenesis are GATA-
binding transcription factors or cAMP response element binding protein (CREB) 
(reviewed by: Gregoire et al, 1998; Rosen, 2005; Poulos et al, 2010).  
 
Mature fat cells (adipocytes) accumulate lipids and produce proteins which 
are next secreted by these cells (for example resistin and leptin, adipsin or 
adiponectin; see Table 1.1 in this Chapter and Chapter 3, section 3.3.2). 
 
When adipogenesis is activated, the cell shape is changed and fibroblast-like 
cells acquire a spherical structure (reviewed by Gregoire et al, 1998). Some 
interesting changes in cell morphology and the level of extracellular matrix (ECM) 
and cytoskeletal elements are also observed. For example, it was shown that when 
adipogenesis was activated in 3T3 cells, decreases in beta and gamma actin, alpha 
and beta tubulin and vimentin were observed (Spiegelman and Farmer, 1982). It 
was suggested that these changes are very early processes that occur during 
differentiation. They can be responsible for the development of the specific 
morphology of adipocytes and they may activate expression of C/EBP factors and 
PPARgamma. 
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1.3.3. Adipogenic transcription factors - crucial regulators of early 
stages of adipogenesis.  
1.3.3.1. CCAAT/enhancer binding protein family. 
One of the most important transcription factors, involved in the adipogenesis 
activation, belong to the CCAAT/enhancer binding protein family (C/EBP). The 
C/EBPs include several nuclear transcription factors: C/EBP α, β, γ, δ, ε (Landschulz 
et al, 1988).  
It was observed that the sequence of different C/EBPs are identical in the C-
terminal part (55 - 65 amino acid residue), in which bZIP domain is present (Hurst, 
1994; Gregoire et al, 1998; Ramji and Foka, 2002). The highly conserved bZIP 
domain has a basic amino-acid rich DNA-binding part and a dimerization motif 
called the “leucine zipper”. The leucine zipper has heptad repeat of four or five 
leucine residues. These residues give α-helical configuration, which then leads to 
the formation of a coiled-coil structure. Dimerization is needed for the DNA binding, 
which is controlled by the basic region. It was shown that the DNA binding depends 
on the amino acid sequence within the basic region (Hurst, 1994). The dimer 
structure has Y-shaped architecture and each arm of this structure is made from the 
basic region and binds to one-half of a sequence in the DNA major groove (Hurst, 
1994). The different C/EBP proteins can form interfamilial heterodimers because of 
the fact that the bZIP domain is highly conserved. The N-terminal of C/EBPs 
contains three short parts conserved in most C/EBPs, which represent the activation 
domain that can stimulate transcription. The activation domain does not occur in 
C/EBPgamma factor, which therefore can form inactivated heterodimers with other 
C/EBPs. The general sequence preferences, specific for these factors is related with: 
RTTGCGYAAY element, where R is A or G and Y is C or T (Osada et al, 1996). 
 
It was noticed that C/EBP proteins are expressed at different levels in 
various tissues. The high expression of C/EBPalpha was observed in the adipose 
tissue, placenta, intestine, liver, and lung, whereas the C/EBPbeta level is quite high 
in the lung, spleen, kidney, adipose tissue, and lung (Ramji and Foka, 2002). 
 
Among functions of C/EBPs are control of metabolism, cell differentiation or 
proliferation and these factors play crucial role in adipogenesis, as was mentioned 
earlier. 
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1.3.3.2. Peroxisome proliferator-activated receptors (PPARs). 
PPARs are transcription factors, which belong to type II nuclear hormone 
receptor family and form heterodimers with retinoid X receptors (RXRs) (Schoonjans 
et al, 1996). They have two conserved domains: the centrally located DNA-binding 
domain and the C-terminal region, which has the ligand-binding domain (LBD) 
(Uppenberg et al, 1998; Lee et al, 2003). Prostaglandins are specific ligands for 
PPARgamma (Nosjean and Boutin, 2002). Among other known ligands for 
PPARgamma are thiazolidinedione (TZD) class of anti-diabetic drugs (Lehmann et 
al, 1995). PPAR with RXRs binds to so-called PPAR response elements (PPREs) 
and regulate transcription of genes.  
PPAR factors, such as PPARα (NR1C1), PPARδ/β (NR1C2), and 
PPARγ  occur in different tissues and have different biological activities. PPARalpha, 
for example is expressed in the heart, muscles or kidney and controls lipid 
homeostasis (Lee et al, 2003; Rosen, 2003).  
 
PPARgamma, as was mentioned earlier in this Chapter, is up-regulated in 
cells treated with adipogenic medium and is responsible for adipocyte differentiation 
(see section 1.3.2).  There are two isoforms of PPARgamma: gamma 1 and gamma 
2 (Zhu et al, 1995). Mouse PPARgamma gene was observed to give two mRNAs, 
which differ at 5’ ends and PPARgamma 2 isoform was characterised by the 
additional 30 N-terminal amino acids. These two mRNAs were related with different 
promoters and tissue-specificity. PPARgamma 2 is treated as an adipocyte-specific 
nuclear hormone receptor (Tontonoz et al, 1994).  
 
1.3.4. Examples of factors and pathways involved in regulation of 
adipogenesis.  
Adipogenesis is controlled by a variety of proteins and pathways that can 
activate or inhibit this differentiation process. One of the suggested adipogenesis 
inhibitors is Pref-1, synthesized as a plasma membrane protein (reviewed by 
Gregoire et al, 1998). The high level of Pref-1 is observed in preadipocytes and its 
downregulation is needed for adipose conversion. This molecule can have two 
forms (50 kDa and 25 kDa) and the bigger one is thought to be responsible for the 
inhibition of adipogenesis (Mei et al, 2002). Pref-1 is also discussed in Chapter 2 
(sections 2.2.5.1 and 2.4.5). 
Adipogenesis is also controlled by the Wnt pathway and beta-catenin 
(Kennell and MacDougald, 2005). In general, the Wnt signalling is related with 
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differentiation processes of cells and organogenesis in mammals.  The family of Wnt 
genes encodes secreted factors (glycoproteins), called “Wnts” and Wnts are 
responsible for different structures created during organogenesis (Dale, 1998; 
Smalley and Dale, 1999). The Wnt-10b ligand is responsible for the regulation of 
adipogenesis and its high level was observed in preadipocytes (Katoh and Katoh, 
2005). It is suggested that Wnt-10b may govern adipogenesis by inhibiting the 
activity of C/EBPalpha and PPARgamma (Ross et al, 2000). It was also noticed that 
adipogenic factors (for example PPARgamma) can inhibit Wnt signalling (Moldes et 
al, 2003). 
The multifunctional protein, beta-catenin, plays an important role in the Wnt 
pathway. In general, the Wnt system regulates both the amount and localisation of 
beta-catenin (Eberhart and Argani, 2001). Briefly, the secreted Wnts bind to the 
“frizzled” membrane receptors, which transfer the signal inside the cell and the 
activity of GSK kinase is inhibited (Figure 1.8). Because of this, beta-catenin can not 
be phosphorylated and can not be degraded in the proteasome. Thus its level 
increases and beta-catenin is translocated into the nucleus. In the nucleus, active 
beta-catenin forms a complex with Tcf/Lef factors and expression of different genes 
is activated (Dale, 1998). When active beta-catenin is accumulated in the nucleus, 
the inhibition of adipogenesis is observed. When the Wnt signalling is turned off, 
adipocyte differentiation is activated.  
 The WNT signalling pathway is also discussed in Chapter 3 (section 3.4.1). 
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Figure 1.8. A schematic presentation of the canonical Wnt signalling pathway. 
Adapted from Dale, 1998. 
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1.4. Thesis aims. 
Work presented in this thesis aimed to increase knowledge about the 
process of adipogenic differentiation in vivo, leading to development of the fat depot 
in rodent back skin. 
  
 The first hypothesis tested in this study was that precursors of fat cells, 
localised in lower back skin dermis, undergo adipogenic differentiation during late 
stages of rodent embryonic development and create the dermal adipose tissue after 
the animal birth. The work in Chapter 2 investigated the timing and location of the 
onset of adipogenesis and the subsequent development of a fat depot in skin dermis. 
This was achieved by dissection and staining of the whole skin and subcutaneous 
fat layer; tracking the accumulation of lipid droplets (Oil Red O analysis) and by 
following the expression of an adipogenic transcription factor C/EBPalpha 
(immunofluorescence technique) at different time points in late embryonic/foetal 
development. 
   
The aim of the work from Chapter 3 was to clarify the hypothesis that 
dynamic changes at molecular level take place between e17 and e19 time points in 
two dermal compartments which are crucial for the development a non-fatty area 
(upper dermis) and the dermal adipose tissue (lower dermis). In addition, the 
adipogenesis process observed in lower dermis was hypothesised to differ in some 
extent from adipogenic differentiation widely investigated using in vitro approaches 
(3T3-L1 cells). Chapter 3 describes a microarray-based study using laser capture 
microdissected cells from embryonic back skin dermis, based on the timing and 
location of the events of adipogenesis established in Chapter 2. 
 
 The work in Chapter 4 was directed at developing tools for functionally 
assessing the activities of genes associated with adipogenesis. It involved modifying 
techniques for culturing pieces of embryonic/foetal skin, or growing dermal cell 
populations, and then examining the effects of an exemplar Egfr gene chosen from 
the microarray lists from Chapter 3. The hypothesis presented in Chapter 4 was that 
the EGF-EGFR signalling pathway is involved in the regulation of adipogenic 
differentiation in vivo in lower dermis between e17 and e19 time points. 
  
 Chapter 5 aimed to establish a protocol for the fluorescence activated cell 
sorting (FACS), in order to dissect a preadipocyte population from embryonic skin 
dermis. Once again this approach was underpinned by the microarray data in 
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Chapter 3, from which the cell surface markers (CD36, Fzd4) were obtained. It was 
hypothesised that FACS sorted CD36-positive cells, represent a lower dermal cell 
population that undergo adipogenesis and create dermal adipose tissue in mouse 
back skin. 
 
Chapter 6 intended to bring together some of the main ideas and themes of 
this thesis; to suggest some answers to more general questions raised from these 
studies about the control of adipogenesis in skin; and to suggest some ideas for 
future studies. 
  
 
 
Chapter 2 : 
The investigation of dermal adipose 
tissue development and an effective 
marker for preadipocyte/adipocyte 
cells in rodent skin dermis. 
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2.1. Introduction. 
 Nowadays, interest in adipocytes (their development and functions) has 
enlarged because of the obesity and high number of fat-related disorders. Widely 
available knowledge about adipogenesis process comes mainly from in vitro studies, 
where a number of cell lines have been used (for example 3T3 cells, for more 
details see Chapter 1, section 1.3.1.1). In addition, the investigation of adipose 
organ development is being investigated in mouse models (Valet et al, 2002).  
 
White adipose tissue is divided into two depots: visceral adipose tissue - 
VAT and subcutaneous adipose tissue - SAT (Cinti, 2001). Subcutaneous fat depots 
beneath mouse skin have either anterior (under the head, near the neck and upper 
limb area) or posterior localisation (near the lower limbs). The VAT has been 
associated with insulin resistance or type 2 diabetes and its removal in humans can 
lead to a decrease of both glucose and insulin levels (Porter et al, 2009). 
Subcutaneous adipose tissue was suggested to have a beneficial effect on the 
metabolism (in relation to its transplantation into visceral fat depots) (Tran et al, 
2008). These few results clearly show how important it is to carry out fat-related 
studies and develop in vivo techniques where more features of adipocytes can be 
investigated. 
 
Fat depots in close proximity and beneath the skin are treated as a 
subcutaneous adipose tissue that seems to develop at foetal level in the form of 
several distinguishable layers that are divided by a connective tissue (Poulos et al, 
2010). During the detailed analysis of subcutaneous fat in pigs and rats, the outer 
layer was observed to differ from other fat layers, because of the presence of fat 
cells around hair follicles (Hausman et al, 1981a; Mersmann et al, 1975). Hausman 
and his colleagues analysed the rat hypodermis layer, where adipogenesis had 
been suggested to be linked with the development of hair follicles (Hausman et al, 
1981a). In addition, some basic analysis of fat depots occurrence in human foetuses 
was carried out (Poissonnet et al, 1984). A suggestion was made that the rat 
hypodermis is anatomically similar to the outer layer of subcutaneous fat in both pigs 
and humans (Hausman et al, 1981a). In rodents fat depot in dermis was named the 
dermal adipose tissue and was observed to be separated from subcutaneous 
adipose tissue by a muscle layer (Cinti, 2007).  
 
The main experiments presented in Chapter 2 were performed on mouse 
back skin specimens in order to test the hypothesis that a population of 
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preadipocytes resides in lower skin dermis of mouse embryos and is being activated 
to undergo adipoenesis at late stages of embryonic development which leads to a 
creation of a dermal adipose tissue in back skin of newborn animals.  
 
In general, available knowledge about fat cells in and beneath the skin was 
performed on different skin sections stained with dyes that bound to lipids. Next, the 
light microscopy allowed information to be obtained about the morphology of fat 
cells and features of accumulated lipids (Hausman et al, 1981a). This in vivo 
analysis however is lacking more advanced study of very early signals of 
adipogenesis, when no fat is yet accumulated in so-called preadipocytes that 
gradually differentiate into mature fat cells. Development of cell culture techniques 
and establishment of preadipocyte cell lines gave insight into the molecular 
mechanisms of adipogenesis and allowed to gain knowledge about genes involved 
in differentiation of fat cells in vitro (for more details see Chapter 1, section 1.3.1.1). 
Next, the use of mouse models helped to study the function of different adipocyte-
related genes (see Chapter 1, section 1.3.1.2). However, there are still questions 
related with the “real” in vivo features of very early steps of adipogenesis. Thus, in 
the second part of Chapter 2, results form the investigation of an in vivo marker for 
preadipocytes and adipocytes in lower rodent skin dermis were shown. The cross-
sections from back skin samples were incubated with antibodies against several 
factors known to be involved in early stages of adipogenesis, mainly based on in 
vitro work. Finally, the antibody, against adipogenic transcription factor C/EBPalpha 
allowed the investigation of the timing and location of cells that undergo adipocyte 
differentiation in lower skin dermis of rats and mice.  
 
To sum up, the first part of the study presented in Chapter 2 is related with 
the analysis of the onset and development of rodent fat cells in lower skin dermis 
(with the main focus on mouse skin) and investigation of the correlation of these 
adipocytes with other subcutaneous fat depots. Next, the marker for preadipocyte 
and adipocyte cells in lower dermis was successfully established which enhanced 
knowledge about general features of early stages of fat cell differentiation. Work 
presented in this Chapter has been published (Wojciechowicz et al, 2008). 
 
In addition, study presented in Chapter 2 helped to set up a more detailed 
experiment where the gene expression pattern of differentiating preadipocytes in 
lower embryonic mouse dermis was obtained during rodent development. This work 
is described in Chapter 3. 
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2.2. Methods. 
2.2.1. Housing, breeding and feeding conditions of rodents. 
Mice (CD1) and rats (PVG), from the Durham University Life Sciences 
Support Unit, were bred and maintained at a temperature of 21oC, with 55% 
humidity and kept on a 12 hour light/dark cycle. All animals were on Harlan Teklad 
2014 Rodent Maintenance diet, and watered and fed ad libitum. 
Analysis of vaginal plugs was used to establish the baseline age of embryos 
used for experiments. Breeding pairs were kept together overnight and the presence 
of a vaginal plug in the morning indicated a successful mating, at which point 
embryos were considered to have undergone 0.5 days of gestation. 
Rodents were sacrificed using carbon dioxide and/or cervical dislocation, as 
under Schedule 1 of the Animal (Scientific Procedures) Act 1986. 
 
2.2.2. Preparation of whole mouse skin samples for the global analysis 
of fat accumulation. 
Animals from multiple developmental time points (few hours, 2 and 6 day old 
mouse newborns) were used in order to collect the skin from their whole bodies for 
global analysis of fat accumulation in mouse skin. First, an incision was made in the 
abdomen of the mouse body from the caudal to dorsal direction. Then, incisions 
were made in the other skin areas of the abdomen part (such as along the limbs, 
neck and tail). Skin was carefully pulled off from the mouse body by cutting off the 
muscle connection between the skin and the body. Skin was not collected from the 
extremities of the animal limbs. Skin from the head and ears was taken from most 
samples, but not from vibrissae pads (because of the tight connection of the skin 
and hair follicles to the mouse body). While the whole skin was removed from the 
mouse body, the biggest anterior fat depots under the skin were not collected. The 
skin area of main interest was related to dermis from the mouse back.  The whole 
skin samples underwent the Oil Red O analysis according to the protocol presented 
in section 2.2.4.  
 
2.2.3. Preparation of skin sections from rodent back skin. 
Skin samples were taken from 15 (e15; 15dE time point), 16.5 - 17 (e17; 
17dE time point), 18 (e18; 18dE time point), 18.5 - 19 (e18.5 - 19; 18.5 - 19dE time 
point) and about 19 (e19; 19dE time point) day old mouse (CD1) embryos. In 
addition, samples were taken from 18 (e18; 18dE time point) and 20/21 (e20/21; 
20/21dE time point) day old rat (PVG) embryos. 
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Samples were also prepared from mouse (CD1) newborns (0.5, 1, 2, 4, 5, 8, 
10, 12, 15, 17 and 19 days, named respectively as 0.5dN, 1dN, 2dN, 4dN, 5dN, 8dN, 
10dN, 12dN, 15dN, 17dN and 19dN time points) and rat (PVG) neonates (at 1, 2 
and 6 days: 1dN, 2dN and 6dN time points).  
 
Skin specimens were collected from the animal back (Figure 2.1 and Figure 
2.2, for detailed analysis of both figures see also section 2.3.2). First, incisions along 
both sites of the rodent back were made from the caudal to dorsal (head to tail) 
direction. Then, skin was cut along the neck and below the tail and a square-like 
piece of back skin was obtained that was carefully removed from rodents by cutting 
the muscle connection between skin and the rest of the body. Fat layers, beneath 
the back skin in anterior and posterior localisations, were collected with the back 
skin specimen for the Oil Red O analysis. Back skin samples, used for 
immunohistochemical analysis and lipid detection in skin dermis, were rolled up. 
Rolled samples were put into the Tissue-Tek® O.C.T.TM Compound (Sakura), then 
snap frozen in liquid nitrogen and kept at -80oC. For lipid detection in skin dermis 
and fat layers seen beneath the skin, back skin samples were not rolled but cut in 
half (Figure 2.2c) and then put into the Tissue-Tek and frozen (in liquid nitrogen).  All 
back skin sections (7 µm for embryonic mouse samples and all rat samples and 10 - 
14 µm from mouse newborns),  were cut on a cryostat (LEICA CM 3050S) and 
attached to SuperFrost®Plus slides (Menzel-Glaser), air dried for up to 90 min at 
room temperature, and then used immediately for lipid detection, 
immunofluorescence or immunohistochemical analysis. The Oil Red O study 
allowed the investigation of lipid depots along the skin and beneath the skin. The 
immunofluorescence and immunohistochemical analysis were related with the 
analysis of skin epidermis and dermis. 
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Figure 2.1. Stages of the back skin removal procedure performed on a one day old 
newborn mouse. a) Incisions were made in the top part of the back skin (near the 
neck area) on both sides of the body. b) Fat depots were observed under the top 
part of back skin. c) Fat depots were observed in the bottom part of mouse body, 
near the limbs. d) The back skin was carefully removed from mouse body. e) A back 
skin sample with fat depots under the skin. S-e: skin from the epidermis site. S-d: 
skin from the dermis site. FLs: fat layers. PF: posterior fat. Specimens were placed 
on a 1 mm2 grid paper. Images were captured using a Ziess StemiSVII microscope. 
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                     c) 
 
 
Figure 2.2. Features of fat depots localised beneath the mouse back skin. a) Fat 
depots attached by thin layers of muscle to the skin. b) Fat depots in the top part of 
the back skin from newborn mice at different stages of development (d - day; N - 
newborn). c) The skin sections were obtained from approximately the central part of 
the back skin specimen. TP: top part of the back skin. BT: bottom part of the back 
skin. S-e: skin from the epidermis site. FLs: fat layers. M: muscle layer. PF: posterior 
fat. Specimens were placed on a 1 mm2 grid paper. Images were captured using a 
Ziess StemiSVII microscope. 
 
 
 
 
 
Skin area used for 
sections. 
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2.2.4. Oil Red O staining and modified H&E staining. 
Skin samples were stained with the Oil Red O dye (Sigma) to detect lipids 
presence along and beneath the skin. In addition, the analysis of fat in rodent skin 
was performed only on the frozen sections. The wax method was not applied for this 
study, because it removes lipids. 
 
The Oil Red O staining protocol was used previously by Richardson et al 
(2005). Prepared on the cryostat back skin sections were washed three times in 
PBS (Phosphate buffered saline; Appendix I) (each wash lasted 5 min) and fixed in 
calcium formal: 4% formaldehyde (Sigma) and 1% calcium chloride (Sigma) for one 
hour at room temperature (RT). Next, samples were incubated for 15 min in 60% 
isopropanol (Sigma) and then stained for 15 min with a filtered solution of three 
parts of Oil Red O (saturated in isopropanol) and two parts of water. For the next 
step skin samples were briefly rinsed in 60% isopropanol, washed thoroughly in 
distilled or double distilled water (dH2O, ddH2O). Cells were counterstained in 
Mayer’s Hematoxylin solution (Fluka) and mounted in Glycergel (DakoCytomation) 
or mowiol (Appendix I). 
When whole mouse skin samples were stained with the red dye, they 
underwent the protocol described above, however the incubation step with the Oil 
Red O dye was related with the thickness of skin (thicker skin - longer incubation, up 
to 30 - 60 min). In addition, whole mouse skin samples were not counterstained in 
Mayer’s Hematoxylin solution and were not mounted in Glycergel. Stained samples 
were kept in PBS at 4oC. 
 
2.2.5. Immunofluorescence analysis. 
2.2.5.1. Pref-1 staining.  
The unfixed skin sections were first washed three times in PBS (each wash 
lasted 5 min) and blocked with 20% goat serum (Sigma) in PBS for 30 min at RT. 
Sections were then incubated with a polyclonal rabbit antibody Pref-1/DKL-1 (PTG) 
overnight at 4oC or 1 hour at room temperature (1:10, 1:50 or 1:100 dilutions in 1% 
goat serum/PBS). Skin sections were washed three times in PBS as described 
above and incubated with goat anti-rabbit antibody (AlexaFluor, for details see 
Chapter 3, Table 3.3B), diluted 1:500 in 1% goat serum/PBS for 1 hour at room 
temperature or overnight at 4oC. Normally DAPI (Insight Biotechnology) was added 
to this secondary antibody solution at a dilution of 1:5000. Sections were then 
washed three times in PBS as before and mounted in anti-fade Immu-mount 
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(Thermo Electron Corporation) or mowiol (Appendix I) and covered by the coverslips. 
Incubations with antibodies were performed in the dark. Slides were kept in 4oC, in 
the dark. 
 
2.2.5.2. PPARgamma staining. 
Skin samples were incubated in 4% paraformaldehyde (Sigma)/PBS for 15 
min at room temperature (RT), next in 0.5% TritonX-100 (Sigma)/PBS for 5 min in 
4oC. Then samples were washed three times in PBS (each wash lasted 5 min) and 
blocked with 20% donkey serum (Sigma) in PBS for 30 min at RT. Sections were 
incubated with a polyclonal rabbit antibody PPARgamma (Abcam) for one hour at 
RT (1:50 dilution in 1% donkey serum/PBS). Skin sections were washed three times 
in PBS as described above and incubated with donkey anti-rabbit antibody 
(AlexaFluor, for more details see Chapter 3, Table 3.3B) diluted 1:500 in 1% donkey 
serum/PBS for one hour at RT. Normally DAPI (Insight Biotechnology) was added to 
this secondary antibody solution at a dilution of 1:5000. Sections were then washed 
three times in PBS as before and mounted with mowiol (Appendix I) and covered by 
the coverslips. Incubations with antibodies were performed in the dark. Slides were 
kept in 4oC, in the dark. 
 
2.2.5.3. C/EBPalpha staining. 
The unfixed skin sections were first washed three times in PBS (each wash 
lasted 5 min) and blocked with 20% goat serum (Sigma) in PBS for 30 min at RT. 
Sections were then incubated with a polyclonal rabbit antibody (C/EBPalpha, Santa 
Cruz Biotechnology) overnight at 4oC (1:50 or 1:300 - 350 dilutions in 1% goat 
serum/PBS). Skin sections were washed three times in PBS as described above 
and incubated with goat anti-rabbit antibody (AlexaFluor, for details see Chapter 3, 
Table 3.3B) diluted 1:500 in 1% goat serum/PBS for one hour at RT. Normally DAPI 
(Insight Biotechnology) was added to this secondary antibody solution at a dilution 
of 1:5000. Sections were then washed three times in PBS as before and mounted in 
anti-fade Immu-mount (Thermo Electron Corporation) or mowiol (see Appendix I) 
and covered by the coverslips. Incubations with antibodies were performed in the 
dark. Slides were kept in 4oC, in the dark. 
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2.2.6. Double staining: Oil Red O and immunohistochemical detection. 
Skin sections were cut and stained with the Oil Red O stain (for details see 
section 2.2.4), but not counterstained. Sections were then processed for 
immunohistochemical detection using the StrepABComplex/HRP Duet, 
Mouse/Rabbit kit from DakoCytomation. Samples were rinsed in water, in TBS 
buffer (Tris buffered saline; Appendix I) for 5 min and incubated with the primary 
antibody (C/EBPalpha, Santa Cruz Biotechnology) diluted (1:50) in TBS/1% bovine 
serum albumin (FLUKA) for 20 min. They were then rinsed with water, placed in 
TBS (5 min) and incubated with the biotinylated goat antibody working solution for 
20 min. Next, samples were rinsed with water, placed in TBS (5 min) and incubated 
with the strepABComplex/HRP working solution for 20 min, then rinsed with water 
and placed in TBS (5 min). They were then incubated with a 3,3’-diaminobenzidine 
tetrahydrochloride-prepared chromogenic substrate solution for peroxidase 
(DakoCytomation) for 6 or 10 min, rinsed in water and mounted in Glycergel 
(DakoCytomation). 
 
 
2.2.7. The microscopic analysis of skin samples from rodents. 
2.2.7.1. Whole mouse skin samples. 
The analysis of the Oil Red O staining on whole mouse skin samples was 
performed on the Ziess StemiSVII microscope (with the digital camera KY-FI030 
JVC and with the KyLink software). Figures from taken photographs were prepared 
on the Adobe Photoshop CS2 v 9.0. 
 
2.2.7.2. Rodent back skin samples. 
The back skin samples, removed from mice were analysed on the Ziess 
StemiSVII microscope (with the digital camera KY-FI030 JVC and with the KyLink 
software). 
Next, rodent back skin sections (obtained from specimens frozen in tissue 
tek - for details see section 2.2.3.) that underwent the Oil Red O and immuno-based 
study, were analysed on a Zeiss Axio Imager.M1 microscope and OpenLab software 
(Improvision). Figures from taken photographs were prepared on the Adobe 
Photoshop CS2 v 9.0. 
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2.2.7.2.1. The calculation of average size of lipid droplets (in relation to 
Figure 2.9). 
Photos of skin sections with accumulated lipids in lower dermis were used in 
order to count the average size of selected lipid droplets (see Figure 2.9), the 
diameter was presented by a yellow line who’s length, given in pixels, was 
transferred into µmeters (according to the scale bar on each analysed image). The 
length of the scale bar was 30 µm which equates to 93 pixels. Based on the simple 
mathematical calculation, a diameter of each selected droplet was obtained in 
µmeters and this counting is presented in Appendix II. The values presented on the 
Figure 2.9 were rounded to the second place after the comma. 
 
2.2.7.2.2. The thickness of the non-fatty skin layer (in relation to Figure 
2.10). 
The thickness of the non-fatty skin layer in skin specimens was shown by the 
vertical yellow lines on photos from mouse back skin samples at different time points 
(see Figure 2.10). 
 
2.2.7.2.3. The “control staining” for the PPARgamma antibody (in 
relation to Figure 2.14). 
The “control staining” was performed on cross-skin sections from back skin 
sample, where incubation in primary antibody was replaced by the incubation in 1% 
donkey or 1% goat serum (in PBS). This allowed the testing of any potential 
background (unspecific staining) from secondary antibody. The control staining for 
PPARgamma antibody was analysed in relation to the overexposure of experimental 
staining (skin samples were incubated with PPARgamma antibody). First, a photo 
was taken from the experimental staining with exposure set up for a bright epidermal 
staining (Figure 2.14 - all left panels). Next, the over-exposure was set up in order to 
analyse the presence of signal along the dermis (Figure 2.14 - all middle panels). 
Finally, the over-exposure time set up for experimental samples was used on the 
control staining (Figure 2.14 - all right panels). The results of this analysis are 
described in section 2.3.4.2. 
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2.3. Results. 
2.3.1. Lipid accumulation in the whole mouse skin. 
In order to analyse the capability to accumulate lipids by mouse skin, the Oil 
Red O staining was performed on the skin removed from the whole rodent body (for 
details see section 2.2.2). Skin was compared in few hours, 2 and 6 day old 
newborn mice. The biggest anterior fat depots beneath the skin were removed from 
these specimens. This aimed to analyse lipid accumulation in skin and not the 
presence of lipids in depots beneath the skin. 
 
In skin from younger animals, the Oil Red O staining was weaker than that of 
older animals (Figure 2.3a, b and c). In skin from the middle back area, staining was 
easily detectable at day 6. Furthermore, in 6 day old mouse specimen, the top edge 
of the whole skin (skin removed from the head/neck) was darker due to the high 
accumulation of red dye in areas seen between hair follicles (Figure 2.3c - top 
panels). These areas stained by the Oil Red O dye were representing droplets of 
lipids. 
 
The amount of accumulated lipids in the whole mouse skin seemed to 
increase during mouse development after birth. 
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Figure 2.3. Whole mouse skin samples stained with red dye (Oil Red O) and 
analysed from the dermis site. Red dye gradually accumulates as mouse skin ages 
and thickens. Darker areas are clearly seen in the middle part of the back skin taken 
from a 6 day old newborn mouse (c - bottom panel). In addition, at day 6 the red dye 
can be easily observed in dermis, between hair follicles (c - top panels). a) A 
newborn mouse just a few hours after birth. b) A 2 day old newborn mouse. c) A 6 
day old newborn mouse. Specimens were placed on a 1 mm2 grid paper. Images 
were captured using a Ziess StemiSVII microscope. The Oil Red O staining on 
whole skin specimens was performed one time. 
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2.3.2. General features of fat depots under the mouse back skin. 
Mouse newborns at different stage of the development were used to obtain 
back skin samples with depots beneath the skin, in close proximity to the neck/head 
(top part of the skin sample) and near the lower limbs (bottom part of the skin 
sample). The localisation of these depots, the general morphology (Figure 2.1 and 
2.2) and the Oil Red O analysis confirmed that they are adipose tissues (Figure 2.6 
and Figure 2.10).   
 
First, incisions along the right and left side of mouse back were made and 
skin was cut from the caudal to dorsal (head to tail) direction (Figure 2.1a and 2.1c). 
Fat layers, were seen under the mouse skin, both in anterior and posterior 
localisation (Figure 2.1a - c). These adipose depots were bounded with both the skin 
layer and the rest of mouse body by thin muscle layers (Figure 2.2a). The 
connection between fat depots and skin seemed to be very fragile and quite loose. 
Thus, it was crucial to carefully cut the connection between the fat depot and the 
rest of the body, otherwise the fat depot would stay on the mouse body and will not 
be lifted with the skin. 
 
  The adipose depots presented near the mouse neck and head could be 
divided into two types: the middle darker part with the triangle-like shape (a possible 
brown fat) and the lighter depot localised around darker depot as well as between 
this brown fat and skin layer (an expected white fat depot) (Figure 2.1e). In the 
posterior area, the fat depots were treated as a white adipose tissue. All these 
adipose depots observed below the skin were referred in this thesis as 
subcutaneous adipose tissue – SAT (see Figure 1.5. Part B in Chapter 1; Figure 
2.1e and section 2.3.3.1 in Chapter 2). Analysed fat depots were presented under all 
analysed mouse specimens (Figure 2.2b). In addition, all fat layers were tightly 
related with the presence of blood vessels (Figure 2.1e).  
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2.3.3. Detailed analysis of the progressive accumulation of fat cells in 
rodent back skin. 
The features of cells that accumulate lipids (adipocytes) in rodent back skin 
(at different stage if their development) were analysed in cross-sections by the Oil 
Red O staining technique. In this analysis, fat depots beneath the back skin were 
included. 
  
2.3.3.1. The general terminology for analysed mouse skin areas and fat 
depots. 
Several terms were used for the description of analysed skin elements and 
fat depots beneath the skin (Figure 2.4).  
 
The subcutaneous adipose tissue (SAT) was observed beneath the top 
(near the mouse neck/head) and bottom (near lower limbs) part of the back skin 
specimen (Figure 2.4; see also Figure 1.5. Part B). This fat depot consisted of 
anterior and posterior white adipose tissue, and interscapular brown adipose tissue. 
 
The dermal adipose tissue (DAT) term was related with the dermis fat layer 
seen in lower skin dermis (Figure 2.4; see also Figure 1.5. Part B). This layer was 
created from cells undergoing adipogenesis that were localised around hair follicle 
end bulbs and between developing hairs. In contrast, the upper dermis (non-fatty 
dermis layer) was devoid of cells that accumulate lipids (no red dye seen). In the 
upper dermis, the Oil Red O staining was positive only in sebaceous glands (Figure 
2.4 - see black arrows). 
 
 In addition, subcutaneous adipose tissue was separated from dermal 
adipose tissue by a non-fatty, muscle skin layer, called the panniculus carnosus 
(Figure 2.4). The panniculus carnosus was present along the whole length of rodent 
back skin below the dermal adipose tissue (see Figure 1.5. Part B).  
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Figure 2.4. A section of back skin from a 10 day old mouse with lipids accumulated 
in the dermis and under the skin layer. Skin section was stained with Oil Red O to 
detect lipids. The dermis layer in lower dermis area, localized between hair follicles, 
was called dermal adipose tissue. The subcutaneous adipose tissue is localised 
below the skin layer and divided from lower dermis by a muscle layer (panniculus 
carnosus). Sebaceous glands, filled with lipids, are shown by black arrows. Scale 
bar = 65 µm. Images were captured using a Zeiss Axio Imager.M1. microscope. A 
schematic division of presented back skin section is shown by drawing on the right. 
Drawing by Pawel Wojciechowicz. 
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2.3.3.2. Lipid droplets in mouse embryonic skin. 
According to preliminary work on the onset of fat cells in mouse skin dermis, 
carried out in Prof. Jahoda’s research group, an observation was made that the 
accumulation of lipids in lower mouse skin dermis takes place at late stages of 
embryonic development. This observation was confirmed by some additional work 
on embryonic back skin samples (Figure 2.5).  
 
Mouse embryos younger than 18 days, had back skin dermis free from fat 
droplets (Figure 2.5a and b). Then, among analysed sections from 18 day old skin, 
only a few cells in the lower dermis seemed to have tiny lipid droplets (Figure 2.5d). 
The accumulation of first easily detectable fat droplets could be observed in animals 
older than e18 time point (Figure 2.5f and g; Appendix III). These lipids were in close 
proximity to hair follicle end bulbs. The multilocular cells, with several small lipid 
droplets localised around round nuclei, were organized in clusters (Figure 2.5g). 
Lipids were not present in all areas of lower skin dermis and many cells free of lipids 
could be observed at e19 time point (Figure 2.5e).  
 
In mouse hair follicles, sebaceous glands were stained positively for the Oil 
Red O after e18 time point (Figure 2.5g). 
 
Subcutaneous adipose tissue (SAT), analysed in 18.5 - 19 day old 
embryonic sample, was easy to detect beneath skin and was intensively stained by 
the red dye (Appendix III). 
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Figure 2.5. Progressive accumulation of lipids in inter-follicular back skin dermis 
during mouse embryonic development. Skin sections were stained with Oil Red O to 
detect lipids. (a, b) e17 time point (c, d) e18 time point. (e, f, g) e19 time point. 
Sebaceous gland is shown by white arrow. Lipid droplets around cell nuclei are 
shown by yellow arrow. (a - f) Scale bar = 30 µm. (g) Scale bar = 15 µm. Images 
were captured using a Zeiss Axio Imager.M1. microscope. The Oil Red O staining 
on embryonic back skin specimens was performed multiple times. Photos in Figure 
2.5 were taken at random areas along back skin with no focus on a specific side of a 
specimen. For the whole embryonic back skin view - see Appendix III.  
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2.3.3.3. Features of back skin and skin-related fat cells during newborn 
mice development. 
The cross-sections from back skin samples (with fat depots beneath the skin) 
were performed from 0.5, 1, 2, 4, 5, 8, 10, 12, 15, 17 and 19 day old newborn mice 
and the Oil Red O staining technique allowed the investigation of features of fat cells 
in skin dermis and beneath skin during mouse development after the animals birth 
(Figure 2.6A - K). 
The subcutaneous adipose tissue (SAT), from the anterior part of a mouse 
body, was observed beneath skin at all analysed time points and was tightly packed 
by fat cells as the red dye stained all areas of the SAT in skin cross-sections (Figure 
2.6A - K). SAT was separated from the back skin by a non-fatty skin layer 
(panniculus carnosus) in all analysed time points (for more details see section 
2.3.3.4). 
 
Fat cells, noticed in lower dermis of mouse embryonic skin (at late stages 
of the development), were seen in skin from half a day old mouse newborn (Figure 
2.7a). The gradual increase of red staining in lower dermis was observed from half a 
day old newborn, while hair follicles were growing along the skin (Figure 2.6 and 
Figure 2.7). A layer of dermal adipose tissue was already easy distinguishable from 
upper dermis in skin samples from 1 and 2 day old animals (Figure 2.6B and C). 
 
The skin thickness varied at analysed time points and these changes were 
related mainly with the size of dermal adipose tissue (Figure 2.6A - K). From day 5 
to day 12 back skin was getting thicker because of growing hairs and the dermal 
adipose tissue took approximately 80% of the dermis thickness (Figure 2.7f). Next, 
in animals older than 12 days, the skin gradually became thinner and the fat layer in 
lower dermis got smaller (50% of dermis thickness at day 19; see Figure 2.6K and 
Figure 2.7i).  
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Figure 2.6. Part A. For description see Figure 2.6. Part C. 
SAT 
SAT 
SAT 
SAT 
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Figure 2.6. Part B. For description see Figure 2.6. Part C. 
SAT 
SAT 
SAT 
SAT 
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Figure 2.6. Part C. Lipid accumulation in back skin specimens with fat depots 
beneath the skin. Skin sections were stained with Oil Red O to detect lipids. 
Samples were prepared from newborn mice at different stages of the development. 
A) 0.5 day old newborn mouse. B) 1 day old newborn mouse. C) 2 day old newborn 
mouse. D) 4 day old newborn mouse. E) 5 day old newborn mouse. F) 8 day old 
newborn mouse. G) 10 day old newborn mouse. H) 12 day old newborn mouse. I) 
15 day old newborn mouse. J) 17 day old newborn mouse. K) 19 day old newborn 
mouse. SAT - subcutaneous adipose tissue seen in anterior part of skin specimens. 
(A - K) Scale bar = 300 µm. Images were captured by a Laser Capture 
Microdissection Microscope (PALM MicroBeam Zeiss Microscope). The Oil Red O 
staining on whole newborn back skin specimens (Figures 2.6 - 2.10) was performed 
between one (8dN, 15dN, 17dN), two (0.5dN, 2dN, 12dN, 19dN) and three (1dN, 
5dN) times. 
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Figure 2.7. The analysis of skin thickness and dermal adipose tissue development in 
lower skin dermis from newborn mouse. Skin sections were stained with Oil Red O 
to detect lipids. The gradual increase in lipid accumulation is observed from 0.5dN 
time point. Dermal adipose tissue layer became thicker from day 0.5 till day 12. After 
day 12, skin became thinner. a) 0.5 day old newborn mouse. b) 1 day old newborn 
mouse. c) 2 day old newborn mouse. d) 5 day old newborn mouse. e) 8 day old 
newborn mouse. f) 12 day old newborn mouse. g) 15 day old newborn mouse. h) 17 
day old newborn mouse. i) 19 day old newborn mouse. (a - i) Scale bar = 30 µm. 
Images were captured using a Zeiss Axio Imager.M1. microscope.  
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During mouse development, the amount and size of fat droplets in lower 
dermis were increasing between hair follicles from 0.5 day old mice (Figure 2.7a - d). 
In addition, at day 0.5, observed lipid droplets varied in their size (Figure 2.8b - right 
panel and Figure 2.8c - bottom left panel). In this half a day old mouse skin, dermis 
areas of cells filled with lipids were surrounded by cells where no fat accumulation 
was seen (Figure 2.8c - all three panels). However, less lipid-free cells in lower 
dermis were present in 0.5 day old newborn skin, when compared with 18.5 - 19 day 
old embryonic back skin (compare Appendix III with Appendix IV). 
 
In general, at 0.5 day, many multilocular-like cells were seen with very small 
lipid droplets (Figure 2.9a). Then, at day one many bigger fat droplets developed 
around small lipids (Figure 2.9b). Observed droplets had a mainly round shape, 
because of the available space between hairs. In skin older than 2 days, dermal 
adipose tissue layer was created from mainly unilocular cells with big fat droplets 
(Figure 2.9c). Droplets had either a round shape or were elongated, as growing hair 
follicles reduced available dermis space and seemed to “squeeze” fat cells against 
each other. The growing tendency of lipid droplets was observed till day 5 and 
accumulated droplets seemed to keep similar (or only slightly different) diameter in 
older mice (Figure 2.7d - i). However, in some skin specimens the clear boundary 
between fat droplets was difficult to identify (Figure 2.9c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                           Chapter 2 
 75 
 
Figure 2.8. Lipid accumulation in lower skin dermis from 0.5 day old newborn mouse. 
Skin sections were stained with Oil Red O to detect lipids. a) Section from the skin 
area above fat depots. b) Section from the middle area of back skin specimen. c) 
Section close to the end of back skin specimen. (a - c) Scale bar = 30 µm. Images 
were captured by the Zeiss Axio Imager.M1. microscope. 
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Figure 2.9. An analysis of fat droplet diameter in lower dermis at selected time 
points. Skin sections were stained with Oil Red O to detect lipids. The gradual 
increase in lipid accumulation and size of lipid droplets is observed from 0.5dN time 
point. a) 0.5 day old mouse skin. b) 1 day old mouse skin. c) 8 day old mouse skin. 
Images were taken from the skin sections above the fat organs in the top part (near 
the head) of specimens. (a - c) Scale bar = 30 µm. Images were captured using a 
Zeiss Axio Imager.M1. microscope. The mathematical calculation of fat droplet 
diameter is presented in Appendix II. 
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2.3.3.4. The non-fatty skin layer (panniculus carnosus) under the mouse 
skin. 
The non-fatty skin layer (panniculus carnosus), without lipids, was seen 
along the whole length of back skin specimens under dermal adipose tissue (see 
Figure 2.4; Figure 2.6 and Figure 2.7). It continuously separated fat cells in lower 
dermis from subcutaneous adipose tissue (SAT) and these two areas filled with 
lipids did not merge at any of analysed time points. 
 
The panniculus carnosus in area where no subcutaneous adipose tissue was 
seen under the skin (middle part of a mouse body), had similar thickness in 
specimens from animals older than 1 day (Figure 2.6B - K and 2.7b - i). In the 
anterior area of back skin, where SAT was seen, thickness of the panniculus 
carnosus seemed to vary in analysed time points. At days 0.5 and 1, the non-fatty 
skin layer was bigger than in other time points (Figure 2.10a and Figure 2.10b). It 
gradually decreased its size from day 5 to 19 (Figure 2.10d - i). 
 
Interestingly, in some analysed specimens, additional, thin fat cell layers (2 - 
3 layers of cells with lipids) were infiltrating the non-fatty skin layer (at day 5; see 
Figure 2.10d). Some of these lipids were close to dermal adipose tissue (Figure 
2.10d).  
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Figure 2.10. Mouse skin sections in close proximity to the anterior white adipose 
tissue and brown adipose tissue (the top part of the back skin specimen) at different 
age. Skin sections were stained with Oil Red O to detect lipids. The thickness 
(marked by yellow lines) of the “non-fatty” skin layer area differs in the top part of 
analysed specimens. The additional thin layers of lipid droplets can be seen under 
the fat dermis layer (dermal adipose tissue), for example at day 5 (d - see area close 
to smaller yellow line). a) 0.5 day old newborn mouse. b) 1 day old newborn mouse. 
c) 2 day old newborn mouse. d) 5 day old newborn mouse. e) 8 day old newborn 
mouse. f) 12 day old newborn mouse g) 15 day old newborn mouse. h) 17 day old 
newborn mouse. i) 19 day old newborn mouse. (a - i) Scale bar = 65 µm. Images 
were captured by a Zeiss Axio Imager.M1. microscope. 
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2.3.3.5. Lipid accumulation in rat skin. 
The pattern of lipid accumulation in rat back skin dermis was similar to that 
seen in mice. However, the first appearance of fat droplets was observed later than 
in mouse specimens (compare Figure 2.5 and Figure 2.11).  The Oil Red O dye did 
not stain any structures in back skin sections from e18 rat embryos (Fig. 2.11a - c), 
but in e20/e21 rat embryonic skin, just before birth, small droplets of lipids were 
visible in the lower dermis (Figure 2.11e). The fat droplets localisation was 
maintained in lower dermis trough all analysed time points. In samples from 
newborn rats, increasing amounts of lipid staining was detectable (Figure 2.11g - o). 
In 1 and 2 day old newborn rat skin, droplets of fat were predominantly clustered 
around follicles in the lower dermis. Subsequently, both the amount of lipid and size 
of droplets increased, and over time more fat droplets were observed between 
adjacent follicles as they became more tightly clustered, so that by 6 days after birth, 
the most prominent staining was seen in the gaps between the follicles. This pattern 
of staining is maintained for at least 3 more days, since in 9 day old newborn rat skin, 
the spaces between hair follicles were almost entirely filled with lipid (based on 
previous work done in Prof. Jahoda’s research group). The Oil Red O staining was 
seen in sebaceous glands of follicles from 1 day old newborn rats (Figure 2.11g) 
and increased progressively.  
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Figure 2.11. Progressive accumulation of lipids in inter-follicular dermis during rat 
skin development. Skin sections were stained with Oil Red O to detect lipids. (a, b, c) 
18 day old rat embryo (18dE). (d, e, f) 20/21 day old rat embryo (20/21dE). (g, h, i) 1 
day old newborn (1dN). (j, k, l) 2 day old newborn rat (2dN). (m, n, o) 6 day old 
newborn rat (6dN). (a, d, g, j, m) Scale bar = 65 µm. (b, e, h, k, n) Scale bar = 30 µm. 
(c, f, i, l, o) Scale bar = 15 µm. Images were captured using a Zeiss Axio Imager.M1. 
microscope. The Oil Red O staining on rat back skin was performed minimum two 
times. 
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2.3.4. The investigation of an in vivo maker for fat-like cells developing 
in rodent dermis skin. 
Because the first, easy to detect Oil Red O staining in lower dermis was 
seen in approximately 18.5 - 19 day old mouse embryo, embryonic skin from late 
stages of the development was used to find an in vivo marker for fat-like cells. This 
work aimed to find a marker for dermis cells just before they start accumulating 
lipids (preadipocytes) and after they undergo adipocyte differentiation (adipocytes). 
 
Several antibodies were chosen for three proteins suspected to be a useful 
marker for preadipocyte/adipocyte cell population in skin: Pref-1, C/EBPalpha and 
PPARgamma. These candidates are known to be involved in early stages of 
adipogenesis, based on in vitro work on for example 3T3 cell lines (for more details 
see Chapter 1, section 1.3). 
 
The immunofluorescence and immunohistochemical analysis was performed 
on skin sections from both rodent embryos and newborns. In addition, photos 
presented in Figures 2.12 - 2.20 were taken randomly from the whole length of 
analysed skin cross-sections. 
 
2.3.4.1. The expression of Pref-1 in embryonic skin.  
 Preadipocyte factor 1 (Pref-1) is a transmembrane glycoprotein, highly 
expressed in 3T3-L1 preadipocytes, before they undergo adipogenesis. Pref-1 is 
suggested to inhibit adipogenesis (Smas and Sul, 1993).  
 
When the immunofluorescence analysis, with the antibody against Pref-1, 
was performed on the 18 day old embryonic rat skin (Figure 2.12), the staining was 
random through the dermis. The antibody signal was seen in the top dermis as well 
as in the lower areas of skin. 
 
 
 
 
 
 
 
 
                                                                                                           Chapter 2 
 82 
 
Figure 2.12. Pref-1 expression in 18 day old rat embryo skin. Back skin sections 
were probed with an antibody against Pref-1. DNA was counterstained with DAPI. 
Scale bar = 30 µm. Fluorescent images were visualised using a Zeiss Axio 
Imager.M1. microscope. The Pref-1 staining was performed four times. 
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2.3.4.2. The antibody against early adipogenic transcription factor: 
PPARgamma.  
 PPAR gamma is expressed at early stages of adipocyte differentiation (see 
Chapter 1, section 1.3.2.2).  
 It was expected that the expression of PPARgamma could be seen in the 
lower dermis at late embryonic developmental stages, thus the antibody staining 
was performed on several time points (Figure 2.13). Surprisingly, the very strong 
PPARgamma staining was seen along the epidermis and through the developing 
hair follicles at e17, e18 and e19 time points (Figure 2.13a - c). However, the whole 
skin dermis was lacking an easy to observe signal. This tendency was continued in 
skin after the mouse birth (Figure 2.13d). Because the intensity of green signal from 
the epidermis was very strong, a suggestion was made that this may hide the signal 
from dermis. Thus, the over-exposure for the green channel was performed for each 
analysed sample and the dermis staining was analysed (Figure 2.14). Some weak 
signal was seen in dermis that might have a nuclear character. However it was 
equal along the whole length of the dermis (Figure 2.14 - middle panels). In addition, 
photos for the “antibody control” samples were taken (no primary antibody 
incubation with only secondary antibody incubation to check the “non-specific 
binding” of the secondary antibody). The pattern of green signal in dermis from 
these control sections resembled the dermis signal observed in over-exposed 
experimental samples (Figure 2.14a - d: compare middle panels with right panels).  
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Figure 2.13. Dynamic changes in expression and localisation of adipogenic 
transcription factor PPARgamma in different stages of mouse skin development. 
Back skin sections (7 µm) were prepared from embryos at e17 (17dE), e18 (18dE) 
and e19 (19dE) time points and from 1 day newborn (1dN) mouse, and then probed 
with antibody against PPARgamma. DNA was counterstained with DAPI. (a - d) 
Scale bar = 30 µm. Fluorescent images were visualised using a Zeiss Axio 
Imager.M1. microscope. The PPARgamma staining was performed multiple times. 
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Figure 2.14. Preliminary PPARgamma antibody staining during different stages of 
mouse skin development with the analysis of a control antibody staining. Back skin 
sections (7 µm) were prepared from embryos at e17 (17dE), e18 (18dE) and e19 
(19dE) time points and from 1 day newborn (1dN) mouse. (a, b, c, d - left and middle 
panels): Skin sections were probed with antibody against PPARgamma. (a, b, c, d - 
right panels): Skin sections were incubated with 1% donkey serum/PBS instead of 
the primary antibody against PPARgamma. (a - d) Scale bar = 30 µm. Fluorescent 
images were visualised using a Zeiss Axio Imager.M1. microscope. 
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2.3.4.3. C/EBPalpha (C/EBPα) identifies differentiating preadipocytes 
around hair follicles in foetal and neonatal rat and mouse skin. 
Expression of C/EBPalpha (C/EBPα) in back skin was analyzed in both rats 
and mice. In rat embryos at e18, strong labelling was visible in the suprabasal layers 
of the epidermis (Figure 2.15). By comparison, in developing hair follicles the 
epithelium was very weakly labelled or unstained. In the skin dermis, at the same 
developmental stage there was no positive labelling for C/EBPalpha. At e20 in rat 
skin, the suprabasal layers of the epidermis were still strongly fluorescent (Figure 
2.15c and d). In the rat dermis at e20, however, a small number of cells now 
displayed strong nuclear staining. These cells were all clustered around or close to 
the lower regions of hair follicles (Figure 2.15c and d). In postnatal rat skin at 1 and 
2 days, the epidermis remained strongly stained for C/EBPalpha, while expression 
in the follicle epithelium remained weak. Within some well-developed follicles, strong 
nuclear staining was also seen in the region of developing sebaceous glands. The 
number of labelled dermal cells had also increased, but staining was still nuclear 
and distributed around the bottom half of hair follicles. By 6 days, C/EBPalpha 
expression in all epithelial compartments was largely unchanged (Figure 2.15i and j). 
Labelled cells in the dermis were now visible between follicles, but were still 
restricted to the lower two thirds of the dermis and few marked cells were seen 
deeper in the dermis than the follicle bases. 
 
Mouse embryos followed an almost identical pattern of C/EBPalpha staining, 
however the timing of events was earlier than in the rat embryos (compare Figure 
2.15 with Figures 2.16 and 2.17). As in the rat, the suprabasal layers of the mouse 
epidermis were strongly stained and the follicle epithelium to a lesser extent 
(Figures 2.16 and 2.17). At e18 time point, clear and strong nuclear staining could 
be identified in skin dermis especially around hair follicle end bulbs (compare Figure 
2.17a with b). Subsequently, the location and pattern of dermal cell labelling 
mirrored that of rat skin, with strongly fluorescent cells visible primarily around the 
follicles initially and then principally between follicles.  
 
By arbitrarily splitting skin into three layers (specifically: epidermis with upper 
follicle containing dermis; middle layer with hair follicle end bulbs; lower part of back 
skin below hairs) it was observed that the stained cells resided predominantly in the 
middle layer, between hair follicle end bulbs (Figure 2.18a and 2.18b).  
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Figure 2.15. Dynamic changes in expression and localisation of adipogenic marker 
C/EBPalpha (C/EBPα) during different stages of rat skin development. Back skin 
sections (7 µm) were prepared from embryos at e18 (18dE) and e20/21 (20/21dE) 
time points and 1 day newborn (1dN), 2 days newborn (2dN) and 6 days newborn 
(6dN) and then probed with an antibody against C/EBPα. Nuclear expression of the 
protein is evident in inter-follicular dermal cells in e20/21 embryos and 1 and 2 day 
old newborn mice, preceding the hair-specific epidermal expression in later stages. 
DNA was counterstained with DAPI. Sebaceous glands are shown by arrows. (a, c, 
e, g, i) Scale bar = 65 µm. (b, d, f, h, j) Scale bar = 30 µm. Fluorescent images were 
visualised using a Zeiss Axio Imager.M1. microscope. The C/EBPalpha staining on 
rat back skin was performed minimum two times. 
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Figure 2.16. Dynamic changes in expression and localisation of adipogenic marker 
C/EBPalpha (C/EBPα) during different stages of mouse skin development. Part A. 
Back skin sections (7 µm) were prepared from embryos at e15 (15dE), e17 (17dE), 
e18 (18dE) and e19 (19dE) time points and from 1 day newborn (1dN) mouse and 
then probed with an antibody against C/EBPα. Strong, nuclear expression of the 
protein is evident in inter-follicular dermal cells from about 18 day old mouse 
embryos.  DNA was counterstained with DAPI. (a, c, e, g, i) Scale bar = 65 µm. (b, d, 
f, h, j) Scale bar = 30 µm. Fluorescent images were visualised using a Zeiss Axio 
Imager.M1. microscope. The C/EBPalpha staining on mouse back skin (Figures 
2.16 – 2.19) was performed multiple times. 
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Figure 2.17. Dynamic changes in expression and localisation of adipogenic marker 
C/EBPalpha (C/EBPα) during different stages of mouse skin development. Part B. 
Back skin sections (7 µm) were prepared from embryos at e17 (17dE), e18 (18dE) 
and e19 (19dE) time points and probed with antibody against C/EBPα. Nuclear 
expression of the protein is evident in inter-follicular dermal cells in 18 day old 
mouse embryos. (a - c) Scale bar = 30 µm. DNA was counterstained with DAPI. 
Fluorescent images were visualised using a Zeiss Axio Imager.M1. microscope. 
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Figure 2.18. Cell type-specific expression of C/EBPalpha (C/EBPα) in different 
layers of 1 day newborn mouse skin. a) Upper, middle and lower parts of the back 
skin were visualised after co-staining with C/EBPalpha antibody together with DAPI. 
C/EBPalpha is detected in skin epithelium (upper panel) and in the cells of inter-
follicular dermis (middle panel) but not below the hair follicle end bulbs (lower panel). 
Scale bar = 65 µm. (b) Expression of C/EBPα is restricted to the dermal cells around 
the bases of hair follicles. Scale bar = 15 µm. Fluorescent images were visualised 
using a Zeiss Axio Imager.M1. microscope. 
 
Figure 2.19. Accumulation of fat droplets in C/EBPalpha (C/EBPα) positive cells. 
Sections of back skin taken from a 2 day old newborn rat were stained with 
C/EBPalpha antibody and counterstained with DAPI. Magnified region showing 
C/EBPalpha nuclear staining and typical adipocyte morphology and fat accumulation 
is shown in box A. Scale bar = 10 µm. Cells were visualised using a Zeiss Axio 
Imager.M1. microscope. 
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2.3.4.3.1. Features of C/EBPalpha-positive cells in mouse skin. 
To verify that the cells expressing C/EBPalpha were in fact the same cells 
that gave rise to adipocytes, the labelled cells were scrutinized microscopically and 
it showed that their nuclei became elongated and crescent shaped, with large round 
cytoplasmic vacuoles, typical of lipid accumulation in adipocytes (Figure 2.19).  
 
Double labelling with C/EBPalpha and the Oil Red O dye, showed that 
C/EBPalpha strongly labelled the nuclei of dermal cells at embryonic day 18 that 
were lacking easy to detect lipid droplets (Figure 2.20a). In skin sections from 1 day 
old newborn rodents, C/EBPalpha staining occurred between and around hair 
follicles in nuclei of dermal cells, most of which contained droplets of fat of varying 
size (Figure 2.20b - d). Older newborn skin showed cells with the same pattern of 
double labelling but with more fat inclusions (Figure 2.20e). 
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Figure 2.20. Analysis of the co-localisation of C/EBPalpha (C/EBPα) and lipid 
accumulation in dermal cells from mouse back skin. (a) A section taken from an 18 
day old embryo (18dE) showed cells whose nuclei expressed C/EBPα however, 
these were not positive for Oil Red O staining. (b, c, d) In 1 day newborn (1dN) skin 
most dermal cells with nuclei expressing C/EBPalpha now have lipid droplets. (e) 
Newborn skin at 2 days (2dN) shows widespread and increased accumulation of Oil 
Red O in dermal cells that expressed C/EBPalpha around the bottom half of the hair 
follicles. (b, e) Scale bar = 65 µm. (a, c) Scale bar = 30 µm. (d) Scale bar = 10 µm. 
Images were visualised using a Zeiss Axio Imager.M1. microscope. The analysis 
was performed twice on 18dE and 2dN time points and one time on 1dN time point. 
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2.4. Discussion. 
 The rodent back skin sample underwent detailed analysis in relation to the 
onset and development of cells accumulating lipids in lower dermis. The main focus 
was on mouse specimens. In addition, other subcutaneous fat depots beneath the 
skin were briefly analysed.  
Hausman described fat cells around hair follicles as the outer subcutaneous 
fat layer that is separated from other subcutaneous layer by a connective tissue (for 
more details see Chapter 1, section 1.2.5). Despite he suggested different 
developmental pattern of this outer layer from other fat depots beneath the skin, it 
seems that this fat layer is treated as a part of the whole subcutaneous adipose 
tissue. Interestingly, it seems that after the basic analysis of fat cells present in lower 
dermis in rats and pigs (Hausman’s or Mersmann’s study, discussed in Chapter 1, 
section 1.2.5), this subject has not been developed into a more specific and detailed 
study. In addition, in the literature a term “infiltrate” is used to describe the presence 
of fat cells in skin (Cinti, 2001), which may suggests that these fat cells are not 
functionally or developmentally interesting study material for scientists (as they only 
“infiltrate” skin). 
 
2.4.1. Lipid accumulation by mouse skin and development of fat cells in 
lower dermis. 
In work presented in Chapter 2, the Oil Red O technique allowed analysis of 
the capability of lipid accumulation by whole mouse skin during a newborns 
development. For this study, the main (biggest) fat depots, presented under the top 
area of back skin, were not included. The older skin was characterised by the darker 
red staining seen under the microscope (Figure 2.3). It appeared the red dye was 
“able” to infiltrate the skin. The darker staining, seen along the analysed back skin 
samples, could be treated as a staining of fat depots inside the skin (if we assume 
that the red dye, after binding to lipids, can be seen under the microscope). In 
addition, a question can be asked if the thickness of the skin influenced the view 
under the microscope (older skin is thicker, thus less light may pass through the 
specimen which could lead to the “illusion” of darker skin). However, this seemed 
not to be an issue, as when the top edge of stained skin was checked under the 
microscope it was clear that the red dye was observed inside the skin dermis, 
between hair follicles, where it bound to the lipid lobules (Figure 2.3c - two top 
panels).  
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Next, the cross-sections from mouse back skin (with fat depots beneath the 
skin) were stained with the Oil Red O dye (section 2.3.3). In general, the first lipids 
were seen in lower dermis from embryos at late stages of their development (Figure 
2.5). The gradual increase of lipid accumulation was seen in skin from newborns 
that lead to a formation of a distinguishable fat layer between developed hair follicles, 
named dermal adipose tissue (Figure 2.6). The similar pattern of fat cells 
development in lower dermis was seen in rat skin, however this lipid accumulation 
process seemed to be activated a couple days later than in mouse skin (Figure 2.11) 
 
In mouse skin dermis, the localisation of developing fat cells in lower dermis 
is in a general agreement with studies on rat or pig skin (Mershman et al, 1975; 
Hausman et al, 1981a; Hausman et al, 1981b). In general, subcutaneous fat 
development starts in foetuses and continues postnatally (Poulos et al, 2010). 
Hausman and his colleagues noticed that in newborn rat skin the localisation of 
lipids in lower dermis (hypodermis) was strictly related with the presence of hair 
follicles. In one day old rat skin, the fat cells were not seen in the lower dermis if the 
hair follicles were not present there (“incomplete” hair follicle development: 
Hausman et al, 1981a).  
In work, presented in this thesis, mouse skin dermis from half a day old 
animal had lipid droplets in close proximity to hair follicle end bulbs (Figure 2.8c - left 
panel). Interestingly, there were areas in lower dermis that consisted of developed 
hair follicles, but did not have lipid droplets (Figure 2.8c - right panel). In addition, 
the heterogeneity in lipid occurrence was seen along the whole length of back skin 
in lower dermis at 18.5 - 19 day old mouse embryo and this feature was maintained 
a couple of hours after the birth. However in older animal less “lipid-free” areas were 
present in lower dermis. These features of lipid occurrence show that precursors of 
fat cells are present in mouse lower skin dermis and they are activated for 
adipogenic differentiation at late embryonic stages of development. This activation is 
not equal in all areas of lower skin dermis. 
  
The morphological features of fat cells in animal skin were similar to these 
observed by other researchers (for example in Hausman’s work: Hausman et al, 
1981a). First multilocular cells were seen with many small lipids around round nuclei 
(Figure 2.8b). Next, the gradual development of unilocular fat cells with big central 
fat droplets were seen, with the “squeezed” nuclei on the peripheral part of the cell 
(Figure 2.9b). In some areas of lower dermis the boundary between fat droplets was 
difficult to observe (Figure 2.9c). The question can be raised, was this difficulty 
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related with the high number of adipocytes filled with lipids in one area of skin 
dermis (and because of the small space between hairs, these fat droplets were 
“squeezed”) or because this area presented one very big mature adipocyte with a 
high number of lipids accumulated in it. 
 
2.4.2. The correlation between skin thickness and hair follicle cell cycle. 
Changes in mouse skin thickness were observed during the newborn 
development and skin became gradually thicker from day 0.5 till day 10 - 12 (Figure 
2.6A - G and H). Then, skin got thinner till day 19 (Figure 2.6I - K). 
A connection between the skin thickness with the fat layer size and the hair 
follicle cycle was analysed in adult mice (Borodach and Montagna, 1956). The study, 
presented in this Chapter confirmed this correlation and showed that it takes place 
during the first couple of weeks of newborn mouse life. To sum up, during the 
anagen stage (the hair follicle growing stage) fat layer got bigger, and when hairs 
moved to the catagen and then telogen phase (resting phase) the fat layer was 
thinner (Figure 2.6A - K). The skin thickness underwent modifications along the 
whole length of skin specimens at each of the analysed time points. 
It appears that not only are the very early stages of adipogenesis in lower 
dermis related with developed hair follicles but also the fully developed dermal 
adipose tissue layer is dependent on the hair follicle cell cycles in mouse skin.  
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2.4.3. Two distinguishable adipose tissue depots in mice separated by 
the non-fatty skin layer (panniculus carnosus). 
It was observed that dermal adipose tissue developed later than 
subcutaneous adipose tissue (SAT) seen beneath the skin. When, for example first 
clear lipid droplets were seen in lower dermis at e18.5 - 19, the SAT organ beneath 
the skin was already developed at this time point (Appendix III). These two fat 
depots were separated by a non-fatty skin layer (panniculus carnosus) that was 
seen along the whole length of back skin samples at each analysed time points 
(Figure 2.6 and Figure 2.10). There was no area that could suggest a connection 
between dermal adipose tissue and SAT. Moreover, during the removal of back skin, 
it was difficult to lift subcutaneous fat depots with the skin and they seemed to be 
slightly better connected with the mouse body than back skin. The fat depots were 
surrounded by thin layers of possible muscle tissue and it was crucial to be delicate 
when back skin was lifted with these fat depots. In addition, stages of hair follicles 
had an influence on dermal adipose tissue, whereas no obvious, dramatic changes 
were seen in SAT beneath the skin, when hairs went from anagen to catagen and 
telogen. Thus, it could be suggested that the mouse dermal adipose tissue layer is a 
developmentally different fat depot from subcutaneous adipose tissues.  
 
When the non-fatty skin layer (panniculus carnousus) was analysed during 
the mouse newborn development, changes in its thickness were mainly related with 
the back skin area where SAT were localised beneath the skin (Figure 2.10). The 
additional, thin fat layers were seen along the non-fatty skin layer, either in close 
proximity to dermal adipose tissue or near SAT beneath the skin. The question can 
be raised, to which fat depot do these additional layers belong, and if their 
occurrence is related with specific features of skin at the particular time point or 
maybe they are just random structures with no apparent importance for the whole 
skin and fat organ function. 
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2.4.4. The differences between upper and lower rodent skin dermis. 
The majority of cells in lower dermis seemed to turn into fat cells and create 
the fat layer, whereas no lipid accumulation was seen in upper dermis at any of the 
analysed time points. This easy to identify difference between two areas of dermis 
may suggest two opposite mechanisms that control differentiation of skin cells and 
their fate depending on the localisation along the dermis. In upper dermis, either 
progenitor fat cells are absent or some inhibitory mechanisms of adipogenesis are 
activated that do not allow cells to accumulate lipids in this area of skin. This 
hypothesis has been discussed in more detail in Chapter 3.  
 
2.4.5. The investigation of an effective in vivo marker of developing fat 
cells in rodent lower dermis. 
Based on the Oil Red O analysis, the first lipids in the lower dermis close to 
hair follicles were seen between e18 - e19 time points, whereas this area of dermis 
was free from red dye in younger skin (Figure 2.5). The occurrence of lipids was 
heterogeneous and cells stained by Oil Red O dye were surrounded by not stained 
areas in lower dermis after e18 time point. Such observation suggested that 
preadipocyte cells (cells committed to undergo adipogenesis, before the lipid 
accumulation) may be seen in embryonic skin between e17 and e19. The next step 
of the study aimed to investigate a marker for fat cells in mouse embryonic skin. 
  
Detailed analysis of adipogenesis in vitro, mainly by using the 3T3 cells, 
identified several proteins crucial for the early stages of adipocyte differentiation, 
such as members of CCAAT-enhancer binding protein family (C/EBPs) or 
PPARgamma (reviewed by Rosen and Spiegelman, 2000). In addition, several 
proteins (for example Pref-1) were identified to be highly up-regulated in 
preadipocytes and their level gradually decreased when cells underwent adipocyte 
differentiation (see Chapter 1, section 1.3.4). Antibodies against Pref-1, 
PPARgamma and C/EBPalpha were used on the rodent back skin samples, in order 
to analyse their expression pattern in in vivo conditions. In addition, an effective 
marker for early fat cells in skin could help to track the occurrence of cells before 
they accumulate lipids.  
 
Despite that Pref-1 expression is abundant in preadipocytes and decreases 
dramatically in differentiated fat cells, it is a questionable marker for preadipocytes in 
vitro (Boney et al, 1996). Moreover, the staining for Pref-1, performed on the 
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embryonic skin, seemed to be quite random along the dermis and was seen not only 
in bottom dermis (where lipid accumulating cells developed) but also in top dermis, 
close to the epidermis (Figure 2.12). Because of this observation a suggestion can 
be made that Pref-1 is not a reliable marker for dermis cells that give a beginning of 
the dermal adipose tissue in vivo. 
 
Next, the antibody against PPARgamma was tested on rodent cross-
sections (Figure 2.13 and Figure 2.14). This antibody stained epidermis whereas the 
dermis seemed to lack the signal. A suggestion can be made that the antibodies 
used are against epitopes for PPARgamma protein that may be somehow hidden in 
skin dermis. The second suggestion may be that at the protein level PPARgamma is 
not seen in lower dermis where cells committed to lipid accumulation are present, 
however this suggestion may be controversial (as it may negate the role of 
PPARgamma in fat cell differentiation both in vitro and in vivo; see Chapter 1, 
sections 1.3.1 and 1.3.2). On the other hand, the clear differences between 
metabolic features of different fat depots have been recently discussed mainly in 
relation to the fat transplantation (for details see Chapter 1, section 1.2.8), thus 
maybe these differences are also related with the regulation of fat cell development 
and maybe dermal adipose tissue is controlled in a slightly different way from other 
known (and widely studied) fat depots. Finally, as the third explanation is that used 
antibodies were not sufficient for back skin sample analysis and gave “fake” staining 
across skin section. 
In order to verify the working efficiency of used antibodies for the detection of 
Pref-1 and PPARgamma, an experiment should be performed on 3T3-L1 
preadipocytes and differentiated 3T3-L1 fat cells. As said previously, Pref-1 protein 
is abundantly expressed in preadipocytes (Wang et al, 2006a), whereas expression 
of PPARgamma protein occurs in 3T3-L1 cells between 42 and 60 hours after the 
induction of adipogenic differentiation (Morrison and Farmer, 1999). Therefore 
samples from both undifferentiated and differentiated 3T3-L1 cells could undergo 
analysis for the expression of Pref-1 and PPARgamma with antibodies used in study 
from Chapter 2 (sections 2.3.4.1 and 2.3.4.2). In addition, both the 
immunofluorescence staining and the western blot analysis of samples from 3T3-L1 
cells could give a better view on the working capabilities of used antibodies.  
 
Then, the antibody against C/EBPalpha worked nicely on rodent dermis skin 
(Figures 2.15 - 2.20). It seems very likely that most cells of the rodent dermis that 
have nuclei labelled with C/EBPalpha at late gestation represent preadipocytes at 
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an advanced stage of adipocyte differentiation and are the same ones that go on to 
make lipids. This idea was supported initially by the independent C/EBPalpha 
immunofluorescence and Oil Red O labelling work that showed close anatomical co-
localisation between the groups of labelled cells, and the observation that increasing 
numbers of C/EBPalpha labelled dermal cells became vacuolated and their nuclei 
took on an elongated moon-shape typical of adipocytes over time. Double staining 
of C/EBPalpha with the Oil Red O dye confirmed this relationship directly and 
showed clearly that lipid accumulation appeared in cells with C/EBPalpha 
expression during development. As C/EBPalpha was seen in dermal cells before the 
start of fat formation, the fact that expression was maintained after lipid 
accumulation suggested that C/EBPalpha may be needed both for the activation of 
adipogenesis, and possibly later to promote the lipid accumulation and maintenance 
of fat cells in vivo in back skin dermis. This work has been published (Wojciechowicz 
et al, 2008). 
Because of the localisation of C/EBPalpha positive cells in close proximity to 
hair follicle end bulbs, there might be a correlation between differentiating fat cells 
and developing hair follicles in mouse back skin. Such relation was discussed in 
pigs and rats skin (Chapter 1, section 1.2.5). However, no detailed study seems to 
be available that would verify this suggestion. 
 
Finally, the analysis of rodent dermis cells and the discovery of an in vivo 
marker for preadipocytes and adipocytes in skin helped to design an experiment 
where more details of dermis cells were analysed. This new study gave the 
possibility to investigate in vivo gene expression pattern in differentiating fat cells 
during embryonic mouse development and is presented in Chapter 3. 
 
In addition, work presented in the next Chapters of this thesis aims to 
discuss the potential correlation between lower dermis cells that are undergoing 
adipogenesis and other skin compartments that are gradually developing in mouse 
back skin dermis. 
 
 
  
 
 
Chapter 3:  
The laser capture microdissection 
(LCM) technique and microarray 
approach for the analysis of 
differentiation processes in skin 
dermis at late stages of mouse 
embryonic development. Implications 
for (better) understanding 
adipogenesis in vivo. 
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3.1. Introduction. 
 Knowledge of how mature fat cells develop is crucial for our understanding of 
adipose biology and pathology so it is perhaps surprising that most of what is known 
about adipogenesis comes from work on cultured cells. In Chapter 2, foetal and 
newborn mice were investigated to establish where and when adipocyte formation 
takes place in developing skin. This work showed that differentiation of cells in the 
lower dermis during late foetal development leads exclusively to the development of 
the dermal layer of fat cells, with no apparent input from the subcutaneous depots 
present beneath the skin. It also confirmed that the initiation of adipogenesis occurs 
close to the lower region of hair follicles as described previously in other species 
(Hausman and Martin, 1982). Up to now, however, there has been no detailed 
analysis of the molecular changes that occur when adipocytes are formed in situ. 
Having established a location for preadipocytes, and knowing the timing of their 
appearance, we have a platform from which to address this question for the first 
time.  
 
Detailed information about adipogenesis comes from in vitro work, involving 
the use of cell culture models, both established cell lines and primary cultures (for 
details see Chapter 1, part 1.3.1.1). Despite the knowledge, gained from this work, 
there is still a need to understand the differentiation process of preadipocytes in vivo. 
Cell culture models have several limitations. In the first place they are in a 2D 
environment and growing on an artificial surface. Thus they lack the third dimension 
and many of the proper contacts with other cells and extracellular elements that 
would normally take place in the body. Indeed recent work has highlighted that three 
dimensional culture systems are more realistic for studying biological processes 
than conventional 2D models (Higgins et al, 2010). In addition, 3T3 cells widely used 
for in vitro adipogenic studies were derived from whole mouse embryos, and not 
adipocyte-like cells. Such cells have to be “pushed” by adipogenic medium in order 
to obtain full adipogenic characteristics. Also, recently there is increasing evidence 
to suggest that different fat deposits have different functions and perhaps even 
developmental origins (Gesta et al, 2007; Porter et al, 2009). Thus, a general model 
like the 3T3 cells may not be representative of all fat depots so detailed investigation 
of the developmental features of different fat depots may eventually be required. 
Keeping in mind the limitations of the above systems, the following section 
discusses studies that have used such culture models for the investigation of 
adipogenesis on molecular level in vitro by microarray approach.  
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The development of microarray technologies has opened a new direction in 
analysis of different processes in cells, tissues and organs at the molecular level 
(Heller, 2002; Chen and Tzeng, 2006). In fat-related studies, cell lines treated with 
adipogenic medium and differentiated into mature adipocytes, have been subjected 
to detailed analysis by microarray technology. Guo and Liao (2000) used the 
cDNA/expressed sequence tag (EST) microarray approach for the analysis of gene 
expression profiles in 3T3-L1 cells (Guo and Liao, 2000). In general ESTs are small 
fragments of cDNA sequence obtained from sequencing pieces of expressed genes 
(Hatey et al, 1998). ESTs have been successfully used for the design of probes for 
microarray analysis. The Gene Discovery cDNA/EST array (Genome Systems) 
allowed researchers to investigate the gene expression profile from undifferentiated 
(day 0) and differentiated (day 6 after the adipogenic treatment) 3T3-L1 cells (Guo 
and Liao, 2000). In total, 83 genes were seen to be up-regulated (with at least 10 
fold difference) in adipocytes, when compared with preadipocytes. This work 
confirmed up-regulation of specific fat-related genes in differentiated cells, such as 
PPARgamma, as well as revealing unknown ESTs seen only in preadipocytes or 
only in adipocytes.  
 
A microarray approach was also used for the detailed analysis of 3T3-L1 
cells during first 24 hours of incubation with adipogenic medium (Burton et al, 2002). 
In this study, RNA was collected from cells at day 0 (just before treatment with 
adipogenic medium) and at 2, 4, 16 and 24 hours after addition of adipogenic 
medium. In this work, the analysis was performed on microarray gene chips from 
Affymetrix with 13,179 cDNA/ESTs (Affymetrix murine Mu11K Array Set). This 
analysis revealed 285 mRNAs with fold changes equal or higher than 5, that were 
differently regulated (up or down) during the first 24 hours of adipogenic 
differentiation in vitro. These genes were known to play a role in cell cycle 
processes (p107) or regulation of transcription (C/EBPbeta). The use of 
bioinformatic self-organizing map (SOM) clustering allowed the authors organize 
285 genes in five clusters, depending on their expression profiles.  
 
A further microarray study analysed 3T3-L1 cells treated with adipogenic 
medium or adipogenic medium with an adipogenic inhibitor (trichostatin A - TsA), at 
time points: 0, 2, 8, 16, 24, 48 and 96 hours (Burton et al, 2004). Prepared cRNA 
was hybridized on Affymetrix MG_U74Av2 microarray gene chips (Affymetrix) that 
have 12,488 cDNA/Expressed Sequence Tags (ESTs) probe sets. The microarray 
data was analysed only for genes with at least a 2 fold-change. After discarding 
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genes common to stimulated or inhibited cells, a total number of 1016 transcripts 
specific to differentiated 3T3-L1 cells were analysed by SOM clustering. The data 
showed the up-regulation of mRNA levels for PPARgamma and C/EBPalpha in 3T3-
L1 cells after 48 hours of treatment with adipogenic medium, not seen in cells 
treated with TsA. In addition, several genes with specific expression profiles (for 
example latexin) were suggested to have potential role in relation to adipogenesis 
(Burton et al, 2004). 
 
Another comprehensive microarray-based study of adipogenesis was 
performed by Soukas et al (2001). Pre-confluent and confluent (day 0) 3T3-L1 cells, 
together with cells treated with adipogenic medium (6 hours, 12 hours and 1, 2, 3, 4, 
7 and 28 days) were hybridized to 11K GeneChip microarrays (Affymetrix). In 
addition, this study included investigation of gene expression profiles in 
preadipocytes and adipocytes isolated from 8-weeks old C57Bl/6J mice, both wild-
type and ob/ob (obese) animals. These cells were isolated from fresh, peri-uterine 
fat pads (white adipose tissue). Analysis of the 3T3-L1 cells, where the κ-means 
clustering algorithm was applied, highlighted 1259 genes differently expressed 
during induced adipogenesis with an increase of at least 3 fold. These genes were 
grouped into 27 clusters, among which 15 had a general up-regulated tendency 
while 12 clusters had genes whose expression was decreased. Overall, this analysis 
showed the complexity of adipogenesis at the mRNA expression level. Many genes 
considered to be involved in adipogenesis (from other types of investigation) were 
observed in this microarray based-study, appearing to confirm their role in the 
adipocyte differentiation process. For example, up-regulation of the PPARgamma 2 
isoform (see Chapter 1, part 1.3.3.2) and of C/EBPalpha was noted during 
differentiation of 3T3-L1 cells (Soukas et al, 2001). The same study included a 
comparison between in vitro and in vivo preadipocytes and mature fat cells. In a 
group of genes common for both in vitro and in vivo preadipocytes was C/EBPdelta, 
whereas among genes enriched in vitro and in vivo in mature adipocytes were 
adiponectin (AdipoQ), C/EBPalpha and PPARgamma 2. As well as similarities 
between in vitro and in vivo cells, some interesting differences were also observed. 
For example, within a group of genes specific to 3T3-L1 preadipocytes was Pref-1, a 
recognised preadipocyte cell marker (Smas and Sul, 1993) and C/EBPbeta which 
has been suggested to play a crucial role in the early stages of adipogenesis in cell 
lines (Cao et al, 1993). In addition, a group of genes with enriched expression 
specific to in vivo adipocytes was created including the Frizzled 4 gene. 
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The global analysis of genes regulated during adipogenesis in 3T3-L1 cells 
was also performed by Hackl et al (2005) where RNA isolated from cells at eight 
time points (0, 6, 12, 24, 48, 72 hours and 7, 14 days) during differentiation was 
used for the microarray-based analysis. This study gave an additional view on 
genes regulated in vitro during adipocyte maturation and biological processes 
activated in such cells.  
 
The microarray data generated from 3T3 cells helped to investigate function 
of selected genes in relation to adipogenic differentiation. Ross et al (2002) 
investigated a potential role of liver X receptor alpha (LXRalpha) in adipogenesis, as 
this gene was specifically expressed in adipocytes when compared with 3T3-L1 
preadipocytes in microarray study.  
 
Microarray techniques have been also applied for the analysis of other types 
of cells that undergo adipogenic differentiation. Such analysis was performed on 
human bone marrow mesenchymal stem cells (hMSCs), which are capable of fat 
cell differentiation when treated with adipogenic medium (Nakamura et al, 2003). In 
this work, genes differently expressed during hMSCs differentiation were organized 
in nine clusters and compared with genes expressed in 3T3-L1 cells. Among genes 
up-regulated in cells treated with adipogenic medium, were known adipogenic 
transcriptional factors, such as C/EBPalpha and PPARgamma 2. In addition, some 
of the up-regulated genes in the early stages of hMSCs cell differentiation, such as 
the transcription factor SLUG, were found to be down-regulated in differentiated 
3T3-L1 cells. This work shows that between different mammals, differences can 
occur in relation to stages/mode of adipocyte differentiation.  
 
It has also become increasingly common to use microarray approaches for 
the global analysis of genes from different adipose tissue depots - white and brown 
fat cells, visceral versus subcutaneous fat depots in different animals, or in relation 
to obese individuals. Features of white and brown hamster preadipocytes were 
analysed by microarray technology by Boeuf et al (2001). Microarray analysis was 
also applied to the investigation of adipocytes in chickens as a means of better 
understanding obesity development in these organisms (Wang et al, 2006b). Wang 
et al (2006b) have identified genes whose expression levels in adipose tissue 
differed between fat line broilers and so-called Bai’er layers at 10 weeks of age (for 
example lipoprotein lipase level was higher in broilers). Urs et al (2004) performed a 
study, where gene expression profiles were analysed in both adipocytes and 
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preadipocytes (from stromal-vascular fraction) of subcutaneous abdominal fat depot 
from women (Urs et al, 2004). This work revealed an enrichment of genes related 
with lipid metabolism (fatty acid binding protein, lipoprotein lipase or perilipin) in 
human adipocytes and high expression of genes associated with extracellular matrix 
components (for example fibronectin) in a preadipocyte fraction from analysed fat 
depot. 
 
In addition, Affymetrix HG-U95 GeneChip arrays were used for analysis of 
adipocytes from non-obese and obese humans (Lee et al, 2005). Adipocytes were 
isolated from abdominal subcutaneous fat of non-diabetic Pima Indians. This work 
revealed that many inflammation-related genes were up-regulated in obese 
individuals including many chemokines, for example the monocyte chemoattractant 
protein-1 MCP-1.  
Microarray analysis, on both subcutaneous and visceral fat cells from 
morbidly obese humans allowed researchers to track differences in gene expression 
profiles between these two fat depots (Ramis et al, 2002). They constructed a cDNA 
microarray that consisted of 154 selected and named genes and 286 human 
adipose tissue-derived cDNA clones. Two genes, carboxypeptidase E and 
thrombospondin-1 were found to be up-regulated in the visceral depot when 
compared with subcutaneous fat cells. 
 
To sum up, adipogenesis process has been intensively investigated in vitro 
in several types of cell lines, among which the most popular are 3T3-L1 cells (see 
section 1.3.1.1. and Table 1.2 in Chapter 1). It is suggested that activation of crucial 
adipogenic factors in vitro takes place during the first 24 - 48 hours of adipogenic 
induction by differentiation medium and the first lipid droplets can be identified in 
differentiating cells by day 3 (Richon et al, 1997; Soukas et al, 2001). The 
microarray approach enhanced knowledge about steps of adipogenic differentiation 
in these cells between day 0 (confluent cells before addition of adipogenic medium) 
and day 28 after the induction of adipogenesis (by adipogenic medium). Such 
studies confirmed the specific expression patterns of adipogenic transcription factors 
(C/EBPs and PPARgamma) or genes involved in cell cycle regulation (p107) during 
first 24 - 48 hours of adipogenesis or the over-expression of genes specific for 
mature fat cells (adiponectin) after several days of differentiation. However, 
microarray approaches revealed some differences in expression profiles between 
different cell lines used for adipogeneic studies as well as suggesting the presence 
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of differences at molecular level between in vitro cell lines and cells isolated from 
adipose deposits and treated as a representative of in vivo conditions. 
 
In addition, different in vivo mouse models have been widely used, to study 
the functions of particular genes relating to adipogenesis, based on over-expression, 
silencing or mutation (see Chapter 1, part 1.3.1.2). Many mouse model-related 
studies have aimed to analyse adipose tissue development processes mainly after 
the birth of animals (reviewed by Valet et al, 2002). Genetically abnormal animals 
are recognised to be important for functional studies. However, in the current work 
the aim was to produce a new global analysis of the events of adipogenesis in vivo, 
at the embryonic stage, and focused on fat cells in lower skin dermis, a population 
not previously analysed at the transcriptional level.  
 
The hypothesis tested in Chapter 3 is that transcriptional changes take place 
in mouse embryonic back skin dermis in vivo between e17 and e19 time points 
which lead to differentiation of lower dermal cells into fat cells and development of 
non-fatty cells in upper dermis. In addition, it was hypothesised that early steps of fat 
cell differentiation observed in vivo in mouse back skin differ in some extent from 
these observed during in vitro adipogenesis in 3T3 cell lines. This work was 
achieved by combining the laser capture microdissection technology with microarray 
analysis in mouse. This investigation revealed interesting differences in gene 
expression profiles between upper dermis, where no lipid accumulation is observed, 
and lower dermis, where dermal adipose tissue develops. The detailed analysis of 
lower dermis cells targeted molecular profile of cells differentiating into adipocytes. 
Such data from lower dermis was compared to available expression data from fat 
cell differentiation in 3T3-based cells (in vitro studies). To best of my knowledge 
such work represents the first global analysis of dynamic processes taking place in 
mouse back skin dermis during the late stages of embryonic development in vivo. 
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3.2. Methods. 
 Microarray related work was carried under the RNase free conditions where 
RNase ZAP (Sigma) and 0.1% DEPC water (Appendix I) were used. All surgical 
tools were baked at 150oC for 2 hours and washed in DEPC water before using. 
Filter tips were free of detectable RNase, DNase and DNA. 
 
3.2.1. Housing, breeding and feeding conditions of rodents. 
For details on mouse age determination, housing, breeding and feeding 
conditions see Chapter 2, section 2.2.1. 
 
3.2.2. Back skin preparation.  
Back skin samples were collected in RNAse free conditions from mouse 
(CD1) embryos between 16.5 and 17 (designated e17 time point), 18 (designated 
e18 time point) and about 19 (designated e19 time point) day old. Embryos were 
transferred into sterile Petri dishes containing MEM - Minimal Essential Medium 
(Sigma) and antibiotics (2 µl/ml Fu - fungizone from Sigma and 1 µl/ml Ge - 
gentamicin from Gibco). Back skin was removed from mouse body, and snap frozen 
in a water-based embedding compound (Tissue Tek) in liquid nitrogen according to 
a protocol described in Chapter 2 (section 2.2.3).   
 
3.2.3. Dermal cell collection and microarray sample preparation. 
3.2.3.1. Back skin sample preparation and H&E staining. 
Back skin samples, frozen in Tissue Tek, were cut on a cryostat (LEICA CM 
3050S) and 10 µm skin sections were placed on PALM Membrane Slides (Nuclease 
and human nucleic acid free PEN/NF (D), Carl Ziess Microscopy). A schematic 
description of the back section preparation is presented in Figure 3.1. In addition, 
the cryostat was wiped with chloroform and slides were kept under UV for 30 min 
before use.  
Slides with skin sections were air-dried for 6 - 10 min, and underwent a 
shortened version of haematoxylin and eosin (H&E) staining. Samples were 
incubated in cold 70% ethanol for 2 min and washed in DEPC water. They were 
then stained for 1 min in haematoxylin (Hematoxylin solution prepared according to 
Mayer, Fluka by Sigma), put into Bluing Solution (Thermo Electron Group) for 1 
minute, stained for 10 sec in EosinY solution (Sigma), and washed in 70% ethanol 
(1 min), 96% ethanol (1 min) and 100% ethanol (Sigma) (1 min). Finally, skin 
sections were dried for 3 - 5 min at room temperature (RT), and used for cell 
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collection on the Laser Capture Microdissection Microscope (PALM MicroBeam 
Zeiss Microscope, CryLaS, FTSS 355-50 with PALM Robo v3.2 software). 
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Figure 3.1. A schematic presentation of back skin sample preparation for the laser 
capture microdissection work. (A, B) Back skin sample cut out from mouse. C) Back 
skin rolled up and frozen in Tissue Tek. D) 10 µm sections cut on the cryostat, then 
placed on PALM Membrane slides and used for the laser capture microdissection 
work. TP - top part of the back skin. BP - bottom part of the back skin. 
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3.2.3.2. Laser capture microdissection (LCM) technique. 
Slides with skin sections were examined under the Laser Capture 
Microdissection (LCM) Microscope and two areas of dermis were selected for the 
subsequent collection of material (Figure 3.2). Area “1” (upper dermis) was 
characterised by cells localised in the upper dermis, close to the epidermal layer, 
whereas Area “2” (lower dermis) was represented by cells from the lower dermis, 
between and around hair follicle end bulbs. Both areas were cut out and catapulted 
by the laser into the lids of PALM Adhesive Caps (Carl Ziess Microscopy). The 
presence of captured skin on the lids was verified on the LCM microscope (Figure 
3.3B and C). 
In order to collect a sufficient amount of material for microarray analysis, 
from each embryonic back skin sample, between six and seven sets of laser-
captured cells were prepared. From each set, two areas of dermis (Area “1” and 
Area “2”) were collected separately using the laser capture apparatus. For each set, 
approximately three slides were prepared with back skin sections. Each set 
represented around 100 pieces of skin for each dermis area, and each piece 
contained between 5 and 15 cells. The specimens from the two areas of dermis 
were collected in two separate PALM Adhesive Caps, then a maximum of 50 µl of 
the lysis buffer RLT (Qiagen) with β-mercaptoethanol (b-ME; Sigma) was added and 
the sample was incubated for 10 min on ice and stored at -80oC.  
Before RNA isolation, six (or seven) sets of cells collected from Area “1” of 
the back skin dermis of one animal were transferred from PALM Adhesive caps into 
one 1.5 ml centrifuge tube (Eppendorf). Then, six (or seven) sets of cells collected 
from Area “2” (in back skin dermis) were combined in another centrifuge tube. To 
sum up, from a single embryonic sample, the minimum number of collected cells 
was around 3000 - 9000 cells per 300 - 350 µl of typical lysis buffer that was used 
for RNA isolation and microarray work. 
 
In addition, three mouse embryos (from the same mother) were used for 
each analysed time point therefore the whole microarray work was performed in 
triplicate with three biological samples. 
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Figure 3.2. A schematic presentation of dermis areas collected on the Laser Capture 
Microdissection microscope and used for RNA isolation. (a - d) Cells were collected 
from upper dermis (Area “1” - shown in green) and lower dermis (Area “2” - shown in 
red) cross-sections cut from back skin of embryos at e17 (17dE), e18 (18dE) and 
e19 (19dE) time points. (d) Back skin section after the cut off cells from dermis 
areas. Scale bar = 150 µm. Images were captured using a Laser Capture 
Microdissection Microscope (PALM MicroBeam Zeiss Microscope). 
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D) 
 
Figure 3.3. Collection of dermal cells on the LCM microscope. (A) Two areas of 
dermis selected for microdissection: upper Area “1” (green) and lowerd Area “2” 
(red). (B, C) Cells from dermis areas collected on the lids of small Eppendorf. (D) Up 
to 6 - 7 sets of dermis cells (from each area) were collected from a single embryo (at 
e17, e18 or e19 time point) and pooled together for RNA isolation and microarray 
sample preparation. Scale bar = 150 µm. Images were captured using a Laser 
Capture Microdissection (LCM) microscope (PALM MicroBeam Zeiss Microscope). 
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3.2.3.3. Microarray sample preparation - molecular biology techniques. 
3.2.3.3.1. Purification of RNA. 
Total RNA was extracted using the RNeasy® Micro kit from Qiagen. Cell 
samples from the dermis (Area “1” and “2”) of 16.5 - 17, 18 and 19 day old mouse 
were adjusted to the final volume of 350 µl with the Lysis Buffer RLT (Qiagen) with 
β-ME. Then 5 µl of a 4 ng/µl carrier RNA solution (Qiagen) was added to each lysate.  
Next, 1 volume (350 µl) of 70% ethanol was added to each lysate and the whole 
sample was transferred to an RNeasy MinElute spin column (Qiagen) in a 2 ml 
collection tube and centrifuged for 15 seconds at 10 000 rpm. The whole flow-
through sample was placed once again on the spin column and centrifuged a 
second time under the same conditions. After the flow-through was discarded, 
700 µl of the supplied buffer RW1 was added to the sample and centrifuged for 15 
seconds at 10 000 rpm. The spin column was placed into a new 2 ml collection tube 
and 500 µl of supplied buffer PRE (with ethanol) was added to the sample and 
centrifuged for 15 seconds at 10 000 rpm. Next, 500 µl of 80% ethanol was added to 
the spin column and centrifuged for 2 min at 10 000 rpm. The spin column was then 
placed into a new collection tube and centrifuged with the lid open at full speed for 5 
minutes. Finally, the spin column was placed into 1.5 ml collection tube and 14 µl of 
RNase-free water (at 65oC) was added to the centre. The column was incubated for 
3 - 5 min at room temperature with the RNase-free water and centrifuged for 1 
minute at full speed to elute RNA. All extraction steps were performed at room 
temperature and the isolated RNA was stored at -80oC.   
 
3.2.3.3.2. RNA quantification and its assessment. 
The quantity of total isolated RNA (and cRNA from section 3.2.3.3.3) was 
determined on either the BioPhotometer (Eppendorf) or on a NanoDrop® 
Spectophotometer (ND-1000 with V3.5.2. software, Labtech International). Diluted 
RNA (1:50, for BioPhotometer) or 1 µl of undiluted RNA (for NanoDrop) was used.  
Additionally, the quality of cRNA (from step 3.2.3.3.3.) could be checked by 
electrophoresis. Between 1 and 2 µl of RNA was loaded on the 1 - 2.0% agarose gel 
(Severn Biotech Ltd), containing Ethidium Bromide (0.1 µl/ml, Fluka) in 1 x Tris 
Acetate-EDTA (TAE) (Appendix I). In addition, between 1 and 2 µl of glycerol 
loading buffer (Appendix I) were added to each sample, before electrophoresis.  
The techniques, presented above, were also used for the analysis of cRNA.  
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3.2.3.3.3. Synthesis and cleanup of Double-Stranded cDNA from Total 
RNA. 
All steps of cDNA synthesis were prepared under RNase free conditions. 
The “GeneChip® Expression 3’-Amplification Reagents Two-Cycle cDNA Synthesis 
Kit” (Figure 3.4) from Affymetrix and MEGAscript® T7 Kit from Ambion were used for 
this work. Incubations were performed in a BiometraR thermocycler and after each 
incubation and addition of new reagents, samples were briefly centrifuged in order to 
collect samples at the bottom of tubes. The “GeneChip Sample Cleanup” Module 
(Affymetrix) was used for the cleanup steps. 
 
3.2.3.3.3.1. First-Cycle cDNA Synthesis. 
3.2.3.3.3.1.1. First-Cycle, First-Strand cDNA Synthesis. 
Reagents for this step were provided in the Affymetrix kit. The T7-Oligo(dT) 
Primer/Poly-A control mix was prepared, which contained 4 µl of 50 µM T7-Oligo(dT) 
Primer and 16 µl of RNase-free water. Between 50 and 150 ng of total isolated RNA 
from each sample was placed in a 0.2 ml PCR tube with 1 µl of T7-Oligo(dT) 
Primer/Poly-A control mix and RNase-free water to a total volume of 5 µl. Tubes 
were incubated for 6 minutes at 70oC and 2 minutes at 4oC. Next, 5 µl of First-Cycle, 
First-Strand master mix was added to each sample. This master mix contained 2 µl 
of 5X 1st Strand Reaction Mix, 1 µl of 0.1M DTT, 0.5 µl of RNase inhibitor, 0.5 µl of 
10mM dNTP and 1 µl of SuperScript II per each sample. Samples were incubated 
for 1 hour at 42oC, 10 minutes at 70oC and at least 2 minutes at 4oC and 
immediately used for the next step of First-Strand cDNA Synthesis (see above).  
 
3.2.3.3.3.1.2. First-Cycle, Second-Strand cDNA Synthesis. 
To each sample, prepared in the First-Cycle, First-Strand cDNA Synthesis 
Step, 10 µl of First-Cycle, Second-Strand master mix were added. This master mix 
contained 4.8 µl of RNase-free water, 4 µl of freshly diluted 17.5 mM MgCl2, 0.4 µl of 
10mM dNTP, 0.6 µl of E. coli DNA Polymerase I and 0.2 µl of RNase H per sample. 
Samples were incubated for 2 hours at 16oC, 10 minutes at 75oC and at least 2 
minutes at 4oC. For the 16oC incubation, the lid of the thermocycler was left open.  
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Figure 3.4. A schematic presentation of experimental steps for microarray samples 
preparation. Samples were prepared according to the two-cycle target labeling 
assay (The “GeneChip® Expression 3’-Amplification Reagents Two-Cycle cDNA 
Synthesis Kit”). Source: http://www.biomics.nl/images/two_cycle_target_labeling.gif 
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3.2.3.3.3.1.3. First-Cycle, IVT Amplification of cRNA. 
The First-Cycle, IVT master mix was prepared for this step (all reagents were 
provided in MEGAscript® T7 Kit) and contained 5 µl of 10X reaction buffer, 5 µl of 
ATP solution, 5 µl of CTP solution, 5 µl of UTP solution, 5 µl of GTP solution and 
5 µl of enzyme mix for a single reaction. 30 µl of prepared First-Cycle, IVT master 
mix were transferred to each reaction sample and samples were incubated for 16 
hours at 37oC and cooled down to 4oC. 
 
3.2.3.3.3.1.4. First-Cycle, Cleanup of cRNA. 
All steps of the cleanup of amplified cRNA were carried at room temperature. 
Samples were transferred into 1.5 ml tube and 50 µl of RNase-free water, 350 µl of 
IVT cRNA Binding Buffer and 250 µl of 100% ethanol were added to each sample. 
Next, samples (700 µl) were added to the IVT cRNA Cleanup Spin Columns in 2 ml 
collection tubes and centrifuged for 15 seconds at 10 000 rpm. The whole flow-
through was placed once again on the spin columns and centrifuged for a second 
time in the same conditions. Next, spin columns were transferred into a new 2 ml 
collection tubes and 500 µl of IVT cRNA Wash Buffer was added to each spin 
column that was then centrifuged for 15 seconds at 10 000 rpm. The flow-through 
was discarded, 500 µl of 80% ethanol was put into each column that was 
centrifuged for 15 seconds at 10 000 rpm. After the flow-through was discarded, all 
spin columns were centrifuged for 5 minutes at maximum speed (13 000 rpm) with 
their caps opened. Next, columns were placed into 1.5 ml collection tubes and 13 µl 
of RNase-free water (pre-warmed to 65oC) was put directly onto each spin column 
membrane. All samples were incubated at room temperature for 3 - 5 minutes and 
centrifuged for 1 minute at maximum speed (13 000 rpm) in order to elute cleaned 
cRNA.  Each sample was quantified and assessed (for details see section 3.2.3.3.2) 
and used for Second-Cycle cDNA Synthesis (section 3.2.3.3.3.2). 
 
3.2.3.3.3.2. Second-Cycle cDNA Synthesis. 
3.2.3.3.3.2.1. Second-Cycle, First-Strand cDNA Synthesis. 
A fresh dilution of 0.2 µg/µl random primers was prepared by mixing 2 µl of 3 
µg/µl random primers with 28 µl of RNase-free water. Next, 550 - 650 ng of each 
purified cRNA sample was placed in a 0.2 ml PCR tube with 2 µl of freshly diluted 
random primers and RNase-free water to a final volume of 11 µl. All tubes were 
incubated for 10 minutes at 70oC and cooled for at least 2 minutes at 4oC. Then, 9 µl 
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of Second-Cycle, First-Strand master mix were added to each sample. This master 
mix contained 4 µl of 5X 1st Strand Reaction Mix, 2 µl of 0.1M DTT, 1 µl of RNase 
inhibitor, 1 µl of 10 mM dNTP and 1 µl of SuperScript II per each sample. Samples 
were incubated for 1 hour at 42oC and cooled for 2 minutes at 4oC. 1 µl of RNase H 
was added to each sample and incubation for 20 minutes at 37oC was performed. 
Next, samples were incubated for 5 minutes at 95oC and cooled for at least 2 
minutes at 4oC.  
 
3.2.3.3.3.2.2. Second-Cycle, Second-Strand cDNA Synthesis.  
A fresh dilution of 5 µM T7-Oligo(dT) Primer was made by adding 2 µl of 
50 µM T7-Oligo(dT) to 18 µl of RNase-free water. 4 µl of freshly diluted T7-Oligo(dT) 
Primer was added to each sample prepared as in the Second-Cycle, First-Strand 
cDNA Synthesis Step (section 3.2.3.3.3.2.1). Then, samples were incubated for 6 
minutes at 70oC and cooled for at least 2 minutes. The Second-Cycle, Second-
Strand master mix was prepared that consisted of 88 µl RNase-free water, 30 µl 5X 
2nd Strand Reaction Mix, 3 µl 10 mM dNTP and 4 µl E. coli DNA Polymerase I per 
sample. 125 µl of this Master Mix was added to each sample that was then 
incubated for 2 hours at 16oC and cooled down to 4oC. Next, 2 µl of T4 DNA 
Polymerase was added to each sample which was incubated for 10 minutes at 16oC 
and at least 2 minutes at 4oC. For the 16oC incubation, the lid of a thermal cycle was 
left open.  
 
Prepared samples were either purified straight after the Second-Cycle, 
Second-Strand cDNA Synthesis or immediately frozen at -20oC and cleaned next 
day. 
 
3.2.3.3.3.2.3. Cleanup of double-stranded cDNA. 
All steps were performed at room temperature. Samples were transferred 
into 1.5 ml tubes and 600 µl of cDNA Binding Buffer was added to each of them. 
Next, samples were added to the cDNA Cleanup Spin Columns in 2 ml Collection 
Tubes and centrifuged for 2 minutes at 10 000 rpm. The whole flow-through was 
placed once again on the spin columns and centrifuged for a second time under the 
same conditions. Then, spin columns were placed into new collection tubes, 750 µl 
of cDNA Wash Buffer was added to each column and the columns centrifuged for 1 
minute at 10 000 rpm. The flow-through was discarded and the spin columns were 
centrifuged with opened caps for 5 minutes at maximum speed (13 000 rpm). Next, 
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they were transferred into 1.5 ml collection tubes and 14 µl of cDNA Elution Buffer 
(pre-warmed to 60oC) was added to each spin column membrane. All samples were 
incubated at room temperature on the bench for approximately 3 - 5 minutes and 
centrifuged for 1 minute at maximum speed (13 000 rpm) in order to elute cDNA. 
Eluted samples were stored at -20oC.  
 
3.2.3.3.4. Biotin-Labeled cRNA - final steps of microarray sample 
preparation. 
3.2.3.3.4.1. Synthesis of Biotin-Labeled cRNA. 
Cleaned double-stranded cDNA (dsDNA) (section 3.2.3.3.3.2.3) was used for 
a synthesis of biotin-labelled cRNA, using the “GeneChip IVT Labeling Kit” 
(Affymetrix). IVT reaction mix was prepared that contained of 12µl dsDNA template, 
4 µl 10X IVT Labeling Buffer, 12 µl IVT Labeling NTP Mix, 4 µl IVT Labeling Enzyme 
Mix, and 8µl of RNase free water giving a total volume of 40µl. This reaction was 
incubated for 16 hours at 37oC in a thermal cycler (Peltier Thermal Cycler).  
 
3.2.3.3.4.2. Cleanup and quantitation of Biotin-Labeled cRNA. 
  Each IVT reaction sample was mixed with 60 µl of RNase-free water, 350 µl 
of IVT cRNA Binding Buffer and 250 µl of 100% ethanol. Next, each sample was 
added to an IVT cRNA Cleanup Spin Column in a 2 ml Collection Tube and 
centrifuged for 15 seconds at ≥ 10 000 rpm. Spin columns were transformed into 
new collection tubes and 500 µl of IVT cRNA Wash Buffer was added to columns 
that were centrifuged for 15 seconds at 10 000 rpm. Next, the spin columns were 
centrifuged with 500 µl of 80% ethanol for 15 seconds at 10 000 rpm. The flow-
through was discarded and columns were centrifuged for 5 minutes at maximum 
speed with opened caps. Spin columns were placed on the 1.5 ml Collection Tubes 
and RNase-free water was applied on the membranes to elute samples that were 
centrifuged for 1 minute at maximum speed. The concentration of Biotin-Labeled 
cRNA was checked by spectrophotometry on a Biomate spectrophotometer 
(Thermo Electron Corporation). 
 
3.2.3.3.4.3. Fragmentation and hybridization of cRNA. 
The Sample Fragmentation Reaction Mix was prepared with 15 µg of cRNA 
(at a final concentration of 0.5 µg/µl), 5X Fragmentation Buffer and RNase-free 
water up to a final volume of 30 µl. Samples were incubated for 35 minutes at 94oC, 
then transferred to new RNase-free 1.5 ml tubes and used for the hybridization step 
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on the genechip. Samples were hybridized on the Mouse Genechip 430 2.0 from 
Array (Affymetrix). The synthesis and cleanup and fragmentation of biotin labeled 
RNA was performed by Dr Claire Higgins in the Department of Dermatology, 
Columbia University, and the hybridization of cRNA onto the genechip was 
performed by Vladan Miljkovic in the GeneChip Analysis facility at Columbia 
University. 
 
3.2.4. The generation of dermis microarray data (DMD) by the 
GeneSpring® GX11.0 software. 
The microarray data from dermal cells (named as the dermis microarray data 
– DMD) was generated on the GeneSpring® GX11.0 software (Silicon Genetics, 
USA) by Dr Claire Higgins at Columbia University (New York). Genechips contained 
100 normalised probe-sets, and GeneSpring was able to use these to normalise 
samples so that they were comparable. Next, the filtration was done on expression-
genes that had to be present in at least one sample. A statistical analysis was 
performed to filter for significant genes based on their p-value (p<0.05). Next, genes 
that were both significantly and differentially regulated were detected by filtering the 
statistically significant genes on a fold change cut off of 2. Three microarray lists 
were generated that contained genes regulated in lower versus upper dermis at e17 
(E17 list), e18 (E18 list) or e19 (E19 list) time points. In addition, microarray data 
were generated with specific gene expression profiles only in lower dermis during 
mouse embryo development (e17 to e18 and from e17 to e19 time points), which 
was called the lower dermis - LD microarray data (the LD microarray list). This LD 
list, contained of genes with fold change equal or higher than 2 in at least one of 
analysed time point (e18 versus e17 or e19 versus e17). For the generation of E17, 
E18 and E19 lists the statistical test used was an unpaired t-test, whereas the One 
Way Analysis of Variance (ANOVA) was used comparing both e18 and e19 back to 
e17 time points (the LD microarray list). 
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3.2.5. The bioinformatics analysis of microarray data. 
 Two bioinformatics tools (described in section 3.2.5.1 and section 3.2.5.2) 
were included in the analysis of the generated microarray data from embryonic skin 
dermis (section 3.2.4), in order to get familiar with different bioinformatics softwares. 
3.2.5.1. The DAVID v6.7 programme. 
The Database for Annotation, Visualization and Integrated Discovery - 
DAVID v6.7 is a web-available programme that permits analysis of the gene lists in 
order to investigate biological features of transcripts. First, a gene list with specific 
ID for the analysed genes (for example by Affymetrix IDs) is uploaded on the DAVID 
web site and then the detailed analysis is performed by using one of the available 
tools (for example “Functional Annotation Clustering” or “Functional Annotation 
Chart”). 
For the work presented in this Chapter the 
“AFFYMETRIX_3PRIME_IVT_ID” was used as identifier, the Mus Musculus as 
species and the “Gene list” as a list type, when the gene lists were uploaded. The 
Affymetrix IDs are verified by DAVID and transformed into known DAVID IDs. In the 
analysed microarray list, several IDs could represent the same gene, and DAVID 
verifies this information and connects all IDs with specific genes (so in the end the 
total number of DAVID IDs is lower that the total number of Affymetrix IDs). Next, 
“Functional Annotation Clustering” analysis was performed. For this, the DAVID v6.7 
tool associates each gene with different terms, for example the term “secreted” is 
associated with genes known to code for secreted proteins, and so on. For each 
term, the number of relevant genes from the analysed gene list is given as well as 
their percentage in relation to the total number of analysed genes. In addition, 
category information is provided and this gives the possibility of checking which data 
base/source the presented term comes from - for example the term “secreted” 
belongs to category “SP_PIR_KEYWORDS”. Each analysed gene can be 
associated with several different terms. The “Count threshold”, as the minimum 
number of genes related with each term, was set to 2. Depending on how many 
analysed genes (from all genes of the microarray list) are related with one term and 
how many genes are known to be related with this term (from all genes based on 
DAVID v6.7 database), such term is characterised by a p-value. The smaller the 
value, the more enriched the group is. In general, the p-value equal or smaller than 
0.05 is treated as highly enriched. In the DAVID analysis presented in this Chapter, 
all created terms (with all given p-values) were taken under consideration and 
analysed. The main aim of the analysis is to investigate the developmental 
processes that occur in mouse embryonic skin dermis. During the developmental 
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and differentiation processes, genes can be activated progressively and we can 
assume that not all crucial genes for a specific pathway will be activated at the same 
time. At the embryonic level, it can be predicted that some genes will not be 
activated whereas other will be. Finally, after a certain time, when the tissue/organ is 
properly developed, all genes related with its function will be present. To illustrate 
this an artificial example can be given for a differentiation process called “process A” 
that is related with the maxumum gene number 70. For example at the e17 time 
point in lower dermis only one gene relating to the “the process A” is up-regulated. 
Then at e18 a further 20 genes are up-regulated and finally 55 genes are regulated 
in e19 (and p-values are smaller - more significant at e18 and e19, when compared 
with p-value at e17). This could indicate that up-regulation of the 1 gene at e17 is 
not random, (even though its upregulation is not statistically significant), and just 
illustrates that the beginning of the process “A” is occuring at e17. 
 
3.2.5.2. The GeneCoDis 2.0 tool. 
The lower dermis (LD) microarray list was analysed by the GeneCoDis 2.0 
tool in order to investigate biological features of genes from lower skin dermis. The 
GO_CC (cellular component) analysis was performed. After an elimination, by the 
GeneCoDis 2.0, genes not showing any annotations, genes were organized in 
groups depending on their known cellular localisation. A minimum number of genes 
associated with each created group was three. The “affy_mouse430_2” was 
selected as a microarray reference list, due to the fact that analysed microarray data 
was generated on the Mouse Genechip 430 2.0 from Affymetrix. Alternatively, the 
“Ensembl” option was used as a reference list.  
 
3.2.6. The verification of dermis microarray data (DMD). 
 In total, eighteen genes, selected from the dermis microarray data, 
underwent the verification work. Seventeen genes were analysed on mRNA level by 
qRT-PCR (see Table 3.2 for details). In addition, antibodies against six genes 
(section 2.2.5.3 in Chapter 2 and Table 3.3A) tracked their expression profile at the 
protein level in embryonic back skin samples (the immunofluorescence analysis). In 
total, five genes (Cebpa, Fabp4, Adipoq, Trps and Egfr) were analysed on both 
mRNA and protein levels. The PDGFRa was analysed only on the protein level. 
Results from the immunofluorescence analysis of C/EBPalpha were presented in 
Chapter 2. The investigation of EGFR expression was described in Chapter 4. 
Finally, results from the rest of staining were included in Chapter 3, section 3.3.  
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Among selected eighteen genes, three (Gremlin 2, trichorhinophalangeal 
syndrome I - Trps and PDGFRa) were characterised by the over-expression in 
upper dermis of mouse embryonic back skin. The other fifteen genes had increased 
expression in lower dermis and majority of these genes were up-regulated during 
embryonic development of lower dermis (for more details see section 3.3). Genes 
up-regulated in lower dermis were selected for this analysis because of their known 
(or suggested) role in adipogenesis in vitro (for example C/EBPalpha) or their high 
up-regulation in fat-related disorders (for example MUPs). 
 
3.2.6.1. Relative mRNA expression. 
The verification analysis of the microarray lists was carried out on RNA that 
was either used earlier for the microarray work from e17 and e18 time points or was 
prepared from another three 19 day old mouse embryos (“additional 19 day 
samples”) from the same litter as the original 19 day old embryos used for the 
microarray samples. These “additional 19 day samples” had to be prepared as the 
original samples from e19 time point were used for the microarray work. In addition, 
one sample from the “additional 19 day samples” was incorporated into the 
microarray work. This gave three samples for e19 time point which were sufficient 
quality to perform microarray analysis in triplicates. For the verification work, RNA 
samples were used before the fragmentation and hybridization steps (section 
3.2.3.3.4.3.). 
 
3.2.6.1.1. First-Strand cDNA Synthesis. 
 Reagents for this step were sourced from Invitrogen. First, the experimental 
sample was prepared, which contained 1 µl of random primers/Oligo(dT) Mix (2:1), 1 
µl of 10 mM dNTP mix, RNA (1 µg) and water (up to 11 µl). The mixture was 
incubated for 5 minutes at 65oC and immediately cooled on ice for at least 1 minute. 
Next, 7µl of Master Mix was added to each experimental sample. This Master Mix 
contained 4 µl of 5X First-Strand Buffer, 1 µl of 0.1 M DTT, 1 µl of RNAseOUTM 
Recombinant Ribonuclease Inhibitor and 1 µl of SuperSctipt TM III per sample. 
Samples were next incubated for 5 minutes at 25oC, 60 minutes in 50oC, 15 minutes 
at 70oC and cooled on ice. Then, 1 µl of RNase H was added to each sample, and 
samples were then incubated 20 minutes at 37oC.  Samples were stored at -20 oC.  
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3.2.6.1.2. The quantitative reverse transcriptase-polymerase chain 
reaction (qRT-PCR). 
 The qRT-PCR was performed on a 7300 or 7500 Fast Real-Time System 
with compatible 7300 or 7500 Fast System software (SDS version 1.4 Applied 
Biosystems), The “ddCt Relative Quantitation” assay was used for this work. 
  
Each individual PCR reaction contained 1 µl of diluted (1:5 or 1:10) cDNA, 1 
µl of primer mix (2.5 µM Forward primer and 2.5 µM Reverse primer), 10 µl of Power 
SYBR Green PCR Master MIX (Applied Biosystems) and 8 µl of sterile water. For 
each cDNA used, four identical reactions were prepared for each set of primers. 
Reactions were performed in 96-well reaction plates (for example: in  MicroAmp® 
Fast Optical 96-Well Reaction Plate with Barcode, 0.1 ml, Applied Biosystems). The 
general conditions of the qRT-PCR reaction and the primer sequences are shown in 
Table 3.1 and Table 3.2 respectively. 
 
 
 
 
Table 3.1. The protocol for qRT-PCR reactions used for the verification of 
microarray data. 
 
Steps: 
 
 
Temperature and time of each step: 
Step 1 95oC; 10 minutes 
Step 2 95oC; 15 seconds 
Step 3 60oC; 1 minute 
Step 5 Back to Step 2, then Step 3 (39 times). 
(Alternative) Step 4 60oC; 5 minutes 
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Table 3.2. The characterisation of primer pairs designed and used for qRT-PCR 
reaction. The verification work of microarray data. 
 
Targeted gene 
(whole name; gene 
symbol) 
 
Forward primer (FP) and reverse (RP) 
primer sequences: 
 
 
Primer 
length 
(bp) 
 
Melting 
temp.** 
(oC) 
 
Product 
length 
(bp) 
Ribosomal protein, 
large, P0 (Rplp0) 
Housekeeping gene 
FP: 5’CACTTACTGAAAAGGTCAAGGC 
RP: 5’AGACCGAATCCCATATCCTCA 
22 
21 
61.6 
64.4 
166 
CCAAT/enhancer 
binding protein, alpha 
(Cebpa) 
FP: 5’CGGTGCGTCTAAGATGAGG* 
RP: 5’ATTTTTGCTCCCCCTACTCG* 
19 
20 
63.4 
64.0 
169 
Peroxisome 
proliferator activated 
receptor gamma 
(Pparg) 
FP: 5’AACAGGCCTCATGAAGAACC* 
RP: 5’CCGGCAGTTAAGATCACACC* 
(transcript variants 1 and 2) 
20 
20 
63.0 
64.4 
174 
Glycerol-3-phosphate 
dehydrogenase 1 
(soluble) (Gpd1) 
FP: 5’GAAGAATATAGTGGCCGTTGG* 
RP: 5’AGGTCGTGATGAGGTCTGC* 
21 
19 
62.2 
63.1 
185 
Fatty acid binding 
protein 4, adipocyte 
(Fabp4) 
FP: 5’GATGAAATCACCGCAGACG* 
RP: 5’GCCCTTTCATAAACTCTTGTGG* 
19 
22 
64.4 
63.5 
182 
CD36 antigen (Cd36; 
CD36/FAT ) 
 
FP: 5’GTGCAAAACCCAGATGACG* 
RP: 5’CAGTGAAGGCTCAAAGATGG* 
(transcript variants 1, 2, 3, 4 and 5) 
19 
20 
64.2 
62.4 
171 
Adiponectin, C1Q 
and collagen domain 
containing (Adipoq) 
FP: 5’ACTTGTGCAGGTTGGATGG* 
RP: 5’CCTTCAGCTCCTGTCATTCC* 
19 
20 
63.7 
63.8 
167 
Angiotensinogen 
(serpin peptidase 
inhibitor, clade A 
member 8)(Agt) 
FP: 5’GCACCCTACTTTTCAACACC* 
RP: 5’TCACGGAGAAGTTGTTCTGG* 
20 
20 
61.0 
62.9 
174 
Complement factor D 
(adipsin) (Cfd; Adn) 
FP: 5’TGAACCCTACAAGCGATGG* 
RP: 5’GTTCCACTTCTTTGTCCTCG* 
19 
20 
63.7 
61.3 
167 
Resistin (Retn) FP: 5’CTTGTCCCTGAACTGCTGG* 
RP: 5’AAGACTGCTGTGCCTTCTGG* 
19 
20 
63.6 
64.6 
182 
Carbonic anhydrase 
3 (Car3) 
FP: 5’TCCTGAACAATGGGAAGACC* 
RP: 5’TCAGCAGCGTATTTTACTCCG* 
20 
21 
63.9 
64.0 
175 
Major Urinary 
Proteins (Mups) 
*** 
FP: 5’GACCTATCCAATGCCAATCG* 
RP: 5’CAGTGAGACAGGATGGAATGC* 
20 
21 
64.1 
64.7 
165 
Haptoglobin (Hp) FP: 5’GGTCAGCTTTTTGCTGTGG* 
RP: 5’TGTACACCCCATCTCCTTCG* 
19 
20 
63.5 
64.9 
160 
Retinol binding 
protein 4, plasma 
(Rbp4) 
FP: 5’CCTTTGTGTTTTCTCGTGACC* 
RP: 5’GATGAAGACCGGATGAAAGC* 
(transcript variants 1 and 2) 
21 
20 
63.4 
63.5 
209 
G0/G1 switch gene 2 
(G0s2) 
FP: 5’AGTGTCCCTCCCAAAGAGC* 
RP: 5’CAGCTCCTGCACACTTTCC* 
19 
19 
63.3 
63.7 
162 
Gremlin 2 homolog, 
cysteine knot 
superfamily 
(Xenopus laevis) 
(Grem2) 
**** 
FP: 5’CTCTGTCATCGTAGAGCTCGAAT 
RP:5’GGAGTCACTCAGGTTCACTGACAT 
23 
24 
63.6 
64.9 
109  
trichorhinophalangeal 
syndrome I (human) 
(Trps) 
FP: 5’TCTCTCTGGCGAAAGAATGC* 
RP: 5’CCCTCTGCTGTTTGTTGAGC* 
(TRPS gene and predicted similar to TRPS 
transcript variants 1, 2, 3 and 4) 
20 
20 
64.5 
64.9 
193 
Epidermal growth 
factor receptor (Egfr) 
 ***** 
FP: 5’GAGGACAACATAGATGACGC* 
RP: 5’CACTACTGAGACAGGTAGGC* 
(transcript variant 1) 
20 
20 
59.7 
56.5 
214 
Frizzled homolog 4 
(Drosophila) (Fzd4) 
****** 
FP: 5’CTCGGCTACAACGTGACC* 
RP: 5’GCACATAAACCGAACAAAGG* 
18 
20 
62.0 
61.9 
145 
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Kruppel-like factor 
10 (Klf10) 
****** 
5’TCCTGGATTCTCTCCTTCAGC* 
5’CCTCCTTTCACAGCCTTTCC* 
21 
20 
64.7 
64.9 
187 
estrogen receptor 
1 (alpha) (Esr1) 
****** 
5’CAGCACCTTGAAGTCTCTGG* 
5’TGTTGTAGAGATGCTCCATGC* 
 
20 
21 
62.7 
62.9 
194 
In reference to Table 3.2. on the previous page: 
* Primers were specifically designed to Mus Musculus genes (using the primer designing tool available from NCBI 
website and based on the website: http://www.basic.northwestern.edu/biotools/oligocalc.html). 
** Showed Tm values were obtained together with desalted primers synthesised by Sigma-Aldrich.  
*** Proteins from MUPs family, for which primers were designed: Mup1, (variant 2), Mup2 (variant 1),  
Mup LOC100048885, Mup10, Mup11, Mup17.  
**** Sequences for gremlin 2 primers were taken from Sudo et al; 2004, they were designed within one exon, 
whereas other primers aimed to span exon-exon junction. 
***** Results from qRT-PCR with primers for EGFR gene were presented in Chapter 4. 
****** Examples of primers sets which occurred to be not efficient for the qRT-PCR analysis (no signal, very 
low/weak signal, not clear results, high variations in Ct values between four reactions performed on one cDNA 
sample, high differences in signal intensity between triplicates), due to poor design or low mRNA levels of genes of 
interest in analysed samples. 
 
 
3.2.6.1.3. The relative mRNA expression based on the qRT-PCR reaction. 
To sum up, the qRT-PCR analysis was performed on back skin samples 
from 17, 18 and 19 day old mouse embryos. For each time point three animals were 
analysed (triplicate biological replicates). From each animal cDNA samples from 
upper dermis (Area “1”) and lower dermis (Area “2”) were used. For each cDNA 
sample, four identical reactions were prepared and analysed. After, the reaction (on 
FAST Real Time Machine), the obtained Ct values were used in order to calculate 
the relative gene expression. The Delta-Delta-Ct (ddCT) method (reviewed by Yuan 
et al, 2006) was applied for this purpose. The Ct (cycle threshold) is a number of 
cycles at which the detected fluorescence signal crosses the established (on the 
7300/7500 Fast System software) threshold. For a single cDNA sample a signal was 
obtained from two, three or four reactions, then Ct values were selected (minimum 
of two and maximum of three Ct values) that were lower or equal to 36 and these 
were used for further analysis. Other cDNA samples with only one Ct value (one 
signal from all four reactions) and/or with any Ct values higher than 36, were treated 
as samples with a very low amount of analysed gene, or undetectable up-regulation 
of analysed gene and their fold-change was treated as “0”. In addition, some Ct 
values higher than 36-38 could be related to a signal obtained by primer-
dimerization, thus it was crucial to take this under consideration and eliminate these 
Cts from further analysis. 
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3.2.6.2. Immunofluorescence analysis.  
 The immunofluorescence analysis was performed on back skin samples 
taken from the same animals as used for both microarray analysis and the 
verification work. Skin sections were also prepared from mice derived from other 
mothers than animals used for microarray analysis and verification work. 
 
3.2.6.2.1. Preparation of skin sections and the staining protocol. 
 Back skin samples and skin sections were prepared according to methods in 
section 2.2.3. 
The unfixed and fixed (see section 3.2.6.2.2) skin sections were first washed 
two or three times in PBS (each wash 5 minutes) and blocked with 20% serum 
(Sigma; for more details see Table 3.3A) in PBS for 30 minutes at RT. Sections 
were then incubated with a diluted primary antibody (overnight at 4oC or 1 hour at 
RT), in 1% serum/PBS. Skin sections were washed three times in PBS as described 
above and incubated with secondary antibody (AlexaFluor; for more details see 
Table 3.3B) diluted 1:500 in 1% serum/PBS for one hour at RT. Normally, DAPI 
(Insight Biotechnology) was added to this secondary antibody solution at a final 
dilution of 1:5000. Sections were then washed three times in PBS as before, 
mounted in mowiol (Appendix I) and covered by coverslips. Incubations with 
antibodies were performed in covered trays. After staining slides were stored at 4oC, 
in the dark. 
 
3.2.6.2.2. Fixation methods using acetone and methanol. 
Three different methods were used that involved these fixatives.  
Acetone/Methanol fixation (A/M). 
Skin sections were incubated in 100% acetone (Sigma) for 10 minutes at -20oC, 
then in 100% methanol (Sigma) for 10 minutes in -20oC. 
Methanol/Acetone no. 1 (M/A no. 1). 
Skin sections were incubated in 100% methanol (Sigma) for 15 minutes at -20oC, 
then in 100% acetone (Sigma) for 2 minutes in -20oC. 
Methanol/Acetone no. 2 (M/A no. 2). 
Skin sections were incubated in 100% methanol (Sigma) for 15 minutes at -20oC, 
Then in 100% acetone (Sigma) for 5 minutes in -20oC. 
 
 
 
                                                                                                           Chapter 3 
                                                                                                 
127 
3.2.6.2.3. Primary and secondary antibodies. 
A summary of the conditions used for different primary antibodies is shown in 
Table 3.3A. Secondary antibodies used are shown in table 3.3B. 
 
 
Table 3.3.A. Summary of primary antibodies and conditions used for the verification 
of dermis microarray data by immunofluorescence. 
* P - polyclonal; M - monoclonal 
** Time and temperature of skin sections incubation with primary antibodies  
*** Type of secondary antibodies used for staining. 
**** A gift from Prof A .Christiano’s laboratory (Columbia University; New York; USA) 
***** Results from EGFR staining have been presented in Chapter 4 
h - hour 
RT - room temperature 
 
 
Table 3.3.B. Summary of secondary antibodies used for the verification work of 
dermis microarray data by immunofluorescence. 
 
Secondary antibody: 
 
Company: 
 
Used/tested 
dilutions: 
DantiG 
(FITC) 
AlexaFluorR 488 donkey 
anti-goat IgG(H+L) 2ml/ml 
Invitrogen/Molecular 
probes 
1:500 
DantiR 
(FITC) 
AlexaFluorR 488 donkey 
anti-rabbit IgG(H+L) 2ml/ml 
Invitrogen/Molecular 
probes 
1:500 
 
 
 
 
 
 
Primary antibody: 
 
 
Details of immunofluorescent staining: 
Antibody/ 
Manufacturer 
Raised in/  
P or M* 
Fixation 
(Fix.) 
Blocking  Dilution Incub.** Sec. 
ant.*** 
FABP4/ 
R&D Systems 
Goat/ P A/M 20% 
donkey  
serum  
1:50 in  
1% donkey  
serum 
overnight  
at 4oC 
 DantiG 
(FITC) 
 
AdipoQ 
(Acrp30)/ 
Santa Cruz 
Biotechnology 
Rabbit/ P No Fix. 20% 
donkey 
serum 
1:50, 1:100 overnight  
at 4oC 
or 1 h at 
RT 
DantiR 
(FITC) 
TRPS**** Rabbit/ P M/A  
no. 1 
20% 
donkey 
serum 
1:5000 in  
1% donkey 
serum 
overnight  
at 4oC 
DantiR 
(FITC) 
PDGFRa/ 
Santa Cruz 
Biotechnology 
Rabbit/ P M/A  
no. 2 
20% 
donkey 
serum 
1:200 in 
1% donkey 
serum 
overnight  
at 4oC 
DantiR 
(FITC) 
EGFR*****/ 
Santa Cruz 
Biotechnology 
Rabbit/ P No Fix. 20% 
donkey 
or goat 
serum 
1:50 or 
1:100 
 
overnight  
at 4oC 
or 1 h at 
RT 
DantiR 
(FITC) 
                                                                                                           Chapter 3 
                                                                                                 
128 
3.3. Results. 
3.3.1. Investigation of genes from E17, E18 and E19 microarray lists. 
A brief schematic description of steps used for the analysis of the microarray 
data is presented in Figure 3.5. The three initial microarray lists, obtained using the 
GeneSpring® GX11.0 software, were termed: “E17”, “E18”, and “E19” 
corresponding to the gestational age of the samples (e17, e18 and e19 time points 
respectively). Each list contained genes with 2 fold or greater increase in expression 
either in upper dermis or in lower dermis of mouse embryonic back skin. Unique 
Affymetrix IDs (probe set) were associated with both known and unknown genes. 
Moreover, a single gene could be represented by several IDs. 
 
Using the Venn function in GeneSpring software, genes common for two or 
three time points (overlapping expression), as well as genes unique for single time 
points were identified (Figure 3.6). The Venn diagram gave a preliminary view on 
the differences and similarities between genes expressed in two areas of skin 
dermis at e17, e18 and e19 time points. IDs that represented genes unique only for 
one list were spotted in each analysed time point (516 IDs in E17 list, 247 IDs in E18 
list and 1416 IDs in E19 list). In addition, genes common for two out of three lists 
were seen in the Venn diagram and the highest number if IDs (663) common for two 
list was observed for e18 and e19 time points, whereas the lowest number of 
common IDs was observed between E17 and E19 lists. Finally, almost 300 IDs were 
spotted to be common for all three lists.  
 
In addition, hierarchical clustering analysis gave a view on the correlations 
between expression intensity of genes in upper (Area “1”) and lower (Area “2”) 
dermis areas at three time points (e17, e18 and e19) (Figure 3.7). Each analysed 
gene (line on a hierarchical combined tree with the gene name shown on the right) 
is characterised by a specific expression intensity (presented by a colour from blue – 
lowest intensity to red – highest intensity) in analysed samples (rows on a 
hierarchical combined tree: upper area “1” or lower area “2” of dermis at three time 
points “17”, “18” and “19”). Rows representing genes from area “1” (upper dermis) 
and area “2” (lower dermis) from E17 list were clustered most closely together (see 
first two rows in Figure 3.7). Genes from area “1” of E18 list were clustered most 
closely with area “1” from E19, list (see two middle rows in Figure 3.7). Then area 
“2” from E18 list shared most similarity with area “2” from E19 list (see last two rows 
in Figure 3.7).   
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E17, E18, E19 MICROARRAY LISTS 
Lists contained of genes up-regulated either in lower or upper mouse skin dermis  
at three embryonic time points: e17, e18 and e19. 
 
 
                                      PRELIMINARY ANALYSIS 
  The analysis of a degree of overlap between genes from E17, E18 and E19 lists.  
  This analysis was done to investigate similarities and differences between genes     
  expressed in two skin dermis areas. It was represented by the Venn diagram and  
  a hierarchical clustering analysis. 
 
In addition, the global analysis of highly up-regulated genes in lower dermis from 
E17 and E19 time points was performed. This work aimed to investigate presence 
  of fat-related* genes during development of lower dermis. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. A schematic presentation of analysis following E17, E18 and E19 
microarray lists generation by GeneSpring® GX11.0 software. *Genes related to 
adipocytes/adipose tissue/adipogenesis studies, diabetes/obesity/insulin/nutrition-
related work, and genes associated with metabolic syndrome/lipid 
metabolism/lipodystrophy terms. 
 
 
 
 
 
 
ANALYSIS OF GENES FROM 
MICROARRAY LISTS 
The bioinformatics analysis (by 
DAVID v6.7 programme) of 
microarray data was performed to 
investigate biological functions and 
involvement in metabolic pathways 
of genes enriched either in upper 
or lower back skin dermis.  
MICROARRAY DATA VALIDATION 
 
To confirm the specific expression 
pattern in embryonic skin dermis of 
selected genes from E17, E18 and E19 
lists. Analysis was performed on: 
1) mRNA level (qRT-PCR) 
2) protein level (immunofluorescence 
analysis) 
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Figure 3.6. Analysis of microarray data generated by using GeneSpring® GX11.0 
software. The Venn diagram represents genes (both up-regulated and down-
regulated) common to two or three time points or to the individual time points 
analysed: e17, e18 and e19. The total number of IDs generated for each microarray 
list is shown in brackets. 
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Figure 3.7. Hierarchical combined tree generated by GeneSpring® GX11.0 software. 
Samples are grouped according to the degree of similarity of their expression 
profiles over the selected probes. Samples with more similar expression profiles are 
grouped closer to each other in the tree. Rows represent analysed embryonic skin 
samples: [1-17] - upper dermis at e17 time point; [2-17] - lower dermis at e17 time 
point; [1-18] - upper dermis at e18 time point; [2-18] - lower dermis at e18 time point; 
[1-19] - upper dermis at e19 time point; [2-19] - lower dermis at e19 time point. Each 
line represents an analysed gene with its name shown on the right. The colour 
range: blue - the lowest (expression) intensity, red - the highest (expression) 
intensity. 
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Lists generated from each time point analysed, were used for the detailed 
investigation of genes either up-regulated in the upper dermis (control samples; 
Area “1”) or up-regulated in lower dermis (experimental area; Area “2”) (Figure 3.8A, 
B and C). Each list contained of IDs representing genes ether up-regulated in upper 
dermis (Area “1”) or up-regulated in lower dermis (Area “2”) (Figure 3.8D). 
Interestingly, upper dermis from the e17 time point was characterised by the lowest 
number of enriched genes in this skin area (90), when compared with number of 
genes enriched in upper dermis at e18 (557) and e19 (1534) time points. In 
comparison, the number of IDs for genes up-regulated in the lower dermis at all 
three time points was quite similar. 
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A)  
B)  
C)  
D)  
Figure 3.8. A schematic presentation of dermis areas used for the generation of E17, 
E18 and E19 microarray lists at three time points. (A) e17 time point. (B) e18 time 
point. (C) e19 time point. (D) Numbers of Affymetrix IDs (from three microarray lists) 
for genes up-regulated in upper dermis (shown in green) or in lower dermis (shown 
in red). 
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Global changes in fat-related gene expression over time.  
 
The Oil Red O staining, performed on embryonic back skin sections, allowed 
the observation of lipid droplets in differentiating fat cells localised in lower skin 
dermis between e18 and e19 time points (Figure 2.5 in Chapter 2). Therefore, the 
microarray work performed on embryonic skin dermis from e17, e18 and e19 time 
points was expected to provide valuable information on adipogenesis in vivo at the 
molecular level.  
Two generated microarray lists, E17 and E19, underwent so-called initial 
global analysis. One aim of this work was to gauge whether, at the stage of the first 
time point (e17), there were indications from the lower dermis that adipogenesis or a 
future transition to the adipocyte phenotype had been initiated. Another was to 
demonstrate that by the final time point (e19), the overall trend towards 
adipogenesis had increased. None of the features of the bioinformatics packages 
that were available to me at the time of the analysis had a specific function or 
classification for very detailed analysis of adipogenesis or fat-related genes. 
Therefore for the preliminary analysis of the microarray data, from the E17 list and 
E18 list, the function of the 100 genes with the highest up-regulation in the lower 
dermis versus the upper dermis was examined by searching databases. All these 
genes from E17 list were characterised by a fold change equal or higher than 4. 
Selected genes from E19 list had a fold change equal and higher than 7. These 
genes were investigated principally through published literature, including using the 
PUBMED website with such main keywords as: adipocytes or adipogenesis, 
diabetes and obesity, insulin or metabolic syndrome. Genes, associated with at least 
one of these terms, were treated as “fat-related genes”, those with functions not 
encompassed by one of these terms were designated as “other genes” (Figure 3.9) 
and genes with as yet no discovered function were classified as “unknown” genes. 
Among analysed 100 genes from E17 list, 42% of the genes were reported in 
studies as “fat-related genes”. The majority of genes (57%) were in the “other” 
category, while a very small number (1%) of genes were “unknown” (Figure 3.9A).  
When the same type of analysis was performed on the E19 microarray lists 
the percentage of fat-related genes had increased to become the majority (60%) 
with half of this number having other functions (Figure 3.9B). Interestingly, the group 
of unknown genes had increased to 10% of the total. 
To sum up, the increasing tendency was seen with numbers of genes 
specific for fat-related terms that were up-regulated in lower dermis during mouse 
embryonic development (from e17 to e19 time points). 
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Figure 3.9. Global characterisation of 100 genes from the E17 (A) and E19 (B) 
microarray lists, displayed as pie charts. Selected genes had the highest fold 
change among all up-regulated genes in the lower dermis versus upper dermis. 
Genes presented in adipocytes/adipose tissue/adipogenesis based studies, or in 
diabetes/obesity/insulin/nutrition-related work or finally, genes associated with 
metabolic syndrome/lipid metabolism/lipodystrophy, were classified into the group of 
fat-related genes. 
 
 
 
                                                                                                           Chapter 3 
                                                                                                 
136 
Changing patterns of gene expression and selection of genes for array 
validation. 
 In addition to the trend showing greater numbers of up-regulated fat-related 
genes over the three time points, fold change values also increased. Thus in the 
E18 list, the range of fold change values was bigger overall than at E17 (see Table 
3.4 with selected genes from microarray data). At E18 the highest fold change was 
about 242 for carbonic anhydrase 3 (Car3) (Table 3.4). In the E19 list, the Car3 
gene had the second highest fold change value, of 489 (gene up-regulated in lower 
dermis). Another gene, with a similar expression pattern to Car3, was adiponectin 
(Adipoq). Again this gene was not present in the E17 list, but then became up-
regulated in the lower dermis at e18 (fold change: 57) and even more strikingly at 
e19 (fold change: 721) where it topped the list of genes up-regulated in the lower 
dermis (Table 3.4). Another cohort of genes showed a marked up-regulation in the 
lower dermis only at day e19. Included in the group were the major urinary proteins, 
adipsin and resistin (Table 3.4). Yet another pattern of expression was revealed by 
genes such as retinol binding protein 4 (Rbp4) or fatty acid binding protein 4 (Fabp4), 
that showed consistent up-regulated gene expression in the lower dermis at all time 
points (Table 3.4). Other features of these genes are discussed later in this Chapter, 
but the initial analysis showed that a) fat-related genes, observed in E17 microarray 
list, are also present in E18 and E19 lists; b) The number, and relative expression 
levels of fat-related genes in the lower dermis increases during development from 
E17 to E19 and c) a number of genes not previously associated with the 
development of fat are prominent in the gene lists. 
 
 All the above mentioned genes were chosen to be verified by qRT-PCR 
analysis. They were selected to cover the different patterns of developmental 
expression and their presence in the general category of “fat-related genes”. Major 
urinary protein-1 had previously been associated with diabetic individuals and not 
adipocyte differentiation (Hui et al, 2009). Others, including fatty acid binding protein 
4 and adiponectin were validated by qRT-PCR and at the protein level by 
immunohistochemistry, since although they have been previously associated with 
adipocytes in mature fat tissues, their developmental involvement in embryonic 
rodent skin dermis has not been yet clearly defined (see section 3.4) Other genes 
chosen for the verification process included three that were up-regulated in upper 
dermis (Table 3.4).  
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Table 3.4. Selected genes from microarray lists: E17, E18 and E19 with specific 
gene expression patterns and fold changes in analysed skin dermis areas. 
The regulation and fold change of selected 
genes from three microarray lists. 
Gene expression profile in lower dermis area (“2”) 
versus upper dermis area (“1”) at three time points: 
         e17                      e18                           e19         
Gene symbol; 
Whole name;  
Affymetrix  ID: 
2 17 vs 1 17 2 18 vs 1 18 2 19 vs 1 19 
Fabp4; fatty acid binding 
protein 4, adipocyte; 
1417023_a_at 
+ 25.73805 
 
+ 91.76061 
 
+ 170.3202 
 
Rbp4; retinol binding protein 
4, plasma; 1426225_at 
+ 15.71429 
 
+ 75.41824 
 
+  60.66678 
 
G0s2; G0/G1 switch gene 2; 
1448700_at 
NP + 19.24273 
 
+  72.4153 
 
Adipoq; adiponectin, C1Q 
and collagen domain 
containing; 1422651_at 
NP +  57.37421 
 
+ 721.3733 
 
Hp; Haptoglobin; 
1448881_at 
NP + 2.511893 + 79.72434 
Car3; carbonic anhydrase 3; 
1449434_at 
NP + 241.5143 
 
+ 489.1857 
 
Mups; predicted gene, 100039054 /// RIKEN 
cDNA 2610016E04 gene /// major urinary protein 
LOC100048885 /// novel member of the major 
urinary protein (Mup) gene family /// major urinary 
protein 1 /// major urinary protein 2 /// predicted 
gene, OTTMUSG00000007428 /// predicted gene, 
OTTMUSG00000007431 /// predicted gene, 
OTTMUSG00000007486 /// predicted gene, 
OTTMUSG00000008509 /// predicted gene, 
OTTMUSG00000012492 /// predicted gene, 
OTTMUSG00000012493 /// predicted gene, 
OTTMUSG00000015595; 
1420465_s_at 
NP NP + 421.3903 
 
Cfd; complement factor D 
(adipsin; Adn); 1417867_at 
NP NP + 12.97235 
Retn; resistin; 1449182_at NP NP + 7.096386 
Trps; trichorhinophalangeal 
syndrome I (human); 
1457445_at 
- 5.823731 
 
- 13.77049 
 
- 53.56554 
 
Grem2; gremlin 2 homolog, 
cysteine knot superfamily 
(Xenopus laevis); 
1418492_at 
NP - 18.70761 
 
- 44.30882 
 
Pdgfra; platelet-derived 
growth factor receptor, 
alpha polypeptide; 
1438946_at 
NP NP - 4.353716 
 
 
   “+”: gene was up-regulated in lower dermis (versus upper dermis) 
   “-”: gene was down-regulated in lower dermis (versus upper dermis) 
“NP: gene was not present in the microarray list with a fold change cut off 2 
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3.3.2. Microarray data validation. 
3.3.2.1. Highly up-regulated genes in lower dermis of mouse embryonic 
back skin.  
 In order to verify microarray data, several genes were selected from 
microarray lists that were characterised by high up-regulation in lower dermis 
(versus upper dermis) in one, two or three analysed time points (Table 3.4). 
 
Retinol binding protein 4 (Rbp4), associated with diabetes and fatty acid 
binding protein 4 (Fabp4) observed in adipose tissue (Janke et al, 2006; Samulin et 
al, 2008) stood out in the microarray lists because at all analysed time points they 
were up-regulated in the lower dermis (Table 3.4). When their expression profiles 
were verified by qRT-PCR reaction (Figure 3.10A and B) this pattern of expression 
was confirmed, showing an increase in the lower dermis from e17 to e19 time points, 
whereas their expression in the upper dermis remained at relatively low levels. The 
highest expression of both genes was seen in lower dermis of e19 time point sample 
(called “19 2”) and the expression levels of lower dermis samples (called “17 1”, “18 
1” and “19 1”) were significantly low when compared with “19 2” samples, based on 
the t-test results (Figure 3.10A and B).  
 
When antibodies against fatty acid binding protein 4 (FABP4) were used to 
investigate distribution of the protein in back skin, immunofluorescence analysis 
confirmed its localisation as being in the lower skin dermis, at all time points (Figure 
3.11). Labelling was visible in the lower dermis at e17 time point (Figure 3.11a), all 
be it with a somewhat patchy distribution, with regions of stronger expression 
alongside areas where staining was clearly weaker. Overall, staining became more 
widespread and increased in intensity at e18 and e19 time points (Figure 3.11b, c) 
but labelling was still predominantly restricted to the lower inter-follicular dermis. 
Magnification of the photo from 19 day old skin section revealed cytoplasmic 
localisation of FABP4 in the cells of the lower dermis (Figure 3.11d). There was little 
or no labelling of the hair follicles or inter-follicular epidermis apart from a line of 
immunofluorescence in the outermost layer, that was apparently non-specific as it 
was also apparent in otherwise blank negative control sections (Figure 3.12). 
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Figure 3.10. Verification of microarray data by qRT-PCR for two genes: Rbp4 and 
Fabp4. The relative mRNA expression for both genes was analysed on samples 
from dermis at: e17 (17), e18 (18) and e19 (19) time points, from upper (Area “1”, 
green) and lower (Area “2”, red) dermis. Data were obtained from triplicate biological 
replicates. The baseline (1-fold change) was established for the e19 lower dermis 
sample (underlined on the figure) and the mRNA levels of the other samples are 
shown relative to this. Both genes are up-regulated in lower dermis (Area “2”) when 
compared with upper area (Area “1”) in all analysed time points. This observation is 
in agreement with in vivo microarray data generated from dermal cells (Table 3.4). 
The mRNA level of Rbp4 increases in lower dermis from e17 to e18 time point and 
then remains at a constant level in lower dermis between e18 and e19 time points 
(Figure 3.10A - red columns). Fabp4 expression gradually increased in lower dermis 
from e17 to e19 time point (Figure 3.10B - red columns). P value refers to the 
comparison with “19 2” sample (* P <0.05, ** P <0.01, *** P <0.001). The “NS” 
indicates not significant differences in the mRNA gene expression. 
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Figure 3.11. Localisation of fatty acid binding protein 4 
(FABP4) in mouse embryonic skin. Back skin sections 
(7 µm) were prepared from embryos at e17 (17dE), 
e18 (18dE) and e19 (19dE) time points and probed 
with antibody against FABP4. Expression of the 
protein is evident in lower part of dermis and in inter-
follicular dermal cells. Scale bar = 30 µm. U - upper 
dermis, L - lower dermis, HF - hair follicle. DNA was 
counterstained with DAPI. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 3.12. Control staining performed together with the investigation of FABP4 
expression in mouse embryonic back skin samples. Control staining for secondary 
antibody (DaG - donkey anti-goat), where primary antibody (for experimental 
samples) was replaced with 1% donkey serum. Control skin sections underwent the 
same fixation method as experimental samples: the Acetone/Methanol fixation (A/M). 
Scale bar = 30 µm. Fluorescent images were visualised using a Zeiss Axio Imager 
M1. microscope. 
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Verification by qRT-PCR was performed for the G0/G1 switch gene (G0s2) 
that is suggested to interact with adipogenic transcriptional factor PPARgamma and 
regulates lipolysis (Zandbergen et al, 2005; Yang et al, 2010b). The results showed 
clear up-regulation of this gene in the lower dermis versus upper dermis in 18 and 
19 day old mouse embryos (Figure 3.13A), a finding consistent with the pattern seen 
in the microarray data (Table 3.4). Interestingly, the qRT-PCR analysis showed that 
this gene was present in upper dermis in all analysed time points, and its levels at 
e17 and e18 time points (samples “17 1” and “18 1”) were at a significantly low level 
when compared with lower dermis sample from e19 time point (sample “19 2”; see 
Figure 3.13A).  
 
Among other genes which up-regulation in lower dermis was observed at 
e18 and was continued at e19 time point was adiponectin (Adipoq; Table 3.4), 
known to be involved in the regulation of adipogenesis process (Fu et al, 2005). Its 
mRNA level was verified by qRT-PCR which confirmed the specific expression 
pattern in lower skin dermis (Figure 3.13B). The expression of Adipoq was 
significantly enriched (based on the t-test analysis) in lower dermis from 19 day old 
skin dermis (sample “19 2”) when compared with upper dermis sample at the same 
time point (“19 1”) and with samples from both dermis areas at e17 and e18 time 
points (“17 1”, “17 2”, 18 1” and “18 2”, see Figure 3.13B).   
In addition, expression of adiponectin was analysed at the protein level by 
immunofluorescence which revealed presence of this protein in back skin sections 
from all analysed time points (Figure 3.14a - d). The positive staining could be 
spotted in cells from lower dermis area, localised between hair follicle end bulbs 
(Figure 3.14d - see white arrow). However, the antibody against AdipoQ stained 
also the upper dermis area, along the epidermis-dermis border as well as dermal 
cells localised very close to hair follicles (Figure 3.14a - d). It could also be 
suggested that the antibodies against AdipoQ stained the very outer areas of hairs 
(dermal sheath). When compared to the negative control the staining with 
adiponectin can be seen to be specific in embryonic back skin (compare Figure 3.14 
with Figure 3.15).   
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Figure 3.13. Verification of microarray data by qRT-PCR for two genes: G0s2 and 
Adipoq. The relative mRNA expression for both genes was analysed on samples 
from dermis at: e17 (17), e18 (18) and e19 (19) time points, from upper (Area “1”, 
green) and lower (Area “2”, red) dermis. Data were obtained from triplicate biological 
replicates. The baseline (1-fold change) was established for the e19 lower dermis 
samples (underlined on the figure) and the mRNA levels of the other samples are 
shown relative to this. Both genes are up-regulated in lower dermis (Area “2”), 
compared with upper area (Area “1”) in e18 and e19 time points. This observation is 
in agreement with in vivo microarray data generated from dermal cells (Table 3.4). 
G0s2 gene is detected in both lower and upper dermis (Figure 3.13A - green and 
red columns), whereas Adipoq is observed only in lower dermis (Figure 3.13B - red 
columns). P value refers to the comparison with “19 2” sample (* P <0.05, ** P <0.01, 
*** P <0.001). The “NS” indicates no significant differences in the mRNA gene 
expression. 
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Figure 3.14. Localisation of Adiponectin (AdipoQ) in mouse embryonic skin. Back 
skin sections (7 µm) were prepared from embryos at e17 (17dE), e18 (18dE) and 
e19 (19dE) time points and probed with an antibody against AdipoQ. Strong staining 
is observed in areas adjacent to hair follicle end bulbs and in dermal sheath. Cells 
close to the epidermis layer are also stained. Weak expression of AdipoQ can be 
seen in cells from the lower dermis (d - see white arrow). (a, b, c) Scale bar = 30 µm. 
(d) Scale bar = 15 µm. HF - hair follicle. DNA was counterstained with DAPI. 
Fluorescent images were visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 3.15. Control staining performed together with the investigation of AdipoQ 
expression in mouse embryonic back skin samples. Control staining for secondary 
antibody (DaR – donkey anti-rabbit), where primary antibody (for experimental 
samples) was replaced with 1% donkey serum. No fixation was used. Fluorescent 
images were visualised using a Zeiss Axio Imager M1. microscope. 
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Examples of other genes, highly up-regulated in the lower dermis from the 
array data, were haptoglobin (Hp), carbonic anhydrase 3 (Car3) or major urinary 
proteins family (Mups) (Table 3.4). These genes have been investigated in obese 
and diabetic individuals (Lynch et al, 1993a; Chiellini et al, 2002; Hui et al, 2009). 
Expression of carbonic anhydrase 3 was also detected in differentiated 3T3 
adipocytes (Lynch et al, 1993b). The qRT-PCR analysis confirmed dramatic up-
regulation of these genes in lower dermis cells from 19 day old mouse embryo 
(Figure 3.16A - C). In addition, low mRNA signal for Hp and Car3 genes was spotted 
in 18 day old skin, in lower dermis (Figure 3.16A and B). Based on the PCR analysis, 
over-expression of Hp gene in lower dermis occurred as the earliest one (very weak 
signal detected from sample “17 2”), and the up-regulation of Car3 took place 
approximately 24 hours later (compare Figure 3.16A and B). The dramatic over-
expression of Hp, Car3 and Mups took place in e19 time point sample from lower 
dermis (Area “2”). No expression of all three genes on mRNA level was seen in 
upper dermis at any of analysed time points (compare Figure 3.16A with 3.16B and 
with 3.16C). The t-test analysis showed highly significant up-regulation of these 
three genes in lower dermis from 19 day old embryonic skin (sample “19 2”), when 
compared with other analysed samples (“17 1”, “17 2”, “18 1”, “18 2” and “19 1”, see 
Figure 3.16A - C). 
 
Based on the microarray data (Table 3.4), among genes up-regulated in 
lower dermis from the oldest skin sample (e19 time point), were adipsin (Adn) and 
resistin (Retn), known to be produced and secreted by mature fat cells and analysed 
in obesity related studies (Lu et al, 2006). This up-regulation was also confirmed by 
the qRT-PCR analysis, where mRNA signal was detected in lower dermis of 19 day 
old skin (Figure 3.17A and B). Therefore, this expression was significantly enriched 
in lower dermis when compared in upper dermis, based on the t-test analysis at 
analysed e19 time point 
 
To sum up, the qRT-PCR work allowed to confirm expression patterns for 
several selected genes from generated microarray data and clearly show either their 
gradual (for example for Fabp4) or very dramatic (for example Hp) up-regulation in 
lower dermis versus upper dermis at all analysed time points. 
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Figure 3.16. Verification of microarray data by qRT-PCR for three genes: Hp, Car3 
and Mups. The relative mRNA expression for genes was analysed on samples from 
dermis at: e17 (17), e18 (18) and e19 (19) time points, from upper (Area “1”, green) 
and lower (Area “2”, red) dermis. Data were obtained from triplicate biological 
replicates. The baseline (1-fold change) was established for the e19 lower dermis 
sample (underlined on the figure) and the mRNA levels of the other samples are 
shown relative to this. Expression of analysed genes is significantly up-regulated in 
lower dermis (Area “2”) when compared with upper area (Area “1”) for the e19 time 
point. This observation is in agreement with in vivo microarray data generated from 
dermal cells (Table 3.4). At e18 time point, both Hp and Car3 genes are detectable 
at low level in lower dermis (Figure 3.16A and Figure 3.16B - red columns). P value 
refers to the comparison with “19 2” sample (* P <0.05, ** P <0.01, *** P <0.001). 
The “NS” indicates no significant differences in mRNA gene expression. 
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Figure 3.17. Verification of microarray data by qRT-PCR for two genes: Adn and 
Retn. The relative mRNA expression for both genes was analysed on samples from 
dermis at e19 (19) time point, from upper (Area “1”) and lower (Area “2”, red) dermis. 
Data were obtained from triplicate biological replicates. The baseline (1-fold change) 
was established from the e19 lower dermis sample (underlined on the figure) and 
the mRNA levels of the other samples (19 1) are shown relative to this. Based on in 
vivo microarray data, the up-regulation of adipsin and resistin in lower dermis 
(versus upper dermis) could be detected at e19 time point (Table 3.4). Therefore 
qRT-PCR reaction was only performed for this time point confirming the expression 
profile of these genes in 19 day old embryonic back skin. Adn and Retn genes were 
up-regulated in lower dermis (Figure 3.17A and Figure 3.17B - red columns). P 
value refers to the comparison with “19 2” sample (*** P <0.001).  
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3.3.2.2. Genes down-regulated in lower dermis versus upper dermis 
(higher expression in Area “1” of mouse skin dermis). 
 As well as genes up-regulated in lower dermis, the microarray work allowed 
to investigate genes specifically expressed in the upper dermis. Three genes, 
observed to be up-regulated in upper dermis, were chosen for the verification work, 
such as gremlin 2 (Grem2), trichorhinophalangeal syndrome I (Trps) and platelet-
derived growth factor receptor alpha (Pdgfra) (Table 3.4). 
 
The up-regulation of Grem2 gene in upper dermis (Area “1”) was observed in 
microarray lists generated from the analysis of 18 and 19 day old back skin samples 
and this expression pathway was confirmed by the PCR work (Figure 3.18). The 
mRNA of Grem2 gene was not detected in both areas of e17 time point skin 
(samples “17 1” and “17 2”) and in lower dermis from 19 day old skin (sample “19 2”). 
In addition, only one out of two biological samples used for qRT-PCR analysis, 
showed the presence of Grem2 gene in lower dermis at e18 time point. 
 
Next, the up-regulation of Trps gene in upper dermis was seen when 
comparing to lower dermis at all analysed time points (Table 3.4), this was seen at 
both the mRNA and protein level (Figure 3.19 and Figure 3.20). The high expression 
of Trps gene was observed in upper dermis samples at all analysed time points 
(Figure 3.19 - green columns), whereas levels of this gene were very low in lower 
dermis areas (Figure 3.19 - red columns). The highest up-regulation of Trps gene in 
sample “19 1” was significantly enriched when compared with expression of this 
gene in lower dermis samples from e17, e18 and e19 time points (compare sample 
“19 1” with samples “17 2”, “18 2” and “19 2” on Figure 3.19). In addition, the 
immunofluorescence analysis showed a positive nuclear staining for TRPS in 
dermal cells close to epidermal layer and in the hair follicles, whereas no signal was 
detected in lower dermis area, between hair follicle end bulbs (Figure 3.20). This 
expression pattern was seen in all three analysed time points. The specificity of the 
primary antibody was also confirmed by the negative control staining (compare 
Figure 3.20 with Figure 3.21). 
 
Finally, the platelet-derived growth factor receptor alpha expression was up-
regulated on the mRNA level (based on microarray data) in upper dermis versus 
lower dermis at e19 time point (with fold change 4.35; see Table 3.4). When platelet-
derived growth factor receptor alpha was analysed on the protein level by 
immunofluorescence, staining was seen in upper area of skin dermis (Figure 3.22). 
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In addition, antibody against PDGFRa seemed to stain the hair follicles. The 
negative control staining was performed in parallel (compare Figure 3.22 with Figure 
3.23). 
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Figure 3.18. Verification of microarray data by qRT-PCR for Grem2 gene. The 
relative mRNA expression for gene was analysed on samples from dermis at: e17 
(17), e18 (18) and e19 (19) time points, from upper (Area “1”, green) and lower 
(Area “2”, red) dermis. Presented data were obtained from duplicate. The third 
biological sample was omitted because of observed water contamination. The 
baseline (1-fold change) was established for the e18 upper dermis sample 
(underlined on the figure) and the mRNA levels of the other samples are shown 
relative to this. Based on E17, E18 and E19 microarray lists, the up-regulation of 
Grem2 gene was observed in upper dermis (Area “1”) at e18 and e19 time points 
(Table 3.4). The qRT-PCR reaction confirmed the presence of this gene in upper 
dermis of e18 and e19 time points (green columns). Among two “18 2” samples only 
one gave a signal during qRT-PCR and this situation can explain the high standard 
deviation for analysed e18 time point from lower dermis (see Figure 3.18 - red 
column). P value refers to the comparison with “18 1” sample (* P <0.05, ** P <0.01, 
*** P <0.001). The “NS” indicates no significant differences in the mRNA gene 
expression. 
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Figure 3.19. Verification of microarray data by qRT-PCR for Trps gene. The relative 
mRNA expression for Trps was analysed on samples from dermis at: e17 (17), e18 
(18) and e19 (19) time points, from upper (Area “1”, green) and lower (Area “2”, red) 
dermis. Data were obtained from triplicate biological replicates. The baseline (1-fold 
change) was established for the e19 upper dermis sample (underlined on the figure) 
and the mRNA levels of the other samples are shown relative to this. Expression of 
Trps is significantly up-regulated in upper dermis (Area “1”) when compared with 
lower area (Area “2”) for all time points. This observation is in agreement with E17, 
E18 and E19 microarray lists (Table 3.4). P value refers to a comparison with “19 1” 
sample (* P <0.05, ** P <0.01, *** P <0.001). The “NS” indicates no significant 
differences in the mRNA gene expression. 
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Figure 3.20. Localisation of trichorhinophalangeal 
syndrome I (TRPS) in mouse embryonic skin. Back 
skin sections (7 µm) were prepared from embryos at 
e17 (17dE), e18 (18dE) and e19 (19dE) time points 
and probed with an antibody against TRPS. The 
nuclear staining of TRPS is observed at all analysed 
time points, beneath the epidermis layer, in cells 
close to the top part of hair follicles (upper dermis) 
and along hair follicles structures (for example in 
dermal papilla). Scale bar = 30 µm. U - upper dermis, 
L - lower dermis, HF - hair follicle, DP - dermal 
papilla. DNA was counterstained with DAPI. 
Fluorescent images were visualised using the Zeiss 
Axio Imager M1. microscope. 
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Figure 3.21. Control staining performed together with the investigation of TRPS 
expression in mouse embryonic back skin samples. Control staining for secondary 
antibody (DaR – donkey anti-rabbit), where primary antibody (for experimental 
samples) was replaced with 1% donkey serum. Control skin sections underwent the 
same fixation method as experimental samples: the Methanol/Acetone (M/A) no.1 
method. Scale bar = 30 µm. Fluorescent images were visualised using a Zeiss Axio 
Imager M1. microscope. 
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Figure 3.22. Localisation of platelet-derived growth 
factor receptor, alpha (PDGFRalpha) in mouse 
embryonic skin. Back skin sections (7 µm) were 
prepared from embryos at e19 (19dE) time point and 
probed with antibody against PDGFRalpha. Staining 
is seen in upper dermis and along hair follicles. Scale 
bar = 30 µm. U - upper dermis, L - lower dermis, HF - 
hair follicle. DNA was counterstained with DAPI. 
Fluorescent images were visualised using a Zeiss 
Axio Imager M1. microscope. 
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Figure 3.23. Control staining performed together with the investigation of 
PGDFRalpha expression in mouse embryonic back skin samples. Control staining 
for secondary antibody (DaR – donkey anti-rabbit), where primary antibody (for 
experimental samples) was replaced with 1% donkey serum. Control skin sections 
underwent the same fixation method as experimental samples: the 
Methanol/Acetone (M/A) no. 2 method. Scale bar = 30 µm. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
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3.3.3. Analysis of E17, E18 and E19 microarray lists by The Database for 
Annotation, Visualization and Integrated Discovery - DAVID v6.7 
programme. 
 The verification work carried out on selected genes from three microarray 
lists (section 3.3.2) confirmed the unique expression profiles of these genes in 
embryonic skin dermis. It also showed that the generated microarray data can be 
treated as a reliable and useful source of information about molecular processes 
taking place during mouse embryonic development in back skin dermis. Moreover, 
selected genes (such as Fabp4, Adipoq, Adn and Retn or Rbp4, Hp, Car3 and Mups) 
that were highly up-regulated in lower skin dermis from e17, e18 and e19 time 
points, have been observed in differentiating adipogenic cell lines and mature fat 
cells or they have been investigated in obese and diabetes related studies (section 
3.3.2).  
 
As the preliminary analysis of E17, E18 and E18 microarray lists (sections 
3.3.1 and 3.3.2) showed that cells from lower skin dermis are characterised by a 
presence of genes specific for fat cells, the next aim was to obtain a broader view on 
changes taking places in this dermis area of mouse embryonic skin between e17 
and e19 time points. In addition, it seemed interesting to perform analysis on all 
genes up-regulated in upper dermis that could confirm the lack of fat-related genes 
(or a very low level of these genes) in dermal cells localised below the epidermis 
layer.  
Therefore, genes from E17, E18 and E19 lists underwent further analysis by 
using the DAVID v6.7 programme. This work permitted features of up-regulated 
genes in lower or upper dermis of mouse embryos at three time points to be 
investigated in relation to biological processes (Gene ontology - Biological Process 
terms: GO_BP terms). The DAVID v6.7 programme also correlated genes with 
known metabolic pathways (KEGG pathway database).  
 
First, each of three microarray lists (E17, E18 and E19) was divided into two 
sub-lists: a list comprising only those genes up-regulated in the upper dermis versus 
lower dermis and a list with genes up-regulated in lower dermis versus upper dermis. 
In total, six sub-lists were created, named as E17 UPPER, E18 UPPER, E19 
UPPER sub-lists and E17 LOWER, E18 LOWER and E19 LOWER sub-lists. These 
gene sub-lists underwent DAVID analysis. This work allowed association of genes, 
based on their known functions and suggested involvement in different molecular 
                                                                                                           Chapter 3 
                                                                                                 
158 
pathways, with both Gene Ontology Biological Process (GO_BP) terms and KEGG 
pathways terms (Table 3.5).  
 
 
Table 3.5. Number of gene ontology biological terms (GO_BP) and KEGG pathways 
terms associated with genes from six microarray sub-lists. The analysis was 
performed by the DAVID v6.7 tool. 
 
Number of terms associated with genes from 
sub-lists: 
 
 
 
 
Sub-lists: 
 
GO_BP 
terms 
 
KEGG 
pathways terms 
 
E17 UPPER 106 - 
E18 UPPER 208 12 
E19 UPPER 419 25 
E17 LOWER 386 28* 
E18 LOWER 347 20 
E19 LOWER 349 32 
* two groups of genes were created from E17 LOWER sub-list that shared the same KEGG pathway term: 
“Glycosphingolipid biosynthesis”.  
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The analysis of Gene Ontology - Biological Process (GO_BP) terms for dermis 
genes. 
Genes from all analysed six microarray sub-lists were related with biological 
terms by the DAVID v6.7 (Table 3.5). The E17 UPPER list was characterised by the 
lowest number of these terms (106). The E18 UPPER and E19 UPPER list had 208 
and 419 terms respectively. All three sub-lists with genes up-regulated in lower 
dermis were associated with similar number of GO_BP terms namely 386, 347 and 
349 (Table 3.5). 
 
The GO_BP terms with the highest percentage of involved genes were 
“cellular process”, common for five analysed gene lists and “metabolic process” for 
three lists (Figure 3.24A). There were three GO_BP terms common for all six lists: 
“cell differentiation”, “developmental process” and “organ development” and the E17 
UPPER sub-list had the highest percentage of genes associated with these three 
terms.  
 
There were several GO_BP terms created only for genes from upper dermis, 
such as “regulation of gene expression”, “regulation of RNA metabolic process” or 
“transcription” (Figure 3.24B). In addition, the “Wnt receptor signalling pathway” and 
“neurogenesis” terms were also associated with genes from upper dermis. The 
percentage of genes from upper dermis involved in these terms decreased from e17 
to e19 time points. 
 
 Many GO_BP terms were associated only with genes from the lower dermis 
(Figure 3.24C). For example, the “response to stimulus” term was associated with a 
high percentage of lower genes with the trend decreasing from e17 to e19 time 
points. Among other terms associated with lower dermis were: “lipid metabolic 
process”, “cellular lipid metabolic process” or “fatty acid metabolic process”, “fat cell 
differentiation” or “brown fat cell differentiation” and the percentage of genes from 
lower dermis that were involved in these categories increased from e17 to e19 time 
points .  
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A) Association of genes from microarray sub-lists with GO_BP 
(Gene ontology - Biological Process) terms. Part A.
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B) Association of genes from microarray sub-lists with GO_BP 
(Gene ontology - Biological Process) terms. Part B.
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Figure 3.24. Part A and B. For description see Figure 3.24. Part C. 
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C) Association of genes from microarray sub-lists with GO_BP 
(Gene ontology - Biological Process) terms. Part C.
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Figure 3.24. Part C. The association of genes from microarray sub-lists with gene 
ontology - biological terms (GO_BP). The analysis was performed by DAVID v6.7 
programme. Single gene can be involved in several terms. 
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KEGG pathways associated with genes from skin dermis. 
The DAVID v6.7 allowed the association of genes (from microarray sub-lists) 
with the online available KEGG (Kyoto Encyclopedia of Genes and Genomes) 
pathways that present known interactions between different genes. Only genes from 
the E17 UPPER sub-list were not associated with pathways which suggests that at 
this time point in the upper dermis, the number of activated genes was not sufficient 
to create a significant KEGG pathway term by DAVID6.7 programme (Table 3.5). 
 
Therefore the KEGG analysis showed that in the lower dermis the activation 
of genes involved in different pathways and known processes takes place earlier 
than in upper dermis. At e17 time point in lower dermis, 28 KEGG pathway terms 
were obtained for the gene sub-list (Table 3.5). At e18 and e19 time points, genes 
were also associated with KEGG pathways. Genes from E18 UPPER sub-list were 
associated with 12 pathways, whereas from the E18 LOWER sub-list with 20 
pathways. There were 25 KEGG pathways associated with the E19 UPPER gene 
sub-list and 32 pathways with the E19 LOWER sub-list.  
 
When the generated KEGG pathways for sub-lists were compared, a clear 
difference between pathways relating to the upper and lower dermis was seen 
(Table 3.6). Among the 12 pathways at e18 in the upper dermis, only three were 
present in the lower dermis (Table 3.6). From 32 pathways at e19 from the lower 
dermis, only two were present in upper dermis at the same time point (Table 3.6). 
More similarities were seen between diferent time points in the upper or lower 
dermis. For example, ten KEGG pathway terms were common for genes from the 
upper dermis at e18 and e19. In the lower dermis, 15 pathways were common 
between the e18 and e19 time points. In addtion, there were six terms related with 
genes up-regulated in lower dermis at each analysed time point (Table 3.6). 
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Table 3.6. The analysis of genes up-regulated in upper and lower dermis at three 
time points (e17, e18 and e19) performed by DAVID v6.7 programme. Genes were 
associated with KEGG pathway terms. “+” - the KEGG term associated with sub-list; 
“-“ -  the KEGG term not associated with sub-list. Single gene can be involved in 
several terms. 
 
* The DAVID v6.7 programme created for E17 LOWER sub-list two groups of genes that shared the same KEGG 
pathway term (“Glycosphingolipid biosynthesis”). These genes were treated as they belong to one term, therefore 
27 terms instead of originally created 28 terms (Table 3.5) are shown in Table 3.6 which are associated with E17 
LOWER sub-list genes. 
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Such KEGG pathway term as “adipocytokine signalling pathway” was 
associated with genes from lower dermis at all analysed time points (Figures 3.25). 
The adipocytokine signalling pathway is associated with the activity of cytokines 
which are secreted by adipose tissue (Guerre-Millo, 2004). Among known 
adipocytokines are adiponectin (AdipoQ), leptin or TNF-α (tumor necrosis factor 
alpha). These take part in lipid and glucose metabolism and inflammatory processes. 
The enrichment of adiponectin gene (Adipoq) in the lower dermis was confirmed by 
the qRT-PCR work (section 3.3.2.1; Figure 3.13B). Both leptin and adiponectin acts 
via receptors (Lepr, Adipor1 and Adipor2) and up-regulation of these receptors in 
lower dermis (versus upper dermis) was observed at all analysed time points on 
mRNA level (Table 3.7).  
 
The next interesting pathway associated with genes only from LOWER sub-
lists was the “PPAR signalling pathway” (Figure 3.25). PPARgamma gene, involved 
in this pathway, was enriched in lower dermis area from e17 till e19 time points and 
its expression was confirmed by the qRT-PCR reaction (section 3.3.5.1; Figure 
3.41B). The number of genes up-regulated in the lower dermis that were associated 
with the “PPAR signalling pathway” term increased from e17 (9) to e19 (18).  
 
Among other KEEG terms specific only to lower gene sub-lists, “fatty acid 
metabolism” term was associated with genes from e18 and e19 time points (Figure 
3.25).  In addition, the “fatty acid elongation in mitochondria”, the “biosynthesis of 
unsaturated fatty acids” and the “insulin signalling pathway” terms were created for 
genes from the lower dermis at e19 time point (Figure 3.25). It is known that 
modifications of fatty acids are observed in fat cells, whereas insulin influences 
lipolysis process in such cells (Pearce, 1983; Duncan et al, 2007). 
 
Interestingly, several terms were associated, by DAVID v6.7 programme, 
with genes from UPPER sub-lists, such as the “MAPK signalling pathway”, the “TGF 
beta signalling pathway” or the “WNT signalling pathway” term (Figure 3.25). The 
“WNT signalling pathway” is known to be invovled in the regulation of adipogenesis 
(Bennett et al, 2002). In general, the Wnt pathway is responsible for the control of 
adipocyte differentiation through both b-catenin-dependent and b-catenin-
independent cascades (Kennell and MacDougald, 2005; Bennett el at, 2002). The 
WNT/B-catenin (canonical) pathway had been related with the inhibiton of 
adipogensis, whereas the non-canonical WNT cascade may activate adipocyte 
differentiation (Kennell and MacDougald, 2005; Nishizuka et al, 2008). Interestingly, 
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the b-catenin gene was not presented in microarray sub-lists that contained of 
genes with equal or greater than 2 fold expression change. In addition, genes 
related with a complex that is responsible for b-catenin degradation (Axin2 and 
Gsk3b) were associated (by DAVID v6.7 programme) with E18 UPPER and/or E19 
UPPER sub-lists (Table 3.8A; Appendix V). Among other genes related with this 
pathway and enriched in upper embryonic skin dermis (versus lower skin dermis) 
were at e18 time point Wnt4 (2-fold change) and Wnt inhibitory factor 1 (Wif1) (3.71-
fold change) genes (Table 3.8A). At the e19 time point, the up-regulation of Wif1 
had a 28 fold increase in upper dermis versus lower dermis. The Wnt4 was related 
with non-canonical WNT pathway and its role may be associated with the activation 
of adipogenesis, whereas Wif1 binds to Wnt proteins and inhibits their activity 
(Nishizuka et al, 2008). The full role Wif1 is still not fully understood and the work of 
Cho et al (2009) has shown that it can in some cases increase adipocyte 
differentiation. 
 In addition to the analysis of sub-lists by DAVID programme, a bioinformatics 
independent analysis was performed on microarray data and presence of several 
genes, related with the WNT signalling pathway (based on available literature and 
online sources) was investigated in LOWER sub-lists. This analysis revealed an 
enrichment of genes specific for the WNT pathway in lower dermal cells that were 
not associated with the “WNT signalling pathway” term by DAVID programme. For 
example Fzd4 (frizzled-4/frizzled homolog 4/Fz-4) gene was up-regulated in all 
analysed time points in lower dermis versus upper dermis (Table 3.8B). In addition, 
this up-regulation in lower dermis versus upper dermis was higher in older (e19) skin 
when compared with younger samples, such as e17 or e18. Frizzled4 gene was 
shown to be enriched in adipocytes from adult mice (Soukas et al, 2001). The 
presence of Fzd4 in lower dermal cells is discussed in Chapter 5, in relation to the 
fluorescence activated cell sorting (FACS) work.  
 
The DAVID v6.7 programme was a useful tool for a global analysis of 
microarray data, however it was important to analyse microarray data also 
independently to such programs to get a better view of gene expression pattern 
based on microarray data. Therefore, in the section below (3.3.4) a combination of 
bioinformatics and non-bioinformatisc analysis was applied for the further 
investigation of presented here microarray data. 
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Association of genes from microarray sub-lists with 
KEGG pathway terms.
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Figure 3.25. The association of genes from microarray sub-lists with KEGG pathway 
terms. The analysis was performed by DAVID v6.7 programme. Note that DAVID 
v6.7 programme did not associate genes from E17 UPPER sub-list with KEGG 
pathway terms. Single gene can be involved in several terms. 
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Table 3.7. The expression profiles of selected microarray genes associated with the 
“adipocytokine signalling pathway” term. Presented genes were associated with the 
analysed term by DAVID v6.7 programme. 
Whole name; gene symbol;  
gene Affymetrix ID: 
Sub-list: Fold change*: 
E17 LOWER + 5.31194 
E18 LOWER + 12.64453 
leptin receptor; Lepr;  
1456156_at 
E19 LOWER + 7.111806 
E17 LOWER + 2.266466 
E18 LOWER NP** 
adiponectin receptor 1; Adipor1; 
1439017_x_at 
E19 LOWER NP** 
E17 LOWER NP** 
E18 LOWER + 2.485648 
adiponectin receptor 2; Adipor2; 
1434329_s_at 
E19 LOWER + 6.915786 
 * regulation (enrichment) in lower dermis versus upper dermis 
** gene was not present in the microarray sub-list with a fold change cut off 2 
 
Table 3.8. The expression profiles of selected microarray genes associated with the 
“WNT signalling pathway” term. (A) Presented genes were associated with the 
analysed term by DAVID v6.7 programme. (B) The additional gene associated with 
the WNT signalling pathway was pointed in the microarray sub-lists during the non-
bioinformatics analysis. 
A) 
Whole name; gene symbol;  
gene Affymetrix ID: 
Sub-list: Fold change*: 
E18 UPPER + 7.553152 axin2; Axin2;  
1436845_at E19 UPPER + 13.53982 
E18 UPPER NP** glycogen synthase kinase 3 beta; 
Gsk3b; 
1439949_at 
E19 UPPER + 2.071018 
E18 UPPER + 2.021527 wingless-related MMTV integration 
site 4; Wnt4; 
1450782_at 
E19 UPPER NP** 
E18 UPPER + 3.718775 Wnt inhibitory factor 1; Wif1; 
1425425_a_at E19 UPPER + 28.04123 
* regulation (enrichment) in upper dermis versus lower dermis 
** gene was not present in the microarray sub-list with a fold change cut off 2 
 
B) 
Whole name; gene symbol; 
gene Affymetrix ID: 
Sub-list: Fold change*: 
E17 LOWER + 2.65587 
E18 LOWER + 7.128446 
frizzled homolog 4 (Drosophila); 
Fzd4; 
1419301_at E19 LOWER + 9.34063 
* regulation (enrichment) in lower dermis versus upper dermis 
** gene was not present in the microarray sub-list with a fold change cut off 2 
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3.3.4. A global comparison study between in vitro (3T3-L1 cells) and in 
vivo (lower dermal cells) adipocyte differentiation. 
 
Strategy: 
Previous analysis in section 3.3.3 where the microarray sub-lists were 
analysed by a DAVID v6.7 programme, showed an enrichment of fat-related genes 
up-regulated in the lower dermis area during mouse embryonic development. The 
next aim was to use this data to compare this “naturally” occurring adipogenic 
differentiation with adipogenesis analysed intensively in in vitro cell lines, especially 
in 3T3-L1 cells (Green and Kehinde, 1974; reviewed by Gregoire et al, 1998). 
 
Initially the aim was to compare the lower dermis (LD) microarray data with 
the microarray data from 3T3-L1 cells lines (Figure 3.26) to investigate qualitative 
and quantitative differences between the two data sets directly. However, in practice 
this proved to be impractical for two reasons. First, much of the key microarray data 
was produced over a much longer time scale, for example 0 to 28 days (Soukas et 
al, 2001). Secondly there were differences in array platforms used and these would 
certainly complicate or annul any attempts to compare the intensity of analysed 
signals for individual genes from both experiments.   
Nevertheless, a broad general microarray analysis/comparison was possible 
with a specific publication in which the expression profile of 3T3-L1 cells undergoing 
adipocyte differentiation from day 0 till up to 96 hours of incubation was investigated. 
(Burton et al, 2004). In this study microarray data was analysed by so-called 
hierarchical clustering which allowed the researchers to organize groups of genes, 
expressed in the differentiating 3T3-L1 cells into clusters depending on their 
expression profiles and whether they were enriched (induced) or repressed over the 
time period. To make the comparison with work in this thesis, genes in lower dermis 
microarray lists were cross referenced directly with genes in the clusters in relation 
to both their presence or absence and as to whether they were enriched or 
repressed in a pattern between the e17 and e19 time points in vivo, as in 3T3-L1 
cells (Figures 3.27 - 3.35). When a gene from an in vitro cluster was also seen in the 
in vivo lower dermis (LD) list it was classified as “present”. Genes from the clusters 
not present in the LD list were treated as “absent”. As a further comparative 
indicator, the expression levels of those in vivo genes in the “present” category were 
drawn graphically over the e17 to s19 time points to see whether their patterns of 
expression mirrored those seen in vitro. 
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The lower dermis (LD) microarray data. 
    
   Expression profiles of genes regulated in lower dermis area during mouse     
   embryonic development. 
  
 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.26. A schematic presentation of analysis carried after the lower dermis (LD) 
microarray data generation by GeneSpring® GX11.0 software. Cells from lower 
dermis area (marked by red rectangles) were collected from embryonic mouse back 
skin at three time points and used for microarray analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In vivo versus in vitro adipogenesis. 
 
A comparison study aimed to reveal similarities and differences between genes 
involved in fat cell differentiation in vitro (cell lines) and genes detected in cells 
from lower dermis that differentiate into adipocytes in vivo (the LD microarray 
data). 
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Observations: 
The first two enriched clusters contained genes whose expression in 3T3-L1 
cells underwent major changes in the hours immediately after the addition of 
adipogenic medium (Figure 3.27A and Figure 3.28A). Of the genes highly up-
regulated 2 hours after adipogenic treatment in the 3T3-L1 cells (enriched Cluster 1) 
only 12% of them were present in the LD data, whereas almost 70% were absent in 
vivo microarray list (Figure 3.27B). All present genes from this cluster were up-
regulated in vivo from e17 to e18 (Figure 3.27C). Similarly only 14% of the genes in 
Cluster 2 whose genes had a peak of expression around 8 hours after adipogenic 
treatment in vitro were present in the LD array lists from foetal skin (Figure 3.28B). 
However, among this cohort some of the in vivo genes followed a different pattern 
and were down-regulated between e17 and e18 (Figure 3.28C).  
A slightly higher percentage (19%) of genes present in in vivo LD microarray 
list was observed in Cluster 3 which contained genes enriched between 16 and 24 
hours of incubation in adipogenic medium (Figure 3.29A and B). A similar 
percentage of genes (21%) was found for Cluster 4, which represented genes 
whose expression peaked around 48 hours after incubation in adipogenic medium 
(Figure 3.30A and B). Most of the genes from Clusters 3 and 4 found in vivo 
followed a similar expression pattern to their counterparts in vitro and only one 
(stem-loop binding protein; Slbp) was down-regulated in vivo between e17 and e19 
(see Figure 3.29C and Figure 3.30C).  
Finally, when the analysis was performed on genes from Clusters 5 and 6, 
representing genes most highly expressed in 3T3-L1 cells after 96 hours in 
adipogenic medium the percentages of genes present in the in vivo microarray data 
were 64% and 39% respectively (Figure 3.31B and Figure 3.32B). Moreover, all 
these genes were up-regulated in vivo from e17 to e19 as in vitro, albeit to differing 
degrees. Therefore it could be said that they were following the same trend if not the 
same pattern as their in vitro counterparts (Figure 3.31C and Figure 3.32C).  
 
In addition to the analysis of up-regulated cluster profiles, the in vivo LD 
array data was also compared to several repressed clusters from the Burton et al 
(2004) work that contained genes down-regulated during the 3T3-L1 adipogenesis. 
For all the three in vitro clusters examined, only 14 - 18% of the genes were also 
present in vivo (Figures 3.33B, 3.34B and 3.35B). Moreover, about 56% of these 
genes showed different trends in vivo, being increased in expression at some points 
between e17 to e19 (compare Figure 3.33A with 3.33C; Figure 3.34A with 3.34C; 
Figure 3.35A with 3.35C). 
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B) The comparison analysis of induced genes from 
Cluster 1 with the in vivo  LD microarray list.
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Figure 3.27. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part A. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 1 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 1 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. White - in vitro 
genes with unclear names and with unrecognized presence in the LD list. (C) In vivo 
expression profile of genes expressed in the lower dermis (from e17 until e19) that 
were also induced in differentiating 3T3-L1 cells in vitro (Cluster 1). The full names 
of genes are included in Appendix VI. 
 
A) In vitro expression pattern of genes induced 
during 3T3-L1 adipocyte differentiation and 
represented by Cluster 1 (in vitro microarray 
study by Burton et al, 2004). 
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B) The comparison analysis of induced genes from 
Cluster 2 with the in vivo  LD microarray list. 
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Figure 3.28. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part B. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 2 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 2 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. White - in vitro 
genes with unclear names and with unrecognized presence in the LD list. (C) In vivo 
expression profile of genes expressed in the lower dermis (from e17 until e19) that 
were also induced in differentiating 3T3-L1 cells in vitro (Cluster 2). The full names 
of genes are included in Appendix VI. 
A) In vitro expression pattern of genes induced  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 2 (in vitro microarray  
study by Burton et al, 2004). 
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B) The comparison analysis of induced genes from 
Cluster 3 with the in vivo  LD microarray list. 
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Figure 3.29. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part C. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 3 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 3 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. White - in vitro 
genes with unclear names and with unrecognized presence in the LD list. (C) In vivo 
expression profile of genes expressed in the lower dermis (from e17 until e19) that 
were also induced in differentiating 3T3-L1 cells in vitro (Cluster 3). The full names 
of genes are included in Appendix VI. 
 
A) In vitro expression pattern of genes induced  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 3 (in vitro microarray  
study by Burton et al, 2004). 
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B) The comparison analysis of induced genes from 
Cluster 4 with the in vivo  LD microarray list.
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Figure 3.30. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part D. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 4 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 4 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. White - in vitro 
genes with unclear names and with unrecognized presence in the LD list. (C) In vivo 
expression profile of genes expressed in the lower dermis (from e17 until e19) that 
were also induced in differentiating 3T3-L1 cells in vitro (Cluster 4). The full names 
of genes are included in Appendix VI. 
A) In vitro expression pattern of genes induced  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 4 (in vitro microarray 
study by Burton et al, 2004). 
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B) The comparison analysis of induced genes from 
Cluster 5 with the in vivo  LD microarray list. 
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C) In vivo  expression profile of genes from lower 
dermis area and present in Cluster 5.
0
5
10
15
20
25
30
Pe
x1
3
Pp
ar
g
Ph
b
Pc
x
Nr
ip1 Sc
d1
Tim
m
23
To
b1
Ta
ldo
1
Fo
ld
 
ch
an
ge
.
e18 vs e17
e19 vs e17
 
Figure 3.31. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part E. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 5 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 5 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. (C) In vivo 
expression profile of genes expressed in the lower dermis (from e17 until e19) that 
were also induced in differentiating 3T3-L1 cells in vitro (Cluster 5). The full names 
of genes are included in Appendix VI. 
A) In vitro expression pattern of genes induced 
during 3T3-L1 adipocyte differentiation and 
represented by Cluster 5 (in vitro microarray 
study by Burton et al, 2004). 
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B) The comparison analysis of induced genes from 
Cluster 5 with the in vivo  LD microarray list. 
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C) In vivo  expression profile of genes from lower dermis area 
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Figure 3.32. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part F. (A) Expression pattern of genes up-regulated (induced) 
in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 6 (adapted 
from Burton et al, 2004). (B) The presence of genes associated with Cluster 6 was 
investigated in the in vivo lower dermis (LD) microarray list. Pink - in vitro genes 
present in the LD list. Green - in vitro genes absent in the LD list. White - in vitro 
genes with unclear names and with unrecognized presence in the LD list. (C, D, E) 
In vivo expression profile of genes expressed in the lower dermis (from e17 until e19) 
that were also induced in differentiating 3T3-L1 cells in vitro (Cluster 6). The full 
names of genes are included in Appendix VI. 
 
A) In vitro expression pattern of genes 
induced during 3T3-L1 adipocyte 
differentiation and represented by 
Cluster 6 (in vitro microarray study by 
Burton et al, 2004). 
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B) The comparison analysis of repressed genes 
from Cluster 1 with the in vivo  LD microarray list.
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Figure 3.33. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part G. (A) Expression pattern of genes down-regulated 
(repressed) in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 1 
(adapted from Burton et al, 2004). (B) The presence of genes associated with 
Cluster 1 was investigated in the in vivo lower dermis (LD) microarray list. Pink - in 
vitro genes present in the LD list. Green - in vitro genes absent in the LD list. White - 
in vitro genes with unclear names and with unrecognized presence in the LD list. (C) 
In vivo expression profile of genes expressed in the lower dermis (from e17 until e19) 
that were also repressed in differentiating 3T3-L1 cells in vitro (Cluster 1). The full 
names of genes are included in Appendix VI. 
A) In vitro expression pattern of genes repressed  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 1 (in vitro microarray  
study by Burton et al, 2004). 
                                                                                                           Chapter 3 
                                                                                                 
178 
B) The comparison analysis of repressed genes 
from Cluster 2 with the in vivo  LD microarray list.
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Figure 3.34. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part H. (A) Expression pattern of genes down-regulated 
(repressed) in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 2 
(adapted from Burton et al, 2004). (B) The presence of genes associated with 
Cluster 2 was investigated in the in vivo lower dermis (LD) microarray list. Pink - in 
vitro genes present in the LD list. Green - in vitro genes absent in the LD list. White - 
in vitro genes with unclear names and with unrecognized presence in the LD list. (C) 
In vivo expression profile of genes expressed in the lower dermis (from e17 until e19) 
that were also repressed in differentiating 3T3-L1 cells in vitro (Cluster 2). The full 
names of genes are included in Appendix VI. 
A) In vitro expression pattern of genes repressed  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 2 (in vitro microarray  
study by Burton et al, 2004). 
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B) The comparison analysis of repressed genes 
from Cluster 3 with the in vivo  LD microarray list.
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Figure 3.35. The global comparison analysis of genes regulated during in vitro and 
in vivo adipogenesis, part I. (A) Expression pattern of genes down-regulated 
(repressed) in 3T3-L1 cells during their adipogenic differentiation shown by Cluster 3 
(adapted from Burton et al, 2004). (B) The presence of genes associated with 
Cluster 3 was investigated in the in vivo lower dermis (LD) microarray list. Pink - in 
vitro genes present in the LD list. Green - in vitro genes absent in the LD list. White - 
in vitro genes with unclear names and with unrecognized presence in the LD list. (C) 
In vivo expression profile of genes expressed in the lower dermis (from e17 until e19) 
that were also repressed in differentiating 3T3-L1 cells in vitro (Cluster 3). The full 
names of genes are included in Appendix VI. 
 
A) In vitro expression pattern of genes repressed  
during 3T3-L1 adipocyte differentiation and  
represented by Cluster 3 (in vitro microarray  
study by Burton et al, 2004). 
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3.3.5. The investigation of similarities and differences at early steps of 
adipogenesis between in vitro and in vivo fat cells. 
The above analysis, although limited, provided initial evidence for clear 
differences between in vitro and in vivo adipocyte differentiation, particularly for 
genes up-regulated in the early stages of the process (8 - 24 hours in vitro). 
However, the caveat remains that these early time points in particular might not be 
comparable with the in vivo ones. Interestingly a similar disparity was seen when 
down-regulation of genes was compared, although here the level of discrepancy 
remained high for all analysed groups of genes. The overall observation that gene 
expression is much more comparable at later time points in adipogenesis provided 
further tentative indications that while final more differentiated profiles might be 
similar in vitro and in vivo, early events/processes might be very different. These 
pointers formed part of the basis for further analysis.  
 
Further analysis: 
As a strategy for further comparing in vivo adipogenesis with known in vitro 
events, it was considered appropriate to break up the lists into specific cellular 
activities. By this means it was hoped that a broad picture would emerge of the 
similarities between in vivo and in vitro differentiation, but that also it would be 
possible to investigate specific questions pertaining to individual genes or gene 
families or pathways and their role in these processes. Given the size of the array 
lists, the many cellular functions/activities contained within them, a limited number of 
categories were analysed, namely: transcription factors; growth/signalling factors; 
the cell cycle; cytoskeleton; extracellular matrix and adipocyte related enzyme 
activity. Most of the analysis was performed through direct examination of the gene 
lists, and investigation of literature and online resources, however for some of the 
groupings (cytoskeleton and extracellular matrix) bioinformatics tools were also used. 
As the final category relates more to lipogenesis and the late stages of adipocyte 
formation, it was anticipated this would provide further clues as to the overall validity 
of the in vivo analysis in that it would be predicted that the most similarities would be 
seen here.   
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3.3.5.1. Adipogenic transcription factors (TFs). 
Several transcription factors and transcription factor families have been 
identified as being associated with the regulation of adipogenesis, with a good deal 
of this data coming from in vitro analyses (Figure 3.36). As there is evidence that 
many of these TFs are crucial for the proper differentiation process, it was important 
to investigate their presence in the lower dermal cells during in vivo adipogenesis 
using the in vivo lower dermis (LD) microarray data. Importantly, transcription factors 
have been shown to be activated in a specific order or cascade. Therefore an 
additional element of the current analysis, apart for asking whether specific TFs 
were present or absent, was to use it to investigate whether the pattern and timing 
of TF activity in the lower dermis was similar to that published elsewhere. This in 
turn could provide information about the validity of the data as a whole. So, for 
example, a haphazard pattern of TF expression would indicate that the data could 
not be trusted in terms of adipogenic processes having a clear link with sample 
timings. Alternatively, if the main pattern of expected TF activity was to be seen in 
the lower dermis, but there was no evidence of TFs normally found very early or 
very late in the process, then this might indicate that sampling had been started too 
late for the former, or had been curtailed too early for the latter. 
 
A recent review of TF activity in adipogenesis was used as a starting point 
for this analysis (White and Stephens, 2010), in which the process is summarised 
and represented diagrammatically as a sequential series (Figure 3.36). Briefly, 
during the very early stages of adipogenesis, activation of AP-1, STATs and KLFs 
receptors takes place. Then the next step is related with up-regulation of C/EBPbeta 
and C/EBPdelta which trigger over-expression of other KLFs and SREBP-1 factors. 
Finally, PPARgamma and C/EBPalpha are activated and they control activation of 
genes in the later stages of adipogenesis (Figure 3.36). These major transcription 
factor families were analysed in the LD microarray data, and results used to build up 
a picture of TF activity in the LD based on the original template.  
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Figure 3.36. A schematic presentation of transcription factors activated during 
adipogenesis. The figure was taken from White and Stephens, 2010. For the full 
names of presented factors see figure 3.42. 
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The activating protein-1 (AP-1) family of transcription factors. 
 Dimeric transcription factors consisting of subnunits c-Jun, Jun-B, Jun-d, c-
Fos and Fos-B, Fra-1 and Fra-2 are referred as AP-1 and many of these have been 
shown to be up-regulated very shortly after activation of adipogenesis (reviewed by 
White and Stephens, 2010). It is suggested that elements of AP-1 might be crucial 
for adipose tissue development in vivo. In the LD microarray data, only two subunits 
of AP-1 were up-regulated at significant levels. Both c-Jun (Jun; jun oncogene) and 
Fos (C-FOS; FBJ osteosarcoma oncogene) had mRNA expression levels highest at 
the early point of comparison: e18 versus e17 compared with the later e19 to e17 
sample time point (Figure 3.37A and B).  
 
Signal transducer and activator of transcription factors (STAT). 
In 3T3-L1 cells, the growth hormone interacts with growth hormone receptor 
and activates phosphorylation of Signal Transducer and Activator of Transcription 
factors (STAT), such as STAT5B and STAT5C which were shown to influence other 
families of adipogenic transcriptional factors: C/EBPs (C/EBPbeta and C/EBPdelta) 
and PPARgamma (Kawai et al; 2007). In addition, other members of the STAT 
family including STAT3 and STAT1 have been related to adipogenic differentiation 
in 3T3-based cell lines (reviewed by White and Stephens, 2010). Interestingly, in the 
LD microarray data, Stat1 gene was the only STAT family member showing 
significant up-regulation during development of the lower dermal cells. It was up-
regulated significantly at the later e19 to e17 comparison point (Figure 3.37C). 
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Figure 3.37. The expression profiles of Jun (A), Fos (B) and Stat1 (C) genes in the 
lower dermis from e17 till e19 time points. Grey columns - regulation at e18 versus 
e17 time points. Black columns - regulation at e19 versus e17 time points. Fold 
change values are based on the lower dermis (LD) microarray list. Jun - Jun 
oncogene. Fos - FBJ osteosarcoma oncogene. Stat1 - signal transducer and 
activator of transcription 1. 
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Krüppel-like factors (KLFs) and early growth response proteins (Krox). 
Krüppel-like zinc finger transcription factors (KLFs) are another group of 
transcription factors, directly linked with adipogenesis (reviewed by White and 
Stephens, 2010; Figure 3.36). Both, KLF4 and KLF5 have been shown to be 
involved in early stages of adipocyte differentiation (Oishi et al, 2005; Birsoy et al, 
2008). In the in vivo LD array data both, Klf4 and Klf5 genes were more highly 
expressed at the earlier (e18 versus e17) than at the later (e19 versus e17) time 
point (Figure 3.38A). In addition, another family member, Krüppel-like factor 15, 
thought to play a role later in the adipogenic cascade (Figure 3.36), was strongly up-
regulated at the later (e19 versus e17) sample time point (Figure 3.38A). Three 
additional KLF family members (Klf3, Klf6 and Klf9) were also present in lower 
dermis and these genes were enriched from e17 time point (Figure 3.38A). Krüppel-
like factors 3, 6 and 9 have been also associated with regulation of adipogenesis (Li 
et al, 2005; Sue et al, 2008; Pei et al, 2011). 
 
Early on in adipogenesis, Krüppel-like factor 4 is thought to activate the 
promoter of C/EBPbeta together with another transcription factor Krox20 (Chen et al, 
2005; Birsoy et al, 2008, see also Figure 3.36). Krox20 gene, also termed Early 
growth response 2 (Egr2) was not seen in the LD microarray data. However, an 
Egr1/Krox24 gene was present in this microarray list with the highest up-regulation 
at the e18 versus e17 time point (Figure 3.38B).  
 
Sterol regulatory element binding protein (SREBP). 
 Sterol regulatory element binding protein (ADD1/SREBP-1) is a basic helix-
loop-helix transcription factor recognized in three isoforms: SERBP-1a, SREBP-1c 
and SREBP-2 (Yokoyama et al, 1993; Kim and Spiegelman, 1996). SREBP-1 was 
shown to take part in promoting adipogenesis in 3T3-based cells (Kim and 
Spiegelman, 1996).   
 Srebp1/Srebf1 gene was present in the lower dermis microarray data and 
this gene was up-regulated significantly in lower dermal cells at the later (e19 versus 
e17) time point (Figure 3.39). 
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Figure 3.38. The expression profiles of KLFs genes (A) and Egr1 (B) gene in the 
lower dermis from e17 till e19 time points. Grey columns - regulation at e18 versus 
e17 time points. Black columns - regulation at e19 versus e17 time points. Fold 
change values are based on the lower dermis (LD) microarray list. Klf3 - Krüppel-like 
factor 3. Klf4 - Krüppel-like factor 4. Klf5 - Krüppel-like factor 5. Klf6 - Krüppel-like 
factor 6. Klf9 - Krüppel-like factor 9. Klf15 - Krüppel-like factor 15. Egr1 - early 
growth response 1. 
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Srebf1  - in vivo  expression.
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Figure 3.39. The expression profiles of Srebf1 gene in the lower dermis from e17 till 
e19 time points. Grey columns - regulation at e18 versus e17 time points. Black 
columns - regulation at e19 versus e17 time points. Fold change values are based 
on the lower dermis (LD) microarray list. Srebf1 - sterol regulatory element binding 
transcription factor 1. 
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CCAAT/enhancer binding proteins (C/EBPs) and peroxisome proliferator-
activated receptor gamma (PPARgamma). 
As was discussed previously (Chapter 1, sections 1.3.1.2 and 1.3.3) family of 
C/EBPs factors and PPARgamma have crucial roles in adipogenic processes and 
the proper development of adipose tissue.  
Analysis of the LD array data showed that Cebpa gene expression was 
significantly and similarly up-regulated through all sample time points (approximately 
2.19 fold at e18 versus e17 and 2.66 fold at e19 versus e17, see Figure 3.40A). A 
higher level of expression was observed for Pparg gene, which showed an increase 
at the later e19 versus e17 time point (Figure 3.40B). The expression of these genes 
was verified at the mRNA level by qRT-PCR analysis on samples from both upper 
and lower dermis from all three analysed time points (Figure 3.41). This analysis 
confirmed up-regulation of these transcriptional factors in vivo during development 
of lower dermal cells. The relative mRNA expression for Cebpa and Pparg genes 
increased in lower dermis cells from e17 to e18 time points (Figure 3.41A and B). 
Both factors were significantly increased in expression at e19 in the lower dermis 
when compared with the lower dermis of e17 time point, according to a t-test. 
Expression of these adipogenic factors was also observed in the upper dermis at all 
analysed time points but the enrichment of these factors in the lower dermis at e19 
time point was significant when compared to their expression in the upper dermis at 
all analysed time points (Figure 3.41).  
 
In relation to other family members, the activation of both C/EBPbeta and 
C/EBPdelta is reported to occur before expression of C/EBPalpha and PPARgamma 
(reviewed by Rosen and Spiegelman, 2000; White and Stephens, 2010). No 
significant expression of either Cebpb or Cebpd genes was observed in the LD 
microarray data at any of the time points. However, the LD microarray data revealed 
up-regulation on the mRNA level of Cebpg gene, which also belongs to the C/EBPs 
family of transcription factors. Cebpg was up-regulated from e17 and at similar 
levels in both e18 and e19 time points (Figure 3.40C). C/EBPgamma was not 
mentioned in studies on C/EBPs transcriptional factors crucial in the regulation of 
adipogenesis (Cao et al, 1991; reviewed by Gregoire et al, 1998).  
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Figure 3.40. The expression profiles of Cebpa (A), Pparg (B) and Cebpg (C) genes 
in the lower dermis from e17 till e19 time points. Grey columns - regulation at e18 
versus e17 time points. Black columns - regulation at e19 versus e17 time points. 
Fold change values are based on the lower dermis (LD) microarray list. Cebpa - 
CCAAT/enhancer binding protein (C/EBP), alpha. Pparg - peroxisome proliferator 
activated receptor gamma. Cebpg - CCAAT/enhancer binding protein (C/EBP), 
gamma. 
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Figure 3.41. Verification of microarray data by qRT-PCR for two genes: Cebpa and 
Pparg. The relative mRNA expression for both genes was analysed on samples 
from dermis at: e17 (17), e18 (18) and e19 (19) time points, from upper (Area “1”, 
green) and lower (Area “2”, red) dermis area. Data were obtained from triplicate 
biological replicates. The baseline (1-fold change) was established for the e19 lower 
dermis sample (underlined on the figure) and the mRNA levels of the other samples 
are shown relative to this. Both genes are up-regulated in lower dermis (Area “2”) 
when compared with upper area (Area “1”) in e18 and e19 time points. This 
observation is in agreement with in vivo microarray data generated from lower 
dermal cells. P value refers to the comparison with “19 2” sample (* P <0.05, ** P 
<0.01, *** P <0.001). The “NS” indicates not significant differences in the mRNA 
gene expression. 
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 It can be said that several transcription factors, which play an important role 
in activation and regulation of adipogenesis seen in studies of cell lines, such as 
3T3-L1 cells (reviewed by White and Stephens, 2010), are also enriched in lower 
dermal cells of mouse back skin during late stages of embryonic development 
(Figure 3.42). 
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Figure 3.42. Transcription factors activated during adipogenesis. Factors in black 
are involved in adipogenesis based on available studies mainly on 3T3 cells. 
Factors marked with red rectangles were regulated in lower dermal cells during 
mouse embryonic development based on the in vivo LD microarray list. The figure 
was adapted from White and Stephens (2010). Factor written in red (C/EBPgamma) 
was observed in the in vivo LD microarray list, however its involvement in the 
regulation of adipogenesis has not been considered (see section 3.3.5.1). C/EBPα - 
CCAAT/enhancer binding protein (C/EBP), alpha. STAT5A - signal transducer and 
activator of transcription 5A. PPARγ - peroxisome proliferator activated receptor 
gamma. KLF15 - Krüppel-like factor 15. SREBP-1/ADD1 - (Srebf1) sterol regulatory 
element binding transcription factor 1. C/EBPs β and δ - CCAAT/enhancer binding 
protein (C/EBP), beta and delta. KLFs 4 and 5 - Krüppel-like factor 4 and 5. STAT1 - 
signal transducer and activator of transcription 1. STAT3 - signal transducer and 
activator of transcription 3. STAT5B - signal transducer and activator of transcription 
5B. STAT5C - signal transducer and activator of transcription AP-1 - activating 
protein-1. c-Jun - (Jun) Jun oncogene. c-Fos - (Fos) FBJ osteosarcoma oncogene. 
KROX20=Egf2 - early growth response 2. KROX24=Egf1 - early growth response 1. 
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Other transcription factors regulated in the lower dermal cells. 
 Apart from the transcription factors whose role in adipogenesis has been 
widely investigated in vitro several additional transcriptional factors families were 
selected from the LD microarray list and examined in relation to available 
information about their involvement in adipogenesis.  
 
The Gata2 gene (for the zinc-finger transcription factor: GATA binding 
protein 2), was down-regulated in lower dermal cells in vivo (Figure 3.43A). 
Previously, expression of this gene was shown to be down-regulated during 
differentiation in vitro of brown adipocytes and it has been suggested that it 
regulates differentiation of brown fat cell lines and primary cells (Tsai et al, 2005).  
 
 
Maf (avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene 
homolog) and Mafb (v-maf musculoaponeurotic fibrosarcoma oncogene family, 
protein B; avian) genes that encode basic leucine zipper (bZIP) transcription factors 
were also regulated in lower dermal cells (Figure 3.43B and C). Maf, also known as 
c-Maf (based on the genecard website), was down-regulated in dermal arrays from 
e17 to e19 time points (Figure 3.43B). Previously c-Maf gene has been shown to be 
down-regulated during adipogenesis of mesenchymal fibroblast cells 58 hours after 
the adipogenic induction by medium in cell culture (Serria et al, 2003).  
 
Among other genes involved in regulation of transcription that were identified 
in the LD microarray data, were Xbp1 (X-box binding protein 1) and Smarca5 
(SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 5). Both genes were up-regulated in lower dermal cells in vivo 
(Figure 3.43D and E). Xbp1 gene has been found previously to undergo a low up-
regulation in differentiating 3T3-L1 cells (Hackl et al, 2005) whereas no publication 
was found that would discuss regulation of Smarca5 expression in these cells.   
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Figure 3.43. The expression profiles of Gata2 (A), Maf (B), Mafb (C), Xbp1 (D) and 
Smarca5 (E) genes in the lower dermis from e17 till e19 time points. Grey columns - 
regulation at e18 versus e17 time points. Black columns - regulation at e19 versus 
e17 time points. Fold change values are based on the lower dermis (LD) microarray 
list. Gata2 - GATA binding protein 2. Maf - avian musculoaponeurotic fibrosarcoma 
(v-maf) AS42 oncogene homolog. Mafb - v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein B (avian). Xbp1 - X-box binding protein 1. Smarca5 - 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 5. 
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In order to complete the analysis of transcription factors whose expression 
changes during adipogenesis, the results of the current work were compared to 
another study where groups of different transcription factors were either up- or 
down-regulated during differentiation of 3T3-L1 cells, based on the applied 
microarray approach (Kim et al, 2007). The presence of these genes, regulated 
during in vitro adipogenesis, was checked in the LD microarray list (Table 3.9). 
Interestingly, among eleven analysed factors from in vitro study, only three were 
present in the in vivo LD microarray list, namely Narg1 (NMDA receptor-regulated 
gene 1), Atrx (alpha thalassemia/mental retardation syndrome X-linked homolog; 
human) and Twist1 (twist gene homolog 1; Drosophila). Both Narg1 and Atrx were 
shown to be up-regulated in 3T3-L1 cells (Kim et al, 2007) and accordingly in the 
dermal arrays both were highly expressed specifically at the e18 time point (Figure 
3.44A, B). Twist1 gene was shown to be down-regulated in differentiating 3T3-L1 
cells, and similarly its level decreased from the e17 to e19 time points in the dermal 
cells in vivo (Figure 3.44C).  
 
 Another observation was that several representatives of previously 
discussed transcription factor families were present in the LD microarray list, but 
their regulation was not discussed by Kim et al (2007) in differentiating 3T3-L1 cells. 
These were Tsc22d1 (TSC22 domain family, member 1), Foxp1 (forkhead box P1), 
Foxh1 (forkhead box H1), Foxn3 (forkhead box N3), Nfix (nuclear factor I/X), Fhl1 
(four and a half LIM domains 1) and Twist2 (twist homolog 2; Drosophila) (Table 
3.45A - G). These genes were characterised by either down-regulation or up-
regulation in lower dermal cells between e17 and e19 time points (Figure 3.45A - G). 
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Table 3.9. Comparison of transcription factors regulated during in vitro (3T3-L1 cells) 
and in vivo (lower dermal cells) adipogenesis. Representatives of several 
transcription factor families were regulated in differentiating 3T3-L1 cells (microarray 
study of Kim et al, 2007; see left column) and their presence in lower dermal cells 
(the lower dermis LD microarray data) was analysed (see right column).  
“In vitro up-regulated genes” in 3T3-L1 cells 
(Kim et al, 2007). 
Presence of “In vitro up-regulated 
genes” (from Kim et al, 2007) in 
lower dermal cells (the LD 
microarray list). 
 
TSC22 domain family 3 (Tsc22d3) NP* 
NMDA receptor-regulated gene 1 (Narg1) +** 
Iroquois related homeobox 5 (Drosophila) (Irx5) NP* 
Forkhead box B2 (Foxb2) NP* 
Alpha thalassemia/mental retardation syndrome 
X-linked homolog (human) (Atrx) 
+** 
“In vitro down-regulated genes” in 3T3-L1 
cells (Kim et al, 2007). 
 
Presence of “In vitro up-regulated 
genes” (from Kim et al, 2007) in 
lower dermal cells (the LD 
microarray list). 
Activating transcription factor 4 (Atf4) NP* 
Activating transcription factor 5 (Atf5) NP* 
Interferon regulatory factor 8 (Irf8) NP* 
Nuclear factor I/B (Nfib) NP* 
Twist gene homolog 1 (Drosophila) (Twist1) +** 
Four and a half LIM domains 2 (Fhl2) NP* 
* gene was not present (NP) in the LD microarray list  
** gene was present (+) in the LD microarray list 
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Figure 3.44. The expression profiles of Narg1 (A), Atrx (B) and Twist1 (C) genes in 
the lower dermis from e17 till e19 time points. Grey columns - regulation at e18 
versus e17 time points. Black columns - regulation at e19 versus e17 time points. 
Fold change values are based on the lower dermis (LD) microarray list. Narg1 -
NMDA receptor-regulated gene 1. Atrx - alpha thalassemia/mental retardation 
syndrome X-linked homolog (human). Twist1 - twist gene homolog 1 (Drosophila). 
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Figure 3.45. The expression profiles of Tsc22d1 (A), Foxp1 (B), Foxh1 (C), Foxn3 
(D), Nfix (E), Fhl1 (F) and Twist2 (G) genes in the lower dermis from e17 till e19 
time points. Grey columns - regulation at e18 versus e17 time points. Black columns 
- regulation at e19 versus e17 time points. Fold change values are based on the 
lower dermis (LD) microarray list. Tsc22d1 - TSC22 domain family, member 1. 
Foxp1 - forkhead box P1. Foxh1 - forkhead box H1. Foxn3 - forkhead box N3. Nfix - 
nuclear factor I/X. Fhl1 - four and a half LIM domains 1. Twist2 - twist homolog 2 
(Drosophila). 
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3.3.5.2. Pref-1, growth hormone and growth factors. 
 The cell line-based studies revealed that different genes are involved in the 
regulation of adipogenesis activation and are crucial for a proper activation of the 
whole adipogenic cascade and such factors are discussed in this section. In addition, 
a presence of such factors in the in vivo LD microarray data is analyed in order to 
establish how similar or different processes observed in embryonic back skin are to 
differentiation of cells in vitro that develop into mature adipocytes.  
 
Pref-1. 
 A preadipocyte marker Pref-1 has been characterised and treated as 
inhibitor of adipogenesis (Wang et al, 2006a; Wang et al, 2010). It is a EGF repeat-
containing transmembrane protein expressed abundantly by 3T3-L1 preadipocytes 
and not present in mature fat cells (Smas and Sul, 1993). As lower dermal cells from 
e17 time point were suggested to represent preadipocytes in vivo, it was expected 
to see dramatic down-regulation of Pref-1 mRNA level from e17 to e19 time points. 
However gene for Pref-1 was not present in the generated in vivo LD microarray 
data which could suggest lack of its regulation during development of dermal cells in 
vivo between e17 and e19 time points. 
 
Growth hormone (GH). 
A growth hormone (GH), which regulates transcription of IGF-1, influences 
adipose tissue and regulates metabolism, was shown to be crucial for differentiation 
of mouse cell lines 3T3-L1 and 3T3-F442A however no effect of GH was seen on 
primary cell lines (reviewed by Gregoire et al, 1998). GH functions through growth 
hormone receptor for which up-regulation has been spotted in differentiating 3T3-L1 
cells (Hackl et al; 2005; Kawai et al, 2007; see also Figure 3.46A). The up-regulation 
of growth hormone receptor (Ghr) mRNA was observed in vivo in developing lower 
dermal cells, with a dramatic increase in expression at the e19 time point (Figure 
3.46B).  
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Growth factors. 
In order to activate adipogenic differentiation, cells are required to obtain 
appropriate signals from the environment in a form of different growth factors, 
depending on type of cell line (reviewed by Gregoire et al, 1998).  
 
Insulin-like growth factors. 
The insulin-like growth factors genes: Igf1 and Igf2 were present in the lower 
dermal microarray data. Igf1 was enriched, whereas Igf2 was down-regulated from 
e17 to e19 (Figure 3.46D and F). Previously both Igf1 and Igf2 were shown to be 
highly up-regulated in differentiating 3T3-L1 cells after 24 hours of adipogenic 
induction (Burton et al, 2004; Hack et al, 2005; see Figure 3.46C and E). In addition, 
the up-regulation of the Igf1 receptor (Igfr1r) was spotted in lower dermal cells 
(Figure 3.46K) as well as the increased expression of insulin-like growth factor 
binding protein genes, such as Igfbp3, Igfbp4 and Igfbp7 (Figure 3.46I and J). Two 
previous microarray-based studies from Burton et al (2004) and Hack et al (2005) on 
3T3-L1 cells showed regulation of Igfbp4, however they revealed different regulation 
patterns for this genes (compare Figure 3.46G with H). The IGBFP3 protein was 
suggested to be an inhibitor of adipogenesis in 3T3-L1 cells (Chan et al, 2009).  
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Figure 3.46. The expression profiles of Ghr (A, B), Igf1 (C, D), Igf2 (E, F), Igfbp4 (G, 
H, I), Igfbp3 (J), Igfbp7 (J) and Igf1r (K) genes. (A, C, E, G, H) The expression 
profiles of analysed genes during in vitro adipogenesis in 3T3-L1 cells (based on 
Burton et al, 2004; Hackl et al, 2005). (B, D, F, I, J, K) The expression profiles of 
selected genes in the lower dermis from e17 till e19 time points. Grey columns - 
regulation at e18 versus e17 time points. Black columns - regulation at e19 versus 
e17 time points. Fold change values are based on the lower dermis (LD) microarray 
list. Ghr - growth hormone receptor. Igf1 - insulin-like growth factor 1. Igf2 - insulin-
like growth factor 2. Igfbp4 - insulin-like growth factor binding protein 4. Igfbp3 - 
insulin-like growth factor binding protein 3. Igfbp7 - insulin-like growth factor binding 
protein 7. Igf1r - insulin-like growth factor I receptor. 
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Other growth factors.  
 There are several growth factors suggested to be mainly related with 
inhibition of adipogenesis (reviewed by Gregoire et al, 1998; reviewed by Rosen and 
Speigelman, 2000). Among these are epidermal growth factor (EGF) or transforming 
growth factor alpha (TGF-alpha) (reviewed by Gregoire et al, 1998). Tgfa and Egf 
genes were not seen in the LD microarray data, however specific expression pattern 
of Egf receptor (Egfr) was observed in lower dermal cells (Figure 3.47A). Because of 
the uncertain role of Egf-Egfr pathway in adipogenesis regulation in vivo in relation 
to back skin adipose tissue, the detailed analysis of this factor in relation to 
adipocyte differentiation in mouse embryonic back skin dermis was performed and is 
presented in Chapter 4 of this thesis. Other growth factors, with suggested 
involvement in regulation of adipogenesis but with no clarified role in this process 
are basic fibroblast growth factor (bFGF; FGF2) and platelet-derived growth factor 
(PDGF) (Neubauer et al, 2004; reviewed by Rosen and Spiegelman). Genes for 
these two factors were not present in the LD microarray data. However, genes for 
fibroblast growth factor receptor 2 (Fgfr2) and platelet-derived growth factor receptor, 
alpha (Pdgfra) were found in the LD data with specific gene expression patterns 
(Figure 3.47B and C). The mRNA expression for all three receptors was highly up-
regulated in lower dermal cells at the e18 time point. At the e19 time point the 
Pdgfra mRNA level underwent the most dramatic down-regulation when compared 
with e17 time point. These observations tallied with other verification work on the 
protein level by immunofluorescence staining against PDGFRa, which also showed 
a marked decrease in its expression in the lower dermis at e19 (see Figure 3.22). 
 
 To sum up, lower dermal cells are characterised by a dynamic regulation, at 
mRNA level, growth hormone receptor and several growth factor receptors (Egfr, 
Fgfr2, Pdgfra, Igfr) together with insulin-like growth factors (Igf1 and Igf2) and insulin 
growth factor binding proteins (Igfbp3, Igfbp4 and Igfbp7) between e17 and e19 time 
points (Figure 3.48). 
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Figure 3.47. The expression profiles of Egfr (A), Fgfr2 (B) and Pdgfra (C) genes in 
the lower dermis from e17 till e19 time points. Grey columns - regulation at e18 
versus e17 time points. Black columns - regulation at e19 versus e17 time points. 
Fold change values are based on the lower dermis (LD) microarray list. Egfr - 
epidermal growth factor receptor. Fgfr2 - fibroblast growth factor receptor 2. Pdgfra - 
platelet-derived growth factor receptor, alpha polypeptide. 
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Figure 3.48. The lower dermis (LD) microarray data revealed regulation of growth 
hormone receptor, several growth factors, growth factor receptors and growth factor 
binding proteins (marked with red rectangles) in lower dermal cells. For the full 
names of presented receptors, factors and proteins see section 3.3.5.2 and Figures 
3.46 - 3.47. 
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3.3.5.3. Cell cycle processes involved in adipogenesis.  
Based on the knowledge about adipogenesis from cell lines (Chapter 1, 
section 1.3.1.1) growth arrest, together with the occurrence of confluence (or its lack, 
depending on the cell type), is the first step of the activation of adipogenesis in vitro 
(Rosen and Spiegelman, 2000). This growth arrest is followed by a clonal expansion 
process and cells require factors which activate/enhance the next steps of 
differentiation. During the clonal expansion one or two rounds of cell division take 
place (Ailhaud et al, 1989; Rosen and Spiegelman, 2000; see also Chapter 1, 
section 1.3.2.1). Preadipocytes need the influence of growth factors in order to 
undergo adipogenic modification, while the expression of so-called adipogenic 
transcriptional factors takes places in a very specific pattern (see sections 3.3.5.1 
and 3.3.5.2). 
 
Genes associated with the cell cycle and observed during 3T3-L1 
differentiation have been summarised in a microarray-based study by Hackl et al 
(2005). To perform the comparative study a summary/digest of the 3T3-L1 study is 
shown in Figure 3.49A, taken from a supplementary data from this paper and 
adjusted for the analysis presented in this section. Figure 3.49A, represents genes 
seen by Hackl et al (2005) in 3T3-L1 cells (written in green or blue or marked by 
coloured circles). The presence of genes from this data was cross-checked with the 
LD microarray data and when genes were found in the dermal array data they were 
marked by red rectangles (Figure 3.49A). In addition, where in vitro associated 
genes were not present in the LD arrays, but other representatives of their families 
were found in vivo, these were also included (in Figure 3.49A, shown by yellow 
rectangles). There were also cell cycle genes in non-coloured circles, if they were 
not seen in both in vitro and in vivo cells. If a gene in non-coloured circle was 
additionally marked by a red rectangle, its presence was only seen in vivo. In total, 
for all analysed genes from Figure 3.49A, only 21% were common for both in vitro 
and in vivo differentiating cells, 32% were specific for only the lower dermal cells 
and 37% were found only in the microarray data from 3T3-L1 cells (Figure 3.49B).  
 
In total, 14 genes were common for both in vitro and in vivo differentiating 
cells. Of these 14 genes, 9 were highly enriched in vitro at 24 hours after adipogenic 
induction (Figure 3.50A) whereas the other five were up-regulated between 12 and 
24 hours after induction (Figure 3.50C). When the expression pattern of these genes 
was investigated in vivo, 13 genes were highly up-regulated at the e18 versus e17 
time point (Figure 3.50B and D). Their expression change at e19 versus e17 was 
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lower when compared with expression change at e18 versus e17 (Figure 3.50B and 
D). Only one gene, centromere protein A (Cenpa) did not share the same 
expression pattern as it was down regulated from e17 (Figure 3.50B - gene marked 
by black star).  
In order to complete the analysis of cell cycle related genes during 
adipogenic differentiation, the microarray data on 3T3-L1 cells from Burton et al 
(2002) and Burton et al (2004) were also used in this study. During the early stages 
of in vitro adipocyte differentiation, specific activation of growth arrest and DNA 
damage genes (GADDs) and proteins involved in regulation of the cell cycle (such 
as GADD153, p18 or p21) have been described (reviewed Gregoire et al; 1998, 
Burton et al 2002, Burton et al, 2004). In the LD microarray data, changes in mRNA 
levels for Gadd153 or p21 (Cdkn1a) were not found. However Gadd45g mRNA was 
observed to change in lower skin dermis, with the highest up-regulation at e18 
(Table 3.10). Gadd45 is believed to be under the control of the adipogenic 
transcriptional factor C/EBPalpha (Constance et al, 1996), as is p21 (Timchenko et 
al, 1996). Richon et al (1997) shown that in cells before adipogenic treatment (day 0) 
and then 1, 2 3 or 4 days after adding adipogenic factors, dramatic changes in 
protein levels can occur with p107, p130 and p107-E2F or p130-E2F complexes 
(Richon et al, 1997). These changes were related to specific activities following the 
experimental induction of adipogenesis in vitro, where a reported growth arrest 
phase is followed by a clonal expansion step. At the mRNA level, p107 gene (Rbl1) 
was observed to be up-regulated at day 1, and then its level subsequently 
decreased (Richon et al, 1997). This expression pattern was not observed for p107 
mRNA in work described in this thesis, and the p107 gene (Rbl1) was not present in 
the generated LD microarray list. 
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Figure 3.49. Genes associated with cell cycle processes during adipogenic 
differentiation in vitro (3T3-L1 cells) and in vivo (cells from lower dermis in mouse 
embryonic back skin). The analysis is based on microarray approach. (A) Figure A 
was adapted from Hackl et al (2005) and in vivo microarray data was compared with 
in vitro data from Hackl et al, 2005. Genes regulated in vitro are marked with 
coloured circles or are written in blue or green, whereas genes spotted in vivo are 
marked with red rectangles. In addition, genes spotted only in vivo and not observed 
by Hackl et al (2005) are shown by yellow rectangles or marked with both non-
coloured circles and red rectangles. (B) The summary of Figure A. Yellow-In vivo: 
genes seen in vivo but not observed in 3T3-L1 cells. Blue-In vitro: genes observed 
during in vitro differentiation but not in vivo. Green-In vitro + In vivo: genes seen in 
both in vitro and in vivo cells. White-Others: cell cycle genes/components presented 
on Figure A not observed in both in vitro and in vivo cells. 
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Figure 3.50. The expression profiles of genes related with cell cycle processes. (A, 
C) The expression profiles of cell cycle genes observed in differentiating 3T3-L1 
cells (based on Hackl et al, 2005). (B, D) The expression profiles of cell cycle genes 
in the lower dermis from e17 till e19 time points. Grey columns - regulation at e18 
versus e17 time points. Black columns - regulation at e19 versus e17 time points. 
Fold change values are based on the lower dermis (LD) microarray list. Genes 
common for in vivo and in vitro cells (A - D) were classified by Hackl et al (2005) into 
two clusters because of their up-regulation in vitro (in 3T3-L1 cells) approximately 12 
- 24h following adipogenic induction and then their subsequent progressive down-
regulation (see A and C). Majority of these genes spotted in in vivo were highly up-
regulated from e17 time point (B and D), except for the Cenpa gene (B - marked 
with a star). Ccnb1 - cyclin B1. Cdc20 - cell division cycle 20 homolog (S. 
cerevisiae). Kpna2 - karyopherin (importin) alpha 2. Prc1 - protein regulator of 
cytokinesis 1. Bub1 - budding uninhibited by benzimidazoles 1 homolog (S. 
cerevisiae). Mad2l1 - MAD2 mitotic arrest deficient-like 1 (yeast). Tacc3 - 
transforming, acidic coiled-coil containing protein 3. Kif22 - kinesin family member 
22. Cenpa - centromere protein A. Tmpo - thymopoietin. Fbxo5 - F-box protein 5. 
Pbk - PDZ binding kinase. Ranbp1 - RAN binding protein 1. Tubb5 - tubulin, beta 5.  
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Table 3.10. Genes related with progression of adipocyte differentiation in vitro and 
their presence or absence in the lower dermis (LD) microarray list (in vivo 
adipogenesis). 
Lower dermis (LD) microarray 
data  
(in vivo approach): 
 
 
In vitro studies  
on cell cycle components: 
 
 
 
e18 versus 
e17  
(fold change) 
 
e19 versus e17 
(fold change) 
p21/SDI-1 
(cyclin-dependent 
kinase inhibitor 1A: 
Cdkn1a) 
 
Cell cycle component which level 
(both mRNA and protein) is 
increased by C/EBPalpha 
(Timchenko et al; 1996). mRNA 
level slightly decreased  1 day 
after adipogenic induction* and 
then its gradual increase from day 
one was seen (Morrison and 
Farmer, 1999). 
 
 
 
 
NP** 
p27 
(cyclin-dependent 
kinase inhibitor 1B: 
Cdkn1b) 
mRNA level dramatically 
decreased till day 2 after 
adipogenic induction*, next a 
slight increase is seen till day 6 of 
induction*. (Morrison and Farmer, 
1999). 
 
 
NP** 
p18 
(cyclin-dependent 
kinase inhibitor 2C: 
Cdkn2c) 
The level of p18 was induced by 
PPARgamma in NIH-3T3 
fibroblasts (Morrison and Farmer, 
1999). In 3T3-L1 cells, low p18 
mRNA level seen at day 0, 
disappears at day 1 and 2 of 
induction*, then an increase of 
p18 is seen from day 3 of 
induction*. 
 
+ 3.779247*** 
 
 
+ 3.988036*** 
 
p107 
(retinoblastoma-like 
1:Rbl1) 
mRNA level dramatically 
increased approximately 24 hours 
after induction*. Next, its level 
decreased at day 2, 3 and 4 after 
adipogenic induction (Richon et 
al, 1997) 
 
 
NP** 
Gadd153 
(DNA-damage-
inducible transcript 3: 
DDIT3) 
The growth arrest gene mRNA 
levels presented in cells before 
adipogenic induction* (day 0) 
dramatically decreased 2 hours 
after the adipogenic induction in 
3T3 cells (Burton et al; 2002). 
 
 
NP** 
Gadd45 
(growth arrest and 
DNA-damage-
inducible, alpha: 
DDIT1) 
Expresssed in differentiated 3T3-
L1 cells and regulated by 
C/EBPalpha (Constance et al; 
1996). 
 
+ 5.532627*** 
 
+ 3.565415*** 
* treatment of analysed cells with adipogenic medium which factors activate fat cell differentiation cascade (see 
Chapter 1, part 1.3.2.2 for more details). 
** gene was not present (NP) in the LD microarray list  
*** gene was present in the LD microarray list and up-regulated from e17 time point 
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3.3.5.4. The use of GeneCoDis 2.0 (gene annotations co-occurrence 
discovery) tool for the analysis of cytoskeletal and extracellular matrix 
genes. 
First the lower dermis (LD) data underwent analysis by the GeneCoDis 2.0 
tool in order to get a view on such features of these genes as cellular localisation. It 
is known, from in vitro studies, that during very early stages of adipogenic 
differentiation (after reaching the confluence and during the up-regulation of 
C/EBPalpha and PPARgamma; Spiegelman and Farmer, 1982; reviewed by 
Gregoire et al, 1998) changes in cytoskeletal proteins and extracellular matix 
components (EMC) are taking place which are crucial for the development and 
maintenance a specific architecture/morphology of fat cells (reviewed by Mariman 
and Wang, 2010).  The lower dermis (LD) microarray data was divided into two sub-
lists (a sub-list with genes of fold change equal and more than 2 at e19 vs e17 and 
the sub-list with genes lower than 2 at e19 vs e17) that were next analysed by the 
GeneCoDis tool. The division was needed because of the limitation in number of 
genes that can be analysed at the same time by GeneCoDis tool. The GeneCoDis 
2.0 tool allowed the investigation of cellular localisation (Gene ontology_Cellular 
Component; GO_CC) of genes differently expressed in the lower skin dermis. The 
GeneCoDis is a freely available tool for the analysis of biological features of a given 
gene group (Carmona-Saez et al, 2007; Nogales-Cadenas et al, 2009). The 
microarray data underwent the analysis by GeneCoDis 2.0 tool and groups with the 
highest number of genes associated with a term for cytoskeletal proteins or a term 
for extracellular matrix components - EMC (“proteinaceous extracellular matrix”) 
were selected. The term “cytoskeleton” (GO:0005856) was defined as “…any of the 
various filamentous elements that form the internal framework of cells…” (citation 
from: http://amigo.geneontology.org/cgibin/amigo/term_details?term=GO:0005856). 
Finally, term “proteinaceous extracellular matrix” (GO:0005578), defined as 
“…A layer consisting mainly of proteins (especially collagen) and 
glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or 
overlying cells such as endothelial and epithelial cells…” (citation from: 
http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005578) was 
used for the selection of EMC from the microarray data. 
   
 
 
 
                                                                                                           Chapter 3 
                                                                                                 
211 
The presence of genes from the in vivo LD list, classified into either 
“cytoskeleton” or “proteinaceous extracellular matrix” term was further analysed in 
microarray data from in vitro differentiating adipocytes (3T3-L1 cells) (microarray 
studies from Burton et al, 2004; Hackl et al, 2005; Kim et al, 2007). This comparison 
verified how many “cytoskeleton” or “proteinaceous extracellular matrix” genes are 
common for both in vitro (3T3-L1) and in vivo cells (from lower dermis) (see below). 
 
Cytoskeleton proteins. 
The group of 64 genes associated with “cytoskeleton” term (by GeneCoDis 
2.0 tool) from the in vivo LD microarray data was compared with several in vitro 
microarray studies (Burton et al, 2004; Hackl et al, 2005 and Kim et al, 2007). Only 
25% of in vivo “cytoskeleton” genes were found in differentiating 3T3-L1 cells 
(Figure 3.51) therefore the majority of cytoskeletal genes from the lower dermal cells 
(75%) were not present on any of the in vitro microarray lists.  
The analysis of differentiating 3T3-L1 cells revealed important changes in the 
levels of several cytoskeletal components and Spiegelman and Farmer (1982) 
showed a dramatic decrease in gene expression of actin (beta and gamma) and 
tubulin (alpha and beta) during adipogenic differentiation. The microarray work by 
Hackl et al (2005) confirmed the specific changes in these cytoskeleton proteins and 
showed specifically that between first 6 and 12 hours of adipogenic induction in 3T3-
L1 cells there was up-regulation of Acta1 (alpha actin) and Actg1 (gamma actin) but 
then after 12 hours a decrease of these genes took place (Figure 3.52A and C). For 
the in vivo LD data presented in this Chapter, only the Acta1 gene was specified and 
its expression profile showed a general up-regulation from e17 to e19 (Figure 3.52B). 
The Hackl et al (2005) study has also revealed specific expression pattern for 
tubulin alpha (Tuba4) and tubulin beta (Tubb5) in 3T3-L1 cells (Figure 3.52D and F). 
Expression of Tuba4 and Tubb5 decreased after 24 hours of adipogenic induction. 
Only tubulin beta (Tubb5) was found on the LD cell array list (Figure 3.52E).  
Moreover, this gene was up-regulated at e18 versus e17 but its down-regulation 
was observed at e19 versus e18 time points (Figure 3.52E). 
 
Hackl et al (2005) showed also that in 3T3-L1 cells other cytoskeleton 
components are undergoing clear down-regulation after 12 hours (for example: 
Myosin light chain 2; tropomyosin 1 and 2; fascin homolog 1; transgelin 1 or 
Calponin 2) or 24 hours (for example transgelin 2) of adipogenic induction therefore 
they share expression profiles either with Acta1 and Actg1 genes (Figure 3.52A and 
C; Cluster 10) or with Tuba4 and Tubb5 genes (Figure 3.52D and F; Cluster 8). The 
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presence of these seven genes (Myosin light chain 2; tropomyosin 1 and 2; fascin 
homolog 1; transgelin 1, Calponin 2 and transgelin 2) was checked in the LD 
microarray list and only three genes (tropomyosin 1; transgelin and transgelin 2) 
were spotted in lower dermal cells (Figure 3.53A - C). All these three genes were 
up-regulated from e17 time point (Figure 3.53A - C).  
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Cytoskeleton
25%75%
In vivo + In vitro
In vivo   
 
Figure 3.51. Cytoskeleton genes. Genes from the lower dermis (LD) microarray data 
that were associated with the cytoskeleton term by GeneCoDis 2.0 tool and their 
presence/absence was analysed in 3T3-L1 cells undergoing adipogenesis (based 
on in vitro microarray data from Burton et al, 2004; Hackl et al, 2005; Kim et al, 
2007). Yellow-In vivo: genes seen in vivo but not observed in 3T3-L1 cells. Green-In 
vitro + In vivo: genes seen in both differentiation processes. 
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Figure 3.52. The expression profiles of Acta1 (A, B), Actg1 (C), Tubb5 (D, E) and 
Tuba4 (F) genes. (A, C, D, F) The expression profiles of analysed genes during in 
vitro adipogenesis in 3T3-L1 cells (based on Hackl et al, 2005). (B, E) The 
expression profiles of selected genes in the lower dermis from e17 till e19 time 
points. Grey columns - regulation at e18 versus e17 time points. Black columns - 
regulation at e19 versus e17 time points. Fold change values are based on the 
lower dermis (LD) microarray list. Acta1 - actin, alpha 1, skeletal muscle. Actg1 - 
actin, gamma 1. Tubb5 - tubulin, beta 5. Tuba4 - tubulin alpha 4. 
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Figure 3.53. The expression profiles of Tpm1 (A), Tagln (B) and Tagln2 (C) genes in 
the lower dermis from e17 till e19 time points. Grey columns - regulation at e18 
versus e17 time points. Black columns - regulation at e19 versus e17 time points. 
Fold change values are based on the lower dermis (LD) microarray list. Tpm1 - 
tropomyosin 1, alpha. Tagln - transgelin. Tagln2 - transgelin 2. 
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The extracellular matrix components (ECM).  
A very broad review on ECM elements was recently published by Mariman 
and Wang (2010) which summarised knowledge about the ECM of fat cells mainly 
based on proteomic work. This study pointed to in vitro differences in ECM elements 
between human, mouse and rat fat cells (Table 3.11). The presence of ECM 
components described by Mariman and Wang (2010) was therefore cross-checked 
with the in vivo lower dermis microarray data and this combined analysis is shown in 
Table 3.11. Only five ECM elements were common for three cell lines (human 
visceral/omental adipocytes, 3T3-L1/3T3-F44A mouse cells and rat white adipose 
tissue primary adipocytes) and in vivo cells from the lower skin dermis (Table 3.11). 
These common elements were two collagens (Collagen a 2(IV) chain and Collagen 
a 1(XV) chain), Laminin b-1 chain, Laminin c-1 chain and Nidogen 1). Of 33 proteins 
listed for the mouse-derived 3T3-L1/3T3-F422A cells, 14 of the representative 
genes were also present in the in vivo LD cell array lists (Table 3.11). In addition, 
there were genes in the in vivo LD microarray data common for ECM proteins in 
human and/or rat cells but not 3T3-based mouse cells (Table 3.11).  
 
The microarray-based work on the dermal adipose layer in mouse back skin 
is aimed at investigating the steps of adipogenesis in vivo. As changes in ECM 
elements are found to be specific for adipogenic cell lines (reviewed by Mariman 
and Wang, 2010) the question was what kind of ECM components are regulated 
during in vivo adipogenesis and how many of these are in common with 3T3-L1 cell 
lines used as the main in vitro model for adipogenesis studies (reviewed by Gregoire 
et al, 1998). First a global analysis of ECM elements was performed where the 
GeneCoDis 2.0 tool associated genes from the LD microarray list with different 
terms depending on the cellular localisation of each gene. A group of 50 genes, 
associated with a term “proteinaceous extracellular matrix” (GO:0005578), was 
selected for further analysis. The presence of these genes was then cross checked 
in microarray data from differentiating 3T3-L1 cells from three studies - Burton et al 
(2004), Kim et al (2007) and Hackl et al (2005). In total, 24% of genes selected from 
the LD list were spotted in differentiating 3T3-L1 cells, whereas 76% of in vivo genes 
were not represented in the in vitro microarray studies (Figure 3.54).  
 
 
 
 
                                                                                                           Chapter 3 
                                                                                                 
217 
Table 3.11. The comparison of ECM elements in fat cells undergoing in vitro 
adipogenesis and in vivo adipocytes from lower skin dermis. The table was modified 
from Mariman and Wang, 2010).  
In vitro adipogenic 
differentiation: 
 
 
ECM components: Human 
*  
 
Mouse 
** 
 
Rat 
*** 
 
In vivo 
lower 
dermal 
cells: 
 
Agrecan 1   +  
Basement membrane-specific heparan sulfate 
proteoglycan core protein (HSPG) (perlecan) +  +  
Betaglycan (transforming growth factor beta receptor 
III)  + +  
Biglycan BGN   +   
Calreticulin CALR  + +   
Cartilage intermediate layer protein CILP1    +  
Chitinase-3-like protein 1 CHI3l1 +  +  
Chondroitin sulfate proteoglycan 4 (NG2 proteoglycan)   +  
Coiled coil domain containing protein 80 CCDC80  +   + 
Collagen a 1(I) chain COL1A1  + +  + 
Collagen a 2(I) chain COL1A2 + +  + 
Collagen a 1(II) chain COL2A1    +  
Collagen a 1(IIII) chain COL3A1  + +   
Collagen a 1(IV) chain COL4A1   + + + 
Collagen a 2(IV) chain COL4A2  + + + + 
Collagen a 3(IV) chain COL4A3    +  
Collagen a 5(IV) chain COL4A5   +   
Collagen a 1(V) chain COL5A1  + +   
Collagen a 2(V) chain COL5A2    +  
Collagen a 3(V) chain COL5A3   + + + 
Collagen a 1(VI) chain COL6A1  + +   
Collagen a 2(VI) chain COL6A2  + +   
Collagen a 3(VI) chain COL6A3  + +   
Collagen a 1(XI) chain COL11A1    + + 
Collagen a 1(XII) chain COL12A1 +  + + 
Collagen a 1(XIV) chain (undulin) COL14A1 +  + + 
Collagen a 1(XV) chain COL15A1 + + + + 
Collagen a 1(XVIII) chain COL18A1 +  +  
Collagen a 1(XXIII) chain COL23A1    +  
Connective tissue growth factor CTGF   +  
Decorin (bone proteoglycan II) DCN + +   
Dermatopontin (tyrosine-rich acidic matrix protein; 
early quiescence protein 1) DPT  + + +  
Dystroglycan 1 DAG1  +  + 
Extracellular matrix protein 1 ECM1  +   
Elastin microfibril interface-located protein 1 EMILIN1 +  + + 
Fibrillin 1 FBN1   + + 
Fibromodulin FMOD   +  
Fibronectin (FN) (cold-insoluble globulin) FN1 + +   
Fibulin-1 FBLN1 +  + + 
Fibulin-2 FBLN2   + + 
Fibulin-3 (EGF-containing fibulin-like extracellular 
matrix protein 1) FBLN3 +  +  
Fibulin-4 (EGF-containing fibulin-like extracellular 
matrix protein 2) EFEMP2  +   
Fibulin-5 (developmental arteries and neural crest 
EGF-like protein FBLN5 
+  +  
Galectin-1 LGALS1 +   + 
Galectin-3-binding protein (lectin galactoside-binding +    
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soluble 3-binding protein) LGALS3BP 
Glypican 1 GPC1  +  +  
Laminin a-2 chain LAMA2   + + 
Laminin a-4 chain LAMA4 + + +  
Laminin b-1 chain LAMB1 + + + + 
Laminin b-2 chain LAMB2 +  +  
Laminin c-1 chain LAMC1 + + + + 
Lumican (keratan sulfate proteoglycan lumican) LUM + +   
Matrilin-2 MATN2 +    
Microfibril-associated glycoprotein 4 MFAP4 +    
Mimecan (osteoglycin) OGN + +  + 
Nidogen 1 (entactin) NID1 + + + + 
Nidogen 2 (osteonidogen) NID2 + +  + 
Periostin POSTN + +   
Proline arginine rich end leucine-rich repeat protein 
(prolargin) PRELP   + + 
Proteoglycan 4 PRG4 +    
SPARC (osteonectin) SPARC + + +  
SPARC-like protein 1 SPARCL1  +  + 
Spondin-1 (F-spondin) (vascular smooth muscle cell 
growth-promoting factor) SPON1 +  + + 
Spondin-2 SPON2 +    
Tenascin-C (TN) (hexabrachion) (cytotactin) 
(neuronectin) (GMEM) TNC +    
Tenascin-N TNN   +  
Tenascin-X TNXB +   + 
Thrombospondin-1 THBS1 +  +  
Thrombospondin-2 THBS2 + +  + 
Transforming growth factor-b-induced protein IG-H3 
(bIG-H3) TGFBI +    
Versican core protein (large fibroblast proteoglycan) 
CSPG2 
+ +   
Versican V3 isoform VCAN   + + 
Continuation of Table 3.11. 
* Human omental/visceral cells 
** 3T3-L1/3T3-F422A mouse cells 
*** primary adipocytes  
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Figure 3.54. Proteinaceous extracellular matrix. Genes from the lower dermis (LD) 
microarray data that were associated with the proteinaceous extracellular matrix 
term by GeneCoDis 2.0 tool and their presence/absence was analysed in 3T3-L1 
cells undergoing adipogenesis (based on in vitro microarray data from Burton et al, 
2004; Hackl et al, 2005; Kim et al, 2007). Yellow-In vivo: genes seen in vivo but not 
observed in 3T3-L1 cells. Green-In vitro + In vivo: genes seen in both differentiation 
processes. 
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Among the ECM constituents observed in 3T3-L1 adipocytes is nidogen 
(reviewed by Mariman and Wang, 2010; Hackl et al, 2005). Microarray studies 
presented by Burton et al (2004), pointed to the enrichment of the nidogen (nidogen 
1) gene between 16 and 24 hours after adipogenic induction, whereas Hackl et al 
(2005) study showed the up-regulation of nidogen 2 during adipogenesis (Figure 
3.55A and C). Both genes were present in the in vivo LD data and both were up-
regulated from e17 to e19 time points (Figure 3.55B and D).  
 
In total, the whole LD microarray data included 14 collagen genes 
represented by different gene expression profiles (Figure 3.56A). Of these, 7 
(namely Col1a1, Col1a2, Col4a1, Col4a2, Col5a3, Col11a1 and Col15a1) are also 
undergoing changes in differentiating 3T3-L1 cells based on the Mariman and Wang 
(2010), Burton et al (2004), Hackl et al (2005) and Kim et al (2007). The microarray 
study performed by Hackl et al (2005), revealed specific expression pattern of three 
collagen genes, Col4a1, Col4a2 and Col6a2 (Figure 3.56B, D and F). Both, Col4a1 
and Col4a2 were up-regulated also in the lower dermal cells of mouse back skin but 
Col6a2 gene was not present in this LD microarray data (Figure 3.56C and E). Kim 
et al (2007) observed the down-regulation of Col1a2 and Col11a1 genes. However 
in the lower dermal cells only Col1a2 underwent down-regulation from e17 to e19 
time points, whereas Col11a1 was up-regulated between e18 and e17 time points 
(Figure 3.56A). Among regulated in vivo (in lower dermal cells) genes but not seen 
in microarray data from the differentiating in vitro 3T3-L1 cells (Burton et al, 2004; 
Hack et al, 2005; Kim et al, 2007) were Col16a1, Col25a1 and Col27a1 yet these 
were associated with a down-regulation during the development of lower dermal 
cells (Figure 3.56A).  
 
ECM elements undergo modifications under the control of so-called ECM 
processing enzymes (summarised by Mariman and Wang, 2010). Procollagens are 
precursors of collagen and they contain of N- and C- terminal peptides that are 
removed during processing. Among enzymes involved in ECM modifications are a 
desintegrin and metalloproteinase with thrombospondin type 1 motif 1 (ADAMTS1), 
a desintegrin and metalloproteinase with thrombospondin type 1 motif 4 (ADAMTS4) 
and a desintegrin and metalloproteinase with thrombospondin type 1 motif 5 
(ADAMTS5), based on the analysis of the secreted proteome in human adipose 
tissue and rodent adipocytes (reviewed by Mariman and Wang, 2010). Genes for all 
mentioned above three ADAMTS were present in the LD data together with 
regulation of Adamts15 gene (Figure 3.57). All these genes were highly up-
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regulated at e18 versus e17 time point. Their expression level at e19 time point 
versus e17 was lower when compared with expression at e18 versus e17 time point. 
Interestingly, Adamts15 gene was characterised by the highest up-regulation at e18 
versus e17 time point when comparing with the other three genes. This gene did not 
appear in microarray work on 3T3-L1 cells from Burton et al (2004), Hackl et al 
(2005) and Kim et al (2007).  
 
Among other enzymes involved in ECM modifications of adipocytes are 
matrix metalloproteinases (Mmp) and metalloproteinase inhibitors (Timp) (reviewed 
by Mariman and Wang, 2010). Hackl et al (2005) described the specific expression 
patterns of matrix metalloproteinase 2 (Mmp2) and two Timp family members 
(Timp2 and Timp3 genes) during the differentiation of 3T3-L1 cells (Figure 3.58A, B 
and D). Interestingly, Timp2 gene was also found in 3T3-L1 cells by Burton et al 
(2004) but with a different expression profile than in Hackl et al (2005) work 
(compare Figure 3.58B and C). In the in vivo LD data, no Mmp2 gene regulation 
was seen and only down-regulation of a different matrix metalloproteinase was 
observed, called Mmp16 (Figure 3.58E). Among metalloproteinase inhibitors 
regulated in lower dermal cells were Timp3 and Timp4 and both of these genes 
were up-regulated from e17 to e19 (Figure 3.58F and G). Both Mmp16 and Timp4 
genes, seen in vivo, were not present in any of the analysed in vitro microarray 
studies on 3T3-L1 cells (Burton et al, 2004; Hackl et al, 2005; Kim et al, 2007).  
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Figure 3.55. The expression profiles of Nid (A, B) and Nid2 (C, D) genes. (A, C) The 
expression profiles of analysed genes during in vitro adipogenesis in 3T3-L1 cells 
(based on Burton et al, 2004; Hackl et al, 2005). (B, D) The expression profiles of 
selected genes in the lower dermis from e17 till e19 time points. Grey columns - 
regulation at e18 versus e17 time points. Black columns - regulation at e19 versus 
e17 time points. Fold change values are based on the lower dermis (LD) microarray 
list. Nid - nidogen 1. Nid2 - nidogen 2. 
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Figure 3.56. The expression profiles of collagen genes. (A, C, E) The expression 
profiles of selected genes in the lower dermis from e17 till e19 time points. Grey 
columns - regulation at e18 versus e17 time points. Black columns - regulation at 
e19 versus e17 time points. Fold change values are based on the lower dermis (LD) 
microarray list. (B, D, F) The expression profiles of selected genes during in vitro 
adipogenesis in 3T3-L1 cells (based Hackl et al, 2005). Col7a1 - collagen, type VII, 
alpha 1. Col9a1 - collagen, type IX, alpha 1. Col16a1 - collagen, type XVI, alpha 1. 
Col25a1 - collagen, type XXV, alpha 1. Col27a1 - collagen, type XXVII, alpha 1. For 
the full names of genes: Col1a1, Col1a2, Col11a1, Col12a1, Col14a1, Col4a1, 
Col4a2, Col5a3 and Col15a1, see Table 3.11. 
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Figure 3.57. The expression profiles of Adamts genes in the lower dermis from e17 
till e19 time points. Grey columns - regulation at e18 versus e17 time points. Black 
columns - regulation at e19 versus e17 time points. Fold change values are based 
on the lower dermis (LD) microarray list. Adamts15 - a disintegrin-like and 
metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15. Adamts4 - 
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 
motif, 4. Adamts5 - a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 5 (aggrecanase-2). Adamts1 - a disintegrin-like and 
metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1. 
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Figure 3.58. The expression profiles of Mmps (A, E) and Timps (B, C, D, F, G) 
genes. (A, B, D) The expression profiles of analysed genes during in vitro 
adipogenesis in 3T3-L1 cells, based on Hackl et al, 2005. (C) The expression profile 
of analysed gene during in vitro adipogenesis in 3T3-L1 cells, based on Burton et al, 
2004. (E, F, G) The expression profiles of selected genes in the lower dermis from 
e17 till e19 time points. Grey columns - regulation at e18 versus e17 time points. 
Black columns - regulation at e19 versus e17 time points. Fold change values are 
based on the lower dermis (LD) microarray list. Mmp2 - matrix metalloproteinase 2. 
Mmp16 - matrix metallopeptidase 16. Timp2 - tissue inhibitor of metalloproteinase 2. 
Timp3 - tissue inhibitor of metalloproteinase 3. Timp4 - tissue inhibitor of 
metalloproteinase 4.    
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3.3.5.5. Late steps of adipogenic differentiation in vivo and in vitro. 
Based on the in vitro adipogenic process, it has been shown that activated 
adipogenic transcriptional factors control the up-regulation of genes related with 
metabolism of lipids and production of proteins secreted by mature adipocytes 
(reviewed by Gregoire et al, 1998; Rosen and Spiegelman, 2000).  
 
Investigation of key enzymes activated during adipogenic differentiation. 
During adipogenesis in vitro, gradual activation of pathways associated with 
metabolism takes place and main pathways together with key enzymes involved in 
these processes have been summarised by Hackl et al (2005) (see Table 3.12 and 
columns “Metabolic pathway” and “Key enzymes”). This work was used for the 
comparison study in order to verify if processes activated during in vitro 
adipogenesis in 3T3-L1 cells are also observed in vivo in lower dermal cells. The in 
vitro/in vivo comparison is shown in Table 3.12 which lists individual genes from the 
3T3-L1 cell work (Hackl et al, 2005) that are analysed in the LD data. In total, from 
33 genes, presented in Table 3.12, 61% of them were spotted in both in vitro and in 
vivo cells, whereas the rest 39% was not present in the LD microarray data (Figure 
3.59A). Therefore in contrast to many previous comparisons, in general there was 
much closer approximation between the data sets at this later stage of 
adipogenesis/lipogenesis.  
 In addition, the LD microarray data, represented in total by 2179 Affymetrix 
IDs, underwent first the analysis on DAVID v6.7 programme for the investigation of 
KEGG pathways associated with genes from this microarray work (Table 3.13). 
Interestingly, among KEGG pathway terms generated for the LD data several were 
associated with metabolism of amino acids: “Valine, leucine and isoleucine 
degradation”, “Cysteine and methionine metabolism”, “Selenoamino acid 
metabolism”, “Glycine, serine and threonine metabolism”, “beta-Alanine metabolism”, 
“Tryptophan metabolism”, “Arginine and proline metabolism” and “Tyrosine 
metabolism” (Table 3.13 - see underlined terms).  
 
The pathway involved in cholesterol metabolism with two key enzymes (3-
hydroxy-3-methylglutaryl-CoA synthase 1 and 3-hydroxy-3-methylglutaryl-CoA 
reductase) was suggested to be activated during the in vitro adipogenesis (Table 
3.12, No.3). Among these two enzymes, only expression of 3-hydroxy-3-
methylglutaryl-CoA synthase 1 took place in the lower dermal cells. In addition, a 
term “steroid biosynthesis” was associated with in vivo microarray data (Table 3.13 - 
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see term shown in italic). In general, cholesterol is known to serve as a precursor for 
the synthesis of different steroids (Hu et al, 2010). Several other genes representing 
enzymes crucial for metabolic processes were regulated in vivo in lower dermal cells. 
These were for example lipoprotein lipase (Lpl), involved in the “triglyceride 
hydrolysis”, acetyl-CoA dehydrogenase, medium chain (Acadm) and isovaleryl-CoA 
dehydrogenase (Acad), both associated with “beta-oxidation” or stearoyl-CoA 
desaturase 1 (Scd1) involved in “unsaturated fatty acid biosynthesis” (Table 3.12, 
No.4, No.5 and No.11).  
All 20 genes, present on both the in vitro and in vivo adipogenic microarray 
lists (Figure 3.59A), were up-regulated in the lower dermal arrays from e17 time 
point (Figure 3.59B). Several genes were very dramatically up-regulated at e19 
versus e17 time points, for example Lpl (lipoprotein lipase; with a 17.98-fold change) 
or Scd1 (stearoyl-Coenzyme A desaturase 1; with a 26.44 fold change) (Figure 
3.59B). Therefore, lower dermal cells are characterised by the dramatic up-
regulation of a high number of metabolic genes at embryonic stages of their 
development in vivo. For example, four genes spotted in the LD microarray list 
represented enzymes involved in triacylglycerol metabolism (Table 3.14). The 
highest up-regulation for these genes was at e19 versus e17 time point where the 
expression of two genes (malic enzyme and fatty acid synthase) was changed 
around 2 fold, whereas two other enzymes (glycerol-3-phosphate dehydrogenase 
and acyl-CoA synthetase long-chain family member 1) showed much higher fold 
changes (compare fold change values in Figure 3.60A, B, C and D). 
 
Glycerol-3-phosphate dehydrogenase (Gpd1) was chosen for the verification 
work by the qRT-PCR technique, as it is the key enzyme involved in the glycerol 
synthesis and interestingly its enhanced activity was observed in adipose tissue of 
obese individuals (Swierczynski et al, 2003). The Gpd1 mRNA was detected at 
three time points, in both upper and lower dermis (Figure 3.61). The up-regulation of 
Gpd1 gene in lower dermis versus upper skin was seen in e18 and e19 time points 
and the increase in its expression in lower dermis occurred between e17 and e19. 
The enrichment of Gpd1 in lower dermis at e19 was significant, according to a t-test, 
when compared with cells from lower dermis at other two time points. The PCR 
results from this analysis confirmed the expression pattern of Gpd1 gene at mRNA 
level (compare Figure 3.60C with Figure 3.61). 
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Table 3.12. Key metabolic pathways and enzymes regulated in 3T3-L1 cells (Hackl 
et al, 2005) and their presence in lower dermal cells (the LD microarray data). 
3T3-L1 cells:  
No. 
 
Metabolic pathway: Key enzyme: 
Lower 
dermal 
cells. 
1. Urea cycle and  
arginine-citrulline 
cycles 
Arginine succinate synthase NP* 
Phosphatidylinositol 3-kinase, regulatory subunit, 
polypeptide 1 
+** 2. Phosphatidylinositol 
 
Myoinositol 1-phosphate synthase A1 NP* 
3-hydroxy-3-methylglutaryl-CoA synthase 1 +** 3. Cholesterol biosynthesis 
/keto-body synthesis 3-hydroxy-3-methylglutaryl-CoA reductase NP* 
4. Triglyceride hydrolysis  
(fatty acid assimilation) 
Lipoprotein lipase (LPL) +** 
Acetyl-CoA dehydrogenase, medium chain 
(Acadm) 
+** 
Isovaleryl-CoA dehydrogenase (Acad/Ivd) +** 
5. beta-oxidation 
Acyl-CoA dehydrogenase, short/branched chain 
(Acadsb) 
NP* 
6. Triglyceride metabolism Adipose triglyceride lipase (Pnpla2/Atgl) +** 
7. CoA biosynthesis Pantothenate kinase 3 (Pank3) +** 
8. Anaplerotic processes Pyruvate carboxylase (Pcx) +** 
9. Branched chain amino acid  
metabolism 
(AKAmetabolism) 
Branched chain ketoacid dehydrogenase E1, 
alpha polypeptide (Bckdha) 
+** 
S-adenosylhomocysteine hydrolase NP* 10. Methylation 
Methionine adenosyltransferase II, alpha (Mat2a) +** 
11. Unsaturated fatty acid 
biosynthesis 
Stearoyl-CoA desaturase 1 (Scd1)  
+** 
12. Nucleotide metabolism Xanthine dehydrogenase NP* 
13. Taurin biosynthesis Cysteine dioxygenase (Cdo1) +** 
14. NH4 
+ metabolism/glutamate 
Glutamate-ammonia ligase (glutamine 
synthase)(Glul) 
+** 
15. Glycolysis Pyruvate kinase 3 NP* 
16. Substrate cycle 
(glycolysis/gluconeogenesi
s) 
Fructose bisphosphatase 2 NP* 
Deoxycytidine kinase NP* 17. Nucleotide biosynthesis 
Ribonucleotide reductase M2 NP* 
18. Pentose phophate shunt Hexose-6-phosphate dehydrogenase (AI785303) 
(H6pd) 
+** 
19. NAD(P) biosynthesis Pre-B-cell colony-enhancing factor (Nampt) +** 
20. Polyamine biosynthesis Ornithine decarboxylase, structural (Odc1) +** 
21. Tetrahydrobiopterin 
biosynthesis 
GTP cyclohydrolase 1 NP* 
22. Purine biosynthesis Phosphoribosyl pyrophosphate amidotransferase 
(Ppat) 
+** 
23. Asparagine biosynthesis Asparagine synthetase (Asns) +** 
24. Long chain fatty acids ELOVL family member 6, elongation of long chain 
fatty AIDS (Elovl6) 
+** 
25. Serine biosynthesis Phosphoserine phosphatase NP* 
26. Gluconeogenesis PEPCK 2 (Riken 9130022B02) NP* 
27. Prostaglandin E 
biosynthesis 
Prostaglandin E synthase (ri|2410099E23; 
ri|9230102G02) (Ptges2) 
+** 
* gene was not present (NP) in the LD microarray list  
** gene was present (+) in the LD microarray list  
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Figure 3.59. Enzymes associated with metabolic pathways during adipogenic 
differentiation in vitro (3T3-L1) and in vivo (cells from lower dermis in mouse 
embryonic back skin). The analysis is based on the microarray approach. (A) The 
presence of key enzymes, seen in 3T3-L1 cells (based on Hackl et al, 2005), was 
investigated in the lower dermal cells (based on the LD microarray list). Blue-In vitro: 
genes related only with 3T3-L1 cells. Green-In vitro + In vivo: genes expressed in 
3T3-L1 cells and lower dermal cells. (B) In vivo expression (based on the LD 
microarray list) of genes common for in vitro and in vivo cells.  
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Table 3.13. KEGG terms associated with genes from the LD microarray data. The 
analysis was performed by DAVID v6.7 programme. 
KEGG terms: 
mmu00903:Limonene and pinene degradation mmu05212:Pancreatic cancer 
mmu00630:Glyoxylate and dicarboxylate 
metabolism mmu00010:Glycolysis / Gluconeogenesis 
mmu00410:beta-Alanine metabolism mmu04520:Adherens junction 
mmu00100:Steroid biosynthesis mmu05215:Prostate cancer 
mmu00450:Selenoamino acid metabolism mmu04512:ECM-receptor interaction 
mmu00910:Nitrogen metabolism mmu05222:Small cell lung cancer 
mmu00030:Pentose phosphate pathway 
mmu04914:Progesterone-mediated oocyte 
maturation 
mmu01040:Biosynthesis of unsaturated fatty 
acids mmu00020:Citrate cycle (TCA cycle) 
mmu00260:Glycine, serine and threonine 
metabolism mmu03320:PPAR signaling pathway 
mmu00350:Tyrosine metabolism mmu03050:Proteasome 
mmu00270:Cysteine and methionine 
metabolism mmu05210:Colorectal cancer 
mmu00380:Tryptophan metabolism 
mmu00280:Valine, leucine and isoleucine 
degradation 
mmu00561:Glycerolipid metabolism mmu04114:Oocyte meiosis 
mmu04150:mTOR signalling pathway mmu04110:Cell cycle 
mmu05217:Basal cell carcinoma mmu04310:Wnt signalling pathway 
mmu00330:Arginine and proline metabolism mmu00190:Oxidative phosphorylation 
mmu00640:Propanoate metabolism mmu05012:Parkinson's disease 
mmu00620:Pyruvate metabolism mmu05016:Huntington's disease 
mmu00071:Fatty acid metabolism mmu04010:MAPK signalling pathway 
mmu03018:RNA degradation mmu05010:Alzheimer's disease 
mmu05214:Glioma mmu04510:Focal adhesion 
mmu04115:p53 signalling pathway mmu05200:Pathways in cancer 
mmu05218:Melanoma  
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Table 3.14. Enzymes involved in triacylglycerol metabolism and enriched at late 
stages of adipogenesis. 
Enzymes related with triacylglycerol 
metabolism and up-regulated during 
late/terminal stages of adipocyte 
differentiation in 3T3-L1 cells (based 
on Gregoire et al, 1998). 
Presence of enzymes related with 
triacylglycerol metabolism in the lower 
dermal cells (based on the LD microarray 
data). 
malic enzyme (Me) +* 
fatty acid synthase (Fasn) +* 
glycerol-3-phosphate dehydrogenase (Gpd) +* 
acyl-CoA synthetase long-chain family 
member 1 (Acsl1) 
+* 
* gene was present (+) in the LD microarray list  
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Figure 3.60. The expression profiles of Fasn (A), Me1 (B), Gpd1 (C) and Acsl1 (D) 
genes in the lower dermis from e17 till e19 time points. Grey columns - regulation at 
e18 versus e17 time points. Black columns - regulation at e19 versus e17 time 
points. Fold change values are based on the lower dermis (LD) microarray list. Fasn 
- fatty acid synthase. Me1 - malic enzyme 1, NADP(+)-dependent, cytosolic. Gpd1 - 
glycerol-3-phosphate dehydrogenase 1 (soluble). Acsl1 - acyl-CoA synthetase long-
chain family member 1.  
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Figure 3.61. Verification of microarray data by qRT-PCR for one gene: Gpd1. The 
relative mRNA expression for gene was analysed on samples from dermis at: e17 
(17), e18 (18) and e19 (19) time points, from upper (Area “1”, green) and lower 
(Area “2”, red) dermis area. Data were obtained from triplicate biological replicates. 
The baseline (1-fold change) was established for the e19 lower dermis sample 
(underlined on the figure) and the mRNA levels of the other samples are shown 
relative to this. Gpd1 gene is up-regulated in lower dermis (Area “2”) when 
compared with upper area (Area “1”) in e18 and e19 time points. This observation is 
in agreement with in vivo microarray data generated from dermal cells (Table 3.4). P 
value refers to the comparison with “19 2” sample (* P <0.05, ** P <0.01, *** P 
<0.001). The “NS” indicates not significant differences in the mRNA gene 
expression. 
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Adipocyte specific products.  
Cell line-based studies on adipocytes revealed a number of proteins 
produced and/or secreted by these cells (reviewed by Gregoire et al, 1998; Rosen 
and Spiegelman, 2000). Presence of several genes specific for mature fat cells was 
checked in the lower dermal microarray data (Table 3.15). The reason was that the 
Oil Red O analysis pointed to the development of fat cells with lipid droplets and an 
increase in their number in lower skin dermis from e17 till e19 time points (Figure 
2.5, Chapter 2).  
  
Among three selected fat-specific products: FABP4, CD36 and perilipin, only 
expression of perilipin was not seen in the LD microarray data. Fabp4 gene 
expression in the lower dermal cells was verified by qRT-PCR and results of this 
analysis were discussed in section 3.3.2 (see also Figure 3.10B). Based on the 
microarray data, Cd36 gene was up-regulated in lower dermis from e17 time point 
(Table 3.15). The qRT-PCR analysis, confirmed the over-expression of Cd36 gene 
in lower dermis during mouse skin development (Figure 3.62A). mRNA for Cd36 
was almost not detected in the upper dermis (Figure 3.62A - green columns), 
whereas, in the lower dermal cells, higher up-regulation of CD36 mRNA took place 
in the e18 sample, when compared with younger specimens (e17 time point). A 
fairly similar level of CD36 was next observed at e18 and e19 (Figure 3.62A - red 
columns). The t-test confirmed a significant enrichment of this gene at e19 in the 
lower dermis when compared with lower dermis area at e17 time point and with 
upper dermis samples at all three analysed time points (Figure 3.62A). 
 
Among proteins known to be produced and secreted by adipocytes are 
resistin, adipsin, angiotensinogen and adiponectin (reviewed by Gregoire et al, 1998; 
Rosen and Spiegelman, 2000). The array data showed that genes for all four 
proteins were regulated during development of LD cells in vivo (Table 3.15). mRNA 
levels for these genes increased significantly but relatively modestly between e17 
and e18, whereas the enrichment of these genes at e19 was very dramatic. 
Quantitative RT-PCR confirmed the high up-regulation of these four proteins at 
mRNA level in lower dermal cells at the latest analysed time point (e19). Results 
from the qRT-PCR analysis for Adipoq, resistin (Retn) and adipsin (Adn) are shown 
in section 3.3.2 (Figure 3.13B and Figure 3.17). The angiotensinogen (Agt) mRNA 
levels in dermal cells are shown in Figure 3.62B. Agt was expressed at detectable 
levels in lower dermal cells (Figure 3.62B - red columns). Its expression increased 
from e17 to e19 time points and the enrichment of this gene at e19 time point was 
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statistically significant (according to a t-test) when compared with samples from 
other time points (Figure 3.62B). 
   
Table 3.15. Genes related with late stages of adipogenesis in 3T3 cells, expressed 
and secreted in mature adipocytes. Their presence or absence was analysed in 
lower skin dermis during mouse embryonic development.  
Lower dermis (LD) microarray data: in vivo approach. 
 
 
In vitro studies (mainly 
on 3T3 cells). Gene symbol 
(Affymetrix ID): 
e18 versus 
e17 (fold 
change) 
e19 versus 
e17 (fold 
change) 
Fat cell specific products* 
fatty acid binding protein 4 Fabp4  (1425809_at) 
 
+ 3.800351** 
 
+ 8.378724** 
 
FAT/CD36 (fatty acid 
transporter) 
Cd36  (1450883_a_at) + 5,071104** + 8,146752** 
Perilipin 1, Perilipin 2 (lipid-
droplet associated proteins) 
NP*** 
Secreted  (by adipocytes) proteins* 
Resistin Retn (1449182_at) + 1.003697** + 5.248189** 
Adipsin Adn/Cfd (1417867_at) + 1.22378** + 12.15824** 
Angiotensinogen Agt (1423396_at) + 3.769306** + 10.97713** 
Acrp30/AdipoQ Adipoq (1422651_at) + 51.95553** + 710.0637** 
* based on the review from Gregoire et al, 1998. 
**gene was present in the LD microarray list and up-regulated from e17 time point 
*** gene was not present (NP) in the LD microarray list  
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Figure 3.62. Verification of microarray data by qRT-PCR for two genes: Cd36 and 
Agt. The relative mRNA expression for both genes was analysed on samples from 
dermis at: e17 (17), e18 (18) and e19 (19) time points, from upper (Area “1”, green) 
and lower (Area “2”, red) dermis area. Data were obtained from triplicate biological 
replicates. The baseline (1-fold change) was established for the e19 lower dermis 
sample (underlined on the figure) and the mRNA levels of the other samples are 
shown relative to this. Both genes are up-regulated in lower dermis (Area “2”) when 
compared with upper area (Area “1”) in e17, e18 and e19 time points. This 
observation is in agreement with in vivo microarray data generated from dermal cells 
(Table 3.4). P value refers to the comparison with “19 2” sample (* P <0.05, ** P 
<0.01, *** P <0.001). The “NS” indicates not significant differences in the mRNA 
gene expression. 
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3.4. Discussion.  
Work presented in Chapter 2 revealed that around e17 and e18 in mice, cells 
from the lower skin dermis, between and around hair follicle end bulbs, undergo 
dynamic changes which lead to adipogenic differentiation and development of the 
dermal adipose tissue layer after birth. The aim of this section of the thesis was to 
identify changes in gene expression during the processes taking place in such cells, 
especially since these developmental events have never been analysed at the 
molecular level in vivo to best of my knowledge. The laser capture microdissection 
(LCM) technique together with the microarray approach proved to be a very suitable 
tool for such a study.  
 
Output of the microarray study.  
This study generated a very large amount of data, with 1001, 1309 and 2460 
Affymetrix IDs for genes differently expressed in the upper and lower dermal cells at 
three time points, respectively at e17, e18 and e19. In addition, 2179 Affymetrix IDs 
characterised genes whose expression changed in lower dermal compartment from 
e17 till e19 time point (the LD microarray data). Consequently, even with the 
assistance of bioinformatics tools, complete analysis of the data was unfeasible 
given the time limits and individual nature of the project. Therefore the aim was to 
concentrate on key questions relating to general biological features of cells from 
lower and upper embryonic dermis and to changes taking place at molecular level in 
lower dermis during embryonic development that give a rise to dermal adipose 
tissue (based on Chapter 2). 
 
The results have: (a) Provided an overall picture of cellular and molecular 
changes during in vivo adipogenesis. (b) Confirmed differences in cellular and 
molecular profiles between cells in the lower and upper dermis and provided some 
indications of what might be happening during embryonic dermis development. (c) 
Shown clear differences between adipogenesis as represented by the 3T3 model 
and that seen in vivo. (d) Highlighted specific genes, and gene families, not 
previously associated with the developmental process.  
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Limitations/disadvantages of the time points, microdissection technique and 
microarray technology - technical discussion. 
It is important to discuss the technical aspects of work preformed and 
presented in this Chapter. Starting from the beginning, the laser capture 
microdissection (LCM) technique was applied to the isolation of dermal areas only at 
three time points (e17, e18 and e19). These adjustments were related with a careful 
isolation of skin specimens, appropriate storage conditions of specimens and 
preparation of back skin cross-sections for the LCM (see sections 3.2.2 and 3.2.3 for 
more details). During the microdissection, each single fragment of a collected 
dermis had to be first carefully marked and then microdissected by a laser. The 
collected pieces were only visible under the microscope and the successful isolation 
of such pieces was dependent on the power settings of the laser as well as on the 
size of marked dermis area. Therefore there is the possibility that some tissue/cells 
that belonged to the follicle dermis rather than inter-follicular dermis could have 
been incorporated into the samples. This is especially likely to happen where an 
obvious follicle structure may not be visible in any given section, but where the 
cryostat slices might be going into or out of a follicle.  
 
In relation to the generated microarray data, arrays themselves are unlikely 
to be perfect e.g. because of alternate splicing  
(see: http://www.people.vcu.edu/~mreimers/OGMDA/summarize.expression.html).  
It has been also reported that in microarray analysis a relatively short data series 
can lead to greater error. Therefore bigger problems can occur in distinguishing a 
real process from random ones when the clustering algorithms are applied for the 
analysis of microarray data (Ernst et al, 2005). The fact that the hierarchical 
clustering analysis here revealed correlations between genes from upper and lower 
dermis at e17 time point or correlated expression profiles of genes from lower 
dermis between e18 and e19 time points (section 3.3.1) could be then due to an 
error in a used clustering algorithm. However, the other explanation of the obtained 
results could be due to the highly dynamic nature of the changes taking place in the 
lower and upper dermis. 
 
The next technical issue relates to the cell types collected from the areas and 
the age of animals used for this work. In Chapter 2, it was observed that between 
e17 and e19 cells of the lower dermis changed from being all unstained by Oil Red 
O dye to having a mixture of fat containing and non-fatty cells. Therefore, if the non-
fatty cells sampled during the LCM process were not adipogenic this could be 
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problematic. The initial and important concern with this experimental strategy was 
that gene expression in cells undergoing adipogenesis in the lower dermis would be 
masked or distorted by “noise” from non-adipogenic cells in the same region. 
However, in this context the work of the previous Chapter 2 providing a long term 
analysis of fat formation in this region until well after birth was highly informative and 
reassuring, since essentially all the cells in this area (apart from those associated 
with vasculature) became fat. Since we have found no evidence of large scale cell 
death following the initiation of adipogenesis in this region (data not shown), this 
indicates that vast majority of the lower dermis cells harvested for microarray were 
adipocyte precursors.  
The main consideration is therefore the timing of events and the fact that the 
process of adipogenesis, while starting at a defined point in time, is not synchronous 
amongst all the lower dermal cells, but a process where adipogenesis is being 
initiated over a considerable time period.  
 
Verification. 
Bearing in mind the above considerations, the verification of selected genes 
from the in vivo microarray data, both at the mRNA and the protein level largely 
confirmed the array results. When conventional RT-PCR was used initially to 
confirm the presence or absence of genes, there was 95 - 100% confirmation of the 
array data in terms of basic expression. Genes selected for analysis by qPCR, were 
shown in the arrays as being enriched in the lower dermis, although some were also 
chosen from the upper dermis. Among genes, for which primer pairs occurred to be 
efficient for the qRT-PCR analysis (see Table 3.2), 100% showed the appropriate 
expression in terms of overall trends and timing, and 100% showed significant 
differences (between upper and lower dermis) for at least one time point.  
 
  At the protein level, 6 out of 7 genes whose expression was investigated and 
for which a working antibody was found showed expression consistent with the array 
data. Again this was true of molecules being expressed in the upper as well as the 
lower dermis. For example TRPS that has been shown to be important in relation to 
hair follicle development in the upper dermis around e14 (Fantauzzo et al, 2008) 
persists as a marker there in late gestation skin. In one case (AdipoQ) there was 
evidence of the expression being more concentrated within the hair follicle dermis, 
than more broadly within the lower dermis.  
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3.4.1. Dynamic changes in two dermal skin compartments during 
mouse embryonic development.  
The microarray data, generated by the GeneSpring software, gave an 
interesting insight into features of back skin compartments at late stages of mouse 
embryonic development. The comparison of genes enriched in upper and lower 
dermis revealed clear differences between these two skin compartments at 
molecular level.  
 
General findings.  
The basic, global analysis of microarray data pointed to a presence of 
enriched genes in both upper and lower dermis areas from e17 to e19 time points 
(section 3.3.1). In addition, the analysis of numbers of Affymetrix IDs for genes 
showing significant differences in expression increased over the sampling points 
from 1001 to 2460 (Figure 3.6) was highly indicative that dynamic events were 
occurring in this dermal compartment at these time points. 
The Venn diagram revealed the presence of genes common for two or all 
three analysed time points which could suggest that enrichment of such common 
genes is important for proper in vivo developmental processes of dermal skin 
compartments. In addition, the hierarchical clustering analysis of the gene 
expression intensity revealed a close correlation between upper and lower dermis at 
e17 time point. Then expression of genes from lower dermis at e18 was correlated 
with expression profile of lower dermis genes at e19 time points, whereas samples 
from upper dermis at e18 and e19 were clustered together because of similarly 
expressed genes in this skin compartment. Therefore specific changes seemed to 
take place between e17 and e18 time points in skin dermis that leaded to a gradual 
development of two distinguishable (at molecular level) dermal compartments: upper 
and lower dermis. 
Because of a correlation between enriched genes from the lower dermis at 
e18 and e19 time points (hierarchical clustering) and a fact that the first lipid 
accumulating cells were observed in this lower dermal compartment after e17 and 
between e18 and e19 (Chapter 2), a question arises about the global features of 
genes enriched in lower dermal cells between e17 and e19 time points. The majority 
of genes with the highest up-regulation in lower dermis at e17 and e19 time point 
(respectively 42% and 60% analysed genes) were related with adipocytes, adipose 
tissue and/or functions of fat cells (Figure 3.9). Therefore it becomes apparent that 
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regulation of gene expression in lower dermis between e17 and e19 time points is 
crucial for the differentiation of fat cells.  
 
Fat-related processes in lower skin dermis. 
 Bioinformatics analysis of gene ontology (GO_BP terms) showed that genes 
from both dermal compartments were associated with general terms for 
differentiation and developmental processes (Figure 3.24. Part A). However only 
genes enriched in lower dermis were associated with terms crucial for the regulation 
of lipid metabolism (Figure 3.24. Part C). 
 
 The KEGG pathway analysis also confirmed differences between upper and 
lower dermis areas. For example, a high number of genes from lower dermis were 
associated with lipid metabolism and adipocyte-specific terms, such as the “fatty 
acid elongation in mitochondria”, the “biosynthesis of unsaturated fatty acids” or the 
“insulin signalling pathway” (Figure 3.25). These processes are widely known to be 
crucial for the regulation of adipogenesis or they are taking place in adipose tissue 
(Pearce, 1983; Guerre-Millo, 2004; Duncan et al, 2007; see also section 1.2.2.2.2 in 
Chapter 1). The occurrence of genes involved in the above mentioned KEGG 
pathways in lower dermal cells between e17 and e19 time points clearly suggested 
the gradual development of fat cells taking place in lower dermal compartment in 
mouse embryonic back skin.  
 
 In addition to the general trends and indicators provided in the initial analysis, 
the array data and the verification process highlighted individual genes. Several 
genes from the in vivo microarray data, whose specific expression profile in skin 
dermis was confirmed by qRT-PCR reaction and/or immunofluorescence analysis, 
seemed to be interesting candidates for a future study of their role in relation to 
dermal cells development and will be discussed further here. 
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CD36/FAT  
The “PPAR signalling pathway” that was associated (by DAVID v6.7 
programme) with several genes from in vivo microarray data (see Figure 3.25) is 
related with activity of fatty acids transporters. Fatty acids can be transported for 
example by FAT/CD36 (fatty acid translocase; CD36 antigen) which is a membrane 
protein (Pohl et al, 2005). In addition, CD36/FAT (fatty acid translocase) is involved 
in metabolism of long-chain fatty acids (Campbel et al, 2004). This translocase was 
seen in 3T3-L1 adipocytes and it plays crucial role in the uptake of fatty acids by 
these cells (Pohl et al, 2005). The expression of CD36 was also linked with 
preadipocyte differentiation processes in 3T3-F422A (Sfeir et al, 1999). In addition, 
the up-regulation of CD36 was seen in a human preadipocyte cell lines derived from 
patients with familiar combined hyperlipidemia (FCHL), which is related with higher 
levels of cholesterol in the blood (dyslipemia) and metabolic syndrome (Meex et al, 
2005). This specific expression pathway suggested the impact of CD36 on 
adipocyte differentiation and its up-regulation in patients may be related with a 
genetic effect (Meex et al, 2005). Also, obesity and type 2 diabetes were related with 
up-regulation of CD36/FAT in subcutaneous adipose depots (Bonen et al, 2006).  
 
The Cd36 gene was selected from microarray data because of its high up-
regulation in lower dermis at e 18 and e19 time points (Table 3.4), and its specific 
expression profile was confirmed by qRT-PCR (Figure 3.62A). The fact that this 
protein can be found in membranes, gave a possibility to suggest it can be a useful 
marker of lower dermis cells committed to adipogenesis. Such marker was then 
tested for the flow cytometry analysis for the collection of CD36 positive cells from 
mouse embryonic skin dermis. This work, performed by the fluorescence activated 
cell sorting (FACS) technique has been successfully performed and is presented in 
details in the Chapter 5.  
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FABP4 (aP2) 
In microarray data, presented in this thesis, the up-regulation of fatty acid 
binging protein 4 (FABP4) was observed in lower dermis (Table 3.4). Fatty acid 
binding proteins are capable of binding long-chain fatty acids and take part in their 
transport as well as in lipid metabolism (Makowski and Hotamisligil, 2004). 
Interestingly, FABP4 has been associated with obesity and type 2 diabetes and its 
higher level was observed in obese children (Khalyfa et al, 2010). FABP4 (also 
known as adipocyte FABP, A-FABP or aP2) was mainly related with the localisation 
in mature adipose tissue. However, more recent work indicated a role of FABP4 in 
the early stages of pig adipocyte differentiation (Samulin et al, 2008). The 
verification work on both mRNA and protein level, confirmed the up-regulation of 
fatty acid binding protein 4 in lower part of skin dermis, around hair follicles at all 
analysed time points (Figure 3.10B and Figure 3.11). In general, fatty acid binding 
protein 4 is highly expressed in adipose tissue (mature adipocytes) and interacts 
with PPARs, has capability to bind long-chain fatty-acids, is involved in the lipid 
metabolism or inflammatory response (reviewed by Gregoire et al, 1998). In addition, 
several studies have been recently preformed in order to investigate relation 
between FABP4 and development of obesity and diabetes. First, studies on chicken 
showed the correlation between FABP gene polymorphism with ligand-binding 
capabilities of FABP that resulted in changes in fat accumulation (Wang et al, 2009). 
Mice deficient for fatty acid binding protein 4 had lower risk of the type 2 diabetes 
development, similarly to humans with specific polymorphism in Fabp4 gene 
(Tuncman et al, 2006). Next, the increased levels of FABP4 were observed in obese 
children (Khalyfa et al, 2010). However, it is important to mention recent work on 
“…multiethnic cohort of postmenopausal women…” (50-79 years old) who were a 
subject of study on the specific polymorphism in Fabp4 gene (haplotype-tagging 
single-nucleotide polymorphisms-tSNPs) which seemed not to have significant 
influence on the risk of diabetes development (Chan et al, 2010). In addition, the 
fatty acid binding protein 4 knockout mouse was characterised by higher weight and 
accumulation of fat mass but no effect on lipid metabolism was seen (Yang et al, 
2010a). To sum up, relation between FABP4, obesity and fat-related disorders is not 
fully understood and has to be elucidated by more detailed study in future. Also, a 
suggestion was made about the use of FABP4 inhibitors as a drug for treatment of 
metabolic disorders (Furuhashi et al, 2007; Furuhashi and Hotamisligil, 2008).  
Taking together mentioned above work on FABP4 with the information from 
the in vivo microarray data, an investigation should be performed for the detailed 
analysis of upper dermis genes and its potential inhibitory role on FABP4 expression. 
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Fatty acid binding protein 4 was expressed at very low level in upper dermis with 
highly up-regulation in lower dermis and this can suggest mechanisms/molecules 
involved in “keeping” the specific expression profile of FABP4 in this dermis 
compartment. By the analysis of microarray data from upper dermis, it might be 
possible to identify novel genes involved in inhibiting fatty acid binding protein 4  
expression that can be a potential new drug in diabetes-related disorders. In 
addition, such work could benefit for the analysis of FABP4 role in mouse back skin 
during embryonic development. The study on FABP4 promoter expression at 
embryonic level, based on the use of site-specific Cre recombinase technology and 
antibodies against FABP4 suggested the presence of this protein at embryonic level 
in brown tissue but also in other tissues (dorsal root ganglia or vertebrae) (Urs et al, 
2006). Also, the expression (on protein level) of FABP4 was analysed in neonatal 
mice skin dermis and observed between hair follicles (Wolnicka-Glubisz et al, 2005). 
The microarray data presented in this thesis could suggest the function of FABP4 in 
mouse embryonic skin dermis development. 
 
To sum up, the microarray data appears to provide a rich source of 
information about genes differently regulated during adipogenesis. By designing 
follow up studies on selected genes it should be possible to either a) further 
understand the role of such genes in developing dermal cells in rodent embryos or b) 
use the information to make practical use of the data to search for example for 
preadipocyte and/or adipocyte markers. Along these lines, further studies were 
performed on two genes, selected from this data (Egfr and Cd36) and are presented 
in Chapter 4 and Chapter 5 respectively. 
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The lower versus upper dermis. 
As biological processes specific for adipocytes were associated with lower 
dermis, a question could be asked why these processes occur only in cells from 
lower dermis and not in the upper dermal cells? What type or types of cells are 
creating this skin compartment and what kind of mechanism (if any) controls a fate 
of these cells? 
Maybe cells from lower dermis compartment are different from the upper 
dermis area and represent cell population committed to adipogenesis from very 
early stages of embryonic development. On the other hand, whole analysed dermal 
compartment could consist of the same or very similar cell type, but only cells from 
lower dermis are obtaining signals to switch them into adipocytes, whereas the 
upper cells are devoid of such signals. In addition to proposed signalling processes, 
maybe both upper and lower cells are obtaining signals that lead to two opposite 
situations: the inhibition of adipogenesis in upper dermis and the activation of fat cell 
maturation in lower dermis area. Finally, if the signalling processes do exist and 
control fate of dermal cells, what is the source of such signals? Is it the epidermis 
layer, hair follicles and/or tissues laying beneath the skin?  
 
In order to investigate signalling pathways that could control differentiation of 
dermal cells in mouse embryos, the generated microarray data was searched for 
genes with interesting expression pattern in back skin between e17 and e19 time 
points (see above). 
 
Evidence for signalling.  
In relation to signalling that might be occurring in the skin dermis, an obvious 
approach was to look for genes, previously reported as being important to this 
process. For example, the DAVID v6.7 programme linked genes enriched in upper 
dermis at e18 and e19 time points (respectively 8 and 19 genes) with the WNT 
signalling term (Figure 3.25). Independent from this bioinformatics analysis of 
microarray sub-lists revealed the presence of other genes specific for the WNT-
based pathway (Table 3.8B). In general, there are three Wnt signaling cascades: the 
canonical pathway, the cell polarity pathway and the Wnt/Ca2+ pathway. Briefly, in 
the WNT-canonical cascade, the Wnts proteins bind to frizzled receptors and the 
cytoplasmic mediators of WNT signaling (Dishevelled proteins - Dvl) are activated. 
Active Dvls inhibit comples of Axin, GSK-3 and APC, that is responsible for the b-
catenin degradation. When this complex is inhibited, degradation of b-catenin does 
not take place. Next, accumulated b-catenin enters nucleus, interacts with TCF/LEF 
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ranscription factors and specific gene expression takes place (see Figure 1.8 in 
Chapter 1). Ross et al (2000) tested the influence of WNT pathway on adipogenesis 
in 3T3-L1 cells. The overexpression of Axin in these cells leaded to activation of 
adipocyte differentiation. The inhibitory effect of this pathway on adipogenesis was 
also observed in myoblasts (Ross et al, 2000). The in vivo and in vitro studies were 
performed in order to analyse WNT cascade during adipogenesis (Prestwich and 
Macdougald, 2007). Axin2 gene, together with Gsk3b gene were up-regulated in 
upper dermis either in both e18 and e19 (Axin2) or only at e19 (Gsk3b) time point 
(Table 3.8A). 
In 18 day old embryonic skin dermis the up-regulation of Wnt4 gene (2-fold 
change) and Wif1 (3.71-fold change) was observed in upper dermis (Table 3.8A). 
Then, at e19 up-regulation of Wif1 was noticed with high fold change (28-fold 
change). The Wnt4 was related with non-canonical WNT pathway and its role may 
be associated with the activation of adipogenesis (Nishizuka et al, 2008), whereas 
the Wnt inhibitory factor 1 (Wif1) binds to Wnt proteins and inhibits their activity. 
Based on the observation in presented study, the Wif1 activity in upper dermis could 
be crucial for the inhibition of WNT cascade in order to keep upper dermis in a form 
of non-fatty layer. However, a comment should be made, that also work is known 
where Wif1 was suggested to increase adipocyte differentiation (Cho et al, 2009). 
This shows that the “real” function of Wif1 remains under the investigation. 
 
On the other hand it was noticed that a gene, widely known to be crucial for 
the Wnt pathway has not been seen in the in vivo data. The enrichment of of beta-
catenin (Ctnnb) gene, crucial element of the canonical WNT signalling pathway, was 
not found in any of the analysed skin area at any on three time points (based on the 
microarray data). The active beta-catenin together with the WNT pathway are 
thought to inhibit adipogenesis (Ross et al, 2000). The controversial explanation 
could be that such gene is not enriched in skin dermis as it simply does not have a 
crucial role for adipogenesis regulation in vivo in this tissue at analysed stages of 
mouse embryonic development. However, this explanation would be against widely 
accepted and verified fact about beta-catenin’s role in the WNT signalling pathway 
and their involvement in in vitro and in vivo adipogenesis (reviewed by Prestwich 
and Macdougald, 2007). Also, maybe changes of this gene were at very low level 
and therefore not spotted in generated microarray data due to a 2-fold value cut off 
(only genes enriched with fold equal or higher at least in one of the comapred time 
points were present in the generated LD data). However on the other hand, if b-
catenin regualtion is related with fold change value lower than 2 in all compared time 
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point (e18 versus e17 and e19 versus e17), it could means that these changes are 
not very significant in relation to specific expression of this gene.  
The next explanation is that the involvement of b-catenin in the regulation of 
this differentiation process in vivo in dermis takes place earlier than the e17 time 
point, which was chosen as the earliest sample point in the present study. 
 
Other potential regulatory genes. 
In relation to the idea that there may be inhibitors of adipogenesis in the 
upper dermis, Gremlin 2 (Grem2) was found to be up-regulated in the upper skin 
dermis and selected for further analysis (Table 3.4). The qRT-PCR analysis 
confirmed its up-regulation in upper dermis at e18 and e19 time points (Figure 3.18). 
Grem2 gene is a representative of bone morphogenetic protein (BMP) antagonist 
family and by binding to BMPs can inhibit the BMP2 and BMP4 (Sun et al, 2006). 
Bone morphogenic protein 4 is involved in the development of different body parts 
and its inhibition can occur by interactions with such inhibitor molecules as noggin or 
gremlin. The gremlin can interact with precursor protein of BMP4 and inhibits its 
development into mature form (Sun et al, 2006). Both gremlin and BMP4 were 
analysed in relation to the development of feather bulb and presence in embryos 
(Bardot et al, 2004).   
 Bone morphogenetic protein 2 (BMP2) can induce differentiation processes 
in cell lines (and in vivo) that lead to development of chondrocytes and adipocytes 
(Date et al, 2004). In addition, BMP4 takes part in regulating adipogenesis in cell 
lines (Bowers et al, 2006). Interestingly, Plikus et al, (2009) suggested the role of 
BMPs in regulation of a hair follicle growth. Moreover, expression of BMP2 observed 
in the fat deposits that surround hair follicles was considered as crucial for the 
interactions between hairs and fat depot (Plikus et al, 2009). Finally, the up-
regulation of a gene with high identity (88%) to gemlin was observed in 3T3-L1 
preadipocytes but not in differentiating preadipocytes or mature adipocytes (Wade et 
al, 2005).  
The exact role of gremlin in regulating adipocyte differentiation has not been 
clearly defined (Wade et al, 2005). Thus, the microarray approach presented in this 
thesis may help to understand its role in adipogenesis, moreover its role in in vivo 
developmental processes in mouse embryonic back skin. Because the dermis 
microarray data showed the up-regulation of Grem2 gene in upper dermis, it is 
possible that enrichment of this genes has a role in the upper dermis as an inhibitor 
of adipogenic differentiation in this skin compartment.  
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Another interesting gene expression pattern that could provide a clue as to 
what controls the difference between the upper and lower dermis is that of 
adiponectin. Adipoq expression in lower skin dermis was verified by the qRT-PCR 
technique (Figure 3.13B). In addition, investigation of AdipoQ protein expression in 
back skin sections by immunofluorescence showed an interesting pattern during late 
stages of embryonic development (Figure 3.14). This analysis showed AdipoQ in 
cells either adjacent to epidermis or along the lower (basal) layer of epidermis. 
AdipoQ-positive cells were also present in the dermal sheath.  
 Adiponectin (AdipoQ) is an adipocyte-derived factor, produced and secreted 
by mature adipocytes and its level dramatically increases during adipogenesis 
(Gregoire, 2001). AdipoQ was suggested to have the autocrine function on the 
adipocyte differentiation in 3T3-L1 cells (Fu et al, 2005). The autocrine function of 
AdipoQ has been pointed in human fat cells (Dietze-Schroeder et al, 2005). In 
addition, the decrease of this adipocytokine was related with some cases of obesity 
(reviewed by Haluzík et al, 2004). The expression profile of adiponectin was 
investigated during mouse embryogenesis (in brown adipose tissue - BAT and 
surrounding BAT tissues) (Fujimoto et al, 2005). Recently, a study was presented on 
human foetuses where the expression of adiponectin was observed at both mRNA 
and protein levels in skin (Corbetta et al, 2005). In this work, the expression of 
AdipoQ was found in the epidermis and underlying dermis of human foetus skin (at 
mid- and late gestation) and during the progressive growth the signal in skin 
decreased. A specific expression patterns of AdipoQ during human foetus 
development lead to a suggestion about the possible involvement of this hormone in 
the regulation of differentiation/developmental processes at embryonic level. 
However this hypothesis remains untested.  
Analysed, in this Chapter, presence of AdipoQ in embryonic mouse skin and 
its mRNA up-regulation in lower skin dermis at e18 and e19, may also suggest its 
potential role in embryonic developmental processes in relation to skin 
compartments, such as dermal adipose tissue. It will be crucial to analyse the 
expression pattern of AdipoQ in skin at earlier (than e17) stages of embryonic 
development and compare this work with findings based on human skin specimens 
(described above). The potential role of AdipoQ is discussed further in the context of 
a more global analysis of signalling in Chapter 6 of the thesis. 
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MicroRNAs. 
In relation to the question about processes that control adipogenesis, there is 
an increasing body of literature suggesting that microRNAs might be important for 
regulation of adipogenesis and indeed specific microRNAs have been identified that 
stimulate adipogenesis in vitro (Xie et al, 2009). Although not the subject of this 
thesis, it must be considered that microRNA regulation could be also important in 
the control of adipocyte differentiation in vivo in lower skin dermis. Therefore, in 
order to fulfil information about events taking place in embryonic skin dermis, a 
future experiment could be designed where miRNA microarrays would verify the 
expression of miRNAs during adipogenesis in lower dermal cells.  
 
The limitations of bioinformatics analysis. 
 The analysis of microarray E17, E18 and E19 sub-lists by DAVID v6.7 
programme gave interesting information about processes and general features of 
cells developing in both dermal compartments. However it seems also important 
here to point out that it is crucial to combine such computational analysis with a 
detailed investigation of microarray data where each single selected gene is 
analysed in relation to a term of interest. This time-consuming, non-computational 
analysis is related with the investigation of any available literature (for example by 
the search of the pubmed website) where a selected gene (from the in vivo 
microarray data) has been spotted in adipogenic-based study. As a result of 
combining the software analysis with the pubmed investigation, a more detailed view 
can be obtained about processes taking place during dermal cells development. An 
example of such “double” analysis is the investigation of genes involved for example 
in the WNT signalling pathway (section 3.3.3) The DAVID v6.7 programme has 
associated several genes from E18 and E19 sub-lists with the “WNT signalling 
pathway” term. When the other four sub-lists were analysed by this programme, the 
“WNT signalling pathway” term was not present for these sub-lists. However, when 
these fours sub-lists were searched for several crucial genes related with WNT 
pathway, it occurred obvious that they are present in this data (Table 3.8). 
 Therefore, despite the usefulness of the computational bioinformatics 
analysis of microarray data it seemed crucial to combine such work with the 
literature search that can give a better view on what is exactly happening in vivo. A 
“double” analysis (bioinformatics and non-bioinformatics) was performed for the 
comparison study of adipogenesis process observed in vitro in cell lines with 
differentiation process in vivo of lower dermal cells that are giving rise to mature fat 
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cells in mouse back skin. This analysis, based on the GeneCoDis2.0 tool and the 
pubmed search is presented in section 3.4.2. 
 
3.4.2. The comparison of in vitro adipogenesis with in vivo development 
of fat cells in lower dermis area. 
 The detailed analysis of generated microarray data in the previous section 
investigated features of developing dermal cells at molecular level. This work 
revealed dynamic processes taking place in embryonic skin dermis in vivo which 
leaded to a progressive differentiation of fat cells in lower dermis area. 
Due to the fact that the early steps of adipogenic differentiation were widely 
analysed in cell lines, mainly in 3T3-L1 cells (Green and Kehinde, 1974; reviewed by 
Gregoire et al, 1998) the next step of microarray data analysis was to investigate if 
changes at mRNA level in in vivo fat cells (lower dermal cells) are the same as 
these observed in differentiating in vitro adipocytes (3T3-L1 cells). In addition to this 
study, a question was asked if it is possible to compare and adjust timing of early 
adipogenic events in 3T3-L1 cells with the time-schedule of processes seen in lower 
dermal cells between e17 and e19 time points. This analysis could help to see if 
(and to what extent) in vitro and in vivo processes of fat cell maturation differ from 
each other. 
  
Advantages and limitations of proposed model for the analysis of adipogenic 
differentiation in vivo. 
 Despite a broad knowledge about adipogenesis, obtained mainly from cell 
lines and verified on mouse models (Chapter 1; section 1.3.1) there is still a need to 
obtain information about fat cell origin, early steps of fat cell maturation and 
mechanisms that control fat cell fate (summarised by Gesta et al, 2007). In addition, 
to best of my knowledge, detailed analysis on fat cells developing between hairs in 
skin dermis has not yet been performed. 
 In addition, several disadvantages can be pointed in widely used in 
adipogenic studies 3T3-L1 cell line, such as the two-dimensional environment of 
growth cells, lack of the contact with other cell types (tissues, organs) and the need 
to use adipogenic medium in order to “push” 3T3-L1 cells into the fully differentiated 
state. These problems were avoided in experimental approach presented in this 
Chapter where the microdissection technique and microarray approach gave 
possibility to track events in three-dimensional, natural environment of cells 
undergoing spontaneous adipogenesis during mouse embryonic development.  
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One of the problems that should be discussed here is the timing of 
performed study and general features of cells selected for this work. The microarray 
data was generated only for three time points (e17, e18 and e19) and the lower 
dermal area was characterised by the heterogeneous nature in relation to the 
occurrence of first lipid droplets in a form of clusters localised between cells that did 
not accumulate yet lipids (Figure 2.5; Chapter 2). Therefore, this short-term study 
was possibly missing some additional information about cells before e17 time point. 
However, from the Chapter 2 analysis, it is clear that the adipogenic differentiation 
process in lower skin dermis did not occur in the synchronised way as it can be 
observed in 3T3-L1 cells. Therefore, as adipogenesis may be initiating after e17 it is 
hoped that the microarray technique will have “picked up” changes in developing 
preadipocytes (early stages of adipogenesis) present in lower dermal compartment 
between e17 and e19 time points. 
 For analysis several available publications were selected where 
adipogenesis has been investigated in 3T3-L1 cells using the microarray approach 
(sections 3.3.4 and 3.3.5). Then, the presence of genes repressed or enriched in 
differentiating 3T3-L1 cells was analysed in the lower dermis (LD) microarray data. 
 
Global analysis. 
First, the global analysis based on the Burton et al (2004) work showed a 
gradual increase in the percentage of genes present in both in vitro and in vivo 
adipogenic process in later stages of such differentiation. In addition, a majority of 
present genes that were up-regulated in vitro was also undergoing enrichment in 
vivo, whereas more than half of present genes that were repressed in vitro were 
actually up-regulated between e17 and e19 time points in vivo. This simple 
comparison work suggested clear differences between 3T3-L1 cells and lower 
dermal cells in relation to early changes occurring during adipogenesis.  
 
Detailed comparisons of adipogenesis differentiation in vivo and in vitro. 
Transcription factors.  
Several families of adipogenic transcriptional factors have been pointed to as 
being crucial for adipogenic differentiation (reviewed by Gregoire et al, 1998; White 
and Stephens, 2010), therefore a presence of these factors was investigated in the 
in vivo microarray data (section 3.3.5.1). It become obvious that several of these 
transcriptional factors were regulated also in vivo in lower dermal cells, such as 
C/EBPalpha, PPARgamma, KLFs family or SREPBP-1 (Figure 3.42).  
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Among members of the Krüppel-like factors (KLFs) that were found in the LD 
microarray list were Klf3, Klf4, Klf5, Klf6, Klf9 and Klf15 genes (Figure 3.38). These 
factors have been widely studied in relation to adipogenesis regulation. For example, 
transgenic animals with knockout for KLF3, were characterised by the decrease in 
an amount of adipose tissue and 3T3-L1 based studies showed the ability of KLF3 
to bind to the promoter of C/EBPalpha (Sue et al, 2008). KLF6 was shown to 
activate adipogenesis for example in 3T3-based cells (Li et al, 2005). Finally, KLF9 
was shown to interact with C/EBPalpha and activate a promoter of PPARgamma2 
(Pei et al, 2011). KLF15 was shown to be up-regulated during adipogenic 
differentiation and its role in regulation of this process has been suggested (Mori et 
al, 2005). The KLF family seemed to be crucial for developmental processes taking 
place in lower skin dermis at embryonic level that lead to development of dermal 
adipose tissue in mouse back skin.  
On the other hand regulation on mRNA level of such transcriptional factors 
as Cebpb, Cebpd or Stat5 was not seen in vivo. The issue about absence of Cebpb 
and Cebpd genes in the LD microarray list is widely discussed later in this section. 
  
In general, transcriptional factors are creating a complicated cascade of 
interactions with each other in order to properly regulate differentiation (Figure 3.42). 
The lack of some of these elements in vivo in mouse back skin, could be related 
with a fact that some other (maybe unknown yet) factors are replacing these 
elements as for example the adipogenesis process that takes part in mouse back 
skin could undergo other regulatory cascade that other fat depots or that all in vitro 
cell-based studies are missing steps that normally takes part in life body in vivo. For 
example, Smarca5 gene was spotted in this data to be up-regulated in vivo (Figure 
3.43E), however no information was found that would define its role in adipogenesis.  
 
Growth factors. 
The analysis of growth factors was also performed on the LD microarray data 
(Figure 3.48). Expression of growth hormone receptor, Igf1, Igf2, Igf1r or Igfbps was 
seen in lower dermal cells. Insulin-like growth factor-1 (IGF-1) is crucial for the 
adipogenesis activation in many cell lines, for example in 3T3-L1 cells (reviewed by 
Gregoire et al, 1998). In addition, IFG-1 was shown to be expressed in adipose 
tissue, for example in rat white adipose tissue - WAT (Peter et al, 1993). It is 
believed that different factors can be secreted by cells undergoing adipogenesis in 
order to trigger this process in other fat cells through autocrine/paracrine stimulation. 
Such a suggestion arose for insulin-like growth factor 1 (IGF-I) in mouse 
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preadipocyte Ob1771 cells (Kamai et al, 1996). IGF-1 interacts with insulin growth 
factor-1 receptor; IGF-1R that was found to be present in 3T3-L1 cells (Huo et al, 
2003). It was also shown that fat cells can produce and secrete insulin-like growth 
factor binding proteins (IGFBPs) which may influence the IGF-1 activity (reviewed by 
Gregoire et al, 1998). The up-regulation of Igf1 and Igfbp4 genes were found in 
microarray based studies during differentiation of 3T3-L1 cells (Hackl et al, 2005). 
To the best of my knowledge Igfbp7, which was up-regulated in the lower dermal 
array (Figure 3.46J) seemed not to be related functionally with adipogenesis in vitro, 
and previously only high serum levels of Igfbp7 were observed in adults with type 2 
diabetes (reviewed by Ruan and Lai, 2010). 
 
Early adipogenic processes in relation to cell cycle regulation. 
Cell line-based studies on adipogenesis show specific changes at early steps 
of adipogensis in relation to cell cycle and re-arrangements of a cell shape with 
dramatic changes of both cytoskeletal and extracellular matrix proteins levels 
(reviewed by Gregoire et al, 1998; reviewed by Rosen and Spiegelman, 2000). 
Depending on cell line, either confluence and cell-cell contact or a lack of the 
confluence are the first signs of changes and the so-called “initial growth arrest” 
taking place. By influencing cells with adipogenic medium (discussed in section 
1.3.2.2 of Chapter 1), cells undergo differentiation, and growth arrest is then 
followed by one or two rounds of the cell division (the “clonal expansion” step) which 
is observed in 3T3 cells. Finally, cells enter the “post-mitotic growth arrest” step and 
then “terminal differentiation” occurs (Morrison and Farmer, 1999). Richon et al 
(1997) performed analysis of 3T3-L1 cell proliferation and DNA synthesis by BrdUrd 
incorporation into these cells. This analysis showed that before adipogenic induction 
only a small number of cells show BrdUrd staining due to quiescence. Then, cells at 
one day after the adipogenic induction were characterised by the high proliferation 
rate due to the high amount of incorporated BrdUrd, whereas at day three these 
cells were undergoing a withdrawal from cell cycle. Not all cell lines that have been 
analysed (primary human preadipocytes) seemed to require the growth arrest step 
said to be needed for adipogenesis (Entenmann and Hauner, 1996). Therefore a 
suggestion was made that the additional rounds of mitosis are occurring due to 
artificial environment in which two-dimensional cells are kept, or such changes 
occurred in the in vivo before cell lines were isolated and cultured (by Rosen and 
Spiegelman, 2000). The question is whether the array findings in this study can 
determine whether in vitro models genuinely mirror in vivo events. 
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Growth arrest and clonal expansion. 
A first step in investigating this question was the verification of the presence 
of cell cycle related genes in lower dermal cells. The global comparison analysis 
revealed that only 21% of cell cycle genes, summarised in by Hackl et al (2005) 
were common for both 3T3-L1 and lower dermal cells (see Figure 3.49A and B). 
These common genes in differentiating 3T3-L1 cells were up-regulated during first 
12 and/or 24 hours of adipogenic induction, and then their quite dramatic down-
regulation took place after one day of adipogenesis (Figure 3.50A and C). These 
common genes, except one (centromere protein A) were up-regulated also in vivo 
from e17 time point and their over-expression was higher at e18 than e19 time point 
(Figure 3.50B and D). Therefore it could be said that this small group of common 
genes is sharing similar expression pattern in differentiating in vitro and in vivo cells.  
 
What seemed more interesting is the fact that 37% of cell cycle genes 
pointed out by Hackl et al (2005) in differentiating 3T3-L1 cells were not seen to be 
regulated in the lower dermal cells.  In addition, several representatives of cell cycle 
genes seen in the LD microarray data (32% of analysed genes, Figure 3.49) were 
not related with 3T3-L1 cells in Hackl et al (2005) study. Therefore in global terms 
there were considerable differences between the present in vivo array data and 
what has been found previously. 
 
The widely described studies on 3T3-L1 cells have revealed specific 
expression profiles of different cell cycle genes. Richon et al (1997) showed that in 
cells before adipogenic treatment (day 0) and then 1, 2, 3 and 4 days after the 
addition of adipogenic factors, dramatic changes at the protein levels occurred for 
p107, p130 and p107-E2F or p130-E2F complexes. At the mRNA level, p107 (Rbl1 
gene) was observed to be up-regulated in 3T3-L1 cells at day 1, and then its level 
subsequently decreased (Richon et al, 1997). This expression pattern was not 
observed for p107 mRNA in work described in this thesis, and the p107 (Rbl1) gene 
was not present in the LD microarray data at any of the time points. 
Specific changes in expression profile of p21, p27 and p18 were spotted 
during the differentiation of 3T3-L1 cells. Morrison and Farmer (1999) showed that 
the p21 gene was up-regulated between day 1 and 3 of adipogenic induction in 3T3-
L1 cells. The mRNA level of p27 dramatically decreased between days 1 and 2 of 
adipogenic induction and then p27 was up-regulated at day 3 in 3T3-L1 cells, 
whereas the up-regulation of p18 was seen from day 3 of adipogenic induction 
(Morrison and Farmer; 1999). Both p21 and p27 belong to the kinase inhibitor 
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protein (KIP) family and the p18 is a member of the inhibitor of cdk4 (INK4) family. 
These inhibitors of cyclin-dependent kinases (cdks) take part in the regulation of cell 
cycle progression (Schafer, 1998). Both p27 (cyclin-dependent kinase inhibitor 1B; 
Cdkn1b) and p21 (cyclin-dependent kinase inhibitor 1A; Cdkn1a) were not regulated 
in lower dermal cells between e17 and e19 time points and only p18 gene (cyclin-
dependent kinase inhibitor 2C; Cdkn2c) was up-regulated in these cells from e17 
time point (Table 3.10). Morrison and Farmer (1999) also showed that the addition 
of adipogenic medium into the confluent 3T3-L1 cells led to the down-regulation of 
cyclin D1 gene (Ccnd1) four days after the adipogenic induction. This gene was also 
regulated in vivo in lower dermal cells (based on the LD microarray data) with about 
2-fold change at e18 versus e17 time-point and approximately 1.7-fold change at 
e19 versus e17 time point. 
 
In addition, the LD microarray data clearly showed over-expression of cyclin-
dependent kinase 4 gene (Cdk4) with a 2.50-fold change at e18 versus e17 time 
point and with a 1.38-fold change at e19 versus e17 time point. Maybe the 
increased expression of Cdk4 at e18 versus e17 time point is important for the 
correct regulation of the cell cycle in vivo. Then, the over-expression of p18 (Cdkn2c) 
in lower dermal cells could be crucial for the accumulation of this protein in the 
dermis between e17 and e19 time points, and its interaction with Cdk4. This 
interaction could be then crucial for inhibition of Cdk4 which could then help to 
withdraw these cells from the cell cycle and “push” them into the adipogenic 
differentiation process and development of mature fat cells. The Cdk4 function was 
investigated in 3T3-L1 cells and its role in the clonal expansion phase as well as in 
the regulation of terminal steps of adipogenesis and control of mature fat function 
was suggested by Abella et al (2005). Therefore it could be interesting to further 
investigate the role of Cdk4 in developing lower dermal cells in embryonic/foetal skin.  
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Timing of in vitro and in vivo adipogenesis. 
As was mentioned already in this section, the generated microarray data did 
not contain either Cebpb or Cebpd genes, suggesting that these two factors did not 
undergo significant enrichment in the lower dermis between e17 and e19. However, 
the up-regulation of these genes could take place in dermal compartment from an 
earlier time than was the scope of this study (for example e16 time point).  
In addition, genes for two major adipogenic transcription factors Cebpa and 
Pparg, known to be enriched from day 2 in differentiating 3T3-L1 cells (after the up-
regulation of Cebpb and Cebpd; Morrison and Farmer, 1999), were also enriched in 
lower dermal cells from e17 till e19 time point (Table 3.4). In addition, the in vivo up-
regulation of p18 gene (Cdkn2c) together with a very robust enrichment of adipsin 
gene (Adn; well known protein secreted by mature adipocytes) at e19 time point 
(Table 3.10 and Table 3.4) revealed quite similar expression pattern of these two 
genes in 3T3-L1 cells between days 3 and 5 during adipogenesis (Figure 3.63). This 
analysis suggests that there is a lower dermal cell population already committed to 
adipogenesis and undergoing dynamic differentiation processes from e17 till e19 
time point. On the other hand the up-regulation of cyclin D1 gene (Ccnd1), seen 
between e17 and e19 time point could suggest the presence of cells in lower dermal 
cells that are at the very early stages of adipocyte differentiation, due to a fact that 
enrichment of this gene takes place in 3T3-L1 cells till day 3 (after adipogenic 
induction) and drops dramatically at day 4 (Figure 3.63). This fact could be 
explained by a heterogeneous nature of lower dermal cells where adipogenesis in 
back skin dermis is a non-synchronised process and at specific time points, around 
fully (or almost fully) differentiated fat cells are still adipocytes that just start to 
undergo changes related with regulation of cell cycle processes. Therefore the 
absence of several cell cycle genes (for p107; p21; p27) together with Cebpb and 
Cebpd genes in the lower dermal microarray data could be also related with the fact 
that that actually these genes do not play a significant role in the regulation of fat cell 
development in vivo between e17 and e19 time point in embryonic back skin dermis. 
In order to fully characterise and define early steps of adipogenesis in vivo in 
lower dermal cells in relation to cell cycle processes, the analysis of these cells at 
the mRNA level should be combined with an investigation at the protein level. The 
reason for this is that some published studies on 3T3-L1 cells showed that not only 
mRNA levels but also protein levels of cell cycle genes significantly are changing 
during in vitro adipogenesis (Richon et al, 1997; Morrison and Farmer, 1999). 
Moreover some cell cycle related genes, for example p130 in differentiating 3T3-L1 
cells, do not change at the mRNA level but actually at the protein level during in vitro  
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Figure 3.63. The suggested model of early steps of adipogenesis and expression 
pattern of several genes associated differentiating 3T3-L1 cells. The figures were 
taken from Morrison and Farmer (1999). Genes regulated in the lower dermis cells 
(based on the microarray data) were circled in grey. 
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adipogenesis (Richon et al; 1997). Finally, in order to verify the state of proliferation 
of lower dermal cells during mouse back skin development, an experiment could be 
performed where the incorporation of BrdUrd would be analysed for example in back 
skin sections from mouse embryos. Finally, all this analysis should be combined 
with younger than e17 time point skin specimens to obtain a fuller view in processes 
taking place in lower dermal cells.  
 
Cytoskeletal and ECM proteins during adipogenesis. 
 The cell line based studies showed that changes in cytoskeletal proteins and 
extracellular matrix components (ECM) are crucial for rearrangements of 
differentiating cells from the fibroblast-like to a spherical shape where the major cell 
space is taken by accumulated lipids. The changes in levels of actin, tubulin or 
different collagen types, have been widely described in both human and rodent-
derived cell lines (reviewed by reviewed by Gregoire et al, 1998; Mariman and Wang, 
2010). In addition, Mariman and Wang (2010) pointed out that the enrichment of 
collagen in in vitro cells could be due to artificial conditions of culturing two-
dimensional cells. Therefore it seemed interesting to verify how many of both 
cytoskeletal and ECM specific genes are up-regulated in vivo during dermal cells 
development. 
The GeneCoDis2.0 tool allowed cytoskeletal and extracellular matrix genes 
regulated in developing lower dermal cells to be identified and compared to 
microarray data from differentiating 3T3-L1 cells (Burton et al, 2004; Hack et al, 
2005; Kim et al, 2007). Striking differences were spotted between in vitro and in vivo 
cells as for example only 25% of cytoskeletal genes and 24% of ECM genes 
regulated in the lower dermal cells were seen in the in vitro microarray data (Figure 
3.51 and Figure 3.54). Therefore, the in vivo developing cells did not share an exact 
ECM protein profile with any of these cells, suggesting that clearly adipogenic 
differentiation in vivo in mouse back skin has its own, specific features. However in 
order to develop a better conclusion the future study should be performed where the 
presence of in vitro ECM proteins in the lower dermal cells could be verified on the 
protein level.  
In general, changes in the expression of different types of collagen (such as 
collagen IV) were observed in differentiating in vitro cells (reviewed by Mariman and 
Wang, 2010). Therefore the LD data was searched for the collagen genes and out of 
14 genes, half of them were also seen in in vitro cells (for example Col4a1, Col4a2). 
Interestingly, half of these in vivo collagen genes were down-regulated during 
development of lower dermal cells from e17 till e19 time points. In addition, the in 
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vitro based studies on adipogenesis revealed regulation of many ECM processing 
enzymes such as ADAMTS, MMP or TIMP and ADAMTS enzymes can be involved 
in processing of procollagens by cutting off their N- or/and C- ends (reviewed by 
Mariman and Wang, 2010). Adamts1, Adamts4 and Adamts5 genes, regulated in 
lower dermal cells, were shown to be associated with adipocytes (section 3.3.5.4). 
The Adamts15 gene, also present in the LD data, was up-regulated during early 
step of adipogenic differentiation in mouse embryonic fibroblasts (Baudry et al, 2006) 
but it seemed not to be so far functionally defined in relation to in vivo development 
of fat cells. What is interesting, is the fact all four Adamts genes had the highest fold 
change regulation at e18 time point (versus e17) whereas at e19 (versus e17) their 
expression was at lower level. Therefore the in vivo cell development from e18 to 
e19 time points could be related with a progressive reduction of ECM processing 
enzymes due to a lack of need to modify ECM components in these developing 
three-dimensional cells. Also it could be interesting to develop a future study where 
the role of ADAMTS15 in developing in vivo lower dermal cells will be analysed due 
to the fact that among all four Adamts genes this one had the most dramatic down 
regulation from e18 to e19 time points. 
 
 To sum up, huge differences between cytoskeletal and ECM proteins 
regulated during in vitro and in vivo adipogenesis clearly suggest that the 
differentiation process observed in two-dimensional cell lines undergo different 
regulation at the level of re-arrangement of morphology and shape of cells than in 
three-dimensional cells in lower dermal area. Probably the artificial environment of 
the cell culture dish is not a normal situation where cells have to activate cascades 
and pathways normally not needed in cells developing in the body. Therefore the 
further investigation of these lower dermal cells could be crucial for the 
understanding the “real” processes under which cells become mature adipocytes. 
 
The late stages of adipogenesis: metabolic processes and production of 
secreted proteins. 
 The final comparison study related to the late stages of adipogenesis 
(lipogenesis) when mature adipocytes are filled with lipid droplets, produce different 
secreted proteins and are involved in the regulation of metabolism (reviewed by 
Gregoire et al, 1998; Rosen and Spiegelman, 2000). Interestingly, in vitro and in 
vivo differentiating cells seemed to share more common genes when undergoing 
later stages of development. Hackl et al (2005) have performed an interesting 
analysis where the key enzymes and metabolic processes activated in 3T3-L1 cells 
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were summarised. The presence of these key enzymes was investigated in the 
lower dermal microarray data and 61% enzymes occurred to be common for both in 
vitro and in vivo developing fat cells. All these common genes were up-regulated 
from e17 time point in lower dermal cells. Moreover, among these 20 common 
genes only five had lower fold change value at e19 time point (versus e17) when 
comparing with e18 time point (versus e17) and the rest 15 had the highest over-
expression at e19 time point (versus e17) (Figure 3.59B). This analysis showed that 
key metabolic processes underwent progressive activation in lower dermal back skin 
at late stages of embryonic development. In addition, in vitro and in vivo cells 
seemed to be similar because of the production of secreted proteins that also take 
place in differentiated fat cells. Among genes of secreted proteins, seen in the LD 
microarray data were resistin (Retn), adipsin (Adn), angiotensinogen (Agt) or 
adiponectin (Adipoq). All four genes were enriched in lower dermal cells from e17 till 
e19 time points with a dramatic over-expression at e19 versus e17 time points. This 
analysis showed that just before an animal birth a very robust expression process in 
developing fat cells takes place, which could be crucial for the establishment of fully 
functional mature fat cells that create dermal adipose tissue after the animal birth.  
The developmental stages of lower dermal cells, observed here on the 
molecular level are therefore more likely to be real in vivo events due to a fact that 
they lead to development of a fat cells that shares features (over-expression of 
mRNA for specific secreted fat proteins, enrichment of genes involved in metabolic 
processes) with mature fat cells differentiated from cell lines or dissected from fat 
depots (reviewed by Gregoire et al, 1998; Soukas et al, 2001).  
 
In addition, the processes related with regulation of transcriptional factors, 
cell cycle genes, cytoskeletal and extracellular matrix proteins in lower dermal cells 
between e17 and e19 time points, are also likely to be real. Moreover, occurrence of 
differences in types of genes regulated at early stages of adipogenesis between 
lower dermal cells and in 3T3-L1 cells could be simply because the experimental 
approach used in this thesis allowed to track features of cells in vivo and not in 
artificial environment of the cell culture dish. 
 
To sum up, work presented in Chapter 3 gave a unique insight into in vivo 
molecular processes taking place in embryonic skin dermis between e17 and e19 
time points. Moreover, this study revealed gene expression patterns in embryonic 
lower dermal cells that give rise to dermal adipose tissue postnatally.  
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4.1. Introduction. 
The aim of this Chapter is to establish an effective ex vivo experimental 
method for the investigation of lipid accumulation in back skin dermis at embryonic 
level, and to perform a functional study of a gene selected from the microarray data 
presented in Chapter 3. An outline of the work described in this Chapter is shown in 
Figure 4.1. 
Based on the dermis microarray data, the specific up-regulation of epidermal 
growth factor receptor (EGFR) expression was observed in lower mouse embryonic 
skin dermis (see Table 4.4). EGFR is a cell-surface receptor known to play a role in 
skin and hair development (Richardson et al, 2009). EGFR can be activated by an 
interaction with epidermal growth factor (EGF) and EGF has been suggested to take 
part in controlling adipogenesis in 3T3-L1 cells (Adachi et al, 1994). EGF enhanced 
differentiation in cells already undergoing adipogenesis, however it inhibited 
adipocyte conversion when added to preadipocytes (cells not yet undergoing 
adipogenesis). In addition, the activation or inhibition of adipogenesis by EGF- 
EGFR pathway (in cell culture) was dependent on concentrations of EGF 
(Harrington et al, 2007). 
The pivotal role of the EGFR-EGF signalling pathway and fat development 
has been observed in vivo. In a mouse model where a dominant negative mutant of 
EGFR was analysed in relation to skin development, 21 day old transgenic animal 
skin was seen to have necrotic hair follicles. This skin was lacking fat cells between 
the hair follicles, the adipose cells had been replaced by a granulomatous tissue 
(Murillas et al, 1995). In addition, unexpected results in relation to decrease in fat 
deposition in skin were observed in postnatal Wa5 mice which had an antimorphic 
EGFR allele (Sugawara et al, 2010).  
The hypothesis tested in this Chapter says that the EGF-EGFR signalling 
pathway can be involved in the regulation of fat cell differentiation in lower dermis at 
late stages of mouse embryonic development. To best of my knowledge, no in vivo 
experiment has been designed so far to verify this hypothesis. Thus, the analysis of 
this hypothesis is presented in this Chapter. First, the verification of EGFR 
expression in back skin dermis was performed by qRT-PCR and immunofluorescent 
staining. Then, an attempt to develop an effective technique for mimicking the in 
vivo-like environment was performed by growing 3D structures (the hanging-drop 
versus the substrate organ culture). Finally, the substrate organ culture technique 
was used for further experiments, where small pieces of embryonic back skin were 
treated with either an inhibitor (AG1478) or an activator (EGF) of EGFR and the 
capability of lipid accumulation was investigated by the Oil Red O staining. 
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Figure 4.1. Summary of work presented in Chapter 4. The aims were to develop 
efficient methods for mimicking in vivo conditions in relation to the analysis of 
embryonic back skin, to analyse development of fat cells in lower skin dermis and to 
perform a functional study for gene from dermis microarray data (from Chapter 3). 
Lipid accumulation capability of embryonic back skin - 
functional study in in vivo-mimicking conditions. 
In vivo-like techniques for: 
Back skin samples: Dermis cells: 
Selection of a growing 
method: 
                             
- the hanging-drop technique 
- the substrate organ culture 
technique 
The use of selected technique for 
investigation of fat accumulation in 
skin. Work performed on mouse 
embryos at e15 - 15.5; e16 - 17 and 
e18.5 - 19 time points.  
 
Investigation of fat 
accumulation in two-
dimensional (2D) and three-
dimensional (3D) cell 
structures. Work performed on 
15 - 15.5 and 18.5 - 19 days 
old mouse embryos. 
Test of 3D technique for skin 
cells growth. 
Establishment of an effective 
method for dermal cells 
isolation from mouse 
embryonic back skin. 
Gene selection from microarray data for 
functional study and verification of a 
gene expression profile in back skin 
samples at e17, e18 and e19 time points: 
- on mRNA level (qRT-PCR) 
- on protein level  
(immunofluorescence analysis) 
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In the second part of Chapter 4, features of embryonic skin dermis were 
analysed in relation to fat accumulation capability. For this study, dermis was used 
from mouse embryos well before the accumulation of fat (e15 - 15.5) and 18.5 - 19 
day old mouse embryos in which the first lipid droplets are easy to detect in close 
proximity to hair follicle end bulbs (see Chapter 2). The aim was to isolate dermal 
cells from these samples, grow them either in two-dimensional (2D) conditions or in 
three-dimensional (3D) spheroid cell culture then analyse their capabilities to 
accumulate lipids. 
In the commonly used 2D monolayer culture method cells attach and grow 
on the artificial surface of cell culture dishes. This technique is widely used for the 
cell-based studies, however it is important to note that when cells are “pushed” to 
recreate an in vivo behaviour, such as the onset of adipogenesis on the culture 
dishes, then the environment is artificial and consequently the observed cell 
changes may not be a representative of the in vivo conditions. Thus, there is a 
general need for techniques that will better recreate the in vivo environment and 
allow cells to be in three-dimensions as happens in the body. The 3D spheroid cell 
culture method allows cells to be suspended in small droplets of culture medium. In 
such an environment, cells gather together and form a sphere. Cells in the sphere 
are not in contact with plastic culture substrates and are surrounded only by medium. 
They therefore interact only with other cells in all dimensions. The 3D spheroid cell 
culture has been successfully applied in hair follicle-related studies by Prof. CAB 
Jahoda’s research group, where a dermal papilla-like structure was recreated 
(Higgins et al, 2010). 
The spheroid cell culture method was used on cells derived from human and 
rodent skin. The general features of such 3D cultures were compared with 2D 
cultures by the analysis of both cytoskeletal and nuclear envelope proteins. Nuclear 
proteins, such as lamins or emerin are important components of the nuclear 
envelope. They interact with each other (for example lamin A with emerin) and take 
part in different processes connected with maintaining cell shape, controlling cell 
function and DNA replication or RNA transcription (Goldman et al, 2002; Hutchison, 
2002; Lee et al, 2001; Vaughan et al, 2001). 
 
In summary, this Chapter builds on the microarray data from Chapter 3, an 
investigation of the gene shown to have differential regulation in vivo in mouse 
dermal cells. It seems possible to use microarray data for the selection of a gene 
whose role in developing embryonic skin compartment can be further investigated. 
In addition, several in vivo-like techniques have been introduced in Chapter 4, in 
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order to verify which method would be the most efficient for the growth of skin 
samples or skin-derived cells and which one would be most suitable for use in the 
functional study of a gene selected from the microarray data. Such work will lead to 
a better understating of pathways involved in dermal adipose tissue development. 
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4.2. Methods. 
Experiments presented in Chapter 4 were repeated at least two times.  
 
4.2.1. Housing, breeding and feeding conditions of rodents. 
Detailed description of housing, breeding and feeding conditions used for 
rodents is presented in Chapter 2, section 2.2.1.  
In addition, section 2.2.1 contains the procedure for a determination of the 
embryos age and methods used to sacrifice animals. 
 
4.2.2. EGFR analysis - verification of the dermis microarray work. 
4.2.2.1. qRT-PCR analysis of the EGFR mRNA level. 
 Preparation of mRNA and details of qRT-PCR were described in Chapter 3, 
section 3.2.6.1.2. Primers used for the verification work were presented in Table 3.2. 
(Chapter 3, section 3.2.6.1.2). 
 
4.2.2.2. Immunofluorescence analysis of EGFR protein. 
The back skin sections from mouse embryos at e17, e18 and e19 time points 
were prepared and stained with antibodies against EGFR according to a method 
presented in Chapter 3, section 3.2.6.2. 
 
4.2.3. The hanging-drop organ culture technique. 
 The hanging-drop technique was used previously for the growth of mouse 
embryonic back skin (Fliniaux et al, 2008). 
Rectangular pieces of mouse back skin, with a maximum size of approx. 2.5 
mm x 3 mm, were cut from 16 - 17 day old mouse embryos (e16 - 17) and 
specimens were placed in media droplets (approximately 30 µl) on Petri dish lids. 
Then, lids were inverted and placed on the bases of the Petri dishes which 
contained sterile water to control humidity. The medium used consisted of D-MEM - 
Dulbecco's Modified Eagle's Medium (Sigma), 1% FBS - foetal bovine serum (Sigma) 
and antibiotics (2 µl/ml Fu - fungizone from Sigma and 1 µl/ml Ge - gentamicin from 
Gibco) as a base (control) medium. In addition, for the experimental medium, either 
the inhibitor of EGFR, AG1478 (with final concentrations of 50 µM and 200 µM, 
prepared from the 10 mM stock; Calbiochem) or the EGFR activator, EGF (with the 
final concentrations of 25 ng/ml and 100 ng/ml, prepared from the 10 µg/ml stock; 
Sigma) were added. The experiment was run for three days, after which samples 
were carefully transferred into Tissue Tek, frozen in liquid nitrogen and kept at -80oC. 
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Frozen specimens were cut on a cryostat (LEICA CM 3050S) and sections 
(7 µm) were attached to SuperFrost®Plus slides (Menzel-Glaser), air dried for up to 
90 minutes at room temperature, and then used immediately for lipid detection (see 
section 4.2.7). 
 
4.2.4. The substrate organ culture technique.  
The organ culture technique was used previously for the growth of mouse 
embryonic back skin by Richardson et al (2009).  
Rectangular pieces of mouse back skin, with a maximum size of approx. 2.5 
mm x 3 mm, were cut from 15 - 15.5, 16 - 17 and 18.5 - 19 day old embryos (named 
as e15 - 15.5; e16 - 17; e18.5 - 19 time points). Specimens were transferred on the 
Nucleopore membrane filters (Whatman), coated with rat-tail collagen type 1 (Sigma) 
(Figure 4.2). Samples were placed with the epidermis side up. Filters were then 
floated on 2 ml of control medium (D-MEM; 1% FBS; antibiotics: 2 µl/ml Fu - 
fungizone and 1 µl/ml Ge - gentamicin) or experimental media (Table 4.1) in a 35 
mm dish. The samples were incubated in 5% CO2 and 37oC for 72 hours. Samples 
were cryopreserved and cryostat sectioned for analysis as described above (see 
section 4.2.3). 
 
 
Table 4.1. Types of experimental media used for the substrate organ culture work. 
 
Experimental medium: 
 
Ingredients: 
 
“Activation”(A) 
medium 
D-MEM; 1% FBS; antibiotics (2 µl/ml Fu - fungizone, 1 
µl/ml Ge - gentamicin); EGFR activator:  
EGF (25 ng/ml or 100 ng/ml, Sigma)  
“Inhibition” (I) 
medium 
D-MEM; 1% FBS; antibiotics (Fu, Ge; for concentrations 
see above); EGFR inhibitor: AG1478 (50 µM or 200 µM 
Calbiochem) 
Adipogenic (ADIP) 
medium 
D-MEM; antibiotics (Fu, Ge; for concentrations see 
above); 15% rabbit serum (Sigma);  
2.6 - 2.07 µM Insulin (Sigma); 100 nM Dexamethasone 
(Sigma); 0.45 mM IMBX (Sigma) 
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Figure 4.2. Preparation of back skin samples for the substrate organ culture work. 
Back skin samples from 15 - 15.5 (a) and 18.5 - 19 (b) day old mouse embryos were 
cut into rectangular pieces and placed on rat-tail collagen-coated membranes (c and 
d). Samples were incubated in different experimental culture medium. Scale bar = 1 
cm. Photo (d) was taken on the Ziess StemiSVII microscope (with the digital camera 
KY-FI030 JVC and with the KyLink software). 
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4.2.5. The establishment of skin cell lines used for two- (2D) and three- 
(3D) dimensional cells. 
 Dermal papilla (DP), dermal sheath (DS) and dermal skin fibroblasts (FI) cell 
lines were established from rodent (mice - CD1 and rats - PVG) and human skin 
samples. Animals were obtained from the animal house at Durham University, 
whereas human skin samples were obtained from the University Hospital of North 
Durham and the Royal Victoria Infirmary Hospital (Newcastle Upon Tyne). All 
human skin samples used for research had patient consent and were treated in 
accordance with the Human Tissue Act 2004. Methods for DP, DS, and FI cell line 
preparations are presented below with human skin samples as an example. 
 
4.2.5.1. Cell lines from human skin samples. 
Skin samples were obtained from different parts of human body (e.g. beard, 
breast biopsy, etc.) and were recorded and numbered (for example, skin sample no. 
2_06 was a second sample given from the hospital in 2006 year). FI, DP and DS 
cells were established from each skin sample and got the same name as the skin 
sample, from which they were established. When skin samples were big and 
contained excess layer of fat tissue, they were cut into smaller pieces and fat layer 
was removed. Then the samples were stored in MEM - Eagle’s Minimum Essential 
Medium (Sigma) with antibiotics (4 µl/ml Fu - fungizone from Sigma and 2 µl/ml Ge - 
gentamicin from Gibco) at 4ºC over night. The next day, samples were washed in 
MEM with antibiotics (4 µl/ml Fu and 2 µl/ml Ge). 
 
4.2.5.1.1. Dermal papilla and dermal sheath cell lines. 
Human end bulbs were cut from the skin sample, transferred into drops of 
MEM and the fat layer was removed from the end bulb. Mouse hair follicles require 
an additional step to remove the collagen cap that surrounds the hair follicle. Next 
the bulb was inverted and the dermal papilla was pushed out from the end bulb 
(Figure 4.3), cleaned from the epithelial matrix, and transferred into 4-well dish 
(Nunclon) that contained MEM with 20% foetal bovine serum (FBS; from Sigma) and 
antibiotics (2 µl/ml Fu - fungizone from Sigma and 1 µl/ml Ge - gentamicin from 
Gibco). Dermal sheath was cleaned and transferred into 4-well dish with MEM, 20% 
FBS and antibiotics (2 µl/ml Fu and 1 µl/ml Ge). DP and DS were put on the bottom 
of the dishes and left for 6 - 7 days in the incubator (37oC, 5% CO2). After one week, 
media was changed. When cells reached 80 - 95% confluence, they were carefully 
transferred into the 35 mm dish (first passage), then into the T25 flask (second 
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passage). After second passage, cells were grown in MEM with 10% FBS and 
antibiotics (2 µl/ml Fu and 1 µl/ml Ge). Dissection of DP and DS was performed 
using the Stemi SV6 microscope (ZIESS). 
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Figure 4.3. Schematic presentation of dermal papilla and dermal sheath 
microdissection from human hair follicle end bulb (sample number: 41_07). (A, B) 
end bulb (EB) surrounded by fat droplets. (C) “cleaned” EB. (D) piece of hair (H) 
pulled put from EB. (E) “inverted” EB; DP- Dermal Papilla; DS- Dermal Sheath. (F) 
DP cut from DS. Photos were taken on the Ziess StemiSVII microscope (with the 
digital camera KY-FI030 JVC and with the KyLink software). 
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4.2.5.1.2. Fibroblasts cell lines. 
For the preparation of skin fibroblasts (FI), the fat layer and the dermis part 
with hair follicle end bulbs were removed from the skin sample. Then, thin skin layer 
was cut into rectangular pieces (approximately 1 mm x 1 mm). Next pieces of skin 
were put into the T25 flask (Nunclon) with MEM, 20%FBS and (2 µl/ml Fu - 
fungizone; 1 µl/ml Ge - gentamicin) and left for a week in the incubator (37oC, 5% 
CO2). After first passage, cells were grown in MEM with 10% FBS and antibiotics (2 
µl/ml Fu and 1 µl/ml Ge). All passages were done, when cells reached 80 - 95% 
confluence. 
 
4.2.5.2. Conditions of growing and splitting cells. 
All established cell lines were grown in T25 or T75 flasks (Nunclon) in the 
incubator (37oC, 5% CO2). Cells were fed twice a week. A growth medium with MEM, 
10% or 20% FBS and antibiotics (2 µl/ml Fu - fungizone; 1 µl/ml Ge - gentamicin) 
was used for feeding cells. When cells reached 80 - 95% confluence, they were 
passaged. For this purpose, cells were washed in PBS (prepared from phosphate-
buffered saline tablets; Sigma or Oxoid) with 0.5mM EDTA. Then they were 
incubated with 1 ml of trypsin (0.25%) with EDTA (Gibco) for 2 - 3 min, in 37oC after 
which the reaction was stopped by adding 2.5 ml of growth medium (see above for 
ingredients). Then, cells were centrifuged (1000 rpm; 5 min; at room temperature). 
The cell pellet was re-suspended in 1 ml of growth medium and cells were placed in 
new T25 or T75 flasks containing 5 ml growth media (10% FBS). 
For the passage description, the “p” letter and the number of passage were 
placed in the cell line name. For example, the 21_07 DP p3 cell line, established 
from dermal papilla from patient number 21 obtained in 2007 year, was at passage 3. 
 
4.2.5.3. Two-dimensional (2D) human cell structures. 
Cells grown on artificial surfaces of the cell culture dishes (35 mm dish; 
Nunclon) and on coverslips in 4-well plates (Nunclon) were treated as the two-
dimensional cells (the 2D cell structures). When cells grown in T25 or T75 flasks 
reached 80 - 95% confluence, the medium was changed to D-MEM (Dulbecco's 
Modified Eagle's Medium from Sigma) with 10% FBS, without antibiotics. After 24 
hours cells were trypsinised, counted using a haemocytometer and seeded at the 
appropriate density for the experiment they were prepared for. For the lipid analysis, 
40 000 cells were seeded into 35 mm dishes (Nunclon), whereas for the 
immunofluorescence analysis, 10 000 cells were seeded into the wells of a 4-well 
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dish (Nunclon) which had a sterile glass coverslip in the bottom. Cells were kept in 
normal/growth medium (D-MEM, 10% FBS) or adipogenic medium (D-MEM, 15% 
rabbit serum, 2.6 µM insulin and 100 nM DEX from Sigma). Cells were incubated in 
37oC and 5% CO2 and medium was changed mainly every second day.  Four days 
after the incubation cells were used for the immunofluorescence and Oil Red O 
analysis.  
 
4.2.5.4. Three-dimensional (3D) human cell structures - spheroid cell 
culture. 
The 3D culture method allows cells to form a spherical aggregate (Figure 
4.4). It was successfully used for the growth of human dermal papilla cells by 
Higgins et al (2010). Cells were placed on the lid of Petri Dishes, in media drops. 
Each medium drop (D-MEM with 10 %FBS, without antibiotics) was 10 µl and 
contained 3 000 cells. For each Petri dish, 50 droplets were prepared and positioned 
about 0.7 - 1 cm apart. The base of Petri dish was filled with sterile PBS (to avoid 
drying of medium drops). The lid with drops was turned over and put on the base. 
The Petri dishes were stacked and on the top of the stack, a Petri dish with H2O was 
put. Droplets were incubated in 37oC, 5% CO2. Once spherical aggregates (spheres) 
formed after 2 - 4 days of incubation, they were transferred (by 10 µl or 20 µl pipette 
tips) into fresh droplets of growth medium (D-MEM with 10% FBS no antibiotics) or 
adipogenic medium (D-MEM, 15% rabbit serum, 2.6 µM insulin and 100 nM DEX 
from Sigma). The transfer of spheres was done under the Stemi SV6 microscope 
(ZIESS). Next, 3D structures were incubated for 4 days in 37oC, 5% CO2 and then 
used for the immunofluorescence and Oil Red O analysis. In addition, the Oil Red O 
analysis was also performed on spheres incubated only 24 hours. 
For the immunofluorescence and lipid analysis, spheres were first collected 
from Petri dishes by 10 µl or 20 µl pipette tips and transferred into Tissue-TekR 
O.C.T.TM Compound (Sakura). From ten to twenty spheres were collected into a 7 x 
7 mm base mold (VWR) with Tissue-Tek, frozen in liquid nitrogen and stored at -
80oC. Next 7µm sections were cut on a cryostat (LEICA CM 3050S) and attached to 
SuperFrost®Plus slides (Menzel-Glaser), these were dried for 90 min at room 
temperature and used for the further analysis (see sections 4.2.5.5 and 4.2.5.6). 
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Figure 4.4. The schematic presentation of a spheroid cell culture technique. Cells 
were suspended in medium droplets, on the Petri Dish lid. The base of each Petri 
Dish was filled with PBS to avoid drying of medium droplet. During incubation in 5% 
CO2 and 37oC, cells gathered together and formed three dimensional cell structures 
(spheres). 
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4.2.5.5. Immunofluorescence analysis of human 2D and 3D cell 
structures.  
Two- and three- dimensional cells were used for the investigation of both 
cytoskeleton and nuclear envelope proteins by the immunofluorescence analysis. 
Used fixation methods and the staining protocol are described below.  
 
4.2.5.5.1. Fixation techniques. 
4.2.5.5.1.1. Acetone/Methanol method. 
Acetone/Methanol method was used when cytoskeleton proteins (aSMA, 
tubulin) were analysed. First, 2D and 3D cell samples (on coverslips or on slides) 
were washed in PBS (3 x 5 min) and incubated with 95% acetone/5% methanol (10 
min, -20oC). Then washed in PBS (3 x 5 min) and used for immunofluorescence 
analysis immediately. Alternatively, they were kept at 4oC for no more than two days 
then washed in PBS (3 x 5 min) and used for immunofluorescence analysis.  
 
4.2.5.5.1.2. Formaldehyde method. 
Formaldehyde method was used for the nuclear envelope proteins lamin 
type A and emerin. First, samples were washed in PBS (3 x 5 min), incubated with 
4% formaldehyde (15 min; at room temperature - RT) and 0.5% Triton-X100 (5 min; 
4oC). Then, samples were washed in PBS (3 x 5 min) and used for 
immunofluorescence analysis immediately. Alternatively, after incubation with 4% 
formaldehyde, samples were stored at 4oC, then washed in PBS (3 x 5 min), 
incubated with 0.5% Triton-X100 (5 min; 4oC), washed in PBS (3 x 5 min) and used 
for immunofluorescence analysis. 
 
4.2.5.5.2. Staining procedure.  
All samples prepared on coverslips and SuperFrost®Plus slides were 
washed in PBS (3 x 5 min). Then samples from back skin sections were incubated 
with 20% goat or donkey serum (Sigma) in PBS for 30 min, whereas the 2D and 3D 
cultured cells were not washed in serum. Next, samples were incubated with 
primary antibodies (Table 4.2) overnight at 4oC (or 1 hour; at RT). Then samples 
were washed in PBS (3 x 5 min) and incubated with secondary antibody 1 hour at 
room temperature (or overnight; at 4oC). Normally DAPI (Insight Biotechnology) was 
added to secondary antibody solutions (Table 4.3), at final dilution of 1:5000. Next, 
samples were washed in PBS (3 x 5 min) and mounted in anti-fade Immu-mount 
(Thermo Electron Corporation). All antibodies were diluted in 1% goat (or donkey) 
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serum/PBS. Immunofluorescence analysis was performed using a Zeiss Axio 
Imager.M1 microscope with OpenLab software.  
 
Table 4.2. Primary antibodies used for immunofluorescence analysis of 2D and 3D 
skin cell structures. 
Antibody: Manufacturer: Type Dilutions: 
α-SMA Sigma Mouse 1:200 
Tubulin Abcam Mouse 1:300 
Jol2 (anti-lamins type A) A gift from Prof C. J. 
Hutchison’s laboratory 
(Durham University, 
UK) 
Mouse 1:10 - 
1:100 
Jol4 (lamin A)* A gift from Prof C. J. 
Hutchison’s laboratory 
(Durham University, 
UK) 
Mouse Undiluted 
Emerin Vector Laboratories Mouse 1:20 
*Jol4 antibody was used for the analysis of lamin A in back skin section from 1 day old newborn rat 
(section 4.3.4.1; Figure 4.13). 
 
Table 4.3. Secondary antibody used used for immunofluorescence analysis of 2D 
and 3D skin cell structures. 
 
Secondary antibody: 
 
Manufacturer: 
 
Dilution: 
 
GantiM 
(FITC) 
AlexaFluor® 488 goat 
anti-mouse IgG(H+L) 
2ml/ml 
Invitrogen/Molecular 
probes 
1:500 
 
4.2.5.6. Lipid detection in human 2D and 3D cell structures. 
Two-dimensional cultures (in 35 mm dishes) and three-dimensional cultures 
(on coverslips) underwent Oil Red O staining. Briefly, cells were washed in PBS (3 x 
5 min) and fixed in calcium formal (see Appendix I) for 1 hour at room temperature. 
Next cells were incubated for 15 min in 60 % isopropanol and then stained for 15 
min with a filtered solution of three parts of Oil Red O (saturated in isopropanol) and 
two parts of H2O. Then cells were briefly rinsed in 60 % isopropanol and washed 
few times in H2O.  
Next, 2 ml of PBS were placed on the 2D cultures, which were then stored at 
4oC. Slides with stained 3D structures were mounted with Glycergel or 
Immunomount mount (Thermo Electron Corporation) and covered with coverslips. 
The Oil Red O analysis was performed using a Zeiss Axio Imager.M1 microscope 
with OpenLab software. 
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4.2.6. Mouse dermis work. 
4.2.6.1. Dermal-epidermal separation. 
Skin separation was performed enzymatically by an established (during this 
PhD study) method based on both work from Richardson et al (2009) and 
consultations with Professor Colin Jahoda. Mouse embryos were collected in a Petri 
dish filled with MEM - Minimal Essential Medium (Sigma) with antibiotics (2 µl/ml 
fungizone from Sigma and 1 µl/ml gentamicin from Gibco) to avoid drying of the skin. 
Then, each animal was attached to a 5% agar plate (filled with MEM with antibiotics) 
by needles in order to stretch skin for the ease of skin removal. Fragments of back 
skin (from the area below the head and above the tail, see Figure 4.2) were carefully 
removed and cleaned of any muscle tissue. Next, rectangular pieces of skin (2.5 
mm x 3 mm) were prepared and collected in a watch-glass filled with MEM and 
antibiotics over ice. Then, skin samples were washed in sterile DPBS (Gibco) twice 
and placed in a cold, filtered solution of 5% trypsin (BD)/6% pancreatin 
(Sigma)/DPBS (1:1:2) and incubated for 40 - 90 minutes (depending on the age and 
size of skin pieces) at 4oC. Then, pieces of dermis were separated from the 
epidermis using watchmakers’ forceps and collected in cold DPBS. Dermal 
specimens were then transferred to a warm solution of collagenase II/DNase I 
working solution (see Appendix I) and incubated for 15 min at 37oC. Then dermis 
was disrupted into a single cell suspension by repeated use of an automatic pipette 
with a 200 µl tip. Once the single cell suspension was obtained, it was centrifuged 
(3000 rpm, 5 min, at room temperature) and the cell pellet was suspended in 1 ml of 
a medium that consisted of MEM (Minimal Essential Medium from Sigma), 
antibiotics (2 µl/ml fungizone from Sigma and 1 µl/ml gentamicin from Gibco) and 
10% FBS (Sigma). Cells were counted and used for the 2D and 3D cell cultures. 
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4.2.6.2. Two-dimensional (2D) rodent cell structures. 
Dermal cells were placed in 35 mm dishes for the 2D cell structures (up to 
200 000 cells per dish) and left in medium (that consisted of MEM; 10% or 20% FBS 
- foetal bovine serum and antibiotics: 2 µl/ml fungizone from Sigma and 1 µl/ml 
gentamicin from Gibco) to settle down and attach to the plastic for about 2 - 3 hours 
(in 5% CO2 and 37oC). Then the media was changed for fresh growth media (treated 
as control media) or adipogenic media (Table 4.1) and the experiment was stopped 
four days later. Cells were used for the Oil Red O analysis (see section 4.2.7). 
 
4.2.6.3. Three-dimensional (3D) rodent cell structures - spheroid cell 
culture. 
The 3D structures were obtained by seeding 3 000 cells in 10 µl growth 
media droplets (MEM; 10% FBS; 2 µl/ml fungizone from and 1 µl/ml gentamicin). Up 
to 50 droplets were placed on the lid of each Petri dish and then the lid was carefully 
transferred on the base of the Petri dish filled with sterile water or PBS (prepared 
from phosphate-buffered saline tablets; Sigma or Oxoid) to avoid drying of droplets 
(Figure 4.4). Stacked Petri dishes were incubated (in 5% CO2 and 37oC) for about 
24 hours to allow cells to settle and make three-dimensional structures. Then 3D cell 
structures (spheres) were transferred to fresh droplets of growth medium (treated as 
a control medium) or adipogenic medium (Table 4.1). Spheres were then incubated 
for another four days and experiments were stopped by placing the 3D structures 
into tissue tek and freezing in liquid nitrogen. Samples were cryopreserved and 
cryostat sectioned for analysis as described above (see section 4.2.3). 
 
4.2.7. Oil Red O staining and modified H&E staining. 
 The Oil Red O staining and modified H&E staining were performed on skin 
sections obtained from hanging drop cultures and substrate organ cultures. Oil Red 
O staining was used on sections of the 3D cell structures. A detailed description of 
these methods is presented in Chapter 2, in section 2.2.4. 
The 2D cultured cells, grown in 35 mm dishes, underwent a shortened 
version of the Oil Red O protocol. Briefly, cells were washed in PBS (3 x PBS; few 
min), fixed in calcium formal solution for 10 min, incubated with 60% isopropanol 
(approximately 5 min) and incubated in the Oil Red O working solution (see section 
2.2.4) for up to 10 min, then washed in 60% isopropanol and PBS. Fixed 2D cells 
were either kept in sterile PBS at 4oC, or mounted with mowiol (see Appendix I), 
covered carefully by circular coverslips and stored at 4oC.  
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4.3. Results. 
4.3.1. EGFR expression in the lower dermis of mouse embryonic back 
skin. 
 One of the genes shown to be up-regulated in the lower dermis in the dermal 
microarray data (detailed analysis of which has been described in Chapter 3) was 
epidermal growth factor receptor (EGFR). This is a cell surface receptor involved in 
skin development, and also in relation to hair follicle development (Richardson et al, 
2009). In addition, the role of EGF receptor has been investigated in 3T3 cell lines 
(Harrington et al, 2007). In the current study, the up-regulation of this receptor was 
observed in E18 and E19 microarray sub-lists (Table 4.4A). In 18 day old lower skin 
dermis, EGFR was up-regulated by 3.8 fold compared to upper dermis, whereas at 
e19 time point the EGFR mRNA was 2.62 fold more prevalent in lower dermis than 
upper. In addition, the lower dermal (LD) microarray data showed changes in EGFR 
expression in lower dermal cells between analysed time points (Table 4.4B). The 
e18 showed about 2.37 fold increased over the e17 and the e19 a 1.75 fold increase 
over e17 (Table 4.4B). 
 
For the verification work of microarray data, qRT-PCR analysis was 
performed on samples from lower and upper dermis areas from e17, e18 and e19 
samples. Only e18 time point was successfully analysed by qRT-PCR reaction with 
all three biological replicates having detectable levels of EGFR mRNA (Figure 4.5A). 
At this time point, cells from lower dermis were significantly enriched for the EGFR 
according to performed t-test analysis. Among three biological replicates from e17 
time point, only one gave a signal during the qRT-PCR reaction. Moreover, at e19, 
one biological sample failed to provide an acceptable signal during the qRT-PCR 
reaction (obtained Ct value was higher than acceptable for this work baseline, for 
the explanation see section 3.2.6.1.3). The other two samples from e19 time point, 
were characterised by a big difference in the EGFR mRNA levels between each 
other. Samples that failed to give signal on the PCR machine were treated as their 
expression of mRNA is equal zero. Therefore, only e18 samples did not have 
unacceptably large standard deviation values (Figure 4.5B). This analysis confirmed 
predictions from microarray data, that EGFR gene seems to be significantly 
enriched in lower dermal cells, at the e18 time point. 
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 Expression of EGFR was also analysed by the immunofluorescence. The 
selected antibody against EGFR failed to work couple of times when used. However 
in several cases this antibody stained epidermis at all analysed time points (Figure 
4.6A). In addition, green signal in dermis area occurred to be weaker when 
compared with epidermal expression of EGFR. In the lower dermis in regions in 
close proximity to hair follicle end bulbs staining for EGFR was visible from e18 
(compare Figure 4.6Ab with Figure 4.6Aa and d). In addition, some areas of the 
lower dermis seemed not to be stained to the same extend as others in back skin 
from 18 day old embryos (compare Figure 4.6Ab with Figure 4.6Ac).  
 
 
Table 4.4. The Egfr gene expression profile in embryonic skin dermis between e17 
and e19 time points. (A) The E18 and E19 microarray sub-lists revealed the 
enrichment of Egfr at mRNA level in lower dermal cells versus upper dermal cells at 
e18 and e19 time points. (B) The lower dermal (LD) microarray list showed the up-
regulation of Egfr gene in lower dermal cells from e17 time point. 
A) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis vs* 
e18 upper dermis  
+ 3.802172  
 
Epidermal growth factor receptor; 
Egfr; 
1435888_at e19 lower dermis vs* 
e19 upper dermis 
+ 2.621013 
B) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
+ 2.377378 
 
Epidermal growth factor receptor; 
Egfr; 
1435888_at 
e19 lower dermis  
vs*  
e17 lower dermis 
+ 1.75338 
* vs - versus 
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Figure 4.5. Verification of microarray data by qRT-PCR for Egfr gene. The relative 
mRNA expression for gene was analysed on samples from dermis at e17 (17), e18 
(18) and e19 (19) time points, from upper (Area “1”, green) and lower (Area “2”, red) 
dermis. The analysis was performed on three biological replicates and only “18 1” 
and “18 2” samples gave signal from all triplicates. (A) There was a significant 
enrichment of Egfr gene in lower dermis versus upper dermis at e18 time point. (B) 
Samples from other time points were characterised mainly by high standard 
deviation values. The baseline (1-fold change) was established for the e18 lower 
dermis sample (underlined on the figure) and the mRNA levels of other samples are 
shown relative to underlined sample. P value refers to the comparison with “18 2” 
sample (* P <0.05, ** P <0.01, *** P <0.001). The “NS” indicates not significant 
differences in the mRNA gene expression between compared samples. 
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A) 
 
B) 
 
Figure 4.6. Dynamic changes in expression and localisation of epidermal growth 
factor receptor - EGFR during mouse embryonic skin development. (A) Back skin 
sections (7 µm) were prepared from embryos at e17 (17dE), e18 (18dE) and e19 
(19dE) time points and probed with antibody against EGFR, diluted 1:50 (d) or 1:100 
(a, b, c). Green staining is seen along epidermis at all analysed time points. EGFR 
signal in lower dermis can be seen in some areas of 18 day old back skin samples 
(b). (B) Control samples, where primary antibody was replaced by 1% serum. DaR - 
donkey anti-rabbit secondary antibody. Slides with skin samples did not undergo 
fixation. DNA was counterstained with DAPI. (A, B) Scale bar = 30 µm. Fluorescent 
images were visualised using a Zeiss Axio Imager M1. microscope. 
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4.3.2. Investigation of the role of EGFR signalling in lipid accumulation 
in embryonic back skin. 
In order to mimic in vivo-like conditions for the analysis of back skin samples, 
two experimental techniques were initially tested: a hanging-drop and a substrate 
organ culture method. The same small, rectangular pieces of back skin taken from 
e16 - 17 day mouse embryos were compared for this purpose. Skin samples were 
either placed on membranes (organ culture technique) or suspended in media 
droplets (the hanging-drop technique). These samples were then incubated in media 
that contained activator or inhibitor of EGF receptor (see Table 4.1 for more details). 
 
Skin cultured using the hanging-drop technique did not look healthy. The 
epidermis was often ripped and separated from dermis. In addition, samples had not 
stayed flat but their ends had rolled and they had a round shape (Appendix VII). 
Thus, this method seemed not to be useful for further study of back skin.  
 
Organ culture, performed on e16 - 17 embryonic mouse skin, incubated in 
the control medium produced healthy-looking samples (Figure 4.7a). When stained 
with the Oil Red O the distribution of staining was not uniform. In a few sections the 
red dye was not seen in the dermis, only in subcutaneous glands (Figure 4.7a - top 
panel). In addition, some samples had small amounts of lipids stained near hair 
follicles (Figure 4.7b - middle panel). Then, for a number of sections, the Oil Red O 
staining gave a stain along the whole dermis (Figure 4.7c - bottom panel). 
Interestingly, many very small red dots were seen around nuclei of dermal cells as 
well as along the hair follicles (Figure 4.8). 
In skin specimens, incubated in medium with the EGFR activator at a 
concentration of 100 ng/ml (Figure 4.7b), the red dye was observed along the 
dermis and hair follicles, and was similar to several skin sections incubated in 
control medium. Finally, the skin was analysed after the incubation with EGFR 
inhibitor and in these skin sections fat cells were not seen in the lower dermis area 
and were not present around hair follicles (Figure 4.7c and d). However, skin from 
the higher concentration of EGFR inhibitor looked less healthy and disruptions (gaps) 
between epidermis and dermis were seen (Figure 4.7d - top panel). In addition, the 
red dye was seen in the area suspected to be a fat depot presented beneath the 
skin (Figure 4.7d - bottom panel). In general, these specimens looked slightly less 
healthy than from other experiments. 
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Figure 4.7. Lipid accumulation in mouse embryonic skin at e16 - 17 time point. The 
substrate organ culture method was applied for the growth of skin pieces. Skin 
sections were stained with Oil Red O to detect lipids. a) Skin after 72h incubation in 
control medium (C). b) Skin after 72h incubation in medium with EGFR activator (A). 
c) Skin after 72h incubation in medium with EGFR inhibitor (I). Red dye in 
sebaceous gland is shown by a black arrow (a - upper panel), whereas small lipid 
droplets in lower dermis are pointed by a yellow arrow (a - middle panel). Green 
arrow identifies an area stained by red dye that might be a fat depot (adipose tissue) 
beneath the skin (c - lower panel). (a, b, c - lower panel and d) Scale bar = 30  µm. 
(c - upper panel) Scale bar = 65 µm. Images were captured using a Zeiss Axio 
Imager.M1. microscope. 
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Figure 4.8. Magnification of a skin section obtained from mouse embryonic skin at 
e16 - 17 time point after the substrate organ culture study. Skin section, after 72h 
incubation in control medium, was stained with Oil Red O to detect lipids. Lipid 
accumulation is shown by red dye. Yellow bars show the lipid droplets in hair 
follicles. HF - hair follicle. Scale bar = 30 µm. Images were captured using a Zeiss 
Axio Imager.M1. microscope. 
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4.3.3. Younger (e15 - 15.5) and older (e18.5 - 19) mouse back skin organ 
culture.  
After the organ culture experiment on 16 - 17 day old embryonic skin, two 
other time points were chosen for further study, younger skin from e15 - 15.5 and 
skin from e18.5 - 19 day old embryonic animals.  
As it was shown (Chapter 2) cells from lower dermis start to accumulate 
easily distinguishable lipid droplets between 18 and 19 day of mouse embryonic 
development. Therefore, it seemed useful to use the organ culture method for the 
analysis of lipid accumulation capability and the role of EGF-EGFR signalling 
pathway in mouse embryonic skin at these times. After 48 hours of incubation the 
skin samples in the different media conditions were cut on the cryostat for the 
analysis of lipid accumulation. Back skin from 15 - 15.5 day old mouse embryos did 
not stain with Oil Red O dye, whereas the older skin was characterised by lipid 
droplets in lower dermis (compare Figure 4.9a with Figure 4.10a). Skin specimen 
from e15 - 15.5, when incubated in a control medium, maintained its fat-free feature 
after 48 hours of incubation (Figure 4.9b). In addition, sections from older specimens, 
incubated in control medium, had areas full of lipids along the whole dermis (Figure 
4.10b - left panel) but also there were sections where lipids were mainly seen in 
lower dermis rather than in upper dermis (Figure 4.10b - right panel). 
In addition, skin samples were incubated for 48 hours in experimental media 
with EGFR activator (EGF) or EGFR inhibitor (AG1478). Dermis compartment in the 
younger skin samples did not show Oil Red O staining after the organ culture, with 
EGF or AG1478 (Figure 4.9c and d). However, the Oil Red O staining was seen in 
samples from 18.5 - 19 day old mice that were incubated with activator or inhibitor of 
EGFR (Figure 4.10c and d).  
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Figure 4.9. Lipid accumulation in mouse embryonic skin at e15 - 15.5 time point. 
The substrate organ culture method was applied for the growth of skin pieces. Skin 
sections were stained with Oil Red O to detect lipids. a) Skin before organ culture 
(BOC). b) Skin after 48h incubation in control medium (C). c) Skin after the 
incubation (48h) in medium with EGFR activator (A). d) Skin after 48h incubation in 
medium with EGFR inhibitor (I). (a - d) Scale bar = 30 µm. Images were captured 
using a Zeiss Axio Imager.M1. microscope. 
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Figure 4.10. Lipid accumulation in mouse embryonic skin at e18.5 - 19 time point. 
The substrate organ culture method was applied for the growth of skin pieces. Skin 
sections were stained with Oil Red O to detect lipids. a) Skin before organ culture 
(BOC). b) Skin after 48h incubation in a control medium (C). c) Skin after 48h 
incubation in medium with EGFR activator (A). d) Skin after 48h incubation in 
medium with EGFR inhibitor (I). (b - right panel): the upper area with less red dye 
when compared with the lower area. (a - d) Scale bar = 30 µm. Images were 
captured using Zeiss Axio Imager.M1. microscope. 
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Skin specimens were also analysed after incubation with adipogenic medium 
in organ culture. As was mentioned in Chapter 1, section 1.3.2.2, adipogenic 
medium contains of factors that activate signalling cascades needed for the 
differentiation of cells into mature adipocytes (fat cells that accumulate lipids). Organ 
culture samples, incubated in such medium in general were characterised by a 
specific rounded shape (Appendix VIII). It seemed that epidermis “aimed to close” 
the skin sample in a kind of round-shape structure, thus it was difficult to decide if 
the red staining seen in the dermis of cross-sections was related to the influence of 
adipogenic medium on skin as the epidermal growth would limit the contact with 
media by growing around the whole sample. Thus, reliable analysis of the influence 
of adipogenic media on organ culture samples seemed not to be possible. Therefore, 
a decision was made to use a different experimental approach for the analysis of the 
influence of adipogenic medium on skin cells. A spheroid cell culture method was 
applied for the analysis of the embryonic skin dermis. Moreover this facilitated study 
of dermal cells without the epidermal cells causing problems.  
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4.3.4. Investigation of skin cells in two- (2D) and three- (3D) dimensional 
structures. 
 Epidermal-dermal interactions are crucial for the hair follicle development 
(Chapter 1, section 1.1.3.1). The question arose if specific cell-cell interactions are 
also important for development of fat cells in skin dermis. Because the lipid 
accumulating cells are localised in the lower and not in the upper dermal 
compartment, it would be interesting to investigate if cells from these two dermal 
areas develop from the same progenitor cells, when and what influences their fate 
during embryonic development. Are there specific epidermal-dermal and/or dermal-
dermal processes crucial for the development of dermal adipose tissue? 
 
 In order to analyse features of only dermal skin compartment, without the 
epidermal layer, at two different stages of embryonic development (e15 - 15.5 and 
e18.5 - 19 time points), an experiment was performed where enzymatic treatment 
(see section 4.2.6.1 for more details) allowed the dermis to be separated from the 
epidermis. Next, dermal cells were used for either two-dimensional (2D) or three-
dimensional (3D) cell culture and the analysis of their lipid accumulation capabilities.  
 
4.3.4.1. Different human skin compartments and 3D culture as a method 
for their analysis. 
 As was mentioned in the introduction to this Chapter, the 3D spheroid cell 
culture method allows cells to be maintained in a spherical aggregate without 
contact to the surface of a cell culture dish as would be the case in conventional 2D 
cell structures. 
 
 In order to become familiar with the 3D spheroid technique, first human and 
mouse skin specimens were used in order to establish cell lines from skin fibroblasts 
(FI) and hair follicle end bulb structures, such as the dermal papilla (DP) and dermal 
sheath (DS). A brief summary of the micro-dissection method of human DP and DS 
is presented in section 4.2.5. These cells were used for the 3D cultures, according 
to the protocol shown in section 4.2.5.4. Human FI, DP and DS cells gave nice, 
spherical structures (Figure 4.11). In most cases, the surface of such structures was 
smooth and they had symmetric rounded shapes.  
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Figure 4.11. Three-dimensional (3D) cell structures obtained from human skin cells. 
(a) dermal sheath - DS cells. (b) dermal papilla - DP cells. (c) skin fibroblast - FI 
cells. 3D structures were created from cells at passage 4 or 6. Cells were 
established from human skin sample number 18_07. (a - c) Scale bar = 100 µm. 
Images were captured using a Carl Zeiss Axiovert 10 inverted microscope (with 
accompanying AnalySIS software). 
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 Both 2D and 3D cell cultures, obtained from human dermal papilla (DP) cell 
lines, were analysed using immunofluorescence to investigate the presence and 
localisation of either cytoskeletal or nuclear envelope proteins (Figure 4.12). Specific 
localisation of alpha smooth muscle actin (aSMA) seen in 2D cell cultures was not 
present in spheres (compare Figure 4.12a with Figure 4.12b). This result was in 
agreement with work shown by Higgins et al (2010), where aSMA signal was lost 
from DP spheres. Also, tubulin did not have its fibrillar-type of localisation in 3D 
structures, and the signal from anti-tubulin antibodies seemed to be present only on 
the outside layer of cells of the sphere (see Figure 4.12c and Figure 4.12d). 
 In addition, nuclear envelope proteins were analysed in both 2D and 3D 
cultures. Lamin A and lamin C are representatives of A-type lamins and the Jol2 
antibody against these nuclear envelope proteins together with antibody against 
another nuclear envelope protein: emerin were used for the analysis of 2D and 3D 
cultured cells. In 2D culture both emerin and A-type lamins displayed round-shape 
nuclei (Figure 4.12e and Figure 4.12g). However, cells kept in 3D structures were 
lacking the round and smooth-like shape of nucleus that was seen in two-
dimensional cells (Figure 4.12f and Figure 4.12h). The nuclei of cells in spheres 
seemed to be “squeezed”. Their shapes were reminiscent of those of intact hair 
follicle end bulb cell nuclei, for example in the dermal papilla (DP), when expression 
of lamin A (by Jol4 antibody) was analysed previously in back skin samples from 
one day newborn rats (compare Figure 4.12f and 4.12h with Figure 4.13).  
  
 In addition, the generated microarray data from mouse embryonic skin 
dermis revealed specific regulation of lamin A gene (Table 4.5). The E19 microarray 
sub-list contained a lamin A gene whose enrichment was related with the upper 
dermis (Table 4.5A). The lower dermis (LD) microarray data showed the down-
regulation of lamin A gene in lower dermal compartment from e17 till e19 time points 
(Table 4.5B). 
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Figure 4.12. Analysis of cytoskeletal and nuclear envelope proteins in two- (2D) and 
three- (3D) dimensional cell structures. Both structures were established from 
human dermal papilla (DP) cells, number 5_07, at passage 7. Although 
characteristic, for 2D structures, the expression pattern observed for alpha smooth 
muscle actin (aSMA) and tubulin (a and c) was lost in 3D structures (b and d). The 
rounded morphology of nuclei in 2D structures, based on emerin and A-type lamin 
localisation (e and g) was not seen in 3D structures where nuclei looked shrunken (f 
and h).  DNA was counterstained with DAPI. Antigens of interest are green: a and b 
- alpha smooth muscle actin (aSMA); c and d - tubulin; e and f - emerin; g and h - A-
type lamins (Jol2 antibody). (a - h) Scale bar = 15 µm. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 4.13. Localisation of lamin A in skin sections taken from a 1 day old newborn 
rat. Expression of lamin A could be seen in dermis cells or hair follicle end bulbs 
cells. DNA was counterstained with DAPI. Antigen of interest is green: lamin A (Jol4 
antibody). DP - Dermal papilla. Scale bar = 15 µm. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
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Table 4.5. The lamin A gene (Lmna) expression profile in embryonic skin dermis 
between e17 and e19 time points. (A) E19 microarray lists revealed the decrease in 
Lmna mRNA in lower dermal cells versus upper dermal cells at e19 time point. (B) 
The lower dermal (LD) microarray list showed the down-regulation of Lmna in lower 
dermal cells from e17 time point.   
A) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
lamin A;  
Lmna; 
1457670_s_at  
e19 lower dermis  
vs*  
e19 upper dermis 
 - 3.381616 
 
B) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
- 1.351853 lamin A;  
Lmna; 
1457670_s_at 
e19 lower dermis 
 vs*  
e17 lower dermis 
- 2.934171 
* vs - versus 
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Jahoda et al (2003) showed that two-dimensional cell cultures obtained from 
both DP and DS are capable of accumulating lipids in the presence of adipogenic 
medium (Jahoda et al, 2003). The behaviour of human dermal papilla (DP) and 
human fibroblast (FI) cells in both 2D and 3D environment was investigated. Once 
formed, structures were incubated either in normal or adipogenic medium for up to 4 
days. 2D cultured FI and DP cells, were stained by the Oil Red O dye, only when 
incubated in adipogenic medium (compare Figure 4.14a and c with Figure 4.14b, d 
and i). In general, spheres from several human fibroblasts samples were 
characterised by the presence of red dye along the whole cross-section of the 
structures in both normal and adipogenic medium (Figure 4.14e - f). Interestingly, in 
some 3D samples from DP cells, the number of areas positive for red dye seemed 
to be lower (or even not present) when compared with fibroblast spheres when 
incubated for 24 hours or 4 days in both normal and adipogenic media (compare 
Figure 4.14e - f with Figure 4.14g - h; see also Appendix IX). 
 
After the successful use of the 3D cell culture method on human skin cells, 
this technique was applied for the analysis of mouse-derived skin cells. This study is 
described in next section (4.3.4.2) of the Chapter 4. 
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Figure 4.14. The analysis of lipid accumulation in 2D and 3D cell structures obtained 
from human skin sample number 5_07. Once 2D and 3D structures were formed, 
they were incubated in normal or adipogenic medium for 4 days. Cell structures 
were stained with Oil Red O to detect lipids. FI - fibroblasts. DP - dermal papilla cells. 
(a - d) Scale bar = 100 µm. (e - h) Scale bar = 15 µm. Images were captured using 
the inverted microscope Carl Zeiss Axiovert 10 (a - d and i) and Zeiss Axio 
Imager.M1. microscope (e - h). 
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4.3.4.2. Mouse dermis cells and their fat accumulation in 2D culture. 
Dermal cells from back skin samples of 15 - 15.5 and 18.5 - 19 day old 
mouse embryos were obtained during enzymatic treatment. Skin from e18.5 - 19 
time point underwent separation of dermis from epidermis allowing the accumulation 
of high numbers of clean pieces of dermis. However, some difficulties were 
encountered with younger skin where the thin epidermis was harder to remove from 
the dermis. Therefore, there is a possibility of low-level contamination of the dermal 
cells with epidermal cells. 
 
Dermal cells were seeded into cell culture dishes in order to obtain 2D cell 
structures (for mode details see section 4.2.6.2). 2D cultures from mouse back skin 
dermis at both e15 - 15.5 and e18.5 - 19 time points grew well in the control medium. 
Their growth in adipogenic medium was slightly inhibited (compare Figure 4.15c and 
e with Figure 4.15d and f; also compare Figure 4.16c and e with Figure 4.16d and f). 
Perhaps as a result of media cells were more likely to stop proliferating and start 
their differentiation process. 
 
The dermal cells from young mouse embryos, when kept in control medium, 
did not accumulate lipids and all cells were small and had the same morphology 
(Figure 4.15a). However changes in the e15 - 15.5 skin derived dermal cells, kept in 
adipogenic medium, were noticed. First, after 48 - 72 hours of the incubation in the 
differentiation medium, small darker “dots” could be observed in cells in the 
cytoplasm around nuclei, which could be an indication of the presence of first tiny 
lipid droplets around nucleus (Figure 4.15d - see white arrows). At day four, cells 
with different morphology could be identified when incubated in adipogenic medium. 
These cells, assumed a round shape because of the lipid droplets in their cytoplasm 
(Figure 4.15f). Depending on the selected area with analysed cells, approximately 
20% of cells appeared to have started adipogenic differentiaion (see marked 
rectangular area in Figure 4.15f). 
 
 Interestingly, dermal cells from 18.5 - 19 day old mouse embryos were 
characterised by the presence of round shaped cells with characteristic lipid droplets 
inside them when kept in normal medium (Figure 4.16a - bottom panel).  These cells 
had features of multilocular cells with several small lipid droplets. The number of fat 
cells remained almost unchanged in normal medium from 48 to 96 hours (compare 
Figure 4.16a, c and e). However, the morphology of these fat cells seems to 
undergo some changes during the incubation period in normal medium, as cells kept 
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longer in normal medium had a single large lipid drop instead of several smaller 
ones (compare Figure 4.16a - bottom panel with Figure 4.16e). The incubation of 
e18.5 - 19 skin derived dermal cells for 48 hours in adipogenic medium lead to the 
occurrence of unilocular fat cells with one large central fat droplet (Figure 4.16b - 
lower panel). Therefore, the adipogenic medium seemed to enhance lipid 
accumulation in fat cells from 18.5 - 19 day old mouse skin dermis. 
In addition, for cells from e18.5 - 19 derived skin dermis, in both media 
conditions and at each time point analysed there were areas where cells did not 
have fat-like morphology (Figure 4.16a - f). 
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Figure 4.15. The general morphology of young embryonic two-dimensional cell 
structures incubated (48, 72 or 96 hours) in control (C) or adipogenic (ADIP) 
medium. Cells were obtained from the dermis of 15 - 15.5 day old mouse embryos 
(e15 - 15.5 time point). (d) Darker “dots” seen around nuclei of cells incubated in 
adipogenic medium are shown by white arrows. (a - f) Scale bar = 100 µm. Images 
were captured on a Carl Zeiss Axiovert 10 inverted microscope. 
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Figure 4.16. The general morphology of old embryonic two-dimensional cell 
structures incubated (48, 72 or 96 hours) in control (C) or adipogenic (ADIP) 
medium. Cells were obtained from the dermis of 18.5 - 19 day old mouse embryos 
(e18.5 - 19 time point). (a - f) Scale bar = 100 µm. Images were captured using a 
Carl Zeiss Axiovert 10 inverted microscope. 
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4.3.4.3. Comparison of lipid accumulation capabilities of mouse 
embryonic dermal cells in two- and three- dimensional cell cultures.  
The 3D spheroid cell culture method, introduced in section 4.3.4.1, is a 
useful method for recreating the in vivo-like environment of human skin derived cells 
(Higgins et al, 2010). This 3D culture technique was tested on cells from embryonic 
mouse dermis. It seemed interesting to investigate whether embryonic cells can be 
grown as spheres. The 3D technique could be a useful for the investigation of 
processes naturally taking place in the body of an embryo. The question asked here 
was if the capability to accumulate lipids differs between dermal cells grown on the 
cell culture dish and suspended in a medium droplet.  
 
 Dermal cells, obtained from 15 - 15.5 and 18.5 - 19 day old mouse embryos, 
were suspended in droplets of normal medium for approximately 24 hours to allow 
cells to settle down. When three-dimensional structures had formed, they were 
transferred to either a fresh droplet of normal (control) medium or adipogenic 
medium for the next four days. Two-dimensional cell cultures were also established 
and the Oil Red O analysis was performed on both cell cultures.  
 
Two-dimensional cell cultures from 15 - 15.5 day old mouse embryos did not 
stain with Oil Red O dye, when kept in normal medium, whereas the adipogenic 
medium leaded to fat cell differentiation and lipid accumulation (compare Figure 
4.17a with Figure 4.17b). Cells that accumulated lipids seemed to be equally 
distributed along the cell culture dish when incubated with adipogenic medium 
(Figure 4.17b - both panels). Interestingly, when these cells were grown as 3D 
structures, the red dye stained intensively spheres from both normal and adipogenic 
medium (compare Figure 4.18a with Figure 4.18b). In addition, areas with red dye in 
spheres grown in normal medium seemed to be organized in clusters surrounded by 
areas less intensively or even not stained by the Oil Red O (Figure 4.18a - both 
panels). Whereas, the whole cross-sections of spheres from adipogenic medium 
were stained by red dye (Figure 4.18b - both panels). Therefore, the environment 
created by the 3D technique seems to enhance accumulation of fat droplets in 
young (e15 - e15.5) dermal cells even in the normal medium. 
 
 The Oil Red O staining of two-dimensional e18.5 - 19 derived skin dermis 
cells, showed the presence of several fat cells in normal medium (Figure 4.17c; 
white arrows show presence of red dye). Cells in adipogenic medium contained 
more cells stained by the dye and these had larger lipid droplets than in normal 
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medium (compare Figure 4.17c with Figure 4.17d). The 3D cultures obtained from 
18.5 - 19 day old mouse embryonic skin were characterised by many areas negative 
for the red dye when grown in normal medium (Figure 4.18c). When cultured in 
adipogenic medium lipid accumulation capabilities in these spheres were enhanced 
(compare Figure 4.18c with Figure 4.18d). 
The cell culturing techniques, clearly revealed differences in relation to fat 
droplet accumulation of dermal cells derived from two analysed time points. 
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Figure 4.17. Lipid accumulation in two-dimensional cell structures incubated for 96 
hours in control (C) and adipogenic (ADIP) medium. Cells were obtained from the 
dermis of 15 - 15.5 and 18.5 - 19 day old mouse embryos. Structures were stained 
with Oil Red O to detect lipids. Red dye in cells from 18.5 - 19 day old mouse 
embryos, kept in control medium, was shown by white arrows (c). (a, b, c, d - top 
panels) Scale bar = 200 µm. (a, b, c, d - bottom panels) Scale bar = 100 µm. Images 
were captured on Carl Zeiss Axiovert 10 inverted microscope. 
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Figure 4.18. Lipid accumulation in three-dimensional cells incubated for 96 hours in 
control (C) and adipogenic (ADIP) medium. Cells were obtained from the dermis of 
15 - 15.5 and 18.5 - 19 day old mouse embryos. Structures were stained with Oil 
Red O to detect lipids. (a - d)  Scale bar = 15 µm. Lipid accumulation was analysed 
by Oil Red O staining. Images were captured using a Zeiss Axio Imager.M1. 
microscope. 
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4.4. Discussion. 
 The microarray work on dermal cells, presented in Chapter 3, allowed 
investigation of gene expression patterns during the embryonic development of fat 
cells in the lower dermis of mouse skin. It is important now to use this data in order 
to be able to better understand the very early steps of fat cell differentiation in vivo. 
Moreover, there is a need for efficient experimental techniques that will successfully 
mimic the environment of the body. These methods may help in the investigation of 
fat cell origin and mechanisms involved in the regulation of adipocyte differentiation 
in skin.  
 
4.4.1. The substrate organ culture technique as a potential tool for 
better understanding fat cell development in vivo. 
 Among two methods tested for the growth of back skin pieces in a three-
dimensional environment, only the substrate organ culture technique was useful. 
The hanging-drop organ culture failed in obtaining healthy skin pieces. The possible 
reason could be that medium droplets in which pieces were suspended were too 
small to maintain the skin fragments. 
 
4.4.1.1. The lipid accumulation capabilities of skin pieces are dependent 
on the age of mouse embryos.  
The substrate organ culture technique tested the capacity of embryonic back 
skin pieces to produce fat in the absence of signals from the different parts of the 
body.  
The youngest tested fragment was obtained from a back skin of 15 - 15.5 
day old mouse embryo, where lipid droplets were not present in dermis and this lipid 
accumulation free feature was maintained in the organ culture experiment (section 
4.3.3). In contrast, skin fragments from 18.5 - 19 day old mouse embryos in which 
back skin had a small number of fat cells in lower dermis surrounded by non-fatty 
cells, were characterised by an increase in areas that accumulated many small lipid 
droplets in skin piece when kept in organ culture conditions.  
Therefore, the capability to accumulate lipids can be maintained in older 
embryonic skin fragments when removed from the body and kept in an in vivo-like 
environment. Maybe once committed to adipogenesis, cells that are in skin dermis 
at e18.5 - 19 time point are irreversibly committed to adipogenisis, moreover they 
could stimulate other dermal cells to undergo this differentiation process. Or it could 
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be that cells from other skin compartments within the analysed skin piece are 
responsible for the activation of lipid accumulation in dermal compartment. 
However, it seems also that signals responsible for the controlling exactly 
which types of cells in embryonic back skin can become adipocytes could be 
dependent on other body sites. It was shown in Chapter 2 that during the 
development of dermal adipose tissue, fat droplets occurred in lower dermis and not 
in hair follicle structures. The size of fat droplets was increased due to progressive 
accumulation of lipids. In addition, an easy to spot layer of dermis free from lipid 
bodies and localised beneath the epidermis was observed in all analysed specimens 
from both mouse embryonic and newborn back skin (Chapter 2). In the organ 
culture samples from e18.5 - 19 day old mouse embryonic back the Oil Red O dye 
stained the whole dermis and even the hair follicle structures. In addition, these 
accumulated lipids were characterised by very tiny diameter droplets. Therefore, it 
seems possible that the specific signals have to occur from other body parts and 
together with signals from the skin compartment they control the balance between 
activation of adipogenesis in lower skin dermis and its inhibition in other skin parts. 
  
4.4.1.2. The role of EGFR signalling in the activation of adipogenesis in 
back skin dermis during the mouse embryonic development.  
One of the important aims of the work presented in the Chapter 4 was to 
verify if the microarray data, obtained from embryonic dermal skin cells (Chapter 3), 
could be used for the selection of genes with a potential important role in the in vivo 
development of dermal adipose tissue. The second aim was to find a reliable 
experimental method that would mimic in vivo environment and help to verify a role 
of microarray-based gene in adipogenic differentiation of lower dermal cells.  
  
The microarray data was searched for a gene with interesting expression 
profile in lower dermal cells from e17 to e19 time points and whose function in 
adipogenesis regulation in vivo has not been clearly defined. The gene of choice 
was epidermal growth factor receptor (EGFR) as it was enriched in lower dermal 
cells at e18 time point, according to microarray data. Its up-regulation in embryonic 
skin dermis at this time point was confirmed both at mRNA and protein level, by 
performed qRT-PCR reaction and immunofluorescence analysis (section 4.3.1). The 
fact that both mRNA and proteins levels of this gene are specific to the same 
analysed time point could be explain as follows. The up-regulation of EGFR mRNA 
could take place in animal couple of hours older that e17 time point and then stayed 
high at e18 time point, when also protein level of EGFR is enriched. However, 
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because the analysis was performed on time points 24 apart from each other, the 
exact moment when the EGFR mRNA level is up-regulated between e17 and e18, 
can not be elucidated in this study, but it can be seen that the expression is 
significantly related with e18 time point.  
According to available literature, the epidermal growth factor receptor is 
known to be involved in development of skin components such as hair (Richardson 
et al, 2003). In addition, the function of EGF (activator of EGFR) was investigated in 
adipocyte differentiation of 3T3-L1 (Harrington et al, 2007). Moreover, in transgenic 
mice with a dominant negative mutation of EGFR (in skin epidermis), the 
replacement of fat layer in skin (by granulomatous tissue) was observed when they 
were a few weeks old (Murillas et al, 1995). In addition, a Waved-5 mouse, 
characterised by a highly limited EGFR-based signalling pathway, had reduced 
thickness of fat layer localised in skin between hair follicles at postnatal days 8.5 
and 10.5 (Sugawara et al, 2010). It is important to mention here that EGFR-related 
studies with mouse models are mainly focused on the analysis of EGFR role in the 
hair follicle development, and observations related with fat deposits seemed to be 
“unexpected” elements of such work (Sugarawa et al, 2010). 
The substrate organ culture technique was applied in a study where 
embryonic skin specimens at different time points were used. These were treated 
with either the inhibitor (AG1478) or activator (EGF) of EGFR in order to verify the 
role of the epidermal growth factor receptor in the regulation of adipogenesis in 
lower skin dermis. Interestingly, among three selected time points (e15 - 15.5, e16 - 
17 and e18.5 - 19), only skin pieces from 16 - 17 day old mouse back skin were 
influenced by inhibitor of EGFR as no staining was seen in these pieces when 
incubated in AG1478, whereas incubation in the normal medium revealed the 
presence of fat droplets in skin specimens.   
 Because the inhibitory effect was seen in dermis area, whereas the red dye 
still stained a fat depot present beneath the dermal layer, a suggestion could be 
made that dermal adipose tissue and the subcutaneous fat layer (beneath the skin) 
do not share the same regulatory mechanism which control adipogenic 
differentiation in vivo. In addition, specimens from this particular time point, looked 
less healthy than samples grown in normal media. A question can be asked if this 
result is related with a potentially toxic concentration of the inhibitor that “destroyed” 
whole skin or if it was related with the inhibition effect of AG1478 on used skin. If the 
second explanation is true, AG1478 either inhibited development of fat cells in lower 
dermis and the lack of the adipocytes disrupted the proper growth of skin. On the 
other hand, the inhibitor of EGFR could influence first epidermis and different dermal 
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cells and as an effect of that, the development of fat cells was inhibited as the 
crucial cell-cell signals in skin were inhibited by AG1478.  
It seemed that the “decision” about right time point in relation to the control of 
adipocyte differentiation in skin is crucial for such organ culture experiments, The 
inhibitory effect on lipid accumulation was seen at  e16 - 17 time point but not for 
example in 18.5 - 19 day old embryonic back skin. Probably when skin from younger 
animals was chosen, the concentration of AG1478 was sufficient to inhibit low levels 
of EGF receptors in lower dermis and this lead to a final inhibition of fat 
accumulation. Then, when such experiment was performed on skin from e18.5 - 19 
time point (where the up-regulation of EGFR is seen in lower dermis versus upper 
dermis, based on microarray data and qRT-PCR), the same concentration of 
AG1478 was not sufficient to inhibit EGFR and then inhibition of fat accumulation 
could not take place (for example because of too low amount of inhibitor and high 
up-regulation of EGFR in older skin).  
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4.4.2. The analysis of skin cells by two- and three-dimensional 
technologies. 
 As it was discussed in previous section, it is possible to analyse the lipid 
accumulation in the intact skin pieces by the in vivo-like organ culture. The next step 
of the study was to investigate features of embryonic skin dermal cells from different 
time points, without the epidermal layer. As the epidermal-dermal interactions are 
crucial for the development of hair follicles, the removal of epidermis could help to 
determine if such interactions exist in relation to dermal adipose layer development.  
The Oil Red O staining of young embryonic mouse back skin sections (e15 - 
15.5 time point) showed no lipid accumulation, and the first lipid droplets in lower 
dermis were only seen at later stages of embryonic development (e18.5 - 19) 
(section 4.3.3). Therefore it was interesting to investigate if the removal of epidermal 
layer could influence the features of dermal cells at e15 - 15.5 and at e18.5 - 19 time 
points. In addition, as lipid droplets were not seen along the whole dermis at the 
younger time point, the question arose if all dermal cells at this time point represent 
the same cell type, and that during the embryonic development different signalling 
pathways determine the adipogenic differentiation in the lower dermis. 
 
First, an efficient cell culture method was investigated for this study in order 
to be able to recreate an in vivo environment. Cell culture techniques on plastic 
substrates are the most popular technologies for the analysis of adherent cell 
activities. Most of the key knowledge on fat cell differentiation was obtained from 
such two-dimensional cell lines, such as 3T3 cells (for more details see Chapter 1, 
section 1.3). However, it is also known that the restriction of cells to two-dimensions 
limits many real interactions with other cells that might normally happen in the body. 
Therefore, a spheroid cell culture method was introduced in this study. Cells are 
seeded into suspended media droplets wherein they aggregate into a 3D spherical 
structure. This method has been successfully applied for the recreating of hair 
follicle structures (Higgins et al, 2010). In work, described in section 4.3.4.1 this 3D 
technique was initially tested on human skin fibroblasts and hair follicle dermal 
papilla cells. The analysis of nuclear envelope proteins in both 2D and 3D cell 
structures showed that cells in spheres had nuclear structures more similar to those 
in cells from intact hair follicle end bulbs (compare Figure 4.12 with Figure 4.13). 
Cultured DP cells are capable of differentiation into adipogenic or osteogenic lines 
and they are considered as an example of adult stem cells (Jahoda et al, 2003). 
Therefore both 2D and 3D cultures from human DP cells were analysed because of 
their lipid accumulation capabilities. The fact that DP cells in 3D structures were less 
                                                                                                           Chapter 4 
 311 
prone to lipid accumulation than fibroblast cells suggests that they may be partially 
recovering or returning to their origin as an intact hair follicle DP. In this context they 
would be reflecting the more differentiated DP role of controlling hair follicle activities, 
and might therefore become less sensitive to adipogenic influences. Assuming that 
this is true and combining it with suggestions from Higgins et al (2010) that spheroid 
cell culture method can help to investigate “real” processes in hair follicle end bulbs 
(in relation to DP structure), this method could be a very useful in-vivo like tool for 
analysis of skin compartments. Therefore, spheroid cell culture method was applied 
in this thesis for the analysis of other cells from skin. 
 
After the successful enzymatic removal of the epidermis from skin of 15 - 
15.5 and 18.5 - 19 days old mouse embryos, dermal cells were able to grow as both 
2D and 3D cultures. It was observed that cells from younger animals lacked lipid 
accumulation capability when grown as 2D cultures in normal medium, but the 3D 
structures were intensively stained by Oil Red O. In addition, such high 
accumulation of the lipids was not seen in 3D cultures obtained from older animals 
grown in normal (control) media (Figure 4.17 and Figure 4.18). Assuming the 
spherical cell culture method mimics the in vivo environment, dermal cells cultured 
in three-dimensional structures could behave as in vivo, but without an epidermal 
layer. Then, the high lipid accumulation in 3D structures at the earlier time point 
could occur due to the fact that these young dermal cells are representatives of 
undifferentiated cells with a high adipogenic capacity which would ordinarily be 
inhibited by the epidermal layer. The absence of epidermal layer, leads to 
uncontrolled differentiation of such cells into adipocytes. The dermal cell population 
at this earlier time point seemed to be potential progenitor of fat cells, as cross-
sections from dermal cell spheres kept in normal medium were stained by the red 
dye.  
Furthermore, the dermal cell population, obtained from 18.5 - 19 day old 
mouse embryos seemed to be characterised by the presence of two cell types, as in 
3D structures from this time point that were kept in normal medium, small lipid 
droplets were surrounded by many lipid-free areas. Probably at this stage of 
embryonic development, one population of cells is being committed to adipogenesis 
(cells in the lower dermis area), the second type of cells (from the upper dermis) are 
not committed to undergo such adipogenic differentiation. These cells from the later 
embryonic developmental stage already “know who they are” and are less plastic 
than younger dermal cells (from e15 - 15.5 time point). Therefore, in the 3D 
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structure, without the epidermis layer, already committed/differentiated cells can not 
be influenced by the lack of epidermis in the same extent as younger dermal cells.  
 
In order to further investigate features of dermal cells and their capability to 
accumulate lipids, the fluorescence activated cell sorting (FACS) was applied to 
isolate, two distinguishable dermal cell types: those fated to become adipocytes and 
those which cannot become adipocytes. This study is presented in Chapter 5. 
 
 
  
 
 
Chapter 5:  
The fluorescence activated cell sorting 
(FACS) technique as an efficient tool 
for the analysis of cell populations 
from mouse embryonic back skin. 
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5.1. Introduction. 
 Chapter 5 describes an approach for the isolation of cells from mouse 
embryonic back skin dermis by a flow cytometry-based technique. Flow cytometry is 
a widely used method for the analysis of cell features, such as cell size, cytoplasmic 
complexity or a presence of specific proteins on cell surface (Mandy et al, 1995). 
The fluorescence activated cell sorting (FACS), based on flow cytometry rules, is 
also a widely used method for the investigation of cell features and provides a 
method for sorting specific cell types from a heterogeneous mixture of cells 
(Herzenberg et al, 2002). The flow cytometry technique has been applied in studies 
on mature rat adipocytes (Bernstein et al, 1989). FACS technology was used to sort 
fat cells from a differentiated murine embryonic stem cell line where adipocytes were 
sorted from heterogeneous cells based on Nile red staining and cell granularity 
(Schaedlich et al, 2010). Nile red is an intensely fluorescent dye that stains lipid 
droplets. Schaedlich et al (2010) showed that sorted cells with increased granularity 
and high uptake of the Nile Red expressed (at the mRNA level) adipsin, adiponectin 
and leptin, known products of mature adipocytes. 
It has been reported that when working with mature fat cells, the size ranges, 
presence of fat globules and tendency to aggregate, makes adipocytes quite a 
demanding material for the flow cytometry analysis (Bernstein et al, 1989).   
 
In this thesis a FACS-based approach was developed in order to sort dermal 
cells that started adipogenesis but were not fully developed fat cells (Figure 5.1). 
First, a marker for fat cells from lower embryonic skin dermis was investigated that 
could be applied for the FACS study. The microarray data from embryonic skin 
dermis, presented in Chapter 3, highlighted two potentially useful surface antigens 
(CD36 and Fzd4) of which one (CD36) proved to be a reliable marker for FACS 
work. CD36 is a known membrane protein of adipocytes that binds long fatty acids 
and its role in regulation of fatty acid metabolism was suggested (Rodrigue-Way et 
al, 2007; Pohl et al, 2005). Fzd4 is a member of a family that encodes receptors for 
Wnt proteins and its expression was shown to be enriched in white adipose tissue 
(peri-uterine fat pads) isolated from 8 weeks old mice (Gupta et al, 2010; Soukas et 
al, 2001). After the successful sort of two dermal cell populations (CD36 positive and 
negative cells) and the analysis of their gene expression profile (by the qRT-PCR), 
the spheroid cell culture method was applied to mimic an in vivo environment of 
sorted cells. The spheroid method, introduced in Chapter 4, helped to grow sorted 
dermal cells in three-dimensional conditions where the presence of fat specific 
genes and their capability to accumulate lipids was investigated by, 
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immunofluorescence and Oil Red O staining respectively. The hypothesis tested in 
this Chapter was that CD36 positive cells, isolated by FACS method from mouse 
embryonic back skin, represent the lower dermal cell population that is predisposed 
to undergo adipogenesis and has a capability to accumulate lipids. 
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Figure 5.1. Summary of work presented in Chapter 5. Study aimed to develop 
efficient method for fluorescence activated cell sorting (FACS) experiment on mouse 
embryonic dermal cells.   
Establishment and optimization of experimental methods 
for the fluorescence activated cell sorting (FACS) study on 
mouse embryonic dermal cells.  
Selection of mouse 
embryos age for FACS 
work (based on the 
investigation of first lipid 
droplets in mouse 
embryonic back skin 
dermis described in 
Chapter 2). 
 
Selection of antibodies for 
FACS work (based on 
dermis microarray data 
from Chapter 3). 
 
Preparation of single-
dermis cells suspension 
from mouse back skin 
(based on a method 
from Chapter 4). 
 
The fluorescence activated cell sorting (FACS) experiment and technical aspects of 
the FACS sort performed on FACS Aria II cell sorter (BD Bioscience) machine. 
 
 
                                       
                                          The analysis of FACS sorted cells: 
 
Establishment of an efficient method for growing FACS 
sorted cells. 
Gene expression profile of 
FACS sorted cells analysed 
by the qRT-PCR reaction. 
 
The growth of FACS-sorted cells in two-dimensional 
(2D) and three-dimensional (3D) cell structures in 
normal/growth medium and adipogenic medium and 
further analysis of these structures. 
 
Immunofluorescence 
analysis of fat-related 
factors/proteins in 2D and 
3D structures. 
2D and 3D cell 
structures stained by 
Oil Red O to detect 
lipids. 
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5.2. Methods. 
A schematic representation of the strategy and processes used in this 
chapter is shown in Figure 5.1.  
Briefly, this work could be split into three stages. The first involved 
optimisation of the methods for obtaining dissociated cells from skin of an 
appropriate age, and of the ideal antibody concentration. The second stage was to 
devise an efficient sorting strategy to obtain sufficient viable cells. The final element 
was directed at validation of the initial sorted populations and then investigations of 
their adipogenic potential.  
 
The flow cytometry work was performed in the Institute of Human Genetics 
(Bioscience Centre; International Centre for life) in Newcastle Upon Tyne, by Dr 
Rebecca Stewart and Mr Ian Dimmick. This work required a journey of 15 - 20 miles 
between Durham and Newcastle therefore there was a delay between dermal cells 
dissociation and final sorting as well as sorting process and culturing of these cells. 
During the journey samples were kept on ice and in the dark. 
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5.2.1. 3T3-F442A cells for the titration work. 
 3T3-F442A cells (kindly provided by Dr Ewa Markiewicz, Durham University) 
were grown in T75 flasks in control medium that consisted of D-MEM with 
GlutaMaxTM (Gibco), 10% NCS, 2% penicillin/streptomycin, 1x Glutamine 
(Invitrogen/Fisher, Sigma) or adipogenic medium (for ingredients see Chapter 4, 
Table 4.1). Next, cells were prepared for the flow cytometry work. First, cells were 
washed in cell culture PBS, and approximately 2 - 3 ml of trypsin with EDTA (Gibco) 
was added for 1 - 2 min. The trypsinisation was stopped by adding 2 ml of MEM-
minimum essential medium (Sigma) with 10% FBS-foetal bovine serum (Sigma) with 
or without antibiotics (for antibiotics details see section 5.2.3) and cells were 
centrifuged 1000 rpm for 5 min. Then, supernatant was removed and the pellet was 
washed in sterile DPBS (Gibco) and centrifuged (1000 rpm, 5 min). Next, the pellet 
was re-suspended in 1 ml of sterile DPBS. In case of cell clumps DNase I was 
added (see Appendix I). Samples (approximately 1 million cells per sample) were 
incubated with antibodies (Table 5.1) and analysed on the flow cytometry machine. 
The minimal working amount of antibodies was 6 µl for the antibody against CD36 
and 5 µl for the antibody against Fzd4 (Figure 5.2 in section 5.3.1). 
 The titration experiment was done on a 3 laser FACSCanto II machine (BD 
Biosciences) with the BD FACSDiva v6.0 software. 
 
5.2.2. Housing, breeding and feeding conditions of rodents used for 
FACS work. 
The detailed information about animals breeding and maintaining conditions 
are presented in Chapter 2, section 2.2.1. 
 
5.2.3. Dermal cells from mouse embryonic back skin. 
Skin splitting was performed on 18.5 - 19 day old mouse embryos. Embryos 
were collected into sterile Petri dishes filled with medium (MEM - minimum essential 
medium from Sigma; antibiotics: 2 µl/ml Fu - fungizone from Sigma and 1 µl/ml Ge - 
gentamicin from Gibco). Next, embryos were attached to 5% agar in a Petri dish, 
and medium (MEM; Fu & Ge antibiotics) was added in order to avoid drying of skin. 
The back skin was cut off from the animals (for details see Chapter 4, Figure 4.2). 
Each skin sample was carefully separated from muscle and cut into small (maximum 
size: 2.5 mm x 3 mm), rectangular pieces. Pieces of back skin were collected into a 
watch glass filled with 500 µl of MEM with antibiotics and kept on ice. Next, skin 
samples were washed twice in 1 ml of sterile DPBS and transferred into a new 
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watch glass with 250 µl of cold, filtered solution of 5% trypsin (BD)/6% pancreatin 
(Sigma)/DPBS (1:1:2) and incubated for 40 - 60 min in 4oC in order to separate 
dermis from epidermis. Next, the epidermis was carefully removed from each piece 
of skin using forceps, and the dermis was placed in a watch glass filled with 500 µl 
of MEM with antibiotics. 
All collected dermal pieces were washed (once or twice) in 1 ml of sterile 
DPBS and transferred into a new watch glass with 1 ml of warm collagenase II with 
DNaseI (Appendix I) and incubated for approximately 15 min at 37oC (in 5% CO2) in 
order to obtain single cells from dermis. Next, the dissociation was continued 
mechanically by 200 µl tip pipette. After 5 min of mechanical dissociation, a fresh 
200 - 600 µl of collagenase II with DNaseI working solution was added and sample 
was kept for 5 - 10 min at 37oC (in 5% CO2). Finally, the mechanical dissociation 
was continued till all dermis pieces were separated into single cells.  Next, the 
sample was transferred into 1.5 ml Eppendorf and centrifuged at 3000 - 3300 rpm 
for 5 min at room temperature (RT). The supernatant was removed and 1 ml of 
sterile DPBS was added to the pellet. In order to keep single cell suspension and to 
avoid cell clumping, the DNaseI was added to a final concentration of 50 µg/ml. 
In addition, all steps of dermal cells preparation for FACS sort were 
performed under the hood and with sterilized tools (120oC; 60 min) and enzymatic 
solutions were filtered (0.2 um) to minimize any potential contamination of skin 
samples. 
 
5.2.4. The fluorescence activated cell sorting (FACS) of dermal cells. 
In order to perform a FACS sort, isolated dermal cells were incubated with 
flurochrome-labelled antibodies (Table 5.1). The number of cells used for the sort 
and the optimal amount of antibodies was established during several experiments 
as discussed in sections 5.3.2 - 5.3.4. The incubation with antibodies lasted up to 2 
hours, on ice and in the dark. Then, cells were washed in DPBS, centrifuged (3000 
rpm; 5 min) and suspended in several ml of fresh DBPS. Just before the FACS sort, 
cells were put through a 30 micron filter (Partec UK) to eliminate any clumps. 
 
 First, unstained (control) cells were analysed on the FACS machine to check 
non-specific signal (auto-fluorescent background) from the dermal cells. Next, 
experimental cells, stained with antibodies were processed through the machine. 
Several cell populations were collected: Negative cell population (no signal for used 
antibodies/markers), CD36+ cells expressing CD36, Fzd4+ cells expressing Fzd4 
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and dual population of cells expressing both CD36 and Fzd4. Different amounts of 
cells were collected in different experiments in order to find the optimal number of 
cells that should be sorted for further analysis (sections 5.3.2 - 5.3.4). 
The fluorescence activated cell sorting (FACS) was performed on FACS Aria 
II cell sorter (BD Bioscience) with 100 micron nozzle at 20PSI and on the BD 
FACSDiva v6.0 software. 
 
Table 5.1. Details of antibodies used for the FACS sort work. 
FACS 
antibodies: 
Fluorochrome: Type: Concentration: Company: 
 
CD36 
 
Allophycocyanin (APC) 
 
Anti-mouse 
 
0.2 mg/ml 
 
BioLegend 
 
Fzd4 
 
Phycoerythrin (PE) 
 
Anti-
human/mouse  
 
 
0.025 mg/ml 
 
R&D 
Systems 
 
 
The final optimized FACS sort protocol (in relation to section 5.3.4). 
Up to 14 embryos provided the dermal cells that were finally suspended in 
sterile DPBS. The DNase I was added before the staining (to a final concentration of 
a 50 µg/ml) and 800 µl of these cells were stained with 36 µl of CD36 antibody. The 
amount of stained cells used for FACS was about 10 million/ml. These cells were 
used for the FACS. In more detail, 200 000 cells (for each analysed cell population) 
were collected into sterile 1.5 ml Eppendorf with 200 µl of medium (MEM; 10%FBS; 
antibiotics: Fu and Ge), these were immediately placed on ice for transportation. In 
total four samples, with 200 000 cells per each sample, were collected for the 
Negative cell population and four for the CD36 positive cells. One sample of each of 
the collected cell types (one for the negative cells and one of the CD36 positive 
cells) was used for RNA isolation, the second and third for the establishment of 2D 
structures and the fourth for the 3D structures. 
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5.2.5. The analysis of FACS sorted cells. 
5.2.5.1. DNA/RNA work. 
Cells, from the sort, were collected into the 200 µl of warm growth medium  
(MEM - minimum essential medium from Sigma; 10% FBS - foetal bovine serum 
from Sigma; antibiotics: 2 µl/ml Fu - fungizone and 1 µl/ml Ge - gentamicin) and kept 
on ice until centrifuged (2000 rpm; 3 min and if needed for additional 2000 rpm; 1 
min). Then, cells were suspended in a total volume of 150 µl of the RLT buffer 
(Qiagen) with beta-mercaptoethanol (b-ME) and kept in -80oC. 
 
5.2.5.1.1. RNA isolation. 
The RNeasy® kit with RNeasy MinElute® columns (Qiagen) were used for 
the RNA isolation from FACS sorted cells. The purification of total RNA from animal 
cells was performed according to the RNeasy®Micro handbook with a few 
modifications in order to enhance the efficiency of cleaning process.  
Briefly, to the 150 µl of prepared samples, additional RLT buffer with b-ME 
(mercaptoethanol) was added to the final volume of 350 µl. Next, one volume of 
70% ethanol (prepared from Sigma’s molecular biological grade ethanol) was added 
to each sample, mixed and transferred to a RNeasy MinElute® spin column and 
centrifuged (>=10 000 rpm; 15 sec). The flow-through was placed once again on the 
column and centrifuged (10 000 rpm; 15 sec). Then, the flow-through was discarded 
and column was washed with 350 µl of buffer RW1 (>=10 000 rpm, 15 sec). Next, 
the DNase digestion step was applied, where 10 µl of DNase I stock solution 
(Qiagen) with Buffer RDD (Qiagen) was placed on the RNeasy MinElute® spin 
membrane and samples were left for 15 min at RT. Then, 350 µl of Buffer RW1 was 
added to columns and samples were centrifuged (>=10 000 rpm; 15 sec). The flow-
through was discarded, 500 µl of Buffer RPE was added and samples were 
centrifuged (>=10 000 rpm, 15 sec). The flow-through was discarded. Then, 500 µl 
of 80% ethanol was added to columns which were then centrifuged (>=10 000 rpm, 
2 min) and the flow-through was discarded. Columns were placed in new collection 
tubes and centrifuged with open lids at full speed for 5 min. Then, columns were 
placed in new 1.5 ml collection tubes and 14 µl of warm (68oC) RNase-free water 
was added to the centre of the spin columns. Columns with warm water were 
incubated for 5 min at RT and centrifuged for 1 min at full speed for the RNA elution. 
The flow-through was placed once again on the column and centrifuged for 1 min at 
full speed. Finally, the purified RNA was used for the cDNA synthesis. 
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5.2.5.1.2. First-strand cDNA synthesis. 
The concentration of purified RNA from FACS sorted cells was checked on 
the NanoDrop® Spectophotometer ND-1000 (with ND-1000 v3.5.2. software) and 
approximately 490 ng of total purified RNA from each sample was used for the 
cDNA synthesis.  
 The SuperScript® III RT kit (Invitrogen) was used for this step. Briefly, each 
sample for cDNA synthesis contained total RNA (490 ng), 1 µl of oligo(dT), 1 µl of 
10mM dNTP mix (Bioline) and RNase free water (to a total volume of 13 µl) and was 
heated to 65oC for 5 min and immediately placed on ice for at least 1 min. Then, a 
7 µl of master mix was added to each sample (4 µl of 5 X First Strand Buffer; 1 µl of 
0.1 M DTT, 1 µl of SuperScriptTM III RT and 1 µl of RNase free water per each 
sample) that was then incubated for 60 min at 50oC. The reaction was inactivated by 
incubation for 15 min at 70oC. All incubation steps were performed on a Biometra 
PCR machine with the lid temperature set up for 99oC. The cDNA was stored at  
-20oC. 
 
5.2.5.1.3. The quantitative RT-PCR reactions. 
The synthesized cDNA from FACS sorted cells was used for the 
investigation of mRNA levels by the quantitative RT-PCR technique. 
 
The cDNA was diluted 1 to 6 in RNase free water and used for the qRT-PCR 
reactions. Briefly, each reaction contained 1 µl of diluted cDNA, 1 µl of 2.5 µM 
forward and reverse primers mix, 10 µl of Power SYBR Green PCR Master MIX 
(Applied Biosystems) and 8 µl of sterile miliQ water. For control samples, no cDNA 
was added. For each set of primers and each cDNA sample, four reactions were 
prepared as repeats. The reactions were performed on 96-well plates (MicroAmp® 
Fast Optical 96-Well Reaction Plate with Barcode, 0.1 ml, Applied Biosystems) 
covered with  MicroAmp® Optical Adhesive Film, Applied Biosystems) on the 7500 
Fast Real-Time System with compatible 7500 Fast System (SDS version 1.4) 
software (Applied Biosystems). Conditions for PCR reactions are shown in Chapter 
3, Table 3.1. Primers used for this analysis are presented in Chapter 3, Table 3.2.  
 
Once the Ct values were obtained, the three samples with the most similar 
Ct values were used for further analysis of relative mRNA expression and the Delta-
Delta-Ct (ddCT) algorithm was applied for this purpose. The baseline (1-fold 
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change) was set up for Negative cells and changes in the expression level in CD36 
positive cells were checked according to this baseline. 
To ensure consistency for each run, dermal cells derived from the embryos 
of one mother were FACS sorted and used for the qRT-PCR analysis. 
  
5.2.5.2. Establishment of two-dimensional (2D) and three-dimensional 
(3D) cell structures from FACS sorted cells.  
Sorted cells were collected into 200 µl of warm MEM with 10% FBS and 
antibiotics (2 µl/ml Fu 1 µl/ml Ge). Cells were kept on ice until used for both two-
dimensional (2D) and three-dimensional (3D) cell structures. 
 
For 2D cell culture, sorted cells were placed either in 35 mm dishes (for the 
Oil Red O staining: approximately 50 000 cells per 35 mm dish, with 1 ml of growth 
medium) or on 60 mm dishes with coverslips (for immunoflorescence: approx. 
100 000 cells, per dish, with 1 ml of growth medium) and left in the incubator (37oC; 
5% CO2) for 90 - 160 min to settle down. Next, medium was changed for fresh 
growth medium and adipogenic medium (Table 5.2), cells were incubated for either 
2 or 4 days (37oC; 5% CO2) after which lipid and immunofluorescence analysis were 
performed (sections 5.2.5.3 and 5.2.5.4).  
 
3D cell structures were established according to protocol described in 
Chapter 4, section 4.2.5.4. Spheres were created after first 24 hours of incubation at  
37oC with 5% CO2. Once formed, three dimensional cell structures were transferred 
by 10 microlitre tip (under the microscope) into fresh media drops (prepared from 
fresh growth medium and adipogenic medium). 3D structures were then incubated 
for either 2 or 4 days (37oC; 5% CO2) and finally transferred into the Tissue Tek, 
carefully frozen in the liquid nitrogen and kept in -80oC. Next, 7 µm sections of 3D 
structures (cut on the cryostat) were used for the lipid detection and the 
immnofluorescence analysis (sections 5.2.5.3 and 5.2.5.4). 
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Table 5.2. Components of the growth and adipogenic medium used for FACS sorted 
cells. 
Type of medium: Components of medium: 
 
Growth medium MEM - Minimal Essentium Medium 
Antibiotics: 2µl/ml fungizone; 1 µl/ml gentamycin 
10% FBS - Foetal Bovine Serum 
Adipogenic medium 
(differentiation medium) 
MEM - Minimal Essentium Medium 
Antibiotics: 2µl/ml fungizone; 1 µl/ml gentamycin 
15% Rabbit Serum (Sigma) 
2.07µM Insulin        (Sigma) 
100nM Dexamethasone – DEX (Sigma) 
0.45mM 3-isobutyl-1-methylxanthine - IBMX (Sigma) 
 
 
5.2.5.3. The Oil Red O staining protocol. 
The Oil Red O dye was used in order to investigate lipid accumulation in 
FACS sorted cells that were incubated in growth and adipogenic medium (as 2D 
and 3D structures) for four days. All steps of the lipid detection were performed at 
room temperature (RT). 
 
 2D cell structures were washed in PBS (3 x PBS; few min), fixed in the 
calcium formal solution for 10 min, incubated with 60% isopropanol (approximately 5 
min) and kept in the Oil Red O working solution for up to 10 min, then washed by 
60% isopropanol and PBS (see Appendix I for details of calcium formal solution and 
section 2.2.4 for the Oil Red O working solution). 2D cells structures were kept in 
PBS, in 4oC. 
Sections from spheres, cut on the cryostat and placed on superfrost slides 
(VWR), were air dried (up to 90 min) and used for the lipid detection. The lipid 
detection was performed according to protocol used for 2D cells (see above). For 
better fixation of spheres, an alternative protocol was applied where the incubation 
in the calcium formal lasted for 1 hour, then samples were incubated in 60% 
isopropanol for 15 min and in Oil Red O working solution for 15 min. Some sections 
with 3D cell structures underwent an additional washing step with 60% isopropanol 
in order to fully remove red dye not attached to lipids (and avoid background/non 
specific staining). Slides with spheres were then mounted with mowiol (Appendix I) 
and covered by coverslips. 
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The analysis of lipid accumulation was performed either on Zeiss Axio 
Imager.M1 (with the OpenlabTM Improvision® software) or on PALM MicroBeam 
Zeiss Microscope, CryLaS, FTSS 355-50 (with PALM@Robo v3.2 software).  
5.2.5.4. Immunofluorescence analysis of FACS sorted cells. 
The analysis of C/EBPalpha was performed on established 2D and 3D cell 
structures that were incubated 2 days in growth and adipogenic medium. Detection 
of FABP4 was performed on structures kept 4 days in both types of media. 
 The immunofluorescent analysis of stained samples was performed on the  
Zeiss Axio Imager.M1 (with the OpenlabTM Improvision® software). 
 
5.2.5.4.1. Protocol for the C/EBPalpha detection.  
 Both, 2D and 3D cell structures were first fixed 15 min in 4% 
paraformaldehyde (Sigma)/PBS at room temperature (RT) and 5 min in 0.5% Triton-
X100 (Sigma)/PBS (at 4oC). Then cells were washed in PBS (3 x PBS; 5 min) and 
blocked in 20% donkey serum/PBS (Sigma) for 30 min, at RT. Fixed  cells were 
incubated (up to 90 min, at RT) with primary antibodies (diluted in 1% donkey 
serum/PBS) against C/EBPalpha (rabbit antibody, dilution 1:100, Santa Cruz 
Biotechnology). Next, cells were washed in PBS (3 - 5 x PBS; 1 - 5 min) and 
incubated (up to 90 min, at RT) with secondary antibody: AlexaFluor® 488 donkey-
anti rabbit, FITC conjugated (diluted 1: 500, Table 3.3.B.) and DAPI (diluted 1:5000). 
Secondary antibody with DAPI was diluted in 1% donkey serum/PBS. Finally, 
samples were washed in PBS (3 - 5 x PBS; 1 - 5 min), mounted with mowiol 
(Appendix I) and 2D and 3D cells were covered with coverslips.  
 
5.2.5.4.2. Protocol for the FABP4 detection. 
Both, 2D and 3D cells were first fixed 10 min in 100% acetone (Sigma; at -
20oC) and 10 min in 100% methanol (Sigma; at -20oC). Then cells were washed in 
PBS (3 x PBS; 5 min) and blocked in 20% donkey serum/PBS (Sigma) for 30 min, at 
RT. Fixed cells were incubated (90 min, at RT) with primary antibodies (diluted in 
1% donkey serum/PBS) against FABP4 (goat antibody, dilution 1:50, R&D 
Systems). Next, cells were washed in PBS (3 - 5 x PBS; 1 - 5 min) and incubated 
(60 min, at RT) with secondary antibody: AlexaFluor® 488 donkey-anti goat, FITC 
conjugated (diluted 1:500) and DAPI (diluted 1:5000). Secondary antibody with 
DAPI was diluted in 1% donkey serum/PBS. Finally, samples were washed in PBS 
(3 - 5 x PBS; 1 - 5 min), mounted with mowiol (Appendix I) and 2D and 3D cells 
were covered with coverslips. 
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5.3. Results. 
5.3.1. The investigation of a surface marker for lower dermal cells 
committed to adipogenesis in mouse embryonic back skin. 
The microarray data, presented in Chapter 3, was examined for a gene 
highly expressed in lower dermal compartment, whose enrichment would take place 
from e17 to e19 time point and which encoded a membrane protein. The specific 
localisation and high expression of this gene in lower dermis was required for the 
selection of cells that, based on the Oil Red O analysis (Chapter 2) were gradually 
accumulating lipids in embryonic skin dermis and create dermal adipose tissue in 
lower dermis. In addition, the specific protein localisation on cell surface was crucial 
for the performance of fluorescence activated cell sorting (FACS) on dermal cells.  
 
Two candidates were found, namely CD36 and Fzd4 (Table 5.3 and Table 
5.4). Both genes were enriched in lower dermal cells when compared with upper 
area of dermis and their expression level increased in the lower skin compartment 
from e17 till the e19 time point (Table 5.3. and Table 5.4). Based on the fold change 
values the enrichment of Cd36 was higher when compared with Fzd4 gene.  
 
Due to this specific expression pattern of CD36 and Fzd4, two antibodies 
were chosen with different fluorochromes in order to perform an analysis of both 
potential markers during the same sort procedure (Table 5.1). An anti-Fzd4 antibody 
was conjugated with phycoerythrin (PE), whereas an anti-CD36 antibody was 
characterised by a presence of allophycocyanin (APC). 
 
The final FACS sort protocol was successfully optimized for anti-CD36 
antibody (sections 5.3.2 - 5.3.4). For the verification work of the expression profile of 
Cd36 gene in embryonic skin dermis, the qRT-PCR reaction with a primer set 
designed for Cd36 gene (see Table 3.2 in Chapter 3) confirmed the significant up-
regulation of Cd36 in lower dermal cells from e17 till e19 time points, when 
compared with cells from upper dermis (see Figure 3.62A in Chapter 3). In addition, 
an attempt was made to analyse the expression of CD36 protein in embryonic back 
skin samples between e17 and e19 time points. However, the antibody (goat 
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polyclonal antibody against CD36; Santa Cruz Biotechnology) used failed to give 
conclusive results (data not shown). 
 
 
Table 5.3. The Cd36 gene expression profile in embryonic skin dermis between e17 
and e19 time points. (A) The E17, E18 and E19 microarray sub-lists revealed 
enrichment of Cd36 at mRNA level in lower dermal cells versus upper dermal cells 
at e17, e18 and e19 time points. (B) The lower dermal (LD) microarray list showed 
the up-regulation of Cd36 gene in lower dermal cells from e17 time point.   
A) 
Whole name; gene symbol; 
probe set Affymetrix ID. 
Time points: Fold change value:  
 
e17 lower dermis vs* 
e17 upper dermis 
+ 9.251164 
 
e18 lower dermis vs* 
e18 upper dermis 
+ 29.43071 
 
CD36 antigen; Cd36; 
1450883_a_at 
 e19 lower dermis vs* 
e19 upper dermis 
+ 52.71146 
 
B) 
Whole name; gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
+ 5.071104 
 
CD36 antigen; Cd36; 
1450883_a_at 
 
e19 lower dermis  
vs  
e17 lower dermis 
+ 8.146752 
 
* vs - versus 
 
Table 5.4. The Fzd4 gene expression profile in embryonic skin dermis between e17 
and e19 time points. (A) The E17, E18 and E19 microarray sub-lists revealed 
enrichment of Fzd4 at mRNA level in lower dermal cells versus upper dermal cells at 
e17, e18 and e19 time points. (B) The lower dermal (LD) microarray list showed the 
up-regulation of Fzd4 gene in lower dermal cells from e17 time point.   
A) 
Whole name; gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e17 lower dermis vs* 
e17 upper dermis 
+ 2.65587 
 
e18 lower dermis vs* 
e18 upper dermis 
+ 7.128446 
 
frizzled homolog 4 (Drosophila); 
Fzd4; 1419301_at 
 
 
 e19 lower dermis vs* 
e19 upper dermis 
+ 9.34063 
 
B) 
Whle name; gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
+ 1.518623 
 
frizzled homolog 4 (Drosophila); 
Fzd4; 1419301_at 
 
e19 lower dermis  
vs  
e17 lower dermis 
+ 2.657529 
 
* vs - versus 
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3T3-F442A cells were chosen for an antibody titration experiment. This cell 
line has been used for the investigation of adipogenesis (Pairault and Lasnier, 
1987). Confluent 3T3-F442A cells accumulated lipids, when incubated in adipogenic 
medium (compare Figure 5.2Aa, b and c).  
 
3T3-F442A cells from either control or adipogenic medium were used for 
flow cytometry analysis (Figure 5.2Ba - d). Unstained cells were used to verify 
background staining (Figure 5.2Ba and Figure 5.2Bc). Then, samples stained with 
antibodies against CD36 and Fzd4 were analysed (for minimal working volume of 
antibodies and their concentrations see section 5.2.1 and Table 5.1). A signal was 
difficult to obtain from cells kept in adipogenic medium (Figure 5.2Bd). Fortunately, 
cells from control medium revealed the presence of cells positive for either CD36 or 
Fzd4 antigen and a small population of cells stained by both antibodies was also 
observed (compare Figure 5.2Ba with Figure 5.2Bb). 
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A) 
 
B) 
 
 
 
 
 
Figure 5.2. Characterisation of adipocyte differentiation in 3T3-F442A cells.  
(A) 3T3-F442A cells stained with Oil Red O to detect lipids. (a) preconfluent cells - 
PC. (b) confluent cells kept 5 days in control medium - C 5d. (c)  confluent kept 5 
days in adipogenic medium (A 5d). (a - c) Scale bar = 100 µm. (a - c) Images were 
captured using a Carl Zeiss Axiovert 10 inverted microscope with accompanying 
AnalySIS software.  
(B) An antibody titration experiment on 3T3-F442A cells. Confluent cells incubated 4 
days in control (a and b) and adipogenic medium (c and d) underwent the flow 
cytometry analysis as cells not stained (a and c) and stained with antibodies against 
CD36 and Fzd4 (b and d). (a - d: top left panels): Two-parameter histograms: FSC-
forward scatter (size of cells), SSC-side scatter (cell-complexity or number of 
internal compartments). (a - d: top right panels): Two-parameter histograms: 
antibody against CD36 with APC-fluorochrome/1-638/67/14-A; antibody against 
Fzd4 with PE-fluorochrome/4-488/585/42-A. (a - d: bottom panels): Intensity of 
staining with specific antibodies. Cells positive for CD36 and/or Fzd4 are marked by 
green squares. 
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5.3.2. Initial FACS sort on dermal cells. 
The aim of this Chapter was to isolate cells committed to adipogenesis in 
lower skin dermis before they become mature adipocytes. The Oil Red O detection 
combined with the immunofluorescence analysis of C/EBPalpha occurrence in lower 
dermal cells, presented in Chapter 2, suggested that embryonic skin from lower 
dermis area older than e17 time point is filled with preadipocytes that express 
adipogenic tranciptional factor (C/EBPalpha) and start to accumulate first small lipid 
droplets between e18 and e19 time point. Therefore, a decision was made to 
perform FACS work on embryonic dermis between 18.5 and 19 day old. 
 
Dermal cells were obtained according to the method described in Chapter 4 
where two steps of enzymatic treatment (based on the use of trypsin, pancreatin 
and collagenase II) allowed a separation of epidermis from dermis layer and a 
dissociation of dermal layer into a single cell suspension.  
 
One pregnant mouse was the donor of embryos for a single FACS 
experiment. During initial FACS experiments, approximately 1 500 000 dermal cells 
were obtained from six embryos. First, unstained cells underwent analysis in order 
to check auto-fluorescence/background, whereas an experimental sample was 
incubated with antibodies against CD36 and Fzd4 (Figure 5.3). It was possible to 
collect cells with high levels of either only CD36 or Fzd4 as well as cells positive for 
both CD36 and Fzd4 markers (compare Figure 5.3Ac with Figure 5.3Bc). The 
highest population of collected cells was negative cells (cells devoid of CD36 and 
Fzd4). Among cells expressing antigens of interest, the highest number of cells was 
obtained for CD36 positive cells (CD36+ cells), whereas Fzd4 positive cells (Fzd4+ 
cells) and dual positive cell population (dual cell population: CD36+ and Fzd4+ cells) 
had lower numbers of cells (Figure 5.3Bc and f). 
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A) Control sample: 
 
B) Experimental sample: 
 
Figure 5.3. Initial FACS experiment. (A) non-stained cells used as control sample. 
(B) cells stained with antibodies against CD36 (APC-fluorochrome: 1-638/67/14-A) 
and Fzd4 (PE-fluorochrome: 4-488/585/42-A). (a, b, c) Two-parameter histograms. 
(d, e) One-parameter histograms. (a) FSC-forward scatter (size of cells), SSC-side 
scatter (cell-complexity or number of internal compartments). (b, c) Gating of 
singlets and collected cells. (d, e) Intensity of staining with specific antibodies. (f) % 
of events during sort reaction. 
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5.3.3. Selection of dermal cell populations sorted by FACS technology 
and their viability. 
It was important to establish optimal conditions for maintaining the viability of 
sorted cells. First, a capability to grow sorted cells as two-dimensional (2D) 
structures was tested. When sorted cells were collected into Eppendorf tubes with 
200 µl of growth medium (MEM with 10% or 20% FBS and antibiotics: Fu and Ge) 
and placed in a 4-well dish (or 35 mm dish) with growth medium, they were able to 
attach to a surface of culture dish (Figure 5.4). In addition, keeping cells on ice (in 
Eppendorf) straight after the sort and before the incubation on cell culture dishes 
seemed to improve the viability of cells.  
 
Fzd4 positive (Fzd4+) cells and dual positive (CD36+ and Fzd4+) cell 
population. 
As was mentioned in the previous section, the Fzd4 positive (Fzd4+) cell 
population was characterised by a low number of collected cells when compared 
with CD36 positive (CD36+) cells. This population had a low viability and low 
percentage of cell survival when seeded onto cell culture dishes (compare Figure 
5.4c with Figure 5.4a, b and d). Therefore this cell population was eliminated from 
further analysis.  
In addition, the number of cells positive for both markers (dual cell 
population: CD36+ and Fzd4+ cells) was lower than the CD36+ cells (Figure 5.3Bc). 
This resulted in longer time needed for the FACS in order to obtain sufficient amount 
of cells positive for both antigens. It was crucial to shorten time of the sort to 
increase cell survival, therefore a decision was made to eliminate also dual cell 
population and focus on the collection of cells displaying high levels of CD36 
antigen.  
 
CD36 positive (CD36+) cells and Negative (CD36- and Fzd4-) cell population. 
It was relatively easy to collect sufficient amount of Negative and CD36+ 
cells that were able to grow when kept as 2D cell structures for up to 7 days (Figure 
5.5a and b). In addition, CD36+ cells had a specific adipocyte-like morphology, as 
they contained of round-shaped droplets that were hypothesised to be accumulated 
lipids (Figure 5.5b). Because of this it seemed that CD36+ cells were likely to be 
cells from the lower skin dermis committed to adipogenesis.   
In addition, to enhance the number of CD36+ sorted cells, the amount of 
antibody used was increased six times in next FACS experiments (36 µl of anti-
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CD36 antibody and 30 µl of anti-Fzd4 antibody per FACS sort experiments; for 
antibody stock concentrations see Table 5.1).  
 
Two populations of CD36+ positive cells. 
One of the next steps for FACS-based study was related with modification of 
the gate for CD36 positive cells. The originally established gate for the sort of CD36 
positive population consisted of cells with the relative fluorescence intensity (for 
APC-antibody against CD36) equal and higher than 1 000 (see Figure 5.3Bc). CD36 
positive cells close to the bottom line of this gate might represent a population of 
cells with auto-fluorescence and not cells positive for CD36 antigen. Therefore an 
experiment was designed where two gates for CD36+ cells were set up: “top” gate 
for cells with the relative fluorescence signal higher than approximately 10 000 and 
“bottom” gate for cells with relative fluorescence signal between about 1 000 and 10 
000 (Figure 5.6). Two collected populations of CD36 positive cells were analysed for 
their capabilities to accumulate lipids (Figure 5.7). The Oil Red O staining showed 
that two-dimensional cell cultures from both sorted cell populations (“top” and 
“bottom”) were capable of lipid accumulation when kept in growth medium for up to 
8 days (compare Figure 5.7a with b and c). Therefore, the original (bigger) gate for 
CD36+ positive cells, with the relative fluorescence signal equal and higher than 
1 000, was treated as a sufficient for the collection of dermis cells expressing CD36 
antigen and undergoing adipogenesis. 
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Figure 5.4. FACS sorted cells placed on the 4-well dish in growth medium. Photos 
were taken approximately 24 hours after placement in the culture dish. N: Negative 
cells (CD36- and Fzd4- cells). CD36+: cells sorted as positive for antibody against 
CD36. Fzd+: cells sorted as positive for antibody against Fzd4. D: dual cells (cells 
positive for CD26 and Fzd4). (c) Fzd4+ cells that attached to cell culture dish are 
shown by white arrows. (a - d) Scale bar = 100 µm. Photos were taken on the 
inverted microscope Carl Zeiss Axiovert 10 with accompanying AnalySIS software.  
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Figure 5.5. FACS sorted cells kept in the growth medium for several days. N: 
Negative cells. CD36+: cells sorted as positive for antibody against CD36. (a - b) 
Scale bar = 1 mm. Photos were taken using an inverted microscope Zeiss Axiovert 
200M microscope with accompanying AxioVision Rel.4.8 Imaging System software.  
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A) Control sample: 
 
B) Experimental sample: 
 
Figure 5.6. The FACS sort experiment with modified gates for cells. (A) non-stained 
cells used as control sample. (B) cells stained with antibodies against CD36 (APC-
fluorochrome: 1-638/67/14-A) and Fzd4 (PE-fluorochrome: 4-488/585/42-A). (a, b, c) 
Two-parameter histograms. (d, e) One-parameter histograms. (a) FSC-forward 
scatter (size of cells), SSC-side scatter (cell-complexity or number of internal 
compartments. (b, c) Gating of singlets and collected cells. (d, e) Intensity of staining 
with specific antibodies. (f) % of events during sort reaction. “T” – Top gate for CD36 
positive cells. “B” – Bottom gate for CD36 positive cells.   
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Figure 5.7. Analysis of two-dimensional (2D) structures derived from FACS sorted 
cells. Oil Red O staining was performed after 8 days of incubation in growth 
medium. a) N - Negative cells. b) CD36+ T - CD36 positive cells collected from the 
“top” gate. c) CD36+ B - CD36 positive cells collected from the “bottom” gate. (a - c) 
Scale bar = 30 µm. Photos were taken using a Zeiss Axio Imager.M1. microscope. 
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5.3.4 Detailed analysis of CD36 positive (CD36+) and Negative FACS 
sorted cells. 
The final, optimized FACS (see section 5.2.4 for protocol) resulted in the 
collection of sufficient amount of CD36+ cells, together with Negative cells (Figure 
5.8). These cells were used for the analysis of mRNA expression profile and to set 
up two-dimensional and three-dimensional cell cultures. 
 
The mRNA expression of fat-related genes in FACS-sorted cells. 
In order to obtain a gene expression profile of sorted cells, several genes 
were chosen (Figure 5.9) based on microarray data generated from mouse 
embryonic skin dermis (Chapter 3).  The qRT-PCR reaction with primers for Cd36 
gene confirmed its high mRNA level in CD36+ sorted cells (Figure 5.9a).  
Interestingly, a very high up-regulation of Fabp4 gene was observed in 
CD36+ cells (Figure 5.9b). This fatty acid binding protein 4, was highly enriched in 
mouse embryonic lower dermal cells between e17 and e19 time points on both gene 
and protein levels (microarray data in Chapter 3; see Table 3.4, Figures 3.10B and 
3.11). In addition, several other adipocyte-related genes, such as adiponectin 
(AdipoQ), GO/G1 switch gene, carbonic anhydrase (CarbAnhyd), haptoglobin, 
retinol binding protein 4 (Rbp4) and Major urinary proteins (MUPs) were highly 
enriched in lower dermal skin compartment according to microarray data (Chapter 
3). All these genes were also enriched in CD36+ cell population (Figure 5.9b, c and 
Figure 5.9f - j). Genes for two crucial adipogenic transcriptional factors, C/EBPalpha 
and PPARgamma, were also up-regulated in CD36+ cells (Figure 5.9d and e).  
 
In addition, two other genes (Gremlin2 and Trps) were also analysed in 
FACS-sorted cells, because of their up-regulation in upper dermis, where no lipid 
accumulation was seen (Chapter 3). Both these genes had higher mRNA levels in 
negative sorted cells when compared with CD36+ cells (Figure 5.8k and Figure 
5.8l). 
 
This preliminary work showed that CD36+ cells are characterised by an 
enrichment of fat-related genes when compared with CD36 negative sorted cells 
and they seemed to represent cells from lower dermal area of mouse back skin. 
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A) Control sample:  
 
B) Experimental sample: 
 
Figure 5.8. The final FACS sort experiment. (A) non-stained cells used as control 
sample. (B) cells stained with antibodies against CD36 (APC-fluorochrome: 1-
638/67/14-A). (a, b, c and e) Two-parameter histograms. (d, f) One-parameter 
histograms. (a) FSC-forward scatter (size of cells), SSC-side scatter (cell-complexity 
or number of internal compartments). (b, e) Gating of singlets and collected cells. (d, 
f) Intensity of staining with specific antibodies. (g) % of events during sort reaction. 
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Figure 5.9. The analysis of relative mRNA expression of selected genes in two 
populations of FACS sorted cells. The relative expression was analysed in CD36 
positive cells and negative cells. The baseline (1-fold change) was established for 
samples prepared from Negative cells. Fabp4 - fatty acid binding protein 4; Adipoq -
aiponectin; Cebpa - CCAAT/enhancer binding protein, alpha; Pparg - Peroxisome 
proliferator activated receptor gamma; G0s2 - G0/G1 switch gene 2; Car3 - carbonic 
anhydrase 3; Hp - haptoglobin; Rbp4 - retinol binding protein 4; Mups - major urinary 
proteins; Grem2 - gremlin 2; Trps - trichorhinophalangeal syndrome I. The analysis 
was performed on FACS sorted cells that were prepared from embryos of the same 
mother and treated as one biological sample. For each analysed gene, Ct values 
from three PCR reactions were used to count standard deviations. 
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Lipid accumulation capabilities 2D and 3D cell structures established from 
FACS sorted cells.  
          It was discussed in Chapter 4 that three dimensional techniques for growing 
cells might have the potential to mimic the in vivo environment for skin-derived cells. 
The spheroid cell culture method revealed differences in lipid accumulation 
capabilities of embryonic cells obtained from the whole dermal compartment when 
compared with cells grown in two-dimensional (2D) cell structures (section 4.3.4.3 in 
Chapter 4). Therefore it seemed interesting to investigate if FACS sorted dermal 
cells, both CD36 positive (CD36+) cells and Negative (CD36-) cells, would also be 
influenced by the growing method in relation to their lipid accumulation features. 
Therefore, the influence of adipogenic medium was analysed in such 2D and 3D cell 
cultures established from FACS sorted populations. 
 
Cells used for this work were derived from the final, optimized FACS sort 
(Figure 5.8). Both, CD36+ and Negative population attached easily to culture dish 
surface when 2D cell structures were established (Figure 5.10). CD36+ cells 
contained rounded structures in their cytoplasm in close proximity to nuclei in growth 
and adipogenic medium (Figure 5.10a and b). The Oil Red O staining confirmed 
presence of lipids in these cell structures in growth medium (Figure 5.11a). 
Moreover the number and size of droplets filled with red were greater in cells 
incubated in adipogenic medium (compare Figure 5.11a with Figure 5.11b).  
 
Negative FACS sorted 2D cells in the growth medium had different 
morphology from CD36+ cells, as no lipid-droplets were observed in their cytoplasm 
and 99% of analysed cells were not stained by red dye (Figure 5.10c and Figure 
5.11c). These negative cells kept 3 days in adipogenic medium contained tiny dots 
around nuclei that were easily stained by red dye at day 4 of adipogenic incubation 
(Figure 5.10d and Figure 5.11d).   
 
Both FACS sorted cell populations also created spheres when grown in 
medium droplets (Figure 5.12). Despite the fact that similar amount of cells was 
used for the spheres establishment, CD36+ cells gave bigger spheres. On the 
surface of some of these 3D cell structures round inclusions could be spotted that 
might represent lipids accumulated on spheres. Interestingly, the Oil Red O staining, 
performed on 3D sections from CD36+ cells, revealed the presence of lipids among 
spheres from both growth and adipogenic medium (Figure 5.13a and b).  As such 
robust lipid accumulation was not seen in 2D cell cultures from CD36+ sorted cells 
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when kept in growth medium, it seemed that the spheroid cell culture method might 
enhance the capability to accumulate lipids in CD36+ positive cells, independent of 
the presence of external factors, such as adipogenic medium (compare Figure 5.11a 
and b with Figure 5.13a and b). Moreover such enhancement for lipid accumulation, 
seen in CD36+ spheres did not take place in spheres from the Negative cell 
population (compare Figure 5.13a with Figure 5.13c). 
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Figure 5.10. The morphology of FACS sorted two-dimensional (2D) cells. N: 
Negative cells. CD36+: cells sorted as positive for antibody against CD36. Sorted 
cells were kept in growth (a, c) or adipogenic (b, d) medium for three days. Darker 
areas seen in Negative cells incubated in adipogenic medium are shown by green 
arrows. Scale bar = 1 mm. Photos were taken using an inverted Zeiss Axiovert 
200M microscope (with accompanying AxioVision Rel.4.8 Imaging System 
software). 
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Figure 5.11. Oil Red O analysis of lipid accumulation in FACS sorted cells grown as 
2D cell structures in normal (growth) and adipogenic medium for four days. (c) 
Negative cell stained with red dye and kept in growth medium is shown by the black 
arrow. (a - d) Scale bar = 150 µm. Photos were taken using a Laser Capture 
Microdissection (LCM) microscope (PALM MicroBeam Zeiss Microscope). 
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Figure 5.12. Three-dimensional (3D) cell structures created from FACS sorted cells. 
(a) Sorted cells gathered together during the first 24 hours of incubation. (b) 3D cell 
structures incubated 2 days in normal growth medium (GM) or adipogenic medium 
(AM) (c) 3D cell structures incubated 4 days in normal growth and adipogenic 
medium. N: Negative cells. CD36+: cells sorted as positive for antibody against 
CD36. (a - c) Scale bar = 100 µm. Photos were taken using a Ziess StemiSVII 
microscope with a KY-FI030 JVC digital camera and accompanying KyLink 
software. 
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Figure 5.13. Oil red O analysis of lipid accumulation in FACS sorted cells grown as 
3D cell structures in normal growth and adipogenic medium for four days. (a - d) 
Scale bar = 15 µm. Photos were taken on the Zeiss Axio Imager.M1. microscope. 
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Protein expression profile in 2D and 3D cell structures from FACS sorted 
cells. 
 CD36+ and Negative cells, grown as 2D and 3D cell cultures underwent 
immunofluorescence analysis where expression pattern of fat-related proteins was 
investigated. 
 
The majority of the CD36+ cells, grown as 2D cell cultures in growth medium 
for two days, displayed a strong nuclear signal for the adipogenic transcriptional 
factor C/EBPalpha in comparison to Negative 2D cultures in growth medium 
(compare Figure 5.14a and Figure 5.14c). In addition, 2D cultures from CD36+ and 
Negative cells seemed to have lost the nuclear localization of C/EBPalpha when 
kept in adipogenic medium (see Figure 5.14b and d). Surprisingly, three-
dimensional cell cultures from both CD36+ and Negative cells had clear nuclear 
C/EBPalpha staining when cultured in growth media (compare Figure 5.15a and 
Figure 5.15c). In addition, spheres obtained from both FACS sorted cell populations 
(CD36+ and negative cells) and kept in adipogenic medium had green staining 
detected mainly at the periphery of 3D structures and it did not have a nuclear 
localisation (see Figure 5.15b and d). 
 
 
Expression of fatty acid binding protein 4 (FABP4) was analysed in FACS 
sorted cells (Figure 5.16 and Figure 5.17). FABP4 was found in adipocytes, and is 
known to be involved in binding fatty acids and was related with obesity (Khalyfa et 
al, 2010). Cytoplasmic labelling for FABP4 was observed in CD36+ cells kept as 2D 
cultures in growth medium, and a slightly stronger staining was seen in adipogenic 
medium (Figure 5.16a and b). In contrast, 2D structures from Negative cell cultures 
were without staining for FABP4 in growth medium although a very weak FABP4 
signal was seen among very few cells in adipogenic medium (Figure 5.16c and d). 
When an antibody against FABP4 was used on 3D cultures, a strong fluorescent 
labelling was observed in spheres from both sorted cell types and in both growth 
and adipogenic media (Figure 5.17a - d). The control staining (no primary antibody) 
revealed much lower signal from secondary antibody when compared with 
experimental samples (compare Figure 5.17a - d with Figure 5.18). Therefore the 
intensive staining seen for antibody against FABP4 in experimental samples could 
be due to a high accumulation of this protein in spheres, especially in peripheral 
cells. 
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Figure 5.14. Expression and localisation of adipogenic transcriptional factor 
C/EBPalpha in FACS sorted cells grown as 2D cell cultures. 2D structures were 
prepared from CD36 positive cells (CD36+) and Negative cells (N) and incubated in 
normal growth medium (GM) and adipogenic medium (AM) for 2 days. (a) CD36 
positive cells in normal growth medium. (b) CD36 positive cells in adipogenic 
medium. (c) Negative cells in normal growth medium. (d) Negative cells in 
adipogenic medium. (a - d) Scale bar = 30 µm. DNA was counterstained with DAPI. 
Fluorescent images were visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 5.15. Expression and localisation of adipogenic transcriptional factor 
C/EBPalpha in FACS sorted cells kept as 3D cell structures. 3D structures were 
prepared from CD36 positive cells (CD36+) and Negative cells (N) and incubated in 
normal growth medium (GM) and adipogenic medium (AM) for 2 days. (a) CD36 
positive cells in normal growth medium. (b) CD36 positive cells in adipogenic 
medium. (c) Negative cells in normal growth medium. (d) Negative cells in 
adipogenic medium. (a - d) Scale bar = 15 µm. DNA was counterstained with DAPI. 
Fluorescent images were visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 5.16. Expression and localisation of fatty acid binding protein 4 (FABP4) in 
FACS sorted cells grown as 2D cell structures. 2D structures were prepared from 
CD36 positive cells (CD36+) and Negative cells (N) and incubated in normal growth 
medium (GM) and adipogenic medium (AM) for 4 days. (a) CD36 positive cells in 
the growth medium. (b) CD36 positive cells in the adipogenic medium. (c) Negative 
cells in normal growth medium. (d) Negative cells in adipogenic medium. (a - d) 
Scale bar = 30 µm.  DNA was counterstained with DAPI. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
 
 
                                                                                                           Chapter 5 
 351 
 
Figure 5.17. Expression and localisation of fatty acid binding protein 4 (FABP4) in 
FACS sorted cells grown as 3D cell structures. 3D structures were prepared from 
CD36 positive cells (CD36+) and Negative cells (N) and incubated in growth 
medium (GM) and adipogenic medium (AM) for 4 days. (a) CD36 positive cells in 
normal growth medium. (b) CD36 positive cells in adipogenic medium. (c) Negative 
cells in normal growth medium. (d) Negative cells in normal growth medium. (a - d) 
Scale bar = 15 µm. DNA was counterstained with DAPI. Fluorescent images were 
visualised using a Zeiss Axio Imager M1. microscope. 
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Figure 5.18. Immunofluorescence analysis of secondary antibody (donkey anti-goat) 
efficiency. Cross-sections with 3D structures obtained from CD36+ sorted cells and 
cultured in growth (GM) and adipogenic medium (AM) for 4 days were incubated 
with 1% donkey serum/PBS instead of an antibody against FABP4 followed by the 
secondary antibody: donkey-anti goat. (a - b) Scale bar = 15 µm. DNA was 
counterstained with DAPI. Fluorescent images were visualised using a Zeiss Axio 
Imager M1. microscope. 
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5.4. Discussion. 
The aim of this Chapter was to isolate and purify a dermal cell population 
from mouse embryonic skin dermis representing cells committed to adipogenesis, at 
the early stages of their differentiation process. 
 
The microarray data, generated from mouse embryonic skin dermis, in 
Chapter 3, provided information about genes specifically regulated in lower dermal 
cells which undergo adipogenesis. This identified a membrane protein, named CD36 
that was highly enriched in lower dermal cells between e17 and e19 time point. In 
addition, enrichment of Fzd4 gene took place in lower dermal cells between 
analysed time points. 
 
First interesting observation from the flow cytometry work was obtained 
during the tritation process performed on 3T3-F442A cells. It was difficult to get 
specific fluorescence for tested antibodies (CD36 and Fzd4) from confluent cells 
grown in adipogenic medium and the signal for tested antibodies was obtained from 
these cells grown in normal medium.  Components of the differentiation medium or 
processes that occurred in differentiating cells could influence the preparation 
process of dermal cell suspension, antibody staining and (or) further analysis of 
cells. Thus, presented in this Chapter an attempt to use embryonic dermis cells 
which would normally undergoing adipogenesis during skin development aimed to 
simplify the analysis of fat cells (both adipocytes and preadipocytes) with flow 
cytometry technology.  
 
A comprehensive optimisation strategy was used to devise the flow 
cytrometry method. This gave sufficient yield to analyse a CD36+ population. The 
optimised protocol for FACS-based cell isolation gave viable cells that were 
successfully cultured in both two- and three- dimensional structures (section 5.3.4). 
The up-regulation (on the mRNA level) of two well known adipogenic transcriptional 
factors: C/EBPalpha and PPARgamma in CD36+ (FACS-sorted) cells (Figure 5.9c 
and d) suggested that this FACS-sorted cell population consists of preadipocytes 
undergoing early stages of adipogenic differentiation in embryonic back skin. In 
addition, the enrichment of several other fat-related genes was observed in CD36+ 
cells (when compared with the Negative cell population), for example Fabp4 (Figure 
5.9b) that has been shown to be exclusively expressed in lower dermal 
compartment of embryonic skin dermis between e17 and e19 time points (Chapter 
3; Figure 3.10B and Figure 3.11). In Chapter 2, it was shown that cells from this 
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lower dermal compartment are undergoing adipogenesis and they create so-called 
dermal adipose tissue. Therefore, the qRT-PCR analysis of fat-related genes in 
FACS-sorted cells showed that cells with high level of CD36 surface marker are 
representative of cells with a gene expression profile similar to cells from lower 
dermal skin area from which dermal adipose tissue develops. Therefore it became 
possible to isolate a population of lower dermal cells predisposed to being mature 
fat cells in vivo. In addition, CD36+ cells kept their “fatty-like” feature when grown on 
cell culture dishes (two-dimensional structures), since the Oil Red O staining 
revealed a presence of lipid droplets in these cells (Figure 5.11a). 
 In addition, the Negative cells (CD36-) were characterised by a high up-
regulation of TRPS gene (Figure 5.9l). Since, the expression of TRPS in the upper 
dermis of embryonic back skin was verified on both protein and mRNA level 
(Chapter 3, Figure 3.19 and Figure 3.20), the Negative cell population seemed to 
represent dermal cells not predisposed to adipogenesis that create a fatty-free layer 
of demis just below the epidermis. Indeed, the majority (99%) of analysed cells were 
not stained by a lipid specific dye when kept in two-dimensional structures (Figure 
5.11c). 
 
In order to verify further features of sorted cells, a spheroid cell culture 
method was applied for the growth of these cells. As it was shown in Chapter 4, the 
spheroid cell culture method would be a useful tool for recreating in vivo-like 
environment for the study of skin cells. Both 2D and 3D cell cultures were obtained 
from CD36+ and Negative cells in order to compare lipid accumulation capabilities in 
cells growth in different conditions. The very first observation was that 3D structures 
obtained from CD36+ cells had bigger diameter when compared with spheres from 
Negative cells (Figure 5.12). The detailed studies on adipogenesis in cell lines 
suggested that at the very early steps of fat cell differentiation, cells undergoing 
approximately two additional rounds of cell division (so-called clonal expansion step; 
reviewed by Gregoire et al, 1998). Therefore, spheres from CD36+ cells that were 
shown to be enriched with fat-related genes (see paragraph above) could increase 
their diameter due to the enhanced process of cell division needed for the fat cell 
differentiation. 
In addition, the Oil Red O staining, revealed highly increased lipid 
accumulation in spheres from CD36+ cells kept in both growth and adipogenic 
medium, when compared with 3D structures from Negative cells (Figure 5.13). 
Therefore, the spheroid cell culture method enhanced lipid accumulation in CD36+ 
cells. The CD36+ spheres seemed to represent structures that contained of either 
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more cells filled with fat droplets or cells that accumulated more and bigger lipid 
droplets when compared with spheres from Negative cells. 
The 3D technique seemed to have also specific influence on the Negative 
(FACS-sorted) cell population. This conclusion was given after the analysis of 
staining for the adipogenic transcription factor: C/EBPalpha in 2D and 3D FACS-
sorted cells. Basically, 2D structures from CD36+ cells had a nuclear staining for 
C/EBPalpha when kept in growth medium, whereas such staining pattern was not 
seen in 2D structures from Negative cells (Figure 5.14). This clearly suggested that 
CD36+ are representative of fat cells undergoing adipogensis and indeed the red 
dye stained some of these two dimensional CD36+ cells but not Negative cells 
(Figure 5.11). However, the nuclear localisation of C/EBPalpha was seen in these 
two cell populations when kept as spheres in growth medium (Figure 5.15). 
Therefore, the 3D spheres seemed to create an environment that not only enhanced 
adipogenesis in already predisposed to this process CD36+ cells (from lower 
dermis; see Figure 5.13a), but also crate favorable conditions for an activation of 
gene crucial for early stages of adipogenesis in “non-fatty” cells and an 
accumulation of lipids in small population of these Negative cells grown as spheres 
(Figure 5.13c). These areas, positive for red dye in 3D Negative cells are still 
surrounded by cells that are not accumulating lipids (lack of the red dye), so they are 
still “resistant” to adipogenesis, maybe due to a high up-regulation of “inhibitory” 
genes that could be crucial to keep a “non-fatty” feature of these skin dermis cells.  
 
Clearly the spheroid cell culture method might create conditions when the 
specific cell-cell interactions occurring (not seen in two dimensional structures) that 
influence dermal cells in relation to their capability to accumulate lipids. In addition, it 
is possible that FACS sorted cells when grown as spheres are lacking the company 
of other dermal cell types and/or contact with other skin/body/blood components that 
are crucial for the control of adipogenesis activation and lipid accumulation. 
Spheroid cell culture seems to mimic in vivo environment when cells can grow in all 
dimensions as happens in a whole organism, but a lack of regulatory signals from 
other skin cells could allow these cells to undergo uncontrolled (enhanced) 
adipocyte differentiation. 
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Future plans 
Using the microarray data (presented in Chapter 3) to provide candidate 
genes combined with the FACS technique (discussed in Chapter 5) could further 
enhance our understanding of adipogenesis in vivo in embryonic back skin. For 
example, the microarray data from embryonic back skin dermis could be searched 
for genes highly enriched in upper dermis, where lipid accumulation does not occur. 
Then, the influence of such factors on FACS sorted cells from dermis could be 
verified by the addition of these proteins to growth media during 3D culture and 
investigation of their effect on lipid accumulation. Similarly, the influence of proteins 
whose mRNA expression level (based again on microarray work from Chapter 3) 
was enriched in lower dermis could be analysed on both CD36+ and Negative cell 
populations kept as spheres.  
It seems interesting to design an experiment which will combine the FACS-
based experimental method from Chapter 5 with a study from Chapter 4, where it 
was suggested that the EGF-EGFR signalling may take part in the regulation of 
adipogenesis in mouse embryonic lower dermis between e17 and e19 time points. 
The FACS sorted cells (CD36+ and Negative populations), once grown as 2D and 
3D structures could be incubated in activator (EGF) and/or inhibitor (AG1478) of 
EGFR and then the lipid accumulation capabilities would be analysed in these 
structures. The experiment on FACS-sorted spheres could help to further verify the 
hypothesis about EGFR role in in vivo adipogenesis and expand the study on 
signalling pathways crucial for the regulation of fat cell fate and differentiation of 
preadipocytes into mature fat cells.  
 
Work presented in Chapter 5 could be also combined with studies from 
Sugihara and his colleagues (Misago et al, 1998; Shimazu et al, 2001; Sugihara et 
al, 2001; Aoki et al, 2004; Toda et al, 2009) where an influence of adipocytes on 
different cell types (for example hair follicles, interfollicular keratinocytes or renal 
epithelial cell line) has been investigated by the interesting culture model. Such 
model was based on a three-dimensional collagen gel matrix culture, where different 
types of isolated cells were growth in a collagen gel with or without fat cells. Misago 
et al (1998) performed an experiment on rat (newborn) skin cells and showed that 
the co-culture of organoid hair follicle cells (HFs) in close proximity to 
(subcutaneous) fat cells revealed an inhibitory influence of adipocytes on 
proliferation of both HFs and fibroblasts, however the differentiation of HFs seemed 
to be speeded up in this experiment. By the use of the collagen gel matrix system on 
cells isolated from rat newborns, Sugihara et al (2001) pointed an activating role of 
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fat cells on both proliferation and differentiation of keratinocytes and an inhibitory 
role of adipocytes on dermal fibroblasts proliferation. In addition, the so-called 
“adipose tissue-organotypic culture system” was established for the three-
dimensional growth (in collagen gel) of isolated and minced fragments of rat 
subcutaneous and visceral adipose tissue depots (Toda et al, 2009).  
The co-culture methods presented by Sugihara and his colleagues (see 
above) could be used for the analysis of FACS-sorted cell populations from mouse 
back skin dermis. For example, sorted cells could be placed in a collagen gel matrix 
and co-cultured in a presence and absence of other embryonic skin cells. Such work 
might enhance knowledge on the cell-cell interactions in skin and on function of 
preadipocytes during embryonic skin development. Moreover the co-culture method 
from Sugihara et al (2001) could be used for the analysis of modified FACS-sorted 
cells. For example, FACS-sorted cells could be isolated from animals with a 
knockout of a gene highly expressed in lower skin dermis (based on microarray data 
from Chapter 3). Such experiment might help to reveal a function of the gene of 
choice in the development of skin compartments at embryonic level.  
 
 
To sum up, the cell sorting technique on embryonic skin samples, presented 
in Chapter 5, can be a useful method for the isolation of fat cells at early stages of 
their development. Moreover, the spheroid cell culture method and experimental 
models from Sugihara and his colleagues (see above) could help to investigate 
features of such cells outside the body and increase knowledge about features of 
cells undergoing adipogenic differentiation.  
 
 
 
  
 
 
Chapter 6:  
Final discussion  
and  
future work. 
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6.1. Different mouse fat depots: their localisation, terminology and 
development in relation to mouse embryonic back skin.  
 As was mentioned in Chapter 1, section 1.2, fat cells (adipocytes), create 
white and brown adipose tissues (respectively WAT and BAT), and they can either 
create easy to distinguish fat depots around internal organs (visceral adipose tissue) 
or just beneath the skin surface (subcutaneous adipose depot). They can also be an 
element of other tissues and organs (along the bone marrow or in the intramuscular 
area) (Gesta et al, 2007). In addition, fat cells have been spotted to “infiltrate” skin 
(Cinti, 2001). Based on the Hausman and Mersmann studies, developing adipocytes 
were observed in lower dermis of rat and pig skin, around hair follicles (Mersmann et 
al, 1975, Hausman et al, 1981a; Hausman et al, 1981b; Hausman and Martin, 1982). 
These fat cells were treated as a representative of the outer layer of subcutaneous 
adipose tissue, divided by a connective tissue from other fat layers (Poulos et al, 
2010).  
 
Subcutaneous adipose tissue (SAT) versus dermal adipose tissue (DAT). 
It was suggested that adipocytes localised in close proximity to hair follicle 
end bulbs (for example in rats and pigs) represent a different developmental pattern 
from other subcutaneous cells (Hausman et al, 1981a; Hausman et al, 1981b). 
However, to best of my knowledge, this suggestion seemed not to be developed in 
more detailed work that would investigate for example molecular features of these 
cells. Also, the word “infiltrate” was used in literature to describe adipocytes 
localisation along different tissues and organs, for example in skin which may 
suggests that these fat cells (for example seen in skin) are not creating a 
compartment big enough to be treated as something significant (for example for the 
function of organ in which fat cells are observed to be present).  
 
 The study presented in this thesis aimed to obtain information on fat cells 
from skin dermis by a use of mouse skin model. The study performed in Chapter 2, 
allowed the onset of the first lipid droplets in the lower dermis of mouse back skin, 
close to developing hair follicles, to be exactly targeted (Figure 2.5). The Oil Red O 
staining was applied to whole back skin sections together with fat depots localised 
beneath the skin (anterior white and brown adipose tissue; prosterior white fat layer; 
named as subcutaneous adipose tissue).  
An interesting initial observation was made while the back skin was removed 
from mice. The fat depots beneath the skin, surrounded by very thin (muscle) layers, 
were loosely connected with skin and it was difficult to lift them in intact form 
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together with skin. Moreover, after the whole back skin sectioning and the Oil Red O 
staining, a difference was observed between fat cells in the skin dermis and fat cell 
beneath skin. Between e18 and e19 time points, when the first lipids were seen in 
the lower dermis, the subcutaneous adipose tissue beneath the skin seemed to be 
quite-well developed and filled densely with lipids (the red staining was observed 
along the whole organ depots, Appendix III). The occurrence of first lipids in lower 
dermis, just before animal birth, was characterised by the heterogeneity (dermis 
areas free from lipids surrounded by areas with lipid droplets). During the further 
development of animal, this heterogeneity was disappearing as more cells in lower 
dermis were filled with lipids and the size of lipid droplets increased. Finally, after the 
animal birth, in skin older than 1 day the easy to distinguish fat layer was seen along 
the whole lower back skin dermis (Figure 2.6). Interestingly from day 1 to about day 
10 - 12, a gradual thickening of skin was observed while anagen hairs were growing 
inside the skin dermis and it seemed to be related also with the increase of fat layer 
thickness (Figure 2.6). Then, the gradual thickening of skin occurred, when hairs 
moved to catagen and telogen phase, which also influenced fat layer that become 
very thin. This confirmed that correlation between that hair follicle cycle and the 
dermal fat cell layer takes place not only in adult mice (Borodach and Montagna, 
1956), but is related with the very first hair cycle after birth. Interestingly, when the 
changes in thickens of dermal adipose tissue were observed during the mouse 
development after the birth, no drastic or significant changes were observed for 
example in relation to localisation or the size of the subcutaneous adipose tissue 
beneath the skin. This shows not only the developmental differences between 
dermal adipose tissue and the subcutaneous adipose tissue but also suggest that 
these two fat depots in the mouse body may be (are likely to be) independently 
regulated.  
 Also, the dermal adipose tissue in lower dermis seemed not to merge with 
the adipose organ, due to a presence of a non-fatty skin layer (panniculus carnosus) 
that was localised under the dermal adipose tissue. Only a thin lipid filled layer (1 - 3 
cells thick) could be observed along the panniculus carnosus either close to dermal 
adipose tissue or to fat organs beneath the skin. Therefore the question arises as to 
whether these additional thin layers of fat cells have any significant influences on the 
general features of subcutaneous fat depots in mice? Moreover, in the upper dermis 
no lipid droplets were seen and this feature was observed at all analysed time points 
(Figure 2.6). Therefore, development of dermal adipose tissue was clearly restricted 
to the lower area of skin dermis.  
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To sum up, because of the very loose connection between skin that 
contained dermal adipose tissue in lower dermis and the subcutaneous adipose 
tissue localised beneath the skin, the difference in timing of these two fat depots, the 
presence of the panniculus carnosus) and finally the lack of lipid droplets in the 
upper dermis area, the suggestion made in this thesis, is that fat cells in skin dermis 
do not only “infiltrate” (Cinti, 2001) skin, but are creating a distinctive fat layer. In 
addition, this layer seemed not to be only an outside layer of subcutaneous fat depot 
(as it is widely suggested; Poulos et al, 2010), but develops and functions as an fat 
depot independent from the rest of the subcutaneous fat.    
 
Fat depot terminology. 
 As was discussed in previous paragraphs, the fat cells localised between 
hair follicles in lower skin dermis create a fat depot with very distinguishable features 
when compared with fat depots localised below the mouse skin and named as the 
subcutaneous adipose tissue. The microarray approach presented in Chapter 3 
showed that dynamic processes take place in both upper and lower dermal 
compartments at embryonic level which are crucial for the creation of a fat layer in 
lower dermis and a non-fatty area in upper dermis below the epidermis. The term 
“dermal adipose tissue” has been used by Cinti (2007) and was incorporated in the 
study presented in this thesis for the description of fat cells localised in lower dermis 
and between hair follicles. Cinti (2007) mentioned that rodent dermal adipose tissue 
is being separated from subcutaneous depots by a muscle layer. The study from 
Chapter 2 has clearly shown that dermal adipose tissue depot does not merge with 
subcutaneous depots at any of the analysed time points. Therefore is seems 
reasonable to use a “dermal adipose tissue” term while working on a mouse fat cell 
layer localised in close proximity to hair follicles in order to point a difference 
between this adipose layer and a subcutaneous fat. 
Interestingly, several recent papers on the subject of skin, hair follicles and 
fat cells surrounding hair follicles in mouse models do not use the name “dermal 
adipose tissue” (Plikus et al, 2008; Plikus et al, 2009; Sugawara et al 2010). They 
seemed to treat adipocytes from lower skin dermis as an integral part of a 
subcutaneous adipose tissue and not as a distinguishable fat layer in mouse. For 
example, the study presented by Plikus et al (2008 and 2009) has discussed the 
role of the BMP pathway in the regulation of hair follicle cycle. This work has 
suggested that adipocytes which surround hairs are involved in the regulation of the 
hair cycle (see section 6.2 of Chapter 6 for more details about this study). Plikus et 
al (2008 and 2009) used such terms as “subcutaneous adipocytes”, “subcutaneous 
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adipose tissue” or “subcutaneous fat” to describe these adipocytes localised in close 
proximity to hairs. Similarly Sugawara et al (2010) described changes in a fat layer 
between hair follicles of a mouse model with highly reduced expression of EGFR 
gene and the analysed fat cells were names as “subcutaneous adipocytes” whereas 
the layer created by these adipocytes was termed “subcutaneous adipose tissue” or 
“subcutis”.  
Studies described briefly above, clearly show that a form of 
misunderstanding exists when fat cells around hair follicles are investigated. 
Therefore, the establishment of a proper terminology for fat depots could be based 
on such work as a study presented in this thesis or a very recent work from Festa et 
al (2011). Festa et al (2011) investigated a role of adipocytes from dermis in the 
regulation of skin stem cell activity (this work is also discussed in section 6.2 of 
Chapter 6). In this work such terms were incorporated as “intradermal adipocyte 
lineage cells”, “intradermal adipocyte” or “intradermal adipose tissue” and 
“intradermal adipocyte layer” in order to describe fat cells/fat layer from skin dermis 
(which are named in this thesis as dermal adipose tissue). Moreover the term 
“subcutaneous” was incorporated for the description of a fat depot “below the skin” 
(Festa et al, 2011).  
 
To sum up, the modification of a terminology for fat tissue depots in mouse 
should be made to distinguish between subcutaneous adipose tissue - SAT 
(adipose organ below the skin and divided from the lower skin dermis by a 
panniculus carnosus layer) and dermal adipose tissue - DAT (localised in lower 
dermis, between hair follicles).  
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Differences between visceral (VAT) and subcutaneous (SAT) and potentially 
between VAT, SAT and dermal adipose tissue (DAT) depot. 
The differences between visceral and subcutaneous depots have been 
recently investigated in relation to their influence on metabolism. It is known that 
high amounts of subcutaneous fat depots, which lead to so-called pear-shaped 
obesity, are related to a lower risk of the onset of diabetes (reviewed by Gesta el at, 
2007). The apple-shaped obesity (high amount of visceral fat depots) is observed in 
patients with diabetes and metabolic syndrome. The growing number of obese 
people and enhanced epidemic of fat-related disorders (see section 1.2.7 in Chapter 
1) lead to the development of surgical procedures for the removal or transplantation 
of fat depots. These attempts aim to improve life of obese patients and help to 
investigate the influence on metabolism of such procedures in both humans and 
rodents. 
 Such work has reached important conclusions in relation to differences 
between subcutaneous and visceral fat depots. It was noticed that removal of 
subcutaneous fat from humans (liposuction procedure) does not benefit them in 
relation to metabolic abnormalities which develop in obese individuals (Klein et al, 
2004). When, omentectomy was applied in order to remove visceral adipose tissue 
(VAT) in humans, levels of both insulin and glucose decreased (Thörne et al, 2002). 
This effect was observed when removal of VAT was combined with adjustable 
gastric banding.  
Finally, studies on the transplantation of preadipocytes, mature adipocytes 
(3T3-L1 or 3T3-F442A cells which are discussed in section 1.3) and different 
adipose depots in rodents aimed to enhance knowledge about biology of adipose 
tissue and metabolic effects of transplantation in host animal (reviewed by Tran and 
Kahn, 2010). Tran et al (2008) performed an experiment on mice, where visceral 
(epididymal) fat (from donor animal) was transplanted into either the subcutaneous 
(SC) or visceral (VIS) fat areas in host animal. In addition, the subcutaneous (flank) 
fat (from donor animal) was transplanted into the SC or VIS fat areas in host animal. 
The visceral area in the host animal was the intra-abdominal cavity (between 
epididymal layers, next to the mesenteric fat, below the liver), whereas the SC area 
was localised below the skin of the back of the recipient. Next, host animals were 
analysed based on their body weight and levels of both glucose and insulin. Animals 
with subcutaneous fat depots transplanted into VIS fat areas had decreased body 
weight and levels of insulin or glucose and they were also characterised by 
improved insulin sensitivity. Features (as above) of animals with subcutaneous 
depot transplanted into SC fat area also improved but less efficiently. Finally, mice 
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with VIS fat transplanted into visceral areas were lacking such effects (Tran et al, 
2008). 
To sum up, it is highly possible that the subcutaneous adipose tissue (SAT) 
has a beneficial effect on the body metabolism, can be considered as a protective 
fat depot and transplantation of such depot could help to treat obesity and metabolic 
disorders (Porter et al, 2009; Tran and Kahn, 2010). Since, the dermal adipose 
tissue (DAT) depot has been suggested in this thesis to be a third distinguishable fat 
depot, it might be possible that DAT differs from SAT and VAT depots because of 
the influence on the body metabolism. The microarray work on lower dermal cells 
has revealed a dramatic up-regulation of several genes whose levels undergo 
changes in obese and/or diabetic individuals (for example MUPs, Rbp4 or Car3; see 
sections 3.3 and 3.4 in Chapter 3 for more details). Maybe the expression of such 
genes in dermal adipose tissue is crucial for both the proper development of this fat 
depot (at embryonic level) but maybe also is related with an involvement of DAT in 
regulation of some metabolic processes after the animal birth. This hypothesis 
should be tested in order to understand better suggested differences between 
different fat depots on the body metabolism. For example, a method could be tested 
for the isolation of dermal adipose tissue from the lower dermal skin compartment. 
Then this depot (isolated from back skin of young healthy mice) could be 
transplanted into SAT and/or VAT depots in normal (control) and obese 
(experimental) mice. An effect on the metabolism could be analysed by the measure 
of blood glucose and insulin levels together with the analysis of the weight of both 
control and experimental animals kept on normal and/or high fat diet.  
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Questions about white and brown fat cells in dermal adipose tissue (DAT), the 
thickness of DAT and about the hair follicle cycle. 
As was mentioned (Chapter 2), dermal adipose tissue undergoes changes in 
its thickness during the first couple of days after the mouse birth which seemed to 
be related with the hair follicle cycle. Such correlation was also suggested to take 
place in adult mice (Borodach and Montagna, 1956).  
It may be interesting to perform an experiment on dermal adipose tissue 
layer from newborn mouse where the amount of accumulated lipids in lower dermis 
could be estimated at different stages of the hair follicle cycle. Such work could be 
based on the quantification analysis of the Oil Red O staining from back skin-cross 
sections. In more details, the red dye that bounds to lipid droplets can be extracted 
from cells and the amount of such eluted solution can be analysed on the 
spectrophotometer. Such technique was successfully used for the analysis of 
differentiating 3T3-L1 cells by the elution of Oil Red O with 100% isopropanol and 
the measurement of an eluted solution at 500 nm (Campbell et al, 2011). This 
analysis might reveal the association between changes in DAT thickening and 
changes in the lipid volume of this fat depot. 
This quantitative study could be also combined with an investigation into the 
type of fat cells (brown or white adipocytes) occurring in the dermal adipose tissue 
during the hair follicle cycle. Due to specific morphological changes of differentiating 
cells from lower dermis (multilocular cells with many tiny lipid droplets become 
unilocular-like cells with mainly one big fat droplet inside the cell; see Chapter 2) it 
could be suggested that dermal adipose tissue consists of (mainly) white adipocytes 
which are responsible for the storage of energy. It is know that white fat cells 
express S-100 protein (calcium binding protein) and leptin (section 1.2.2.2.2.3. in 
Chapter 1 for more details on leptin), whereas brown adipocytes are expressing the 
uncoupling protein 1 (UCP-1), which is crucial for the release of energy in a form of 
heat and serves as a marker for brown fat cells (Cinti, 2001; Cinti, 2007). The 
microarray data obtained from mouse embryonic back skin (Chapter 3) revealed the 
up-regulation of several representatives of S100 protein family in lower dermal cells 
(see Appendix X) as well as the up-regulation of a leptin gene at e19 versus e17 
time point in lower dermis where dermal adipose tissue develops (see Appendix 
XI.A). The UCP-1 was not found in microarray data from embryonic back skin 
dermis. This observation suggests that between e17 and e19 time points, 
adipogenic differentiation occurs that lead to development of mature white-like fat 
cells. One of the future experiments could analyse the expression (on protein level) 
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of leptin and S-100 proteins in embryonic skin dermis between e17 and e19 time 
points.  
As was mentioned in section 1.2.2.3 (Chapter 1), fat cells seem to undergo 
reversible transdifferentiation where white adipocytes are capable of becoming 
brown fat cells (Cinti, 2007). A study by Cousin et al (1992) has revealed the 
presence of UCP-1 in cells that belong to white adipose depot in rats. In addition, 
cold exposure led to an increase in a number of brown adipocytes (Cousin et al, 
1992). The question asked here is whether a process of transfdifferentiation occurs 
along the dermal adipose tissue? After birth, the thickening of skin dermis during 
hair follicle development could lead to a progressive white fat cell development and 
increased accumulation of lipids in these adipocytes (Chapter 2; Figure 2.6). Then, 
in animals older than 12 days, skin “shrinks” while hair follicles stop growing and 
clearly the thickness of the dermal adipose depot in lower dermis decreases (Figure 
2.6). Maybe this specific change in dermal adipose tissue is due to a 
transdifferentiation process where white adipocytes become brown adipocytes that 
start expressing UCP-1 and releasing the energy from accumulated lipid droplets 
and this will lead to decrease in amount of accumulated lipids in lower skin dermis. 
The alternative explanation of the dermal adipose layer thinning during the hair 
follicle catagen/telogen could be that some apoptotic processes occur in lower 
dermis 12 days after the birth, which are crucial for the decrease in the skin 
thickness. The suggested hypotheses could be tested by the analysis of UCP-1, 
leptin and S100 proteins expression (for example by immunofluorescence analysis) 
and the cell death (for example by the TUNEL approach - terminal deoxynucleotidyl 
transferase-mediated deoxyuridine triphosphate nick end-labeling) along the back 
skin dermis from newborn mice (between 0.5 and 19 days old). These two 
suggested processes (transdifferentiation and apoptosis) could be regulated by 
specific cell-cell interactions along the skin and for example could be controlled by 
hair follicle cycle. 
The potential correlation between hair follicles and fat cells surrounding hairs 
has become recently the major topic of several studies where the regulation of hair 
follicle cycle is being investigated (Plikus et al, 2008; Plikus et al, 2009; Festa et al, 
2011). Such work seems to open a new direction in understanding correlations 
between different compartments of skin and is being discussed in more details in 
section 6.2 of this Chapter. 
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6.2. The experimental techniques mimicking in vivo environment for 
skin and potential signalling pathways in back skin crucial for dermal 
adipose tissue development - interactions between different skin 
compartments. 
 
 As was shown in Chapter 4, the “selection” of relevant genes from the 
microarray data seems to be crucial for further exploiting the work presented in this 
thesis.  
 
The specific enrichment of epidermal growth factor receptor (EGFR) was 
found in the lower dermal cells at e18 time point (section 4.3.1 in Chapter 4). The 
EGFR - EGF signalling pathway was suggested previously to be related with 
adipogenesis in 3T3 cells (Adachi et al, 1994). When the EGFR-EGF signalling 
pathway was disrupted (mouse model work) in relation to the hair follicle cycle, 
changes in subcutaneous layers were notices, however this correlation has not been 
analysed in more detail (Sugawara et al, 2010). In this PhD study, the substrate 
organ culture technique has suggested that EGFR signalling pathway influencing 
skin development at embryonic level, and EGF receptor might be crucial for proper 
adipocyte differentiation of cells from lower dermal area (Chapter 4). 
  
  The growth of cells on cell culture dishes is a widely used technology for the 
analysis of cell features but its main disadvantage is that such cells are lacking the 
third dimension and do not interact with other cells in all directions as it happens in 
the live body. Therefore, in Chapter 4, the spheroid cell culture technique was used, 
where dermal cells (separated from epidermis) were grown in 3 dimensions, did not 
touch the culture dish surface and were surrounded only by other cells. This work 
aimed to analyse the lipid accumulation capabilities of young (e15 - 15.5) and old 
(e18.5 - 19) dermal cells. The fact that the young cells on cell surface dishes (2D 
cells) did not accumulate lipids was understandable in relation to the lack of lipid 
formation in skin from such young animals, however the situation changed 
dramatically when young cells were kept in 3D structures and lipids in the form of 
red dye staining was present through the 3D structures. In addition, 3D cell 
structures from older embryonic skin had lipids, but organized in clusters, and free-
from lipids areas were seen. The main difference between the in vivo and in vitro 3D 
environments was the lack of epidermal cells. Thus the possibility is that the 
epidermis layer “normally” influences younger skin and “keeps” it in a kind of un-
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differentiated stage (in relation to adipogenesis) at e15 - 15.5. When this layer is not 
present and cells are kept in 3D structure (so in in vivo-like, “normal” conditions but 
lacking the epidermis layer), then the lack of inhibition signal makes all young 
dermis cells capable of undergoing adipogenesis. Perhaps dermal cells at e15 - 
15.5 resemble more closely mesenchymal stem cells, that are very plastic and if not 
properly controlled by other cell types (for example epidermis layer) can very easily 
(in a proper environmental conditions - 3D structure) undergo adipogenesis.   
 
Next, as progressive development of the embryo takes place (from e15 - 15.5 to 
e18.5 - 19), which is also related with gradual development of hairs, the 
“rearrangement“ in skin dermis takes place. Perhaps the epidermis influences 
dermal cells that are in close proximity to the epidermal layer, and tries to maintain 
the non-fatty profile of these dermal cells, for example by signals that “switch on” 
inhibitory processes against adipogenesis in these dermal cells (as microarray data 
showed that, see Chapter 3). Then because of the gradual development of dermis 
and hairs, the hair follicle end bulbs may influence the lower dermal cells that 
surround end bulbs and this “activates” adipogenesis in precursor cells. This leads 
to progressive development of preadipocytes from precursor cells (between e17 and 
late e18) and leads to accumulation of lipids at e19 in cells close to hair follicle end 
bulbs. If this is true, then dermal cells from the 18.5 - 19 day old animal, kept in a 3D 
environment are characterised by much less plasticity and they may already be 
committed to very particular dermis cell types. Therefore, in these 3D structures, the 
lack of epidermis does not have the same influence as it does on much younger 
cells, and around cells committed to be adipocytes (filled with lipids), non-fatty cells 
are presented that kept their profile because of all inhibitory processes already 
activated in them.  
 
The process described here is named the epidermal-dermal-skin appendage 
interaction theory. It seems to make sense especially since the interactions between 
epidermal and dermal cells leads to development of hairs (Chapter 1, section 
1.1.3.1). Then, such interactions could be crucial for further maturation of back skin. 
In addition, the correlation between developing hairs and fat cells has been already 
suggested (Hausman et al; 1981) and was shown in mouse back skin specimens in 
work presented in this thesis (Chapter 2). Nowadays, attempts are being made to 
understand the regulatory mechanisms of the hair follicle cycle in relation to skin 
stem cell niches and the involvement of fat cells in the regulation of the hair growth 
(Plikus et al, 2008; Plikus et al, 2009; Festa et al, 2011). Plikus et al (2008, 2009 
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and 2011) investigated the hair follicle cycling (in mouse models after the plucking of 
hairs) and discussed the importance of a skin (inter-follicular) macro-environment for 
the function of hair follicle stem cells and further proper regulation of the hair follicle 
cycle. This work was focused on the analysis of the expression patterns of BMP 
proteins (for example BMP2), suggested to be involved in the regulation of hair 
development. Interestingly, Plikus and his colleagues found changes in the level of 
BMP2 protein along fat dermal cells that surrounded hair follicles. The BMP2 
expression was not detected in the early stages of anagen and it gradually appeared 
at the latest anagen stages and in the first stage of telogen phase (so-called 
refractory phase) whereas it faded at late telogen (so-called competent phase) and 
again re-appeared in skin dermis of anagen hairs. In addition, the antagonist of 
BMPs, called noggin, was observed to oscillate from dermal sheath to dermal papilla 
(DP) during the progression of anagen and it faded in DP at the end of anagen but 
was not observed in adipocytes between hairs. The over-expression of the BMP 
antagonist (noggin) led to a decrease in the telogen (refractory) phase. The mouse 
model was created were noggin was over-expressed in skin under the keratin 14 
promoter (keratin 14 is expressed in the interfollicular epidermis and along the outer 
root sheath of hairs). This allowed for the down-regulation of BMP signaling pathway 
at early telogen which led to a dramatic reduction of the telogen phase length and 
quicker entry to anagen. Plikus et al (2008, 2009) suggested that there are two 
niches crucial for the proper functioning of skin stem cells and further normal hair 
cycle occurrence, one related with the bulge region of the hair (micro-environment) 
and the second region related with fat cells around hairs (macro-environment) (see 
Figure 6.1b). The BMP-based signalling along the micro-environment is crucial for 
the proper occurrence of hair follicle cycle.  
The microarray work in Chapter 3 has revealed the up-regulation of another 
BMP antagonist, gremlin 2 in the upper dermis of mouse embryonic back skin at e18 
and e19 time points (Figure 3.18). Gremlin 2 has been linked to the inhibition of 
adipogenesis however its exact role remains elucidated (Wade et al, 2005; see alse 
section 3.4.1 in Chapter 3). It will be interesting in future work to test the hypothesis 
that the proper regulation of BMP signalling is crucial for the regulation of dermal 
skin compartment development (at embryonic level: non-fatty upper dermis verus 
adipocytes in lower skin dermis) and for controlling the hair follicle cycle after birth. 
 
Work by Festa et al (2011) has also focused on the role of fat cells from 
lower dermis in the regulation of the hair follicle cycle. In this study, the presence of 
adipocyte precursor cells in the fat layer localised between hair follicles (named as 
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the intradermal fat layer) was revealed by the FACS approach and showed that 
such FACS-isolated cells from skin dermis can accumulate lipids when cultured for 3 
days. Festa et al (2010) suggested that the size of the intradermal fat layer 
increases probably due to the activation of this adipocyte precursor cell population 
and the further development of mature fat cells. In addition, the proliferation process 
of adipocyte precursors can give higher number of these precursors and the 
proliferation is activated at the catagen stage of the hair cycle. This work has also 
suggested that the presence of adipocyte precursors in dermis is crucial for the 
proper activity of stem cells in skin and the normal presence of the hair cycle. Two 
mouse models have been applied for thus study. The Ebf-/- mice (with a mutation in 
the early B cell factor 1 gene) were characterised by a decrease of fat layer in lower 
skin dermis and the Azip mouse (“fatless” mouse with a dominant-negative C/EBP 
under the fatty acid binding protein-4 promotor) was lacking white mature adipocytes 
in different fat depots including the skin dermis. Both mice had delayed occurrence 
of hair coat development but this feature disappeared after time point p15. However 
the Ebf-/- mice had defects in hair follicle cycle progression (telogen and catagen 
morphology was seen from time point p21 till p56), whereas the analysis of hairs at 
p21 in the Azip mice revealed the anagen induction similar to a wild type mouse. 
The FACS-based analysis of skin adipocyte precursors showed that Ebf-/- mice 
were lacking such population of cells. The transplantation of FACS-sorted wild type 
adipocyte skin precursors into the Ebf-/- mouse skin (at time point p21) allow for the 
induction of hair follicle regeneration. Therefore, the general conclusion was that 
adipocyte precursor cell in the intradermal fat depot are needed for the proper 
activation of hair follicle development by probably proper regulation of stem cell 
activity in hairs (bulge stem cells) (Festa et al, 2011). Finally, this work has 
suggested the PDGF (plateled-derived growth factor) as a possible molecule 
responsible for proper skin stem cell activity, since the high up-regulation of this 
factor was observed in adipocyte precursors from skin dermis.  
In work presented in Chapter 3, the up-regulation of the PDGFR (plateled-
derived growth factor receptor), on mRNA and protein levels, was observed in the 
upper dermis of embryonic back skin dermis (Figure 3.22). Based on the data 
presented by Festa et al, 2011, PDGFR expression was observed in the follicle 
dermal papilla but was not observed in the upper interfollicular dermis in adult mice. 
It could be interesting to further investigate expression of PDGF and PDGFR along 
the embryonic skin dermis in mouse models used by Festa et al (2011) to reveal the 
“real” and “exact” functional role of the PDGF-PDGFR signaling pathway in relation 
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to the development of dermal compartments (at embryonic level) and further 
regulation of hair follicle cycle after birth. 
 
The above work by Plikus et al (2008 and 2009) and Festa et al (2010) tries 
to answer questions about regulatory mechanisms crucial for the hair follicle cycle. 
Additional aspect of this work should be included where not only involvement of 
adipocytes in the hair follicle cycle takes place but also where the hair follicles are 
crucial for the proper development and maintenance of the dermal adipose tissue 
layer. Specific interactions between hair follicle end bulb cells and lower dermal cells 
could occur that activate fat cell differentiation in the lower dermal compartment. If 
such interactions are occurring, the question should be asked about the type of 
signals between skin cells that are crucial for development of different skin 
compartments. The follicle end bulb incorporates the dermal papilla (DP) and dermal 
sheath (DS) which are crucial for the controlling of hair growth and cycle (Chapter 1, 
section 1.1.3). In addition, the cultured cells from DP and DS are capable to 
differentiate into for example adipocytes (Jahoda et al, 2003). Maybe cells from hair 
follicle end bulbs are capable of “sending” signals to cells in lower dermis area, and 
controlling the “fatty” features of these lower dermis cells. The microarray data from 
dermal cells (presented in Chapter 3), together with information about proteins for 
example enriched and secreted by hair follicles could help to reveal a potential 
signalling pathways important for dermal adipose tissue development.  
 
Leptin - leptin receptor interactions between hair follicles end bulb and cells 
from lower dermis. 
Leptin is expressed abundantly by mature adipocytes and changes in its 
levels were correlated with obesity (Chapter 1, section 1.2.7). Leptin interacts 
through leptin receptors and was suggested to work in an autocrine way on animal 
adipocytes, however its influence was not observed on human adipocytes (from 
subcutaneous depots) (Aprath-Hausman et al; 2001).  In the dermis microarray data, 
presented in this thesis, expression of leptin receptor and leptin increases in lower 
dermis cells during mouse embryonic development (see Appendix XI). In addition, 
the leptin and leptin receptor were analysed in 14.5 day old murine fetus and their 
presence was observed in developing hair follicles (Hoggard et al; 1997). The 
presence of leptin (in the hair matrix and inner root sheath of the hair bulb) and 
leptin receptor in human hairs (papilla cells) was also reported (Iguchi et al; 2001). 
In addition, leptin and leptin receptor are also seen in the human epidermis 
(Poeggeler et al; 2010). Because of the localisation of leptin along the skin, a role of 
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leptin in hair development was suggested (Poeggeler et al; 2010). Based on the 
above mentioned literature and the presence of both leptin and leptin receptor 
genes in the microarray data, a suggestion can be made that leptin produced by the 
hair compartment may be influencing the cells from lower dermis (trough leptin 
receptors seen in these dermal cells) and take part in controlling adipogenesis in 
vivo in skin. Perhaps this occurs first (at embryonic level), where the leptin produced 
in hair structures influences the hair follicle development. Then, when skin is getting 
older, developed hairs (dermal papilla for example) secrete leptin to adjacent dermis 
cells which, as was shown by the microarray data, have up-regulation of the leptin 
receptor. Finally, as an effect of that interaction between e17 and e19, leptin from 
hair follicles influences adipogenesis in the lower dermis.  
 
Adiponectin and its localisation along the back skin. 
An interesting observation in this thesis was related to adiponectin 
expression in back skin samples. Based on the microarray study and the qRT-PCR 
verification work, Adipoq mRNA expression was up-regulated in lower dermis versus 
upper dermis and increased in lower dermis during mouse back skin development 
(Chapter 3, Table 3.4 and Figure 3.13B). When antibodies against AdipoQ were 
used, interestingly the expression of this protein was seen along the hair follicles in 
the very outer layer of hairs and in the upper as well as the lower dermis. This 
“confusing result” could be attributed to unspecific binding of the antibodies used. 
On the other hand there may be an explanation for such a protein expression 
pattern for adiponectin. Adiponectin, similarly to leptin is produced and secreted by 
mature adipocytes, and its level changes during obesity/diabetes and it can have an 
autocrine influence on fat cells (Dietze-Schroeder et al; 2005). In relation to skin, 
perhaps the adiponectin can be abundantly expressed by different compartments of 
the skin such as hair follicles (as with leptin, see above). The hairs will produce 
adiponectin and gradually secrete it to the adjacent dermal cells and this secretion 
takes part at least between e17 ad e19 (based on the staining presented in Chapter 
3, Figure 3.14). The dermis microarray data (DMD) showed that adiponectin 
receptors are up-regulated in lower dermis versus upper dermis in all analysed time 
points (Chapter 3, Table 3.7). Thus, maybe secreted AdipoQ from the outer layers of 
hairs interacts with adiponectin receptors present in lower dermal cells. This 
interaction (together with many other processes that control adipogenesis in vivo), 
activates preadipocytes to gradual differentiation and as a result of that, the 
dramatic increase of AdipoQ on mRNA level takes place in 18 and 19 day old 
embryonic lower skin dermis.  
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  Therefore there are at least two potential signalling pathways, leptin and 
AdipoQ, that might fit with the idea about signalling in back skin between hair follicle 
end bulbs and lower dermal cells and control of dermal adipose tissue development. 
The verification of such hypothesis could be carried for example in three 
dimensional spheres established from dermal cells at different embryonic 
developmental stages. These spheres could be treated with factors abundantly 
expressed by hair follicle end bulbs, for example adiponectin or/and leptin. In 
addition, the silencing (RNAi) of receptors in lower dermal cells that are specific for 
proteins secreted by end bulbs (adiponectin, leptin) could be performed before the 
treatment of these cells with a factor of interest. Then, the lipid accumulation 
capability of such spheres would be analysed. 
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6.3. Tracking the preadipocytes and adipocytes in vivo - why such 
analysis is important? 
 The basic knowledge about fat cell differentiation (adipogenesis) comes 
mainly from in vitro studies where many cell lines have been established and 
usefully used in order to track adipogenesis (for detailed description see Chapter 1, 
section 1.3). Despite these studies there is still a gap related with understanding the 
very early stages of adipogenesis in vivo. Especially now, when a suggestion was 
made that different fat depots may have different developmental origin and 
metabolic functions (Gesta et al, 2007).  
3T3 cells, have been used widely to track adipocyte differentiation from so 
called preadipocyte state (cells committed to be mature fat cells, but not 
accumulating lipids yet) to the development of adipocytes (mature fat cells with 
accumulated lipid droplets). However, several disadvantages can be pointed here in 
relation to the use of such cells. First of all, these cells developed from a Swiss cell 
line that was established by mincing whole mouse embryos between age 17 and 19 
(Green and Kehinde, 1974; Green and Meuth, 1974; Green and Kehinde, 1975; 
Green and Kehinde, 1976). Originally, these cells did not accumulate lipids and after 
some time in cell culture conditions, they gradually start to accumulate fat in a form 
of clusters, and from these cells 3T3-fat cells were derived.  In general, 3T3-L1 and 
3T3-F422A are widely known cell lines that undergo adipogenesis. As, these cells 
have not been derived from a particular fat depot, thus it seemed impossible to use 
this model for tracking differences in adipocyte differentiation processes that lead to 
a development of different fat depots. Next, these cells, although committed to 
adipogenesis, have to be “pushed” by adipogenic medium that activate whole 
cascade of changes in these cells and lead to the development of mature fat cells. 
Thus, it can not be said that all steps specifically occurring during adipogenesis in 
vitro, in these cells, represent exactly and truly the “real” processes that take part in 
live body. Finally, by keeping cells on artificial surfaces of culture dishes, these two-
dimensional cells are lacking the third dimension. That is not a case in the life body, 
where cells develop in all dimensions, have contact with other fat cells, and create 
three-dimensional fat organs. Also, during developmental processes in the body, a 
particular type of cell, tissue or organ is in close proximity to other type of cells, 
tissues and organs. The cell-cell interaction between different organs could be 
crucial for proper cell differentiation and development. For example, the epidermal-
dermal interactions lead to hairs development (Chapter 1, section 1.1.3.1). 
In addition, the adipose organ is known to have an endocrine function that 
influences other organs however the autocrine functions of several fat-secreted 
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proteins have been observed (reviewed by Kim and Moustaid-Moussa, 2000). This 
clearly suggests that for the proper development of adipocytes, signals from other 
fat cells (an maybe other type of cells) can be important during fat depot 
development. This suggestion could be difficult to verify by using for example, 3T3-
L1 or 3T3-F442A cell lines.  
All the above mentioned disadvantages of 3T3 cell lines show the need for 
developing in vivo approaches for the analysis of fat depots. Thus many mouse 
models have been set up, where for example crucial for early steps of adipogenesis 
genes have been silenced (Valet et al, 2002). Mouse models helped to track 
functions of particular genes in relation to for example abnormalities in fat depots 
occurrence or development of metabolic disorders. Interestingly for some of mouse 
knockouts (for example C/EBPs or PPARgamma) as well as changes in fat depots, 
a quick death (at birth, death in utero) occurs, which clearly shows that many crucial 
adipogenic processes take place at embryonic level and influences the whole body. 
However due to an early death of such mouse models, it is difficult to carry studies 
on very early stages of adipogenesis in vivo. In addition, the generation of a 
transgenic model seems to be a time consuming process and not always occupied 
by a quick and successful outcome.  
 
Thus, in this thesis an in vivo approach was developed to track not only 
adipocytes cells that are able to accumulate lipid but also preadipocytes during 
mouse back skin development. When the first signs of lipids were tracked in back 
skin (discussed in section 6.1), the investigation of a reliable in vivo marker for 
preadipocytes was performed (Chapter 2). As such a marker seemed not to be 
available for in vivo work so far, several in vitro adipogenic markers were tested, 
such as PPARgamma , Pref-1 and C/EBPalpha, widely associated with early stages 
of adipocyte differentiation (see Chapter 1, section 1.3). Only the antibody against 
C/EBPalpha allowed preadipocytes and adipocytes to be tracked in mouse 
embryonic skin, whereas other antibodies gave questionable results (Figures 2.12 – 
2.14). This could be a result of the antibodies not being appropriate for 
immunofluorescence technique used on skin sections, or an occurrence of 
differences between adipogenesis in vivo in skin dermis and adipocyte 
differentiation process observed in vitro in cell lines.  
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6.4. The microarray approach and gene expression profiles during 
mouse embryonic dermis development in vivo.  
 
Dermal adipocytes and dermal non-fatty cells. 
The microdissection technique together with the microarray approach 
permitted a detailed in vivo study (Chapter 3). Microarray data obtained from lower 
and upper dermal cells between e17 and e19 time points showed that during the 
late stages of embryonic development, the dermal cells differentiate into at least 
two-very specific cell populations, adipocytes and non-fatty cells. Therefore, dermis 
divided into two layers in adults (papillary localised below epidermis and lower 
reticular layer; see also section 1.1.2 in Chapter 1) undergoes also an earlier 
subdivision at embryonic level. Interestingly, these two cell types (adipocytes and 
non-fatty cells) with totally opposite features are developing in the same skin 
compartment and co-exist with each other. This observation seemed to be very 
important in relation to the analysis of mechanisms that control adipogenesis, fate of 
cells and “decide” how and when particular type of cell develops into a fat organ.  
 
In vivo versus in vitro adipogenesis. 
The comparison analysis of microarray data from developing lower dermal 
cells (in vivo adipocytes) with microarray-based studies on differentiating 3T3-L1 
cells (in vitro adipocytes), presented in sections 3.3.4 and 3.3.5 of Chapter 3, 
revealed a clear difference in a number and type of genes regulated at early stages 
of these in vivo and in vitro adipogenic differentiation processes. This difference can 
be due the fact that some of the processes so widely analysed in cell lines that 
undergo adipogenesis (3T3-L1 cells, reviewed by Gregoire et al, 1998) are effects of 
a treatment with adipogenic medium of two-dimensional cells that are removed from 
their normal environment (life body). Whereas the gene expression patterns 
observed in lower dermal cells from mouse embryonic back are real changes that 
take place in three dimensional cells present in their natural environment (life body). 
On the other hand, the in vivo analysis should, in future, be supplemented by similar 
microarray work on samples from 15 or 16 day old embryos that would verify the 
presence or absence of some genes not seen in the 17 to 19 day old mouse 
embryos.  
 
Dermal fat cell origin. 
As was mentioned in Chapter 1, it is still not clear about the origin of fat cells 
(Chapter 1, section 1.2.3). It is generally suggested that fat cells develops from 
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mesenchymal stem cells (MSCs), similar to muscles and bone (Billon et al; 2008, 
Gesta et al; 2007). Based on the work presented in this thesis, a suggestion can be 
made that adipocytes in lower dermis “share” developmental origin with dorsal 
mouse dermis. The dorsal dermis develops from so-called somites which are 
segmental units of the paraxial mesoderm (Olivera-Martinez et al; 2004). Therefore, 
it might be suggested that dermal adipose tissue, fully created after birth, originates 
from paraxial mesoderm. 
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6.5. Future study in relation to the dermis microarray data.  
The work presented in this thesis has opened a new direction in the analysis 
of skin compartments and interactions between all skin compartments that lead to 
development of the dermal fat layer. To the best of my knowledge such work that is 
giving insight into molecular processes in the embryonic dermis has never been 
presented before. Thus, it is important to think about future directions of this study 
that will produce increased knowledge about very early stages of adipogenesis in 
vivo and might help in better understanding mechanisms that control adipocyte 
differentiation in life body.  
 
Additional time points. 
Due to a fact that microarray data, generated during this PhD study, was 
obtained only from three time points (e17, e18 and e19), it could be crucial to 
perform and experiment, where dermal samples from other time points would be 
collected and used for the microarray analysis. By analyzing younger skin (e14, e15, 
e16), it might be possible to analyse the features of precursor cells that develop into 
preadipocytes and obtain information about very early stages of in vivo 
adipogenesis.  
 
Selection of genes from generated microarray data. 
 As was shown in Chapter 4, functional studies on selected genes (eg EGFR) 
from the dermal microarray data are crucial to verify the function of genes in early 
processes of adipogenesis in vivo. It was shown that the organ technique helps to 
maintain in vivo-like environment for skin and permits the influence of particular 
factors on the whole three-dimensional skin structure to be analysed. This 
environment is crucial for the function of skin and interactions between its 
compartments. Future work should try to analyse more genes selected from the 
microarray data. This work could be especially related to genes from the top/upper 
dermis that is characterised by the presence of genes involved in inhibition of 
adipogenesis. It could help to find a useful inhibitor of fat cell differentiation that 
either could prevent or help to treat the abnormalities related with excess 
accumulation of lipids. The organ culture work with fragments of back skin might be 
a good model for a preliminary verification of the influence of such genes (their 
products) on skin cell development and their capability to accumulate lipids. 
 
One future direction could be based on early FABP4 expression and its 
specific localisation in mouse back skin. The work presented in Chapter 3, showed 
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that FABP4 on both mRNA and protein level is highly up-regulated in lower skin 
dermis between e17 and e19 time points (Figure 3.10B and Figure 3.11). This fatty 
acid binding protein 4 binds and transports fatty acids and since its involvement in 
the development if insulin resistance has been suggested, and attempts are being 
made to find an efficient inhibitor of FABP4 (Suhre et al, 2011). The function of 
FABP4 in relation to the development of dermal adipose tissue can be analysed by 
the use of one of such suggested FABP4 inhibitors. For example, the influence of a 
selected FABP4 inhibitor (for example the small-molecule FABP4 inhibitor 
BMS309403 discussed by Suhre et al, 2011) could be analysed in relation to lipid 
accumulation on intact pieces of embryonic back skin (organ culture method from 
Chapter 4) or FACS-sorted CD36+ cells kept in 3D structures (that are highly 
expressing FABP4 and are suggested to represent lower dermal cells undergoing 
adipogenesis; see work presented in Chapter 5).  
As a further example of future experiments, the presence of FABP4 could be 
used for the analysis of function of other genes selected from a microarray data 
(Chapter 3). A transgenic animal could be obtained with a specific over-expression 
of a gene with high up-regulation in lower dermis (based microarray data; for 
example retinol binding protein 4; see Figure 3.10A in Chapter 3) under the FABP4 
promoter. In addition, this promoter could be used to drive over-expression in the 
lower dermis of a gene known to be highly up-regulated in upper dermis (also based 
on microarray data; for example gremlin 2; see Figure 3.18 in Chapter 3). This could 
allow for the expression of a selected gene in the lower dermis of embryonic skin 
and permit analysis of the role of the chosen gene in the inhibition/activation of 
adipogenesis in mouse embryonic dermal compartments.  
 
The further analysis of FACS-sorted dermis cells. 
In Chapter 5, the establishment of a fluorescence activated cell sorting 
(FACS) protocol to provide detailed analysis of dermal cell populations was 
described. This work showed that selected membrane protein could be an efficient 
marker for cells that undergo adipocyte differentiation in skin dermis. CD36+ positive 
cells were capable of accumulating lipids in normal medium. Then, the qRT-PCR 
analysis showed the up-regulation of fat-related genes in this cell population in 
comparison with negative (for CD36) sorted cells.  
It seems that the FACS tool may be useful in the further analysis of different 
embryonic dermal cell populations that are crucial for the proper development of 
skin compartments. This may give the possibility of analysing processes within 
these cells that are responsible for adipogenesis inhibition or activation. The FACS 
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allows cells to be collected that are committed to adipogenesis and by keeping them 
in 3D structures and incubating (or performing a silencing experiment with iRNA or 
overexpression work) using factors “picked” from the microarray data (for example 
highly up-regulated genes known to be related with obese and/or diabetic patients), 
it is possible to investigate what exactly controls adipogenesis in skin. This 
knowledge can then perhaps be used for the development of pharmaceuticals for 
treatment of fat-related disorders. 
 
6.6. To sum up. 
 To sum up, the work presented in this thesis may be a new beginning for the 
investigation of fat cell origin and development. It may help to understand 
mechanisms that inhibit and activate adipocyte differentiation in vivo in skin and in 
the long term may benefit with the treatments of disorders that are result of 
abnormal fat accumulation in the body. 
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Appendix I  
 
Reagents and working solutions. Part A. 
 
 
Immunofluorescence staining and the Oil Red O staining (reagents in alphabetical 
order): 
 
Calcium formal solution (100 ml)                               
(4% formaldehyde. 1% calcium chloride):    Prepare 100 ml of 4% formaldehyde 
(from 37% formaldehyde solution; 
Sigma) in H2O*. 
 Add calcium chloride (granular 
anhydrous; Sigma) to 4% formaldehyde 
to a final volume of 1%.   
 
Mowiol (Stock):                6 g  glycerol 
     2.4 g mowiol (mowiol 4-88) 
6 ml H2O* 
                                        12 ml 0.2 M Tris (pH 6.8) 
Leave stirring over-night at 37oC then 
leave for 10 min at 50oC. Centrifuge and 
add to a supernatant DABCO (1.4-
diazobicylo-(2.2.2)-octane) to final 
concentration of 2.5%. Aliquots (500 µl) 
kept in -20oC. 
 
4 % paraformaldehyde (100 ml):    Add slowly 4 g of paraformaldehyde 
(Sigma) to PBS (up to 100 ml) and warm 
it up (50 - 60oC) till it dissolves and is 
transparent. 
 
PBS - Phosphate buffered saline (5 liters): 40.00 g NaCl  
9.03 g Na2HPO4 2H2O or 7.2 g 
Na2HPO4  
        1.45 g KH2PO4  
       1.00 g KCl  
       Adjust pH to 7.4 
 Up to 5 liters of H2O* 
        
1.0 M Tris buffer; pH 6.8 (1 liter):  121.14 g Tris base 
      Adjust pH to 6.8 
Up to 1 liter of H2O* 
 
0.2 M Tris buffer; pH 6.8 (100 ml):  20 ml 1.0 M Tris (pH 6.8) 
      80 ml H2O*   
 
10X TBS (Stock; 1 liter):    24.23 g Trizma HCl 
80.06 g NaCl 
Adjust pH to 7.6  
Up to 1 liter of.H2O* 
 
0.5% TritonX-100 (100 ml):                          0.5 ml TritonX-100 (Sigma) 
up to 100 ml PBS 
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Reagents and working solutions. Part B. 
 
 
RNA and DNA work (reagents in alphabetical order): 
 
DEPC water:  Add appropriate amount of DEPC 
(diethylpyrocarbonate; Sigma) to miliQ 
water or H2O* in order to obtain conc. 
0.1%. Incubate overnight at room 
temperature and autoclave. 
  
DNA ladder (100 µl):                                    5 µl the stock ladder (1 Kb Plus DNA  
Ladder; conc. 1µg/µl; Invitrogen Life 
Technologies) 
                                                                     20 µl loading buffer 
                                                                     75 µl H2O* 
 
 
0.5 M EDTA (500 ml):   93.05 g EDTA sodium salt 
up to 500 ml of H2O* 
pH 8.0 
   
Loading Buffer:          15% Ficoll 
5 mM EDTA pH 8.0 
Bromophenol blue 
Made up in H2O* 
  
Or 
 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
30% glycerol in H2O* 
 
50 x TAE buffer - Stock buffer (1 liter):  242 g Tris base 
57.1 ml glacial acid acid 
100 ml 0.5 M EDTA (pH 8.0) 
up to 1 liter of H2O* 
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Reagents and working solutions. Part C. 
 
 
Reagents (in alphabetical order) for dermis splitting work: 
 
Collagenase II / DNase  I working solution:  Add approx. 3900 units of collagenase II 
(Worthington) and 100 µl of 1mg/ml 
DNase I into 15 ml of MEM-minimal 
essential medium (Sigma) with 
antibiotics: 2 µl/ml fungizone (Sigma) 
and 1 µl/ml gentamicyn (Gibco). 
 
1 mg/ml DNase I (Stock):     0.01 g DNase I (Roche) 
      10 ml DPBS (Gibco) 
      Mix slowly. 
 
6% pancreatin (100 ml):          Add 6 g of pancreatin (Sigma) to DPBS   
                                                                     (Gibco, up to 100 ml DPBS). 
Leave stirring over-night at 4oC. 
Centrifuge and collect supernatant. 
Aliquots (500 µl) kept in -20oC. 
Filter (0.2 µm syringe filter) before the     
use. 
 
5% trypsin (100 ml):               5 g trypsin (BD)  
                                                                      up to 100 ml DPBS (Gibco) 
Aliquots (500 µl) kept in -20oC. 
Filter (0.2 µm syringe filter) before the      
use. 
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Reagents and working solutions. Part D. 
 
 
Reagents for adipogenic medium (in alphabetical order): 
 
100 nM DEX (dexamethasone):  Prepared from 50 µM DEX (Sigma) and 
used for adipogenic medium. 
 
1 M IBMX (3-isobutyl-1-methylxanthine) (Stock no. 1):  
Dissolve 250 mg of IBMX (Sigma) in  
1.125 ml of DMSO (dimethyl sulfoxide; 
Sigma) (needs warming up). Aliquots 
(50 µl) kept in -20oC. Filter (0.2 µm 
syringe filter) before the use. 
 
0.1 M IBMX (3-isobutyl-1-methylxanthine) (Stock no. 2; 500 µl): 
      50 µl of 1 M IBMX Stock no. 1 
      450 µl of DMSO 
Stock no. 2 used for the 0.45 mM IBMX   
for adipogenic medium. 
 
5 mg/ml Insulin (Stock no. 1):   Dissolve 50 mg of Insulin (Sigma) in 10 
ml sterile water* (pH 2-3). Aliquots (50 
µl) kept in -20oC. Filter (0.2 µm syringe 
filter) before the use. 
 
207 µM Insulin (Stock no. 2; 1 ml):  237.2 µl 5 mg/ml Insulin Stock no. 1 
762.8 µl of MEM (with or without antib) 
Stock no. 2 used for the 2.07 µM Insulin 
for adipogenic medium. 
       
 
*Used water: distilled or double-distilled water 
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The mathematical calculation of the average diameter of lipid droplets. 
  
Lipid droplets were analysed in mouse skin dermis sections that were prepared from 
back skin specimens at different time-points (Figure 2.9). The diameter of lipid 
droplets was calculated according to length of the scale bar (30 µm = 93 pixels). 
 
 
 
                                            
                                    Length:   
Time-point: 
 
Pixels 
 
       
     µM 
 
27 8.709677 
18 5.806452 
0.5 day 
4 1.290323 
20 6.451613 
57 18.3871 
1 day 
122 39.35484 
100 32.25806 8 day 
99 31.93548 
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Appendix III 
 
Lipid accumulation in subcutaneous adipose tissue (SAT) and dermal adipose tissue 
(DAT) associated with back skin from 18.5 - 19 day old mouse embryo. 
 
 
Lipid accumulation in back skin section and fat depots beneath the skin from 18.5 - 
19 day old mouse embryo (18.5 - 19dE) was analysed by Oil Red O dye. 
Subcutaneous adipose tissue (SAT) is shown by blue arrow. Dermal adipose tissue 
(DAT) is shown by green arrows. Left panel: Scale bar = 300 µm. Right panels: 
Scale bar = 150 µm. Images were captured by Laser Capture Microdissection 
Microscope (PALM MicroBeam Zeiss Microscope). 
 
 
 
 
SAT 
DAT 
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Appendix IV 
 
Lipid accumulation in subcutaneous adipose tissue (SAT) and dermal adipose tissue 
(DAT) associated with back skin from half a day old newborn mouse. 
 
 
Lipid accumulation in back skin section with fat depots beneath the skin from 0.5 
day old newborn mouse (0.5dN) was analysed by Oil Red O dye. Subcutaneous 
adipose tissue (SAT) is shown by blue arrow. Dermal adipose tissue (DAT) is shown 
by green arrows. Left panel: Scale bar = 300 µm. Right panels: Scale bar = 150 µm. 
Images were captured by Laser Capture Microdissection Microscope (PALM 
MicroBeam Zeiss Microscope). 
 
 
SAT 
DAT 
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Appendix V 
 
Genes from microarray data associated with the Wnt signalling pathway by DAVID 
v6.7 programme.   
 
 
 
The WNT signalling pathway generated by KEGG database with underlined steps where 
genes from microarray sub-lists were present. The analysis was performed by DAVID v6.7 
programme. Steps underlined in red - genes from E18 UPPER sub-list; in blue - genes from 
E19 UPPER sub-list. The WNT signalling pathway was addapted from KEGG pathway 
website. 
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Appendix VI 
 
The full names of genes presented in Figures 3.27 - 3.55. For more details see 
section 3.3.4 in Chapter 3. 
 
Figure 
number: 
Gene 
symbol: 
Whole name: 
Rhob ras homolog gene family, member B 
Thbd thrombomodulin 
3.27 
Tsc22d1 TSC22 domain family, member 1 
Hspd1 heat shock protein 1 (chaperonin) 
Mafb v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B 
(avian) 
Mknk2 MAP kinase-interacting serine/threonine kinase 2 
Sphk1 sphingosine kinase 1 
Sdc1 syndecan 1 
Ank3 ankyrin 3, epithelial 
3.28 
Bcat1 branched chain aminotransferase 1, cytosolic 
Aqp1 aquaporin 1 
Cdc45l cell division cycle 45 homolog (S. cerevisiae)-like 
Ccnb1 cyclin B1 
Ccne2 cyclin E2 
Hells helicase, lymphoid specific 
Kpna2 karyopherin (importin) alpha 2 
Lmo4 LIM domain only 4 
Mcm5 minichromosome maintenance deficient 5, cell division cycle 46 (S. 
cerevisiae) 
Mcm7 minichromosome maintenance deficient 7 (S. cerevisiae) 
Mcm2 minichromosome maintenance deficient 2 mitotin (S. cerevisiae) 
Osmr oncostatin M receptor 
Pnp1 /// Pnp2 purine-nucleoside phosphorylase 1 /// purine-nucleoside phosphorylase 
2 
Kif20a kinesin family member 20A 
3.29 
Slbp stem-loop binding protein 
Glul glutamate-ammonia ligase (glutamine synthetase) 
Igfbp4 insulin-like growth factor binding protein 4 
3.30 
Gart phosphoribosylglycinamide formyltransferase 
Pex13 peroxisomal biogenesis factor 13 
Pparg peroxisome proliferator activated receptor gamma 
Phb prohibitin 
Pcx pyruvate carboxylase 
Nrip1 nuclear receptor interacting protein 1 
Scd1 stearoyl-Coenzyme A desaturase 1 
Timm23 translocase of inner mitochondrial membrane 23 homolog (yeast) 
Tob1 transducer of ErbB-2.1 
3.31 
Taldo1 transaldolase 1 
Tank TRAF family member-associated Nf-kappa B activator 
Slc19a1 solute carrier family 19 (sodium/hydrogen exchanger), member 1 
Fasn fatty acid synthase 
Ldhb lactate dehydrogenase B 
Me1 malic enzyme 1, NADP(+)-dependent, cytosolic 
Qk quaking 
Apoc1 apolipoprotein C-I 
Ddt D-dopachrome tautomerase 
Fah fumarylacetoacetate hydrolase 
Cbr3 carbonyl reductase 3 
Alad aminolevulinate, delta-, dehydratase 
Rab3d RAB3D, member RAS oncogene family 
Scarb1 scavenger receptor class B, member 1 
Itga6 integrin alpha 6 
3.32 
Hadh hydroxyacyl-Coenzyme A dehydrogenase 
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S3-12 plasma membrane associated protein, S3-12 
Rnf11 ring finger protein 11 
Bckdhb branched chain ketoacid dehydrogenase E1, beta polypeptide 
Cdkn2c cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 
Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 
Hipk2 homeodomain interacting protein kinase 2 
Cd1d1 CD1d1 antigen 
Dld dihydrolipoamide dehydrogenase 
Arl4a ADP-ribosylation factor-like 4A 
Scp2 sterol carrier protein 2, liver 
Nnmt nicotinamide N-methyltransferase 
Aoc2 /// Aoc3 amine oxidase, copper containing 2 (retina-specific) /// amine oxidase, 
copper containing 3 
Cfd complement factor D (adipsin) 
Bnip3 BCL2/adenovirus E1B interacting protein 3 
Thrsp thyroid hormone responsive SPOT14 homolog (Rattus) 
Lpl lipoprotein lipase 
Scd1 stearoyl-Coenzyme A desaturase 1 
Dgat2 diacylglycerol O-acyltransferase 2 
Hp haptoglobin 
Adipoq adiponectin, C1Q and collagen domain containing 
Dnm3 dynamin 3 
Fbn1 fibrillin 1 
Fbln2 fibulin 2 
Il6st interleukin 6 signal transducer 
3.33 
Ly6c1 /// Ly6c2 lymphocyte antigen 6 complex, locus C1 /// lymphocyte antigen 6 
complex, locus C2 
Emp3 epithelial membrane protein 3 
Ogn osteoglycin 
Pdpn podoplanin 
Pltp phospholipid transfer protein 
Twist2 twist homolog 2 (Drosophila) 
Vcl vinculin 
Tspan6 tetraspanin 6 
3.34 
Timp3 tissue inhibitor of metalloproteinase 3 
Dnm3 dynamin 3 
Cxcl1 chemokine (C-X-C motif) ligand 1 
H2-T10 /// H2-
T17 /// H2-T22 
/// H2-T9 
histocompatibility 2, T region locus 10 /// histocompatibility 2, T region locus 
17 /// histocompatibility 2, T region locus 22 /// histocompatibility 2, T region 
locus 9 
Thbs2 thrombospondin 2 
Vcam1 vascular cell adhesion molecule 1 
Cdkn2b cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 
Egr1 early growth response 1 
Fos FBJ osteosarcoma oncogene 
Gtpbp4 GTP binding protein 4 
Klf4 Kruppel-like factor 4 (gut) 
Anxa1 annexin A1 
3.35 
Acot10 /// 
Acot9 acyl-CoA thioesterase 10 /// acyl-CoA thioesterase 9 
Continuation of Appendix VI prom previous page. 
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Appendix VII 
 
Lipid detection in back skin specimens from 16 - 17 day old mouse embryos used 
for the hanging-drop organ culture experiment. 
 
 
 
 
a) Skin sample kept in control (normal growth) medium. b) Skin sample kept in 
medium with EGFR activator (EGF). c) and d) Skin samples kept in medium with 
EGFR inhibitor (AG1478). Incubation lasted 72 hours and skin sections were 
analysed by Oil Red O dye to detect lipids. (a - left panel, b - d) Scale bar = 65 µm 
(a - right panel) Scale bar = 30 µm. Images were captured using Zeiss Axio 
Imager.M1. microscope. 
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Appendix VIII 
 
Lipid detection in skin specimens from 15 - 15.5 and 18.5 - 19 day old mouse 
embryos used for the substrate organ culture experiment. 
 
                           a)  
 
 
 
 
 
 
                
 
 
 
 
 
                           b) 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
a) Skin sample from 15 - 15.5 day old mouse embryonic back skin kept in 
adipogenic medium. b) Skin sample from 18.5 - 19 day old mouse embryonic back 
skin kept in adipogenic medium. Incubation lasted 48 hours and skin sections were 
analysed by Oil Red O dye to detect lipids. (a) Scale bar = 65 µm. (b) Scale bar = 30 
µm. Images were captured using Zeiss Axio Imager.M1. microscope. 
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Appendix IX 
 
The analysis of lipid accumulation in 3D cell structures, obtained from human skin 
sample number 18_06. 
 
 
 
 
(*) Once spheres were established in a medium droplet, they were incubated in 
normal or adipogenic medium for 24 hours. Cell structures were stained with Oil Red 
O to detect lipids. FI - fibroblasts. DP - dermal papilla cells. Scale bar = 15 µm 
Images were captured using Zeiss Axio Imager.M1. microscope. 
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Appendix X 
 
Expression profiles of genes encoding calcium binding proteins in embryonic skin 
dermis, based on microarray data. For more details see section: Questions about 
white and brown fat cells in dermal adipose tissue (DAT), the thickness of DAT 
and about the hair follicle cycle. in Chapter 6. 
 
Table presented in Appendix X contains calcium binding proteins expression profiles in 
embryonic skin dermis between e17 and e19 time points. (A, B, C) The E17, E18 or E19 
microarray sub-lists revealed the enrichment of analysed genes at mRNA level in lower 
dermal cells versus upper dermal cells at e17, e18 or e19 time points. (D) The lower dermal 
(LD) microarray list showed the up-regulation of analysed gene in lower dermal cells from 
e17 time point. 
A) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e17 lower dermis vs* 
e17 upper dermis 
+ 4.363894 
 
e18 lower dermis vs* 
e18 upper dermis  
+ 4. 817356 
 
S100 calcium binding protein A16; 
S100a16; 
1447676_x_at 
 
 
e19 lower dermis vs* 
e19 upper dermis 
+ 6.481481 
 
B) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e17 lower dermis vs* 
e17 upper dermis 
NP** 
e18 lower dermis vs* 
e18 upper dermis  
+ 3.270873 
 
S100 calcium binding protein A14; 
S100a14; 
1449166_at 
 
 
e19 lower dermis vs* 
e19 upper dermis 
NP** 
 
C) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e17 lower dermis vs* 
e17 upper dermis 
NP** 
e18 lower dermis vs* 
e18 upper dermis  
+ 2.170815 
 
S100 calcium binding protein A10 
(calpactin); 
S100a10; 
1416762_at 
 
e19 lower dermis vs* 
e19 upper dermis 
NP** 
D) 
Whole name; 
gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
+ 2.632241 S100 calcium binding protein A10 
(calpactin); 
S100a10; 
1416762_at e19 lower dermis  
vs*  
e17 lower dermis 
+ 1. 699655 
* vs - versus 
** NP - gene not present in microarray list 
 416 
Appendix XI 
 
Expression profiles of genes encoding leptin and leptin receptor in embryonic skin 
dermis, based on microarray data. For more details see section: Leptin - leptin 
receptor interactions between hair follicles end bulb and cells from lower 
dermis. in Chapter 6. 
 
Table presented in Appendix XI contains leptin (A) and leptin receptor (B) expression profiles 
in embryonic lower skin dermis between e17 and e19 time points. The fold change values 
are based on the lower dermis (LD) microarray data. 
A) 
Whole name; gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
- 1.087906 Leptin; Lep;  
1422582_at 
e19 lower dermis  
vs  
e17 lower dermis 
+ 3.644211 
B) 
Whole name; gene symbol; 
probe set Affymetrix ID. 
Time points: 
 
Fold change value:  
 
e18 lower dermis 
vs*  
e17 lower dermis 
+ 6.40568 leptin receptor; Lepr; 
1425644_at 
e19 lower dermis  
vs  
e17 lower dermis 
+ 2.512982 
* vs - versus 
 
 
